LogoPeqSERPE
logoCabeceraNinos

Hemos leído sobre ... Artritis Inflamatorias

Última actualización: 18 noviembre 2024
 
Hemos leído...
OCTUBRE 2024

      • Hestetun SV, Rudsari HK, Jaholkowski P, Shadrin A, Haftorn KL, Andersen S, et al.
        Incidence and genetic risk of juvenile idiopathic arthritis in Norway by latitude.
        Arthritis Rheumatol. 2024 Oct 21. doi: 10.1002/art.43040. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39431377/

      • Dahlberg A, Tydén H, Jöud AS, Kahn F, Berthold E.
        Screening for comorbid autoimmune disease should be considered in children with ANA positive juvenile idiopathic arthritis - results from the south-Swedish juvenile idiopathic arthritis cohort.
        Pediatr Rheumatol Online J. 2024 Oct 19;22(1):92. doi: 10.1186/s12969-024-01030-x.
        https://pubmed.ncbi.nlm.nih.gov/39425228/

      • Milatz F, Pedersen MJ, Klotsche J, Liedmann I, Niewerth M, Hospach A, et al.
        Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort.
        Pediatr Rheumatol Online J. 2024 Oct 21;22(1):93. doi: 10.1186/s12969-024-01027-6.
        https://pubmed.ncbi.nlm.nih.gov/39434096/

SEPTIEMBRE 2024

      • Glerup M, Kessel C, Foell D, Berntson L, Fasth A, Myrup C, et al; Nordic Study Group of Paediatric Rheumatology (NoSPeR).
        Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort
        RMD Open. 2024 Sep 5;10(3):e004317. doi: 10.1136/rmdopen-2024-004317.
        https://pubmed.ncbi.nlm.nih.gov/39242113/ 

      • Abel D, Anderson D, Kallan MJ, Utidjian L, Burnham JM, Chang JC, et al.
        Assessing Methotrexate Adherence in Juvenile Idiopathic Arthritis Using Electronic Health Record-Linked Pharmacy Dispensing Data.
        Arthritis Care Res (Hoboken). 2024 Sep 23. doi: 10.1002/acr.25441. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39313474/

      • Vojinović J, Foeldvari I, Dehoorne J, Panaviene V, Susic G, Horneff G, et al; Paediatric Rheumatology International Trials Organisation (PRINTO).
        Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.
        Rheumatol Ther. 2024 Sep 12. doi: 10.1007/s40744-024-00703-z. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39264536/

      • Vega-Fernandez P, Rogers K, Avar-Aydin PO, Quinlan-Waters M, Huggins J, Brunner HI, Lovell DJ, et al.
        Validation of the ankle-specific pediatric arthritis ultrasound scoring system in children with juvenile idiopathic arthritis.
        Semin Arthritis Rheum. 2024 Sep 1;69:152545. doi: 10.1016/j.semarthrit.2024.152545. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39260231/

      • Snipaitiene A, Slegeryte A, Uktveris R, Sileikiene R, Jakucionis P, Baranauskaite A, Jankauskaite L.
        The importance of ultrasound examination in care of juvenile idiopathic arthritis patients: 9 months follow-up study.
        Front Pediatr. 2024 Sep 12;12:1414384. doi: 10.3389/fped.2024.1414384.
        https://pubmed.ncbi.nlm.nih.gov/39328590/

      • Costello A, Rasooly I, Weiss P.
        Rheum for Improvement? Delayed Diagnosis of Juvenile Idiopathic Arthritis: A Narrative Review.
        Arthritis Care Res (Hoboken). 2024 Sep 22. doi: 10.1002/acr.25438. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39308000/

      • Randell RL, Reeve BB, Weitzman ER, von Scheven E, Zigler CK, Li Z,  et al.
        Pain Interference in Juvenile Idiopathic Arthritis.
        J Rheumatol. 2024 Sep 18:jrheum.2024-0254. doi: 10.3899/jrheum.2024-0254. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39218453/

      • Gowda NC,Aggarwal A.
        Primary Immunodeficiencies: When is it not just "JIA".
        Best Pract Res Clin Rheumatol. 2024 Sep;38(3):101960. doi: 10.1016/j.berh.2024.101960.
        https://pubmed.ncbi.nlm.nih.gov/38851969/

      • Päkkilä TS, Seppälä TS, Vähäsalo P, Karttunen TJ.
        Histological synovitis score in juvenile idiopathic arthritis and other pediatric synovial inflammatory conditions
        Pathol Res Pract. 2024 Sep 12;263:155588. doi: 10.1016/j.prp.2024.155588. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39303406/

AGOSTO 2024

      • Brunner HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, Alexeeva E, Appenzeller S, et al; Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO).
        Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label, Phase III Study.ÇJ Rheumatol. 2024 Aug 15:jrheum.2024-0298. doi: 10.3899/jrheum.2024-0298. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39089836/

      • Jittawattanarat B, Charuvanij S, Tangcheewinsirikul S, Sukharomana M.
        Prevalence of HLA-B27, clinical characteristics and treatment outcomes in children with enthesitis-related arthritis.
        BMC Pediatr. 2024 Aug 30;24(1):555. doi: 10.1186/s12887-024-05032-2.
        https://pubmed.ncbi.nlm.nih.gov/39215234/

      • Kishimoto K, Asai S, Suzuki M, Sato R, Hasegawa J, Terabe K, Imagama S.
        Clinical features of juvenile onset ankylosing spondylitis in Japanese patients.
        Mod Rheumatol. 2024 Aug 29:roae065. doi: 10.1093/mr/roae065.
        https://pubmed.ncbi.nlm.nih.gov/39206863/

      • Mori M.
        Overview of the Treatment Goal, the Method of Evaluating Disease Activity/Physical Function, Activities of Daily Living, and Traditional Care for Systemic or Articular Juvenile Idiopathic Arthritis in Japan.
        Children (Basel). 2024 Aug 6;11(8):952. doi: 10.3390/children11080952.
        https://pubmed.ncbi.nlm.nih.gov/39201887/

      • Attuparambath S, Venkataraman S, Chanu AR, Handa G, Bagri N.
        A Cross-Sectional Study Assessing the Functional Status in Children With Juvenile Idiopathic Arthritis and Its Correlation With Their Quality of Life and Burden on Caregivers.
        Cureus. 2024 Aug 5;16(8):e66178. doi: 10.7759/cureus.66178.
        https://pubmed.ncbi.nlm.nih.gov/39233946/

      • Yiğit RE, Ulu K, Çağlayan Ş, Sözeri B.
        Real-life data of etanercept efficacy and safety in juvenile idiopathic arthritis: a 24-month retrospective study at a single center.
        Expert Opin Biol Ther. 2024 Aug;24(8):855-862. doi: 10.1080/14712598.2024.2388193.
        https://pubmed.ncbi.nlm.nih.gov/39088092/39088092/

      • Sidhique R, Bagri NK, Jana M, Pandey RM, Pandey S, Venkatesh P, et al.
        Disease Damage in Juvenile Idiopathic Arthritis.
        Indian J Pediatr. 2024 Aug 30. doi: 10.1007/s12098-024-05239-2.
        https://pubmed.ncbi.nlm.nih.gov/39212855/

      • Harris JG, Bingham CA, Vora SS, Yildirim-Toruner C, Batthish M, Bullock DR, et al.
        Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement
        Network.
        Front Pediatr. 2024 Aug 2;12:1434074. doi: 10.3389/fped.2024.1434074.
        https://pubmed.ncbi.nlm.nih.gov/39156025/

      • Mördrup K, Jungner JG, Broström E, Palmblad K, Bartholdson C.
        Benefits of a Juvenile Arthritis Support Program (JASP-1) for children recently diagnosed with Juvenile Idiopathic Arthritis and their parents.
        BMC Rheumatol. 2024 Aug 15;8(1):35. doi: 10.1186/s41927-024-00404-8.
        https://pubmed.ncbi.nlm.nih.gov/39143588/

      • Ohinmaa A, Wen J, Currie GR, Benseler SM, Swart JF, Vastert SJ, Yeung RSM,
        Marshall DA. Validation of the EQ-5D-Y-5L parent-proxy version among children with juvenile idiopathic arthritis.
        Qual Life Res. 2024 Aug 14. doi: 10.1007/s11136-024-03682-4.
        https://pubmed.ncbi.nlm.nih.gov/39141175/

      • Pandya J, Menino Rosenbluth LJ, Adams AB.
        Physical Activity and Sports for Children With Juvenile Idiopathic Arthritis.
        HSS J. 2024 Aug;20(3):409-415. doi: 10.1177/15563316241247828.
        https://pubmed.ncbi.nlm.nih.gov/39108443/

      • Saleh R, Sundberg E, Olsson M, Tengvall K, Alfredsson L, Kockum I, et al.
        Genetic association of antinuclear antibodies with HLA in JIA patients: a Swedish cohort study.
        Pediatr Rheumatol Online J. 2024 Aug 26;22(1):79. doi: 10.1186/s12969-024-01017-8.
        https://pubmed.ncbi.nlm.nih.gov/39187888/

      • Tang H, Zhong Y, Wu Y, Huang Y, Liu Y, Chen J, et al.
        Increased neutrophil extracellular trap formation in oligoarticular, polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis: biomarkers for diagnosis and disease activity.
        Front Immunol. 2024 Aug 9;15:1436193. doi: 10.3389/fimmu.2024.1436193.
        https://pubmed.ncbi.nlm.nih.gov/39185410/

      • Pudjihartono N, Ho D, O'Sullivan JM.
        Integrative analysis reveals novel insights into juvenile idiopathic arthritis pathogenesis and shared molecular pathways with associated traits.
        Front Genet. 2024 Aug 8;15:1448363. doi: 10.3389/fgene.2024.1448363.
        https://pubmed.ncbi.nlm.nih.gov/39175752/

      • Niibo P, Nikopensius T, Jagomägi T, Voog Ü, Haller T, Tõnisson N, et al.
        Genetic susceptibility to temporomandibular joint involvement in juvenile idiopathic arthritis.
        J Oral Rehabil. 2024 Aug 27. doi: 10.1111/joor.13834. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39192486/

      • Quilis N, Mesa-Del-Castillo Bermejo P, Boix P, Juanola O, Bernabeu P, Francés R, Andrés M.
        Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis.
        Pediatr Rheumatol Online J. 2024 Aug 1;22(1):69. doi: 10.1186/s12969-024-01006-x.
        https://pubmed.ncbi.nlm.nih.gov/39090751/

      • Haley EK, Barshad G, He A, Rice E, Sudman M, Thompson SD, et al.
        Using Functional Genomic Data in Monocytes/Macrophages and Genotyping to Nominate Disease-Driving Single Nucleotide Polymorphisms and Target Genes in Juvenile Idiopathic Arthritis.
        bioRxiv [Preprint]. 2024 Aug 19:2024.08.19.608312. doi: 10.1101/2024.08.19.608312.
        https://pubmed.ncbi.nlm.nih.gov/39229078/
JULIO 2024

      • Brunner HI, Akikusa JD, Al-Abadi E, Bohnsack JF, Boteanu AL, Chedeville G, Cuttica R, De La Pena W, Jung L, Kasapcopur O, Kobusinska K, Schulert GS, Neiva C, Rivas-Chacon R, Rizo Rodriguez JC, Vazquez-Del Mercado M, Wagner-Weiner L, Weiss JE, Wouters C, Posner H, Wouters A, Chang C, White C, Kanik K, Liu S, Martini A, Lovell DJ, Ruperto N.
        Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthrtis: preliminary results of an open-label, long-term extension study.
        Ann Rheum Dis. 2024 Jul 20:ard-2023-225094. doi: 10.1136/ard-2023-225094. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/38849152/

      • Weiss PF, Brandon TG, Aggarwal A, Burgos-Vargas R, Colbert RA, Horneff G, et al.
        Classification Criteria for Axial Disease in Youth with Juvenile Spondyloarthritis.
        Arthritis Rheumatol. 2024 Jul 22. doi: 10.1002/art.42959. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/39039899/

      • Balay-Dustrude E, Weiss JE, Goh YI, Rubin N, Bullock DR.
        Intra-articular corticosteroid utilization and characterizations of use in juvenile idiopathic arthritis within the PR-COIN registry.
        Front Pediatr. 2024 Jul 23;12:1423362. doi: 10.3389/fped.2024.1423362. 
        https://pubmed.ncbi.nlm.nih.gov/39108690/

      • Migowa AN, Hamdi W, Hashad S, Etayari H, Abushhaiwia A, Ferjani H, et al.
        Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry.
        Pediatr Rheumatol Online J. 2024 Jul 22;22(1):67. doi: 10.1186/s12969-024-01000-3.
        https://pubmed.ncbi.nlm.nih.gov/39039515/

      • Baggett KH, Brandon TG, Xiao R, Weiss PF.
        Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study.
        J Rheumatol. 2024 Jul 1;51(7):708-714. doi: 10.3899/jrheum.2023-1203.
        https://pubmed.ncbi.nlm.nih.gov/38561193/

      • Naddei R, Ridella F, Bovis F, Trincianti C, Avrusin I, Januskeviciute G, Burrone M, Rebollo-Giménez A, Minden K, Ekelund M, Barone P, Rumba-Rozenfelde I, Shafaie N, Swart JF, Ruperto N, Ravelli A, Consolaro A; Pediatric Rheumatology International Trials Organization (PRINTO).
        Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score.
        Rheumatology (Oxford). 2024 Jul 4:keae326. doi: 10.1093/rheumatology/keae326. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/38964350/

      • Schmidt T, Mossberg A, Berthold E, Król P, Linge P, Bengtsson AA, Kahn F, Månsson B, Kahn R.
        Synovial fibroblasts from children with oligoarticular juvenile idiopathic arthritis induce migration and prolong viability of neutrophils.
        Front Pediatr. 2024 Jul 3;12:1376371. doi: 10.3389/fped.2024.1376371.
        https://pubmed.ncbi.nlm.nih.gov/39022217/

JUNIO 2024

      • Balay-Dustrude E, Weiss NS, Sutton A, Shenoi S.
        Predictors of Disease Activity in Patients With Juvenile Idiopathic Arthritis at 12 and 24 Months After Diagnosis.
        ACR Open Rheumatol. 2024 Jun 17. doi: 10.1002/acr2.11701. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/38885948/

      • Polat MC, Çelikel E, Tekin ZE, Kurt T, Kaplan MM, Güngörer V, et al.
        When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?
        Eur J Pediatr. 2024 Jun;183(6):2725-2731. doi: 10.1007/s00431-024-05538-y.
        https://pubmed.ncbi.nlm.nih.gov/38554171/

      • Kearsley-Fleet L, Baildam E, Beresford MW, Douglas S, Foster HE, Southwood TR, Hyrich KL; UK JIA Biologics Register.
        Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study.
        Lancet Rheumatol. 2024 Jun 3. doi: 10.1016/S2665-9913(24)00087-0. Epub ahead of print
        https://pubmed.ncbi.nlm.nih.gov/38843858/

      • Brunner HI, Schulert GS, Sproles A, Thornton S, Cornejo GV, Antón J, et al; Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO).
        S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.
        Arthritis Res Ther. 2024 Jun 25;26(1):125. doi: 10.1186/s13075-024-03347-0.
        https://pubmed.ncbi.nlm.nih.gov/38918871/

      • Di Donato G, Attanasi M, Mariarita d' Angelo D, La Bella S, Di Ludovico A, Chiarelli F, Breda L.
        Associations of C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with disease activity in patients with juvenile idiopathic arthritis.
        BMC Rheumatol. 2024 Jun 17;8(1):26. doi: 10.1186/s41927-024-00390-x.
        https://pubmed.ncbi.nlm.nih.gov/38886765/

      • Ferrillo M, Gallizzi R, Marotta N, Longo UG, Spagnolo A, Ammendolia A, Giudice A, de Sire A.
        Temporomandibular joint rehabilitative approaches for children and adolescents affected by juvenile idiopathic arthritis: A systematic review.
        Int J Paediatr Dent. 2024 Jun 11. doi: 10.1111/ipd.13225. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/38863137/

MAYO 2024

      • Tharwat S, Nassar MK, Salem KM, Nassar MK.
        Extraarticular manifestations of juvenile idiopathic arthritis and their impact on health-related quality of life.
        Clin Rheumatol. 2024 May 26. doi: 10.1007/s10067-024-07008-0. Epub ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/38797812/

      • Marino A, Baldassarre P, Ferrigno C, Biuso A, Minutoli M, Baldo F, et al.
        Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic Arthritis.
        Children (Basel). 2024 May 16;11(5):600. doi: 10.3390/children11050600.
        https://pubmed.ncbi.nlm.nih.gov/38790595/

      • van Dijk BT, Bergstra SA, van den Berg JM, Schonenberg-Meinema D, van Suijlekom-Smit LWA, van Rossum MAJ, et al.
        Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.
        Pediatr Rheumatol Online J. 2024 May 10;22(1):53. doi: 10.1186/s12969-024-00989-x.
        https://pubmed.ncbi.nlm.nih.gov/38730442/
      • Möhlmann JE, de Roock S, Egas AC, Weijden ET, Doeleman MJH, Huitema ADR, et al
        Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay.
        Pediatr Rheumatol Online J. 2024 May 7;22(1):52. doi: 10.1186/s12969-024-00988-y.
        https://pubmed.ncbi.nlm.nih.gov/38715014/
      • Choong N, Batthish M, Berard RA, Chédeville G, Feldman BM, Houghton KM, Huber AM, James S, Proulx-Gauthier JP, Rumsey DG, Schmeling H, Toupin-April K, Guzman J; CAPRI Registry Investigators.
        The Relationship of Fatigue, Pain Interference and Physical Disability in Children Newly Diagnosed with Juvenile Idiopathic Arthritis.
        Arthritis Care Res (Hoboken). 2024 May 20. doi: 10.1002/acr.25377.
        https://pubmed.ncbi.nlm.nih.gov/38769616/

      • Fusama M, Nakahara H, Miyamae T, Mori M, Urata Y, Kawahata K, et al.
        Challenges Nurses Face in Providing Care for Patients with Juvenile Idiopathic Arthritis.
        Mod Rheumatol. 2024 May 6:roae041. doi: 10.1093/mr/roae041.
        https://pubmed.ncbi.nlm.nih.gov/38722031/

ABRIL 2024

      • Sener S, Aliyev E, Batu ED, Balik Z, Bayindir Y, Cam V, Basaran O, Bilginer Y, Ozen S.
        Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.
        Clin Rheumatol. 2024 Apr 29. doi: 10.1007/s10067-024-06925-4. Online ahead of print.
        https://pubmed.ncbi.nlm.nih.gov/38683443/

      • Milatz F, Klotsche J, Niewerth M, Sengler C, Windschall D, Kallinich T, et al.
        Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening.
        arthritis Res Ther. 2024 Apr 10;26(1):82. doi: 10.1186/s13075-024-03312-x.
        https://pubmed.ncbi.nlm.nih.gov/38600543/

      • Costello A, Twilt M, Lerman MA; CARRA Registry Investigators.
        Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database.
        Pediatr Rheumatol Online J. 2024 Apr 8;22(1):41. doi: 10.1186/s12969-024-00968-2.
        https://pubmed.ncbi.nlm.nih.gov/38589909/

MARZO 2024

      • Shenoi S, Horneff G, Aggarwal A, Ravelli A.
        Treatment of non-systemic juvenile idiopathic arthritis.
        Nat Rev Rheumatol. 2024 Mar;20(3):170-181. doi: 10.1038/s41584-024-01079-8. 
        https://pubmed.ncbi.nlm.nih.gov/38321298/

      • Zajc Avramovič M, Toplak N, Markelj G, Emeršič N, Avčin T
        Long-term follow-up of 109 children with juvenile idiopathic oligoarthritis after first intra-articular corticosteroid injection.
        Arthritis Res Ther. 2024 Mar 14;26(1):69. doi: 10.1186/s13075-024-03303-y.
        https://pubmed.ncbi.nlm.nih.gov/38486285/

      • Rypdal V, Glerup M, Rypdal M, Arnstad E, Aalto K, Berntson L, et al. ; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
        Disease activity trajectories from childhood to adulthood in the population-based Nordic juvenile idiopathic arthritis cohort.
        RMD Open. 2024 Mar 8;10(1):e003759. doi: 10.1136/rmdopen-2023-003759.
        https://pubmed.ncbi.nlm.nih.gov/38458760/

      • Cetrelli L, Lundestad A, Gil EG, Fischer J, Halbig J, Frid P, Angenete O, et al.
        Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis-an explorative cross-sectional study.
        Pediatr Rheumatol Online J. 2024 Mar 9;22(1):36. doi: 10.1186/s12969-024-00972-6.
        https://pubmed.ncbi.nlm.nih.gov/38461338/

      • Sande NK, Kirkhus E, Lilleby V, Tomterstad AH, Aga AB, Flatø B, Bøyesen P.
        Validity of an ultrasonographic joint-specific scoring system in juvenile idiopathic arthritis: a cross-sectional study comparing ultrasound findings of synovitis with whole-body magnetic resonance
        maging and clinical assessment.
        RMD Open. 2024 Mar 1;10(1):e003965. doi: 10.1136/rmdopen-2023-003965.
        https://pubmed.ncbi.nlm.nih.gov/38428979/

      • Collin M, Christidis N, Hagelberg S, Arvidsson LZ, Larheim TA, Ernberg M, et al.
        Temporomandibular involvement in children and adolescents with juvenile idiopathic arthritis: a 2-year prospective cohort study.
        Sci Rep. 2024 Mar 6;14(1):5512. doi: 10.1038/s41598-024-56174-3.
        https://pubmed.ncbi.nlm.nih.gov/38448491/

FEBRERO 2024

    • Tan J, Renton WD, Whittle SL, Takken T, Johnston RV, Tiller G, et al.
      Methotrexate for juvenile idiopathic arthritis.
      Cochrane Database Syst Rev. 2024 Feb 9;2(2):CD003129. doi: 10.1002/14651858.CD003129.pub2.
      https://pubmed.ncbi.nlm.nih.gov/38334147/

    • Lokhandwala S, Townsend J, Ciurtin C.
      Existing and Emerging Targeted Therapies in Juvenile Psoriatic Arthritis: Challenges and Unmet Needs.
      Paediatr Drugs. 2024 Feb 4. doi: 10.1007/s40272-023-00618-2.
      https://pubmed.ncbi.nlm.nih.gov/38310623/

    • Fan J, Li X, Yang J, Zhang S, Qu H, Ji D, et al.
      Revealing Novel Genomic Insights and Therapeutic Targets for Juvenile Idiopathic Arthritis through Omics. Rheumatology (Oxford).
      2024 Feb 5:keae078. doi: 10.1093/rheumatology/keae078.
      https://pubmed.ncbi.nlm.nih.gov/38317060/

    • Sabounji MM, Ndiaye A, Diallo S.
      Profile of HLA-B27-positive enthesitis/spondylitis-related arthritis in Senegal, West Africa.
      Pediatr Rheumatol Online J. 2024 Feb 29;22(1):31. doi: 10.1186/s12969-024-00969-1.
      https://pubmed.ncbi.nlm.nih.gov/38424655/

    • Dimitrijevic Carlsson A, Wahlund K, Kindgren E, Frodlund M, Alstergren P.
      Increase in stress contributes to impaired jaw function in juvenile idiopathic arthritis: a two-year prospective study.
      Pediatr Rheumatol Online J. 2024 Feb 26;22(1):30. doi: 10.1186/s12969-024-00966-4.
      https://pubmed.ncbi.nlm.nih.gov/38409027/

    • Avery CN, Russell ND, Steely CJ, Hersh AO, Bohnsack JF, Prahalad S, Jorde LB.
      Shared genomic segments analysis identifies MHC class I and class III molecules as genetic risk factors for juvenile idiopathic arthritis.
      HGG Adv. 2024 Feb 18;5(2):100277. doi: 10.1016/j.xhgg.2024.100277.
      https://pubmed.ncbi.nlm.nih.gov/38369753/

    • Hernández-Huirache HG, Armenta-Medina D, Rodea-Montero ER. Clinical,
      Immunological and Inflammatory Characteristics among Mexican Children with Different Subtypes of Juvenile Idiopathic Arthritis: Exploring the Correlation between Anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF).
      Pediatr Rep. 2024 Feb 7;16(1):151-162. doi: 10.3390/pediatric16010014.
      https://pubmed.ncbi.nlm.nih.gov/38391002/

    • Starkhammar Johansson C, Dimitrijevic Carlsson A, Wahlund K, Alstergren P.
      Periodontal Health in Children with Juvenile idiopathic arthritis.
      Eur J Paediatr Dent. 2024 Feb 1;25:1. doi: 10.23804/ejpd.2024.1913. PMID: 38353519.
      https://pubmed.ncbi.nlm.nih.gov/38353519/

    • Sequeira SB, McCormick BP, Hasenauer MD, McKinstry R, Ebert F, Boucher HR.
      Juvenile Idiopathic Arthritis is Associated With Early Medical and Surgical Complications Following Primary Total Hip Arthroplasty: A National Database Study.
      Arthroplast Today. 2024 Feb 5;26:101289. doi: 10.1016/j.artd.2023.101289.
      https://pubmed.ncbi.nlm.nih.gov/38344442/

    • Butler S, Sculley D, Santos D, Girones X, Singh-Grewal D, Coda A.
      Using Digital Health Technologies to Monitor Pain, Medication Adherence and Physical Activity in Young People with Juvenile Idiopathic Arthritis: A Feasibility Study.
      Healthcare (Basel). 2024 Feb 2;12(3):392. doi: 10.3390/healthcare12030392.
      https://pubmed.ncbi.nlm.nih.gov/38338277/

    • Kim D, Song J, Mancuso N, Mangul S, Jung J, Jang W.
      Large-scale integrative analysis of juvenile idiopathic arthritis for new insight into its pathogenesis.
      Arthritis Res Ther. 2024 Feb 10;26(1):47. doi: 10.1186/s13075-024-03280-2.
      https://pubmed.ncbi.nlm.nih.gov/38336809/

    • Tuomi AK, Rebane K, Arnstad ED, Berntson L, Fasth A, Glerup M, et al.
      Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2024 Feb 2;22(1):25. doi: 10.1186/s12969-023-00931-7.
      https://pubmed.ncbi.nlm.nih.gov/38308280/

ENERO 2024

    • Shoop-Worrall SJ, Macintyre VG, Ciurtin C, Cleary G, McErlane F, Wedderburn LR; Childhood Arthritis Prospective Study (CAPS) Principle Investigators; Hyrich KL.
      Overlap of ILAR and Preliminary PRINTO Classification Criteria for Non-Systemic Juvenile Idiopathic Arthritis in an Established UK Cohort: Results from the Childhood Arthritis Prospective Study.
      Arthritis Care Res (Hoboken). 2024 Jan 11. doi: 10.1002/acr.25296. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/38212149/

    • Vojinović J, Foeldvari I, Dehoorne J, Panaviene V, Susic G, Horneff G, et al.
      Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.
      Rheumatology (Oxford). 2024 Jan 4;63(1):140-148. doi: 10.1093/rheumatology/kead183.
      https://pubmed.ncbi.nlm.nih.gov/37140539/

    • Lovell DJ, Tzaribachev N, Henrickson M, Simonini G, Griffin TA, Alexeeva E, et al.
      Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
      Rheumatology (Oxford). 2024 Jan 18:keae025. doi: 10.1093/rheumatology/keae025. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/38243722/

    • Milatz F, Albrecht K, Minden K, Marschall U, Klotsche J, Callhoff J.
      Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data.
      Pediatr Rheumatol Online J. 2024 Jan 5;22(1):10. doi: 10.1186/s12969-023-00948-y.
      https://pubmed.ncbi.nlm.nih.gov/38183044/

    • Mazzoni A, Annunziato F, Maggi L.
      T lymphocytes-related cell network in the pathogenesis of juvenile idiopathic arthritis: a key point for personalized treatment.
      Curr Opin Rheumatol. 2024 Jan 1;36(1):40-45. doi: 10.1097/BOR.0000000000000991.
      https://pubmed.ncbi.nlm.nih.gov/37905987/

 
DICIEMBRE 2023

    • Costi S, Armiraglio E, Pregnolato F, Chighizola CB, Marino A, Randelli PS, et al.
      Diagnostic and prognostic role of synovial tissue analysis in juvenile idiopathic arthritis: a monocentric study.
      RMD Open. 2023 Dec 14;9(4):e003296. doi: 10.1136/rmdopen-2023-003296.
      https://pubmed.ncbi.nlm.nih.gov/38097272/

    • Antón J, Moreno Ruzafa E, Lopez Corbeto M, Bou R, Sánchez Manubens J, Carriquí Arenas S, et al.
      Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.
      J Health Econ Outcomes Res. 2023 Dec 20;10(2):141-149. doi: 10.36469/001c.85088.
      https://pubmed.ncbi.nlm.nih.gov/38145114/

    • Krarup H, Pedersen TK, Frid P, Nørholt SE.
      Long-Term Follow-Up of Orthognathic Surgery in 19 Patients with Juvenile Idiopathic Arthritis.
      J Oral Maxillofac Res. 2023 Dec 31;14(4):e4. doi: 10.5037/jomr.2023.14404.
      https://pubmed.ncbi.nlm.nih.gov/38222878/

    • Polat MC, Çelikel E, Tekin ZE, Güngörer V, Kurt T, Tekgöz N, et al.
      Assessment of quality of life and physical activity in patients with oligoarticular juvenile idiopathic arthritis in remission.
      Eur J Pediatr. 2023 Dec 10. doi: 10.1007/s00431-023-05367-5. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/38071637/

    • Bingham CA, Harris JG, Qiu T, Gilbert M, Vora SS, Yildirim-Toruner C, et al.
      Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis.
      Arthritis Care Res (Hoboken). 2023 Dec;75(12):2442-2452. doi: 10.1002/acr.25168.
      https://pubmed.ncbi.nlm.nih.gov/37308458/

    • Lato-Kariakin E, Kuźnik-Trocha K, Gruenpeter A, Komosińska-Vassev K, Olczyk K, Winsz-Szczotka K.
      Investigation of Glycosaminoglycans in Urine and Their Alteration in Patients with Juvenile Idiopathic Arthritis.
      Biomolecules. 2023 Dec 2;13(12):1737. doi: 10.3390/biom13121737.
      https://pubmed.ncbi.nlm.nih.gov/38136608/

NOVIEMBRE 2023

    • Gheshlaghi N, Thomas M, Trehan N, Harrison M, De Vera MA.
      Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of juvenile idiopathic arthritis in Canada: a scoping review.
      Pediatr Rheumatol Online J. 2023 Nov 6;21(1):134. doi: 10.1186/s12969-023-00917-5.
      https://pubmed.ncbi.nlm.nih.gov/37932754/

    • Knieper AM, von Stuckrad ASL, Minden K, Goetzke CC, Kallinich T.
      Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis.
      Z Rheumatol. 2023 Nov 3. German. doi: 10.1007/s00393-023-01442-2.
      https://pubmed.ncbi.nlm.nih.gov/37921883/

    • Ronsivalle V, Marrapodi MM, Tirupathi S, Afnan L, Cicciù M, Minervini G.
      Prevalence of temporomandibular disorders in juvenile idiopathic arthritis evaluated with diagnostic criteria for temporomandibular disorders: A systematic review with meta-analysis.
      J Oral Rehabil. 2023 Nov 27. doi: 10.1111/joor.13625.
      https://pubmed.ncbi.nlm.nih.gov/38012098/

    • Halbig JM, Jönsson B, Gil EG, Åstrøm AN, Rypdal V, Frid P, Augdal TA, Fischer J, Cetrelli L, Rygg M, Lundestad A, Tylleskär K, Nordal E;
      Norwegian JIA Study – Temporo-mandibular Involvement, Oral Health, Uveitis, Bone Health, Quality of Life in Children with Juvenile Idiopathic Arthritis. Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis - a prospective multicenter cohort study.
      BMC Oral Health. 2023 Nov 20;23(1):895. doi: 10.1186/s12903-023-03510-0.
      https://pubmed.ncbi.nlm.nih.gov/37986155/

    • Valenzise M, D'Amico F, Tripodi E, Zirilli G, Alibrandi A, Gallizzi R, Sutera D, Cafarella G, Lugarà C, Wasniewska MG.
      Thyroid function in pediatric patients with juvenile idiopathic arthritis.
      Endocrine. 2023 Nov 20. doi: 10.1007/s12020-023-03600-7
      https://pubmed.ncbi.nlm.nih.gov/37982947/

    • Gicchino MF, Marzuillo P, Melone R, Zarrilli S, Miraglia Del Giudice E, Olivieri AN, Di Sessa A.
      The dual role of body mass index on Juvenile Idiopathic Arthritis course: a pediatric experience.
      Eur J Pediatr. 2023 Nov 28. doi: 10.1007/s00431-023-05348-8.
      https://pubmed.ncbi.nlm.nih.gov/38015262/ 
 
OCTUBRE 2023

    • Nguyen K, Barsalou J, Basodan D, Batthish M, Benseler SM, Berard RA, et al; ReACCh-Out and CAPRI Registry Investigators.
      A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
      Rheumatology (Oxford). 2023 Oct 18:kead560. doi: 10.1093/rheumatology/kead560. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37851400/

    • d'Angelo DM, Attanasi M, Di Donato G, Lapergola G, Cannataro G, Flacco M, et al.
      Serum calprotectin and joint ultrasound in the definition of disease relapse in non-systemic juvenile idiopathic arthritis: a prospective longitudinal study.
      Clin Exp Rheumatol. 2023 Oct 13. doi: 10.55563/clinexprheumatol/qumh2o. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37877377/

    • McErlane F, Boeri M, Bussberg C, Cappelleri JC, Germino R, Stockert L, et al.
      Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment.
      Pediatr Rheumatol Online J. 2023 Oct 21;21(1):129. doi: 10.1186/s12969-023-00906-8.
      https://pubmed.ncbi.nlm.nih.gov/37865801/

    • Vassis S, Resnick CM, Nørgaard M, Strawn KM, Grove H, Noeldeke B, et al
      Impact of physiotherapy on orofacial manifestations of juvenile idiopathic arthritis
      Pediatr Rheumatol Online J. 2023 Oct 12;21(1):116. doi: 10.1186/s12969-023-00900-0.
      https://pubmed.ncbi.nlm.nih.gov/37828517/

 
AGOSTO 2023

    • Kaplan MM, Kurt T, Polat MC, Sezer M, Ekici Tekin Z, Çelikel E, et al.
      Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication.
      Eur J Pediatr. 2023 Aug 1. doi: 10.1007/s00431-023-05123-9. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37526705/

    • Loredo C, Yañez P, Hernández-Díaz C, Cruz-Arenas E, Ventura-Ríos L.
      Low prevalence of subclinical synovitis in patients with juvenile idiopathic arthritis (JIA) in long-term clinical remission on medication.
      Clin Rheumatol. 2023 Aug 5. doi: 10.1007/s10067-023-06729-y. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37542584/

    • Gupta A.
      Serum Calprotectin in Juvenile Idiopathic Arthritis: A Hope or Hype?
       Indian J Pediatr. 2023 Aug 17. doi: 10.1007/s12098-023-04803-6. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37587382/

    • Zulian F, Pierobon B, Zannin ME, Politi C, Vittadello F, Meneghel A, Tirelli F, Martini G.
      Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study.
      Pediatr Rheumatol Online J. 2023 Aug 10;21(1):81. doi: 10.1186/s12969-023-00869-w.
      https://pubmed.ncbi.nlm.nih.gov/37563674/

    • Spekking K, Anink J, de Boer P, Bergstra SA, van den Berg JM, Schonenberg-Meinema D, et al.
      Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up
      Pediatr Rheumatol Online J. 2023 Aug 26;21(1):90. doi: 10.1186/s12969-023-00874-z.
      https://pubmed.ncbi.nlm.nih.gov/37633893/

    • Wu P, Huang C, Liao PF, Ruperto N, Zeng H.
      Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis.
      Int J Rheum Dis. 2023 Aug 11. doi: 10.1111/1756-185X.14845. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37563978/

    • Siu WHS, Wang CJ, Wu CT, Wu CY, Ou LS.
      C1-C2 subluxation in enthesitis-related arthritis: two case reports and literature review of ten cases.
      Pediatr Rheumatol Online J. 2023 Aug 3;21(1):77. doi: 10.1186/s12969-023-00862-3.
      https://pubmed.ncbi.nlm.nih.gov/37537687/

    • Sapountzi E, Tsinopoulou VR, Kotanidou EP, Giza S, Galli-Tsinopoulou A.
      Coexistence of Autoimmune Thyroiditis and Juvenile Idiopathic Arthritis
      Cureus. 2023 Aug 30;15(8):e44384. doi: 10.7759/cureus.44384. eCollection 2023 Aug.
      https://pubmed.ncbi.nlm.nih.gov/37654906/

    • Ribeiro SCCR, Sales LP, Fernandes AL, Perez MO, Takayama L, Caparbo VF, et al. 
       Bone erosions associated with systemic bone loss on HR-pQCT in women with long standing polyarticular juvenile idiopathic arthritis
      Semin Arthritis Rheum. 2023 Aug 5;63:152247. doi: 10.1016/j.semarthrit.2023.152247. Online ahead of print.
    • https://pubmed.ncbi.nlm.nih.gov/37595510/

    • Zhao WJ, Deng JH, Li CF.
      Lipid profiles in patients with juvenile idiopathic arthritis: a systematic literature review and meta-analysis.
      Lipids Health Dis. 2023 Aug 25;22(1):136. doi: 10.1186/s12944-023-01885-1. Erratum in: Lipids Health Dis. 2023 Sep 8;22(1):148.
      https://pubmed.ncbi.nlm.nih.gov/37626321/

    • Hestetun S, Andersen S, Sanner H, Størdal K.
    • Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study
    • RMD Open. 2023 Aug;9(3):e003333. doi: 10.1136/rmdopen-2023-003333.
    • https://pubmed.ncbi.nlm.nih.gov/37648397/

    • Ozer Y, Yildiz M, Turan H, Tarcin G, Bingol Aydin D, Gunalp A, et al.
      Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
      Clin Rheumatol. 2023 Aug 30. doi: 10.1007/s10067-023-06747-w. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37646858/

    • Chaplin H, Bosworth A, Simpson C, Wilkins K, Meehan J, Nikiphorou E, Moss-Morris R, Lempp H, Norton S.
      Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process.
      PLoS One. 2023 Aug 9;18(8):e0289760. doi: 10.1371/journal.pone.0289760.
      https://pubmed.ncbi.nlm.nih.gov/37556424/

    • Edupuganti S, Khine S, Gupta R, Yadav D, Singh A.
      Secukinumab-Induced Crohn's Disease in a Patient Treated for Juvenile Idiopathic Arthritis
      Cureus. 2023 Aug 20;15(8):e43825. doi: 10.7759/cureus.43825. eCollection 2023 Aug.
      https://pubmed.ncbi.nlm.nih.gov/37736437/

    • Currie GR, Kennedy BL, Benseler SM, Yeung RSM, Swart JF, Vastert SJ, et al.
      Managing juvenile idiopathic arthritis within the context of their life: What we learnt from children and youth living with juvenile idiopathic arthritis and their parents.
      Musculoskeletal Care. 2023 Aug 19. doi: 10.1002/msc.1805. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37596866/

    • Lineham B, Maggs R, Pandit H, Sharma H, Foster P.
      Outcomes of ankle joint distraction in a paediatric and young adult cohort presenting with symptomatic ankle arthritis.
      J Pediatr Orthop B. 2023 Aug 7. doi: 10.1097/BPB.0000000000001115. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37548659/

    • Tomé C, Oliveira-Ramos F, Campanilho-Marques R, Mourão AF, Sousa S, Marques C, et al.
      Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activation
      RMD Open. 2023 Aug;9(3):e002901. doi: 10.1136/rmdopen-2022-002901.
      https://pubmed.ncbi.nlm.nih.gov/37652558/

 
JULIO 2023

    • Oliveira Ramos F, Rodrigues AM, Melo AT, Aguiar F, Brites L, Azevedo S, et al.
      Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.
      Arthritis Res Ther. 2023 Sep 21;25(1):177. doi: 10.1186/s13075-023-03166-9.
      https://pubmed.ncbi.nlm.nih.gov/37735435/

    • Bagri NK, Chew C, Ramanan AV.
      Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward.
      Paediatr Drugs. 2023 Sep 29. doi: 10.1007/s40272-023-00594-7. 
      https://pubmed.ncbi.nlm.nih.gov/37775678/

    • Pedersen ML, Neve-Græsbøll A, Herlin T, Glerup M.
      Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2023 Sep 23;21(1):107. doi: 10.1186/s12969-023-00897-6.
      https://pubmed.ncbi.nlm.nih.gov/37742033/

    • Baraliakos X, van der Heijde D, Sieper J, Inman RD, Kameda H, Li Y, Bu X, et al
      Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study.
      Arthritis Res Ther. 2023 Sep 18;25(1):172. doi: 10.1186/s13075-023-03128-1.
      https://pubmed.ncbi.nlm.nih.gov/37723577/

    • Perrin T, Coutier L, Ranchoup J, Rifard A, Eymery M, Ohlmann C, et al.
      Methotrexate does not affect lung function in children with juvenile idiopathic arthritis.
      Pediatr Pulmonol. 2023 Sep 13. doi: 10.1002/ppul.26681. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37701972/

    • Şahin N, Özdemir Çiçek S, Paç Kısaarslan A, Dursun İ, Poyrazoğlu MH, Düşünsel R.
      The effect of intra-articular steroid injection on the cartilage and tendon thicknesses in juvenile idiopathic arthritis.
      Mod Rheumatol. 2023 Sep 27:road093. doi: 10.1093/mr/road093. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37757466/

    • Karadağ ŞG, Coskuner T, Demirkan FG, Sonmez HE, Ozdel S, Çakan M, et al.
      Do the features of juvenile psoriatic arthritis change according to age? A comprehensive evaluation of the PeRA Research Group Registry.
      Rheumatology (Oxford). 2023 Sep 19:kead496. doi: 10.1093/rheumatology/kead496. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37725366/

    • McGrath T, Guzman J, Tucker L, Shiff NJ, Yaskina M, Tupper S, Rumsey DG; ReACCh-Out Investigators.
      Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort.
      Pediatr Rheumatol Online J. 2023 Sep 16;21(1):102. doi: 10.1186/s12969-023-00885-w.
      https://pubmed.ncbi.nlm.nih.gov/37715224/

    • Peltoniemi SOO, Glerup M, Lahdenne P, Eklund KK, Aalto K.
      Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis- results of the 18-year cohort follow-up study.
      Pediatr Rheumatol Online J. 2023 Sep 1;21(1):94. doi: 10.1186/s12969-023-00878-9.
      https://pubmed.ncbi.nlm.nih.gov/37658392/

    • Alshaya M, Alrasheed A, Almutairi N, Albanaqi I, Laxer RM, Alhammad A.
      Reactive Arthritis in Children: Case report and Narrative Review and Proposed therapy.
      Curr Pediatr Rev. 2023 Sep 13. doi: 10.2174/1573396320666230913103007. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37702166/

JULIO 2023

    • Ozdel S, Sönmez HE, Çağlayan Ş, Akgün Ö, Aydın T, Baba Ö et al.How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience.
      Pediatr Rheumatol Online J. 2023 Jul 20;21(1):72. doi: 10.1186/s12969-023-00860-5.
      https://pubmed.ncbi.nlm.nih.gov/37475055/

    • Pelassa S, Raggi F, Rossi C, Bosco MC.
      MicroRNAs in Juvenile Idiopathic Arthritis: State of the Art and Future Perspectives.
      Biology (Basel). 2023 Jul 12;12(7):991. doi: 10.3390/biology12070991.
      https://pubmed.ncbi.nlm.nih.gov/37508421/

    • McIntosh SM, Kerut C, Hollenshead PP, Askins DH, Mansourian K, Palowsky ZR et al.
      Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations.
      Life (Basel). 2023 Jul 21;13(7):1601. doi: 10.3390/life13071601.
      https://pubmed.ncbi.nlm.nih.gov/37511975/

    • De Nardi L, Pastore S, Rispoli F, Tesser A, Pin A, Taddio A, Tommasini A.
      Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis.
      Clin Exp Rheumatol. 2023 Jul;41(7):1548-1552. doi: 10.55563/clinexprheumatol/b37xbd.
      https://pubmed.ncbi.nlm.nih.gov/37140616/

    • Polat MC, Ekici Tekin Z, Çelikel E, Güngörer V, Kurt T, Kaplan MM et al.
      The Juvenile Spondyloarthritis Disease Activity Index Is a Useful Tool in Enthesitis-Related Arthritis: Real-Life Data.
      J Clin Rheumatol. 2023 Jul 27. doi: 10.1097/RHU.0000000000002001. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37496150/

    • Bansal N, Pasricha C, Kumari P, Jangra S, Kaur R, Singh R.
      A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management.
      Autoimmun Rev. 2023 Jul;22(7):103337. doi: 10.1016/j.autrev.2023.103337.
      https://pubmed.ncbi.nlm.nih.gov/37068698/

    • Zhao W, Li C, Deng J.
      A systematic review and meta-analysis of environmental factors associated with juvenile idiopathic arthritis.
      Int J Rheum Dis. 2023 Jul;26(7):1235-1247. doi: 10.1111/1756-185X.14729.
      https://pubmed.ncbi.nlm.nih.gov/37309290/

    • Elfving A, Harila-Saari A, Nilsson L, Berntson L.
      An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis.
      BMC Pediatr. 2023 Jul 15;23(1):365. doi: 10.1186/s12887-023-04181-0.
      https://pubmed.ncbi.nlm.nih.gov/37454049/

    • Heshin-Bekenstein M, Baron S, Schulert G, Shusterman A, Fidel V, Ben-Shahar Y, Shukrun R, Binenbaum Y, Elhasid R.
      Neutrophils extracellular traps formation may serve as a biomarker for disease activity in oligoarticular juvenile idiopathic arthritis: a pilot study.
      Arthritis Res Ther. 2023 Jul 31;25(1):135. doi: 10.1186/s13075-023-03104-9.
      https://pubmed.ncbi.nlm.nih.gov/37525216/

    • Cafarotti A, Marcovecchio ML, Lapergola G, Di Battista C, Marsili M, Basilico R et al.
      Kidney function and renal resistive index in children with juvenile idiopathic arthritis.
      Clin Exp Med. 2023 Jul;23(3):759-766. doi: 10.1007/s10238-022-00898-x.
      https://pubmed.ncbi.nlm.nih.gov/36129558/

    • Al-Jaberi L, Simonds MM, Brescia AMC.
      CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment.
      Rheumatology (Oxford). 2023 Jul 5;62(7):2594-2600. doi: 10.1093/rheumatology/keac617.
      https://pubmed.ncbi.nlm.nih.gov/36342195/

 
MAYO 2023

    • Brunner HI, Tzaribachev N, Louw I, Penades IC, Avila-Zapata F, Horneff G, et al; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) investigators.
      Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.
      Arthritis Care Res (Hoboken). 2023 May 23. doi: 10.1002/acr.25156. Epub ahead of print
      https://pubmed.ncbi.nlm.nih.gov/37221146/

    • Vojinović J, Foeldvari I, Dehoorne J, Panaviene V, Susic G, Horneff G, et al; Paediatric Rheumatology International Trials Organisation (PRINTO).
      Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.
      Rheumatology (Oxford). 2023 May 4:kead183. doi: 10.1093/rheumatology/kead183. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37140539/

    • Chan OM, Lai BM, Leung AS, Leung TF, Ho AC.
      High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong.
      Pediatr Rheumatol Online J. 2023 May 3;21(1):45. doi: 10.1186/s12969-023-00825-8.
      https://pubmed.ncbi.nlm.nih.gov/37138335/

    • Tsitsami E, Sarrigeorgiou I, Tsinti M, Rouka EC, Zarogiannis SG, Lymberi P.
      Natural autoimmunity in oligoarticular juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2023 May 3;21(1):44. doi: 10.1186/s12969-023-00823-w.
      https://pubmed.ncbi.nlm.nih.gov/37138302/

    • Altaffer AL, Weiss P.
      Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study.
      Pediatr Rheumatol Online J. 2023 May 2;21(1):43. doi: 10.1186/s12969-023-00822-x.
      https://pubmed.ncbi.nlm.nih.gov/37131195/

    • Sukharomana M, Charuvanij S.
      Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.
      Clin Rheumatol. 2023 Jun;42(6):1665-1674. doi: 10.1007/s10067-023-06569-w.
      https://pubmed.ncbi.nlm.nih.gov/36892711/

 
ABRIL 2023

    • Bousquet B, Kellenberger CJ, Caprio RM, Jindal S, Resnick CM.
      Does Magnetic Resonance Imaging Distinguish Juvenile Idiopathic Arthritis From Other Causes of Progressive Temporomandibular Joint Destruction?
      J Oral Maxillofac Surg. 2023 Apr 4:S0278-2391(23)00331-2. doi: 10.1016/j.joms.2023.03.016. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37086749/

    • Cooper SM, Currie GR, Kromm S, Twilt M, Marshall DA.
      Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2023 Apr 21;21(1):37. doi: 10.1186/s12969-023-00818-7
      https://pubmed.ncbi.nlm.nih.gov/37085775/

    • Kyllönen MS, Kautiainen H, Jääskeläinen E, Puolakka K, Vähäsalo P.
      Use of psychotropic medication in incident juvenile idiopathic arthritis patients from 2000 to 2014: a case-control cohort study.
      Clin Exp Rheumatol. 2023 Apr 6. doi: 10.55563/clinexprheumatol/26u6uu. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37083175/

    • Nijhuis L, Swart JF, Prakken BJ, V Loosdregt J, Vastert SJ.
      The clinical and experimental treatment of Juvenile Idiopathic Arthritis.
      Clin Exp Immunol. 2023 Apr 19:uxad045. doi: 10.1093/cei/uxad045. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37074076/

    • Schanberg LE, Mulugeta LY, Akinlade B, Brunner HI, Chen J, Colbert RA, Delgaizo V, Gastonguay MR, Glaser R, Imundo L, Lovell DJ, Leu JH, Mostafa NM, Nelson RM, Nigrovic PA, Nikolov NP, Rider LG, Rothwell R, Sahajwalla C, Singh R, Sinha V, Yancey CL, Yao L.
      Therapeutics Development in Polyarticular Course Juvenile Idiopathic Arthritis (pcJIA): Extrapolation, Dose Selection and Clinical Trial Design; Workshop Proceedings and Recent Updates.
      Arthritis Rheumatol. 2023 Apr 17. doi: 10.1002/art.42534. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37067688/

    • Backström M, Salo H, Kärki J, Aalto K, Rebane K, Levälampi T, Grönlund MM, Kröger L, Pohjankoski H, Hietanen M, Korkatti K, Kuusalo L, Rantalaiho V, Huhtakangas J, Relas H, Pääkkö T, Löyttyniemi E, Sokka-Isler T, Vähäsalo P.
      The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register.
      Pediatr Rheumatol Online J. 2023 Apr 14;21(1):35. doi: 10.1186/s12969-023-00814-x.
      https://pubmed.ncbi.nlm.nih.gov/37060076/

    • Otobo TM, Tolend M, Meyers AB, Sudol-Szopinska I, Joshi S, Stimec J, Herregods N, Jaremko JL, Tse SML, Haroon N, Moineddin R, Tzaribachev N, Appenzeller S, Znajdek M, Perez M, Ligha AE, Jans L, Inarejos Clemente EJ, Weiss P, Papakonstantinou O, Kirkhus E, van Rossum MAJ, Rumsey DG, Carrino J, Akikusa JD, Conaghan PG, Doria AS.
      Determination of Relative Weightings for Sacroiliac Joint Pathologies in the OMERACT Juvenile Arthritis Magnetic Resonance Imaging Sacroiliac Joint Score.
      J Clin Med. 2023 Apr 6;12(7):2729. doi: 10.3390/jcm12072729.
      https://pubmed.ncbi.nlm.nih.gov/37048812/

    • Kirchner S, Klotsche J, Liedmann I, Niewerth M, Feldman D, Dressler F, Foeldvari I, Foell D, Haas JP, Horneff G, Hospach A, Kallinich T, Kuemmerle-Deschner JB, Moenkemoeller K, Weller-Heinemann F, Windschall D, Minden K, Sengler C.
      Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis - data from a German Inception cohort.
      Pediatr Rheumatol Online J. 2023 Apr 12;21(1):31. doi: 10.1186/s12969-023-00811-0.
      https://pubmed.ncbi.nlm.nih.gov/37046303/

    • Roemer J, Klein A, Horneff G.
      Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis.
      Rheumatol Int. 2023 Apr 11. doi: 10.1007/s00296-023-05323-4. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37039854/

    • Hamad Saied M, van Straalen JW, de Roock S, de Joode-Smink GCJ, Swart JF, Wulffraat NM, Jansen MHA.
      Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: A long-term follow-up study.
      Vaccine. 2023 Apr 7:S0264-410X(23)00381-X. doi: 10.1016/j.vaccine.2023.03.074. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37032229/

    • Brix N, Glerup M, Foell D, Kessel C, Wittkowski H, Berntson L, Fasth A, Nielsen S, Nordal E, Rygg M, Hasle H, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR) group.
      Inflammatory Biomarkers Can Differentiate ALL with Arthropathy from JIA Better Than Standard Blood Tests.
      JPediatr. 2023 Apr 4:113406. doi: 10.1016/j.jpeds.2023.113406. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37023943/

    • Backström M, Tarkiainen M, Gottlieb BS, Trincianti C, Qiu T, Morgan E, Lovell DJ, Bovis F, Löyttyniemi E, Ruperto N, Vähäsalo P, Consolaro A.
      Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way.
      Rheumatology (Oxford). 2023 Apr 2:kead151. doi: 10.1093/rheumatology/kead151. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/37004166/

 
MARZO 2023

    • Tanatar A, Akgün Ö, Çağlayan Ş, Bağlan E, Otar Yener G, Öztürk K, Çakan M, Sönmez HE, Sözeri B, Aktay Ayaz N.
      Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.
      Expert Opin Biol Ther. 2023 Mar;23(3):305-313. doi: 10.1080/14712598.2023.2185132.
      https://pubmed.ncbi.nlm.nih.gov/36825474/

    • Hamdi W, Ferjani H, Carlomagno R, Dusser P, Echaubard S, Belot A, et al.
      Factors associated with poor prognosis of hip arthritis in juvenile idiopathic arthritis: Data from the JIR cohort.
      Musculoskeletal Care. 2023 Mar 10. doi: 10.1002/msc.1755. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36896923/

    • Sukharomana M, Charuvanij S.
      Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.
      Clin Rheumatol. 2023 Mar 9. doi: 10.1007/s10067-023-06569-w. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36892711/

    • Chausset A, Lambert C, Belot A, Merlin E, Cannizzaro E, Kone-Paut I, et al.
      Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study.
      Pediatr Rheumatol Online J. 2023 Mar 14;21(1):24. doi: 10.1186/s12969-023-00809-8.
      https://pubmed.ncbi.nlm.nih.gov/36918902/

    • Sande NK, Lilleby V, Aga AB, Kirkhus E, Flatø B, Bøyesen P.
      Associations between power Doppler ultrasound findings and B-mode synovitis and clinical arthritis in juvenile idiopathic arthritis using a standardised scanning approach and scoring system.
      RMD Open. 2023 Mar;9(1):e002937. doi: 10.1136/rmdopen-2022-002937.
      https://pubmed.ncbi.nlm.nih.gov/36963783/

    • Felis-Giemza A, Chmurzyńska K, Kołodziejczyk B, Gazda A.
      Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
      Rheumatol Int. 2023 Mar 1. doi: 10.1007/s00296-023-05293-7. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36859560/

    • Wittmann N, Mishra N, Gramenz J, Kuthning D, Behrendt AK, Bossaller L, Meyer-Bahlburg A.
      Inflammasome activation and formation of ASC specks in patients with juvenile idiopathic arthritis.
      Front Med (Lausanne). 2023 Mar 1;10:1063772. doi: 10.3389/fmed.2023.1063772. 
      https://pubmed.ncbi.nlm.nih.gov/36936231/

FEBRERO 2023

    • Maccora I, Oliverio T, Pagnini I, Marrani E, Mastrolia MV, Simonini G.
      Baricitinib for juvenile idiopathic arthritis: a monocentric case series
      Ann Rheum Dis. 2023 Feb 8:ard-2022-223815. doi: 10.1136/ard-2022-223815. 
      https://pubmed.ncbi.nlm.nih.gov/36754594/

    • Glerup M, Tagkli A, Küseler A, Christensen AE, Verna C, Bilgrau AE, Nørholt SE, Herlin T, Pedersen TK, Stoustrup P.
      Incidence of orofacial manifestations of juvenile idiopathic arthritis from diagnosis to adult care transition: a population-based cohort study.
      Arthritis Rheumatol. 2023 Feb 20. doi: 10.1002/art.42481. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36806745/

    • Gruca M, Orczyk K, Zamojska J, Niewiadomska-Jarosik K, Stańczyk J, Smolewska E.
      Why and How Should We Assess the Cardiovascular Risk in Patients with Juvenile Idiopathic Arthritis? A Single-Centre Experience with Carotid Intima-Media Measurements.
      Children (Basel). 2023 Feb 22;10(3):422. doi: 10.3390/children10030422.
      https://pubmed.ncbi.nlm.nih.gov/36979980/

    • Zemthangpuii F, Maheshwari A, Gulati S, Sharma S, Mahto D, Chandra J.
      Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27Z
      Indian J Pediatr. 2023 Feb 10. doi: 10.1007/s12098-022-04414-7. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36763251/ 

    • Khawaja K, Kalas R, Almasri N.
      Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates.
      Pediatr Rheumatol Online J. 2023 Feb 7;21(1):14. doi: 10.1186/s12969-023-00796-w.
      https://pubmed.ncbi.nlm.nih.gov/36750870/

    • Rochette E, Saidi O, Merlin É, Duché P.
      Physical activity as a promising alternative for young people with juvenile idiopathic arthritis: Towards an evidence-based prescription.
      Front Immunol. 2023 Feb 13;14:1119930. doi: 10.3389/fimmu.2023.1119930.
      https://pubmed.ncbi.nlm.nih.gov/36860845/

    • Bento da Silva A, Lourenço MH, Gonçalves MJ, Branco JC, Costa M, Mourão AF.
      Arthritis or maybe not? Pachydermodactyly: the great mimicker of juvenile idiopathic arthritis
      ARP Rheumatol. 2023 Feb 18. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36802346/

    • Imbach KJ, Treadway NJ, Prahalad V, Kosters A, Arafat D, Duan M, Gergely T, Ponder LA, Chandrakasan S, Ghosn EEB, Prahalad S, Gibson G.
      Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing.
      Pediatr Rheumatol Online J. 2023 Feb 15;21(1):17. doi: 10.1186/s12969-023-00787-x.
      https://pubmed.ncbi.nlm.nih.gov/36793127/

    • Guo Y, Fang Y, Zhang T, Pan Y, Wang P, Fan Z, Yu H.
      Axial involvement in enthesitis-related arthritis: results from a single-center cohort
      Pediatr Rheumatol Online J. 2023 Feb 6;21(1):13. doi: 10.1186/s12969-023-00792-0.
      https://pubmed.ncbi.nlm.nih.gov/36747282/

    • Feng R, Lu M, Yin C, Xu K, Liu L, Xu P.
      Identification of candidate genes and pathways associated with juvenile idiopathic arthritis by integrative transcriptome-wide association studies and mRNA expression profiles.
      Arthritis Res Ther. 2023 Feb 8;25(1):19.
      https://pubmed.ncbi.nlm.nih.gov/36755318/

ENERO 2023

    • De Somer L, Bader-Meunier B, Breton S, Brachi S, Wouters C, Zulian F.
      Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2023 Jan 23;21(1):7. doi: 10.1186/s12969-023-00789-9
      https://pubmed.ncbi.nlm.nih.gov/36691078/

    • Naveen R, Guleria S, Mohindra N, Aggarwal A.
      Predictors of long-term functional outcomes of juvenile idiopathic arthritis-enthesitis related arthritis: a single centre experience.
      Rheumatology (Oxford). 2023 Jan 25:kead032. doi: 10.1093/rheumatology/kead032. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36702467/

    • Naddei R, Rebollo-Giménez A, Burrone M, Natoli V, Rosina S, Consolaro A, Ravelli A.
      Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate.
      J Clin Med. 2023 Jan 3;12(1):367. doi: 10.3390/jcm12010367.
      https://pubmed.ncbi.nlm.nih.gov/36615167/

    • La Bella S, Rinaldi M, Di Ludovico A, Di Donato G, Di Donato G, Salpietro V, Chiarelli F, Breda L.
      Genetic Background and Molecular Mechanisms of Juvenile Idiopathic Arthritis.
      Int J Mol Sci. 2023 Jan 17;24(3):1846. doi: 10.3390/ijms24031846.
      https://pubmed.ncbi.nlm.nih.gov/36768167/

    • Murias S, Boteanu A, Calvo I, Nuñez E, Bravo B, Bustabad S, Camacho M, Clemente D, Graña J, de Inocencio J, Lacruz L, Mesa-Del-Castillo P, Nieto-González JC, Pinedo MDC, Quesada E, Vargas C, Antón J.
      What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment.
      Reumatol Clin (Engl Ed). 2023 Jan;19(1):26-33. doi: 10.1016/j.reumae.2022.11.002.
      https://pubmed.ncbi.nlm.nih.gov/36603964/

    • Stoustrup P, Resnick CM, Abramowicz S, Pedersen TK, Michelotti A, Küseler A, et al.
      Temporomandibular Joint Juvenile Arthritis Working Group. Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus-Based Recommendations.
      Arthritis Rheumatol. 2023 Jan;75(1):4-14. doi: 10.1002/art.42338. Epub 2022 Nov 25.
      https://pubmed.ncbi.nlm.nih.gov/36041065/

    • d'Angelo DM, Attanasi M, Di Donato G, Lapergola G, Flacco M, Chiarelli F, Altobelli E, Breda L.
      The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study.
      Int J Mol Sci. 2023 Jan 14;24(2):1671. doi: 10.3390/ijms24021671.
      https://pubmed.ncbi.nlm.nih.gov/36675189/

    • Zare N, Mansoubi M, Coe S, Najafi AA, Bailey K, Harrison K, Sheehan J, Dawes H, Barker K.
      An investigation into the relationship between nutritional status, dietary intake, symptoms and health-related quality of life in children and young people with juvenile idiopathic arthritis: a systematic review and meta-analysis.
      BMC Pediatr. 2023 Jan 2;23(1):3. doi: 10.1186/s12887-022-03810-4.
      https://pubmed.ncbi.nlm.nih.gov/36593466/

 
DICIEMBRE 2022

    • Badin D, Leland CR, Bronheim RS, Balmuri N, Lee RJ.
      Synovectomy in juvenile idiopathic arthritis: A systematic review and meta-analysis
      Medicine (Baltimore). 2022 Dec 9;101(49):e32278. doi: 10.1097/MD.0000000000032278.
      https://pubmed.ncbi.nlm.nih.gov/36626489/

    • Wedderburn LR, Ramanan AV, Croft AP, Hyrich KL, Dick A; CLUSTER Consortium.
      Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis
      Ann Rheum Dis. 2022 Dec 5:annrheumdis-2022-222553. doi: 10.1136/ard-2022-222553. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36600186/

    • Duran G, Bayraktar D, Kalkan AC, Turkucar S, Makay B, Unsal SE, Genc A.
      Investigating Wrist Joint Position Sense and Hand Functions in Children With Polyarticular Juvenile Idiopathic Arthritis With Wrist Involvement
      Clin Pediatr (Phila). 2022 Dec 29:99228221147175. doi: 10.1177/00099228221147175. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36579857/

    • Sunthornsup W, Vilaiyuk S, Soponkanaporn S.
      Effect of educational brochure compared with video on disease-related knowledge in patients with juvenile idiopathic arthritis: A randomized controlled trial
      Front Pediatr. 2022 Dec 9;10:1048949. doi: 10.3389/fped.2022.1048949. eCollection 2022.
      https://pubmed.ncbi.nlm.nih.gov/36568417/

    • Frkovic M, Kujundzic M, Cavka M, Jelusic M.
      Successful use of adalimumab as a conservative treatment for bilateral knee lipoma arborescens in patient with psoriatic juvenile idiopathic arthritis - case report and review of literature
      Front Pediatr. 2022 Dec 6;10:1014536. doi: 10.3389/fped.2022.1014536. eCollection 2022.
      https://pubmed.ncbi.nlm.nih.gov/36561488/

    • Kasap Cuceoglu M, Basaran O, Soyer O, Ozen S.
      Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?
      J Clin Med. 2022 Dec 8;11(24):7291. doi: 10.3390/jcm11247291.
      https://pubmed.ncbi.nlm.nih.gov/36555908/

    • Elnaggar RK, Elfakharany MS.
      Aqua-Plyometric Exercises-Induced Changes in Muscle Strength, Bone Mineral Properties, and Physical Fitness in Patients With Juvenile Idiopathic Arthritis: A 12-Week, Randomized Controlled Trial
      Pediatr Exerc Sci. 2022 Dec 19:1-8. doi: 10.1123/pes.2022-0044. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36535274/

    • Roberts JE, Williams K, Dallas J, Eckert M, Huie L, Smitherman E, Soulsby WD, Zhao Y, Son MBF; CARRA Registry Investigators.
      Insurance Status and TNF Inhibitor Initiation Among Children with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry
      J Rheumatol. 2022 Dec 15:jrheum.220871. doi: 10.3899/jrheum.220871. Online ahead of print.PMID: 36521922
      https://pubmed.ncbi.nlm.nih.gov/36521922/

    • Berntson L, Palm J, Axling F, Zarelius P, Hellström PM, Webb DL.
      Haptoglobin in Juvenile Idiopathic Arthritis
      Pediatr Rheumatol Online J. 2022 Dec 15;20(1):117. doi: 10.1186/s12969-022-00777-5.
      https://pubmed.ncbi.nlm.nih.gov/36517828/

    • Del Giudice E, de Roock S, Vastert SJ, Wulffraat NM, Swart JF, van Dijkhuizen EHP.
      Patients' and parents' satisfaction to improve patient care in JIA: factors determining acceptable symptom state measured with JAMAR
      Rheumatology (Oxford). 2022 Dec 14:keac658. doi: 10.1093/rheumatology/keac658. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36515484/

    • Jonyk L, Sagawa Junior Y, Tordi N, Ballot Schmit C.
      Description of physical activity in children with juvenile idiopathic arthritis using accelerometry
      Arch Pediatr. 2022 Dec 10:S0929-693X(22)00227-5. doi: 10.1016/j.arcped.2022.11.003. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36513538/

    • Berthold E, Dahlberg A, Jöud A, Tydén H, Månsson B, Kahn F, Kahn R.
      The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis - results from the south-Swedish juvenile idiopathic arthritis cohort
      Pediatr Rheumatol Online J. 2022 Dec 9;20(1):114. doi: 10.1186/s12969-022-00765-9.
      https://pubmed.ncbi.nlm.nih.gov/36494819/

    • Gieling J, van den Bemt B, Hoppenreijs E, Schatorjé E.
      Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors
      Pediatr Rheumatol Online J. 2022 Dec 5;20(1):109. doi: 10.1186/s12969-022-00769-5.
      https://pubmed.ncbi.nlm.nih.gov/36471348/

    • Stoustrup P, Rahimi H, Twilt M, Goh YI, Pedersen TK, Herlin T, Spiegel L;
      Temporomandibular joint Juvenile Arthritis Work group (TMJaw) Assessment of orofacial symptoms in juvenile idiopathic arthritis: Validation of a consensus-based short patient questionnaire
      J Rheumatol. 2022 Dec 1:jrheum.220667. doi: 10.3899/jrheum.220667. Online ahead of print.PMID: 36455952
      https://pubmed.ncbi.nlm.nih.gov/36455952/

    • Frenkel Y, Kraushar I, Hamad Saied M, Haviv R, Uziel Y, Heshin-Bekenstein M, Ling E, Amarilyo G, Harel L, Tirosh I, Spielman S, Berkun Y, Butbul Aviel Y.
      Obstacles in Early Diagnosis of Children With Juvenile Idiopathic Arthritis: A Nationwide Israeli Retrospective Study
      J Rheumatol. 2022 Dec 1:jrheum.220359. doi: 10.3899/jrheum.220359. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36455949/

 
NOVIEMBRE 2022

    • Horneff G, Borchert J, Heinrich R, Kock S, Klaus P, Dally H, Hagemann C, Diesing J, Schönfelder T.
      Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study.
      Pediatr Rheumatol Online J. 2022 Nov 16;20(1):100. doi:10.1186/s12969-022-00755-x.
      https://pubmed.ncbi.nlm.nih.gov/36384690/

    • van Straalen JW, de Roock S, Giancane G, Consolaro A, Rygg M, Nordal EB, Rubio-Pérez N, Jelusic M, De Inocencio J, Vojinovic J, Wulffraat NM, Bruijning-Verhagen PCJ, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO).
      Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study.
      Pediatr Rheumatol Online J. 2022 Nov 14;20(1):96. doi: 10.1186/s12969-022-00763-x.
      https://pubmed.ncbi.nlm.nih.gov/36376976/

    • Broekaert IJ, Klein A, Windschall D, Rogalski B, Weller-Heinemann F, Oommen P, et al.
      Development of Inflammatory Bowel Disease in Children with Juvenile Idiopathic Arthritis Treated with Biologics.
      J Pediatr Gastroenterol Nutr. 2022 Nov 17. doi: 10.1097/MPG.0000000000003656. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36399775/

    • Hahn T, Daymont C, Beukelman T, Groh B, Hays K, Bingham CA, Scalzi L; CARRA Registry investigators.
      Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.
      Pediatr Rheumatol Online J. 2022 Nov 25;20(1):107. doi:10.1186/s12969-022-00770-y.
      https://pubmed.ncbi.nlm.nih.gov/36434731/

    • Baydoun S, Jousse-Joulin S, Saraux A, Dusser-Benesty P, Borocco C, Galeotti C, et al.
      Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort.
      Rheumatol Ther. 2022 Nov 23:1-14. doi: 10.1007/s40744-022-00512-2. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36427176/

    • Bardan I, Fagerli KM, Sexton J, Kvien TK, Bakland G, Mielnik P, Hu Y, Lien G, Flatø B, Molberg Ø, Kristianslund EK, Aga AB.
      Treatment response to tumor necrosis factor inhibitors and methotrexate monotherapy in adults with juvenile idiopathic arthritis: Data from NORDMARD.
      J Rheumatol. 2022 Nov 15:jrheum.220645. doi: 10.3899/jrheum.220645. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36379571/

    • van Straalen JW, de Roock S, Giancane G, Alexeeva E, Koskova E, Mesa-Del-Castillo Bermejo P, Zulian F, Civino A, Montin D, Wulffraat NM, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO).
      Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry.
      Pediatr Rheumatol Online J. 2022 Nov 18;20(1):103. doi:10.1186/s12969-022-00762-y.
      https://pubmed.ncbi.nlm.nih.gov/36401230/

    • Giacalone VD, Cammarata-Mouchtouris A, Moncada-Giraldo D, Shenoy SPV, Ponder LA, Gergely TR, et al
      Immunometabolic Analysis of Synovial Fluid from Juvenile Idiopathic Arthritis Patients.
      Immunohorizons. 2022 Nov 1;6(11):768-778. doi: 10.4049/immunohorizons.2200052.
      https://pubmed.ncbi.nlm.nih.gov/36445361

    • Stoll ML, Wang J, Kau CH, Pierce MK, Morrow CD, Geurs NC.
      Pro-Inflammatory Oral Microbiota in Juvenile Spondyloarthritis: A Pilot Study
      Children (Basel). 2022 Nov 17;9(11):1764. doi: 10.3390/children9111764.
      https://pubmed.ncbi.nlm.nih.gov/36421212/ 
  
OCTUBRE 2022

    • Oommen PT, Strauss T, Baltruschat K, Foeldvari I, Deuter C, Ganser G, et al.
      Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives on interdisciplinary care.
      Clin Immunol. 2022 Sep 30;245:109143. doi: 10.1016/j.clim.2022.109143. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36191738/

    • Civino A, Bovis F, Ponzano M, Alighieri G, Prete E, Sorrentino S, Magni-Manzoni S, Vinti L, Romano M, Santoro N, Filocamo G, Belotti T, Santarelli F, Gorio C, Cattalini M, Stabile G, Conter V, Rondelli R, Pession A, Ravelli A; ONCOREUM Study group.
      Development and initial validation of the ONCOREUM score to differentiate childhood cancer with arthropathy from juvenile idiopathic arthritis.
      J Pediatr. 2022 Oct 3:S0022-3476(22)00868-X. doi: 10.1016/j.jpeds.2022.09.046. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36202241/

    • Thiele F, Klein A, Klotsche J, Windschall D, Dressler F, Kuemmerle-Deschner J, Minden K, Foeldvari I, Foell D, Mrusek S, Oommen PT, Horneff G.
      Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival.
      Rheumatology (Oxford). 2022 Oct 12:keac587. doi: 10.1093/rheumatology/keac587. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36222562/

    • Raggi F, Cangelosi D, Consolaro A, Rossi C, Pelassa S, Cortese K, Gagliani MC, Morini M, Segalerba D, Brignole C, Bocca P, Marimpietri D, Trincianti C, Ravelli A, Eva A, Bosco MC
      Extracellular vesicle-derived microRNAs as potential biomarkers in oligoarticular juvenile idiopathic arthritis patients: methodological challenges and new perspectives.
      Clin Transl Med. 2022 Oct;12(10):e1067. doi: 10.1002/ctm2.1067.
      https://pubmed.ncbi.nlm.nih.gov/36178089/

    • Yamasaki Y, Nakamura A, Kubota T, Mitsunobu T, Moriyama M, Takei S, Okamoto Y.
      Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis.
      Mod Rheumatol. 2022 Oct 5:roac125. doi: 10.1093/mr/roac125. Online ahead of print.PMID: 36197747.
      https://pubmed.ncbi.nlm.nih.gov/36197747/

 

AGOSTO 2022

    • Udaondo C, Núñez Cuadros E, Murias S, Remesal A, Alcobendas R, Guerrero C, Guillen-Martin S, Escuredo M, Aleo E, Alonso D, Tagarro A, De Santiago E, Camacho-Lovillo M, Diaz F, Arenas D, Camacho P, Lirola MJ, Díaz Almirón M, Calvo C.
      Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study.
      Front Pediatr. 2022 Aug 11;10:917731. doi: 10.3389/fped.2022.917731.
      https://pubmed.ncbi.nlm.nih.gov/36034561/

    • Schujovitzky D, Ziv A, Heshin Bekenstein M, Eylon S, Grossman Z, Hashkes PJ, Uziel Y, Haviv R.
      Measuring the knowledge of juvenile idiopathic arthritis among Israeli paediatricians and paediatric orthopaedic surgeons: what needs to be improved?
      Clin Exp Rheumatol. 2022 Aug 5. doi: 10.55563/clinexprheumatol/7j9es3. 
      https://pubmed.ncbi.nlm.nih.gov/35930493/

    • Brunner HI, Foeldvari I, Alexeeva E, Ayaz NA, Calvo Penades I, Kasapcopur O, et al; Paediatric Rheumatology INternational Trials Organization (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG).
      Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.
      Ann Rheum Dis. 2022 Aug 12:annrheumdis-2022-222849. doi: 10.1136/ard-2022-222849.
      https://pubmed.ncbi.nlm.nih.gov/35961761/

    • Bakry R, Klein MA, Horneff G.
      Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis.
      Eur J Rheumatol. 2022 Aug 9. doi: 10.5152/eurjrheum.2022.21090.
      https://pubmed.ncbi.nlm.nih.gov/35943454/

    • Ringold S, Dennos AC, Kimura Y, Beukelman T, Shrader P, Phillips TA, Kohlheim M, Schanberg LE, Yeung RSM, Horton DB; CARRA Registry Investigators.
      Disease Recapture Rates After Medication Discontinuation and Flare in JIA: An Observational Study within the Childhood Arthritis and Rheumatology Research Alliance Registry.
      Arthritis Care Res (Hoboken). 2022 Aug 3. doi: 10.1002/acr.24994. 
      https://pubmed.ncbi.nlm.nih.gov/35921198/

    • Burgos-Vargas R, Loyola-Sanchez A, Ramiro S, Reding-Bernal A, Alvarez-Hernandez E, van der Heijde D, Vázquez-Mellado J.
      A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis.
      Arthritis Res Ther. 2022 Aug 8;24(1):187. doi: 10.1186/s13075-022-02877-9.
      https://pubmed.ncbi.nlm.nih.gov/35941676/

    • Hata T, Hirata A, Ota R, Hosohata K, Nishihara M, Neo M, Katsumata T.
      Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database.
      Ther Clin Risk Manag. 2022 Aug 24;18:843-853. doi: 10.2147/TCRM.S375890.
      https://pubmed.ncbi.nlm.nih.gov/36046102/

    • Park J, Batthish M, Berard RA, Chédeville G, Proulx-Gauthier JP, Rumsey DG, Tucker LB, Wong S, Guzman J; CAPRI Registry Investigators.
      Comparing Canadian pediatric rheumatology practice to the 2019 ACR Juvenile Idiopathic Arthritis guidelines. Results from the CAPRI Registry
      Rheumatology (Oxford). 2022 Aug 17:keac468. doi: 10.1093/rheumatology/keac468.
      https://pubmed.ncbi.nlm.nih.gov/35977388/

    • Stoustrup P, Resnick CM, Abramowicz S, Pedersen TK, Michelotti A, Küseler A, et al; Temporomandibular Joint Juvenile Arthritis Working group (TMJaw).
      Management of orofacial manifestations of juvenile idiopathic arthritis: Interdisciplinary consensus-based recommendations.
      Arthritis Rheumatol. 2022 Aug 30. doi: 10.1002/art.42338. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/36041065/

    • Koker O, Aliyeva A, Sahin S, Adrovic A, Yildiz M, Haslak F, Gunalp A, Barut K, Kasapcopur O.
      An overview of the relationship between juvenile idiopathic arthritis and potential environmental risk factors: Do early childhood habits or habitat play a role in the affair?
      Int J Rheum Dis. 2022 Aug 30. doi: 10.1111/1756-185X.14431.
      https://pubmed.ncbi.nlm.nih.gov/36039559/

    • Brandelli YN, Stone M, Westheuser V, Huber AM, Joshi N, Reid A, Stringer E, Stevens D.
      Parent Risk Perceptions, Physical Literacy, and Fundamental Movement Skills in Children With Juvenile Idiopathic Arthritis
      Pediatr Phys Ther. 2022 Aug 12. doi: 10.1097/PEP.0000000000000948.
      https://pubmed.ncbi.nlm.nih.gov/35960134/

    • Zhang J, Hu S, Luo X, Huang C, Cao Q.
      Causal association of juvenile idiopathic arthritis-associated uveitis with depression and anxiety: a bidirectional Mendelian randomization study.
      Int Ophthalmol. 2022 Aug 10. doi: 10.1007/s10792-022-02462-8.
      https://pubmed.ncbi.nlm.nih.gov/35947254/

    • Mensink MO, Eijkelkamp N, Veldhuijzen DS, Wulffraat NM.
      Feasibility of quantitative sensory testing in juvenile idiopathic arthritis
      Pediatr Rheumatol Online J. 2022 Aug 9;20(1):63. doi: 10.1186/s12969-022-00715-5.
      https://pubmed.ncbi.nlm.nih.gov/35945540/

    • Cetrelli L, Bletsa A, Lundestad A, Gil EG, Fischer J, Halbig J, Frid P, Angenete O, Lillevoll I, Rosén A, Tylleskär KB, Luukko K, Nordal E, Åstrøm AN, Skeie MS, Feuerherm AJ, Sen A, Rygg M.
      Vitamin D, oral health, and disease characteristics in juvenile idiopathic arthritis: a multicenter cross-sectional study.
      BMC Oral Health. 2022 Aug 8;22(1):333. doi: 10.1186/s12903-022-02349-1.
      https://pubmed.ncbi.nlm.nih.gov/35941635/

    • Weiss JE.
      Prediction model for juvenile idiopathic arthritis: Challenges and opportunities
      J Pediatr. 2022 Aug 5:S0022-3476(22)00706-5. doi: 10.1016/j.jpeds.2022.07.045.
      https://pubmed.ncbi.nlm.nih.gov/35934127/

    • Dąbkowska K, Wojdas M, Kuźnik-Trocha K, Wisowski G, Gruenpeter A, Komosińska-Vassev K, Olczyk K, Winsz-Szczotka K.
      GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept-Relationship with ADAMTS4, ADAMTS5, and PDGF-BB.
      J Clin Med. 2022 Aug 29;11(17):5069. doi: 10.3390/jcm11175069.
      https://pubmed.ncbi.nlm.nih.gov/36079004/

    • Zeller L, Tyrrell PN, Wang S, Fischer N, Haas JP, Hügle B.
      α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
      Pediatr Rheumatol Online J. 2022 Aug 13;20(1):66. doi: 10.1186/s12969-022-00721-7.
      https://pubmed.ncbi.nlm.nih.gov/35964131/

 
JULIO 2022

    • Gerss J, Tedy M, Klein A, Horneff G, Miranda-Garcia M, Kessel C, Holzinger D, Stanevica V, Swart JF, Cabral DA, Brunner HI, Foell D.
      Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial.
      Ann Rheum Dis. 2022 Jul;81(7):990-997. doi: 10.1136/annrheumdis-2021-222029.
      https://pubmed.ncbi.nlm.nih.gov/35260388/

    • Srinivasalu H, Oliver M, Stoll ML, Weiss PF, Colbert RA; CARRA Juvenile Spondyloarthritis Workgroup.
      Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis.
      Clin Exp Rheumatol. 2022 Jul;40(7):1442-1446. doi: 10.55563/clinexprheumatol/gyrtjo.
      https://pubmed.ncbi.nlm.nih.gov/35485412/

    • García-Fernández A, Briones-Figueroa A, Calvo-Sanz L, Andreu-Suárez Á, Boteanu A.
      Evaluation of flare rate and reduction strategies for bDMARDs in juvenile idiopathic arthritis: real world data from a single-centre cohort.
      Rheumatol Int. 2022 Jul;42(7):1133-1142. doi: 10.1007/s00296-022-05108-1.
      https://pubmed.ncbi.nlm.nih.gov/35304642/

    • Lim LSH, Shobhan S, Lokku A, Ringold S, Pullenayegum E.
      Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials.
      Pediatr Rheumatol Online J. 2022 Jul 30;20(1):57. doi: 10.1186/s12969-022-00719-1.
      https://pubmed.ncbi.nlm.nih.gov/35907978/

    • McAlpine SM, Roberts SE, Hargreaves BKV, Bullock C, Ramsey S, Stringer E, Lang B, Huber A, György B, Erdélyi F, Issekutz TB, Dérfalvi B.
      Differentially expressed inflammation-regulating microRNAs in oligoarticular juvenile idiopathic arthritis.
      J Rheumatol. 2022 Jul 15:jrheum.220160. doi: 10.3899/jrheum.220160. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35840148/

    • Tollisen A, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A, Flatø B.
      Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis.
      J Rheumatol. 2022 May 15:jrheum.211245. doi: 10.3899/jrheum.211245. Epub ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35569834/

    • Oskarsdottir SA, Kristjansdottir A, Gudmundsdottir JA, Kamban SW, Licina ZA, Gudmundsdottir DB, Gudjonsdottir B.
      Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study.
      Pediatr Rheumatol Online J. 2022 Jul 15;20(1):48. doi: 10.1186/s12969-022-00706-6.
      https://pubmed.ncbi.nlm.nih.gov/35841034/

    • Grazziotin LR, Currie G, Twilt M, IJzerman MJ, Kip MMA, Koffijberg H, Bonsel G, Benseler SM, Swart JF, Vastert SJ, Wulffraat NM, Yeung RSM, Armbrust W, van den Berg JM, Marshall DA.
      Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2022 Jul 23;20(1):51. doi: 10.1186/s12969-022-00713-7.
      https://pubmed.ncbi.nlm.nih.gov/35870932/

    • Han H, Xiao JH, Weng Y, Liang H, Han C, Yi C, Lin K, Wu H.
      Evidence of persistent glial cell dysfunction in the anterior cingulate cortex of juvenile idiopathic arthritis children: a proton MRS study.
      Pediatr Rheumatol Online J. 2022 Jul 27;20(1):53. doi: 10.1186/s12969-022-00711-9.
      https://pubmed.ncbi.nlm.nih.gov/35897107/

    • Tiller G, Renton WD, Tan J, Whittle S, Avery J, Munro J, Buchbinder R.
      Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis.
      Pediatr Rheumatol Online J. 2022 Jul 23;20(1):52. doi: 10.1186/s12969-022-00710-w.
      https://pubmed.ncbi.nlm.nih.gov/35870945/

 
JUNIO 2022

    • Furness L, Riley P, Wright N, Banka S, Eyre S, Jackson A, Briggs TA.
      Monogenic disorders as mimics of juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2022 Jun 18;20(1):44. doi: 10.1186/s12969-022-00700-y.
      https://pubmed.ncbi.nlm.nih.gov/35717242/

    • Shiff NJ, Shrader P, Correll CK, Dennos A, Phillips T, Beukelman T; CARRA Registry Investigators.
      Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.
      Rheumatology (Oxford). 2022 Jun 15:keac335. doi: 10.1093/rheumatology/keac335. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35703945/

    • Goodman SM, Springer BD, Chen AF, Davis M, Fernandez DR, Figgie M, et al.
      2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
      Arthritis Rheumatol. 2022 Jun 20. doi: 10.1002/art.42140. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35732511/

    • Marino A, Orsini F, Pregnolato F, Cimaz R.
      Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.
      J Rheumatol. 2022 Jun;49(6):654-656. doi: 10.3899/jrheum.211039. Epub 2022 Mar 15.
      https://pubmed.ncbi.nlm.nih.gov/35293329/

    • Shipa MR, Heyer N, Mansoor R, Deakin CT, Madenidou AV, Bouraioui A et al.
      Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years.
      Semin Arthritis Rheum. 2022 Aug;55:152038. doi: 10.1016/j.semarthrit.2022.152038. Epub 2022 May 28.
      https://pubmed.ncbi.nlm.nih.gov/35660170/

    • Rahman MM, Laila K, Rahman SA.
      Efficacy and safety of tofacitinib in the treatment of refractory cases of polyarticular course juvenile idiopathic arthritis: A study from Bangladesh.
      Int J Rheum Dis. 2022 Jun;25(6):678-684. doi: 10.1111/1756-185X.14324. Epub 2022 Apr 18.
      https://pubmed.ncbi.nlm.nih.gov/35435319/

    • Oen K, Toupin-April K, Feldman BM, Berard RA, Duffy CRM, Tucker LB et al.
      Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: Results from ReACCh-Out.
      Rheumatology (Oxford). 2022 Jun 17;keac350. doi: 10.1093/rheumatology/keac350. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35713497/

    • Akca UK, Batu ED, Sener S, Balik Z, Cuceoglu MK, Atalay E, Basaran O, Bilginer Y, Ozen S.
      The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study.
      Clin Rheumatol. 2022 Jun;41(6):1785-1792. doi: 10.1007/s10067-022-06080-8. Epub 2022 Jan 29.
      https://pubmed.ncbi.nlm.nih.gov/35091782/

    • Storwick JA, Brett AC, Buhler K, Chin A, Schmeling H, Johnson NA, Fritzler MJ, Choi MY.
      Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis.
      Autoimmun Rev. 2022 Jun;21(6):103086. doi: 10.1016/j.autrev.2022.103086. Epub 2022 Apr 6.
      https://pubmed.ncbi.nlm.nih.gov/35398272/

    • Majumder S, Guleria S, Aggarwal A.
      IL-36γ in enthesitis-related juvenile idiopathic arthritis and its association with disease activity.
      Clin Exp Immunol. 2022 Jun 11;208(2):212-219. doi: 10.1093/cei/uxac027.
      https://pubmed.ncbi.nlm.nih.gov/35325069/

    • McKenna D, McLaughlin D, Campbell C, Mulholland M, Thompson A, Loughran C, Jackson P, Rooney M.
      Fifteen-minute guide to managing oligoarticular juvenile idiopathic arthritis.
      Arch Dis Child Educ Pract Ed. 2022 Jun;107(3):175-181. doi: 10.1136/archdischild-2020-321088. Epub 2021 Jun 3.
      https://pubmed.ncbi.nlm.nih.gov/34083213/

    • Kostik MM, Gaidar EV, Sorokina LS, Avrusin IS, Nikitina TN, Isupova EA et al.
      Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics.
      Front Pediatr. 2022 Jun 15;10:849940. doi: 10.3389/fped.2022.849940. eCollection 2022.
      https://pubmed.ncbi.nlm.nih.gov/35783325/

    • Taxter A, Donaldson BC, Rigdon J, Harry O.
      Association Between Patient-Reported Outcomes and Treatment Failure in Juvenile Idiopathic Arthritis.
      ACR Open Rheumatol. 2022 Jun 17. doi: 10.1002/acr2.11444. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35715962/

    • Keskitalo PL, Kangas SM, Sard S, Pokka T, Glumoff V, Kulmala P, Vähäsalo P.
      Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center.
      Pediatr Rheumatol Online J. 2022 Jun 16;20(1):42. doi: 10.1186/s12969-022-00701-x.
      https://pubmed.ncbi.nlm.nih.gov/35710418/

MAYO 2022

    • Chang MH, Bocharnikov AV, Case SM, Todd M, Laird-Gion J, Alvarez-Baumgartner M, Nigrovic PA.
      Patterns of arthritis flare reveal joint-specific memory together with sustained risk for new joint accumulation.
      Arthritis Rheumatol. 2022 May 23. doi: 10.1002/art.42240. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35606924/

    • Kip MMA, de Roock S, Currie G, Marshall DA, Grazziotin LR, Twilt M, et al
      Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis.
      Rheumatology (Oxford). 2022 May 18:keac299. doi: 10.1093/rheumatology/keac299. Online ahead of print..
      https://pubmed.ncbi.nlm.nih.gov/35583252/

    • Brunello F, Tirelli F, Pegoraro L, Dell'Apa F, Alfisi A, Calzamatta G, Folisi C, Zulian F.
      New Insights on Juvenile Psoriatic Arthritis.
      Front Pediatr. 2022 May 26;10:884727. doi: 10.3389/fped.2022.884727. 
      https://pubmed.ncbi.nlm.nih.gov/35722498/

    • Smith AD, Saqib B, Lee RR, Shoop-Worrall S, Hyrich KL, McDonagh JE, Cordingley L.
      Is time a healer? How quality of life changes over time reported by parents of children and young people with Juvenile Idiopathic Arthritis.
      Rheumatology (Oxford). 2022 May 24:keac312. doi: 10.1093/rheumatology/keac312. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35608307/

    • Tollisen A, Selvaag AM, Aasland A, Ingebrigtsen T, Sagen J, Lerdal A, Flatø B.
      Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis.
      J Rheumatol. 2022 May 15:jrheum.211245. doi: 10.3899/jrheum.211245. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35569834/

ABRIL 2022

    • Sumner EJ, Almeida B, Palman J, Bale P, Heard C, Holzinger D, Roth J, Foell D, Robinson E, Ursu S, Wallace C, Gilmour K, Wedderburn LR, Ralph E.
      Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.
      Clin Rheumatol. 2022 Apr 29. doi: 10.1007/s10067-022-06165-4. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35486225/

    • Mannion ML, Cron RQ.
      Therapeutic strategies for treating juvenile idiopathic arthritis.
      Curr Opin Pharmacol. 2022 Apr 20;64:102226. doi: 10.1016/j.coph.2022.102226. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35461129/

    • Torres-Fernandez D, Perez-Heras I, Fernandez-Manso B, Galán Del Río P, Gonzalez-Granado LI, de Inocencio J.
      IgA deficiency and autoimmune comorbidities in Juvenile Idiopathic Arthritis.
      An Pediatr (Engl Ed). 2022 Apr 19:S2341-2879(22)00050-3. doi: 10.1016/j.anpede.2022.03.004. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35459637/

    • van Straalen JW, van Stigt Thans M, Wulffraat NM, de Roock S, Swart JF.
      A diagnostic prediction model for separating juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome.
      J Pediatr. 2022 Apr 20:S0022-3476(22)00344-4. doi: 10.1016/j.jpeds.2022.04.029. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35460700/

    • Naddei R, Di Gennaro S, Guarino A, Troncone R, Alessio M, Discepolo V.
      In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study.
      Pediatr Rheumatol Online J. 2022 Apr 22;20(1):31. doi: 10.1186/s12969-022-00689-4.
      https://pubmed.ncbi.nlm.nih.gov/35459143/

    • de Sonnaville WFC, Steenks MH, Speksnijder CM, Wulffraat NM, Rosenberg AJWP.
      Challenging the silent temporomandibular joint paradigm in children with juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2022 Apr 2;20(1):22. doi: 10.1186/s12969-022-00681-y.
      https://pubmed.ncbi.nlm.nih.gov/35366915/

 
MARZO 2022

    • Chun A, Muhammad LN, De Ranieri D.
      Comparison of efficacy between triamcinolone acetonide and triamcinolone hexacetonide for intraarticular therapy in juvenile idiopathic arthritis: a retrospective analysis.
      BMC Rheumatol. 2022 Mar 31;6(1):18. doi: 10.1186/s41927-022-00249-z.
      https://pubmed.ncbi.nlm.nih.gov/35354497/

    • Lee JJY, Eng SWM, Guzman J, Duffy CM, Tucker LB, Oen K, Yeung RSM, Feldman BM; ReACCh-Out Investigators.
      A comparison of Juvenile Idiopathic Arthritis classification systems with the Research in Arthritis in Canadian Children, Emphasizing Outcomes (ReACCh-Out) cohort.
      Arthritis Rheumatol. 2022 Mar 14. doi: 10.1002/art.42113. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35289119/

    • Fingerhutová Š, Jančová E, Doležalová P.
      Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
      Front Pediatr. 2022 Mar 7;10:823847. doi: 10.3389/fped.2022.823847
      https://pubmed.ncbi.nlm.nih.gov/35321008/

    •  Alongi A, Giancane G, Naddei R, Natoli V, Ridella F, Burrone M, Rosina S, Chedeville G, Alexeeva E, Horneff G, Foeldvari I, Filocamo G, Constantin T, Ruperto N, Ravelli A, Consolaro A; Pediatric Rheumatology International Trials Organization (PRINTO).
      Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.
      RMD Open. 2022 Mar;8(1):e002042. doi: 10.1136/rmdopen-2021-002042.
      https://pubmed.ncbi.nlm.nih.gov/35256534/

 
FEBRERO 2022

    • El Tal T, Ryan ME, Feldman BM, Bingham A, Burnham J, Batthish M, Bullock D, Ferraro K, Gilbert M, Gillispie-Taylor M, Gottlieb B, Harris JG, Hazen M, Laxer RM, Lee TC, Lovell D, Mannion M, Noonan L, Oberle E, Taylor J, Weiss JE, Yildirim Toruner C, Morgan EM.
      Consensus Approach to a Treat to Target Strategy in Juvenile Idiopathic Arthritis Care: Report from the 2020 PR-COIN Consensus Conference.
      J Rheumatol. 2022 Feb 1:jrheum.210709. doi: 10.3899/jrheum.210709.
      https://pubmed.ncbi.nlm.nih.gov/35105705/

    • Schulz C, Fuehner S, Schlüter B, Fobker M, Sengler C, Klotsche J, Niewerth M, Minden K, Foell D.
      Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA.
      Pediatr Rheumatol Online J. 2022 Feb 2;20(1):8. doi: 10.1186/s12969-022-00668-9.
      https://pubmed.ncbi.nlm.nih.gov/35109858/

    • Poddighe D, Romano M, Dossybayeva K, Abdukhakimova D, Galiyeva D, Demirkaya E.J.
      Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders.
      Clin Med. 2022 Feb 18;11(4):1089. doi: 10.3390/jcm11041089
      https://pubmed.ncbi.nlm.nih.gov/35207358/

    •  Zic C.
      Considerations for the Primary Care Provider Caring for Patients with Juvenile Idiopathic Arthritis Receiving Biologic Therapy.
      Pediatr Ann. 2022 Feb;51(2):e54-e56. doi: 10.3928/19382359-20220118-02. Epub 2022 Feb 1.
      https://pubmed.ncbi.nlm.nih.gov/35156891/

    • McHugh A, Chan A, Herrera C, Park JM, Balboni I, Gerstbacher D, Hsu JJ, Lee T, Thienemann M, Frankovich J.
      Profiling Behavioral and Psychological Symptoms in Children undergoing treatment for Spondyloarthritis and Polyarthritis.
      J Rheumatol. 2022 Feb 1:jrheum.210489. doi: 10.3899/jrheum.210489. 
      https://pubmed.ncbi.nlm.nih.gov/35105715/

    • Collin M, Ernberg M, Christidis N, Hedenberg-Magnusson B.
      Salivary biomarkers in children with juvenile idiopathic arthritis and healthy age-matched controls: a prospective observational study.
      Sci Rep. 2022 Feb 25;12(1):3240. doi: 10.1038/s41598-022-07233-0.
      https://pubmed.ncbi.nlm.nih.gov/35217774/

    • Zhang J.
      Mendelian Randomization Study Implies Causal Linkage Between Telomere Length and Juvenile Idiopathic Arthritis in a European Population.
      J Inflamm Res. 2022 Feb 15;15:977-986. doi: 10.2147/JIR.S354619.
      https://pubmed.ncbi.nlm.nih.gov/35210806/

    • Chen G, Deutsch GH, Schulert G, Zheng H, Jang S, Trapnell B, Lee P, Macaubas C, Ho K, Schneider C, Saper VE, de Jesus AA, Krasnow M, Grom A, Goldbach-Mansky R, Khatri P, Mellins ED, Canna SW.
      Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers.
      Arthritis Rheumatol. 2022 Feb 21. doi: 10.1002/art.42099. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/35189047/

    • Al-Naimi A, Toma H, Hamad SG, Ben Omran T.
      Farber Disease Mimicking Juvenile Idiopathic Arthritis: The First Reported Case in Qatar and Review of the Literature.
      Case Rep Genet. 2022 Feb 10;2022:2555235. doi: 10.1155/2022/2555235. 
      https://pubmed.ncbi.nlm.nih.gov/35186337/

    • Lewis KA, Osier N, Carrasco R, Chiou J, Carter P, Garcia A, Flowers E, Gennatas ED, Nguyen C, Rana A, Brown SA, Tiziani S.
      Serine, N-acetylaspartate differentiate adolescents with juvenile idiopathic arthritis compared with healthy controls: a metabolomics cross-sectional study.
      Pediatr Rheumatol Online J. 2022 Feb 10;20(1):12. doi: 10.1186/s12969-022-00672-z.
      https://pubmed.ncbi.nlm.nih.gov/35144633/ 

    • Butler S, Sculley D, Santos D, Fellas A, Gironès X, Singh-Grewal D, Coda A.
      Effectiveness of eHealth and mHealth Interventions Supporting Children and Young People Living With Juvenile Idiopathic Arthritis: Systematic Review and Meta-analysis.
      J Med Internet Res. 2022 Feb 2;24(2):e30457. doi: 10.2196/30457.
      https://pubmed.ncbi.nlm.nih.gov/35107431/
ENERO 2022

    • Verstegen RHJ, Shrader P, Balevic SJ, Beukelman T, Correll C, Dennos A, Phillips T, Feldman BM; CARRA Registry investigators.
      Dosing Variation at Initiation of Adalimumab and Etanercept is not Associated with Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry study.
      Arthritis Care Res (Hoboken). 2022 Jan 18. doi: 10.1002/acr.24859.
      https://pubmed.ncbi.nlm.nih.gov/35040593/

    • Glerup M, Arnstad ED, Rypdal V, Peltoniemi S, Aalto K, Rygg M, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
      Changing patterns in treatment, remission status and categories in a long-term Nordic cohort study of juvenile idiopathic arthritis.
      Arthritis Care Res (Hoboken). 2022 Jan 10. doi: 10.1002/acr.24857.
      https://pubmed.ncbi.nlm.nih.gov/35015381/ 

    • Martini A, Lovell DJ, Albani S, Brunner HI, Hyrich KL, Thompson SD, Ruperto N.
      Juvenile idiopathic arthritis.
      Nat Rev Dis Primers. 2022 Jan 27;8(1):5. doi: 10.1038/s41572-021-00332-8.
      https://pubmed.ncbi.nlm.nih.gov/35087087/

    • Zhao Y, Sullivan E, Son MB, Beukelman T.
      Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA.
      Ann Rheum Dis. 2022 Jan 27:annrheumdis-2021-221694. doi: 10.1136/annrheumdis-2021-221694.
      https://pubmed.ncbi.nlm.nih.gov/35086815/

    • Kaya Akca U, Batu ED, Sener S, Balik Z, Kasap Cuceoglu M, Atalay E, Basaran O, Bilginer Y, Ozen S.
      The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study.
      Clin Rheumatol. 2022 Jan 29. doi: 10.1007/s10067-022-06080-8.
      https://pubmed.ncbi.nlm.nih.gov/35091782/

    • Gavra H, Tirosh I, Spielman S, Greenberger S, Amarylio G, Harel L, Ben-Amitai D, Avitan-Hersh E, Yonatan BA.
      Validation of the psoriasis epidemiology screening tool (PEST) and the new early arthritis for psoriatic patients (EARP) in pediatric population: pilot study.
      Clin Rheumatol. 2022 Jan 14. doi: 10.1007/s10067-021-06009-7.
      https://pubmed.ncbi.nlm.nih.gov/35028742/

    • Rubin S, Ohana O, Goldberg O, Peled O, Gendler Y, Habot-Wilner Z, Levinsky Y, Tal R, Harel L, Amarilyo G.
      The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2022 Jan 29;20(1):5. doi: 10.1186/s12969-022-00666-x.
      https://pubmed.ncbi.nlm.nih.gov/35093116/

    •  van Dijkhuizen EHP, Ridella F, Naddei R, Trincianti C, Avrusin I, Mazzoni M, Sutera D, Ayaz NA, Penades IC, Constantin T, Herlin T, Oliveira SK, Rygg M, Sanner H, Susic G, Sztajnbok F, Varbanova B, Ruperto N, Ravelli A, Consolaro A; Paediatric Rheumatology International Trials Organisation (PRINTO).
      Validity and reliability of four parent/patient reported outcome measures for juvenile idiopathic arthritis remote monitoring.
      Arthritis Care Res (Hoboken). 2022 Jan 10. doi: 10.1002/acr.24855.
      https://pubmed.ncbi.nlm.nih.gov/35015379/

    •  Yarwood A, Shoop-Worrall S, Lopez-Isac E, Smith SL, Morris AP; Childhood Arthritis Prospective Study (CAPS) group, Bowes JD, Tordoff M, Hyrich KL, Thomson W, Eyre S.
      No evidence that genetic predictors of susceptibility predict changes in core outcomes in JIA.
      Rheumatology (Oxford). 2022 Jan 7:keab942. doi: 10.1093/rheumatology/keab942.
      https://pubmed.ncbi.nlm.nih.gov/35015833/

    • Van Der Heijden H, Fatou B, Sibai D, Hoyt K, Taylor M, Cheung K, Lemme J, Cay M, Goodlett B, Lo J, Hazen MM, Halyabar O, Meidan E, Schreiber R, Jaimes C, Ecklund K, Henderson LA, Chang MH, Nigrovic PA, Sundel RP, Steen H, Upadhyay J.
      Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2022 Jan 15;20(1):3. doi: 10.1186/s12969-022-00662-1.
      https://pubmed.ncbi.nlm.nih.gov/35033099/

    • Fischer J, Dirks J, Klaussner J, Haase G, Holl-Wieden A, Hofmann C, Hackenberg S, Girschick H, Morbach H.
      Effect of Clonally Expanded PD-1high CXCR5-CD4+ Peripheral T Helper Cells on B Cell Differentiation in the Joints of Patients With Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis.
      Arthritis Rheumatol. 2022 Jan;74(1):150-162. doi: 10.1002/art.41913.
      https://pubmed.ncbi.nlm.nih.gov/34196496/

 
DICIEMBRE 2021

    • Młyńczyk J, Abramowicz P, Stawicki MK, Konstantynowicz J.
      Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice.
      Rheumatol Int. 2021 Dec 31;1-13. doi: 10.1007/s00296-021-05077-x. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34971434/

    • Jones JT, Smith C, Becker ML, Lovell D, CARRA Registry Investigators.
      Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes.
      Arthritis Care Res (Hoboken). 2021 Dec;73(12):1739-1745. doi: 10.1002/acr.24418.
      https://pubmed.ncbi.nlm.nih.gov/33242376/

    • Giancane G, Campone C, Gicchino MF, Alongi A, Bava C, Rosina S et al.
      Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis.
      Arthritis Care Res (Hoboken). 2021 Dec;73(12):1722-1729. doi: 10.1002/acr.24415. Epub 2021 Oct 11.
      https://pubmed.ncbi.nlm.nih.gov/33242352/

    • Bhardwaj U, Bagri NK, Lodha R, Kabra SK, Velpandian T, Pandey RV.
      Efficacy of Pulse Dexamethasone in non-systemic Juvenile Idiopathic Arthritis: a double-blind randomised controlled trial.
      Rheumatology (Oxford). 2021 Dec 9;keab914. doi: 10.1093/rheumatology/keab914. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34888654/

    • Garner AJ, Saatchi R, Ward O, Hawley DP.
      Juvenile Idiopathic Arthritis: A Review of Novel Diagnostic and Monitoring Technologies.
      Healthcare (Basel). 2021 Dec 4;9(12):1683. doi: 10.3390/healthcare9121683.
      https://pubmed.ncbi.nlm.nih.gov/34946409/

    • Sol Funk R, Becker ML.
      Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis.
      Front Pharmacol. 2021 Dec 9;12:768599. doi: 10.3389/fphar.2021.768599. eCollection 2021.
      https://pubmed.ncbi.nlm.nih.gov/34955838/

    •  Bagri NK, Karmakar S, Haldar P, Lodha R, Kabra SK.
      Role of Serum MRP8/14 in Predicting Response to Methotrexate in Children With Juvenile Idiopathic Arthritis.
      J Clin Rheumatol. 2021 Dec 1;27(8):e336-e341. doi: 10.1097/RHU.0000000000001406.
      https://pubmed.ncbi.nlm.nih.gov/32658390/ 

 
 
NOVIEMBRE 2021

    • Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, et al for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG).
      Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
      Lancet. 2021 Nov 27;398(10315):1984-1996. doi: 10.1016/S0140-6736(21)01255-1.
      https://pubmed.ncbi.nlm.nih.gov/34767764/

    • Mora JR, Wong R, Shaikh M, Askelson M.
      Analysis of the Immunogenicity from Abatacept-Treated Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Findings From Two Phase III Clinical Trials.
      ACR Open Rheumatol. 2021 Nov 18. doi: 10.1002/acr2.11375. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34792858/

    • Balevic SJ, Becker ML, Gonzalez D, Funk RS.
      Low Etanercept Concentrations in Children With Obesity and Juvenile Idiopathic Arthritis.
      J Pediatr Pharmacol Ther. 2021;26(8):809-814. doi: 10.5863/1551-6776-26.8.809.
      https://pubmed.ncbi.nlm.nih.gov/34790070/

    • Oliveira Ramos F, Rodrigues A, Magalhaes Martins F, Melo AT, Aguiar F, Brites L, et al.
      Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases.
      RMD Open. 2021 Nov;7(3):e001766. doi: 10.1136/rmdopen-2021-001766.
      https://pubmed.ncbi.nlm.nih.gov/34819385/

    • Gomes CMF, Terreri MT, Moraes-Pinto MI, Pinheiro MM.
      Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis under TNFα inhibitors: a 24-month prospective study.
      Adv Rheumatol. 2021 Nov 27;61(1):71. doi: 10.1186/s42358-021-00226-z.
      https://pubmed.ncbi.nlm.nih.gov/34838126/

    • Reiser C, Zeltner NA, Rettenbacher B, Baumgaertner P, Huemer M, Huemer C.
      Explaining juvenile idiopathic arthritis to paediatric patients using illustrations and easy-to-read texts: improvement of disease knowledge and adherence to treatment.
      Pediatr Rheumatol Online J. 2021 Nov 8;19(1):158. doi: 10.1186/s12969-021-00644-9.
      https://pubmed.ncbi.nlm.nih.gov/34749738/

    • Lundberg V, Eriksson C, Lind T, Coyne I, Fjellman-Wiklund A.
      How children with juvenile idiopathic arthritis view participation and communication in healthcare encounters: a qualitative study.
      Pediatr Rheumatol Online J. 2021 Nov 2;19(1):156. doi: 10.1186/s12969-021-00642-x.
      https://pubmed.ncbi.nlm.nih.gov/34727931/

    • Hügle B, Krumrey-Langkammerer M, Haas JP.
      Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication.
      Pediatr Rheumatol Online J. 2021 Nov 29;19(1):163. doi: 10.1186/s12969-021-00653-8.
      https://pubmed.ncbi.nlm.nih.gov/34844609/

    • Roß J, Foeldvari I, Krajewski KL, Butscheidt S, Beil FT, Stücker R, Spiro AS.
      Does Juvenile Idiopathic Arthritis Affect the Course of Legg-Calvé-Perthes Disease? A Case-Control Study with a Mean Follow-Up of 8 Years.
      Children (Basel). 2021 Nov 5;8(11):1014. doi: 10.3390/children8111014.
      https://pubmed.ncbi.nlm.nih.gov/34828727/

    • Omar AA, Ahmed S, Rodrigues JC, Kayiza A, Owino L.
      Progressive pseudorheumatoid dysplasia misdiagnosed as juvenile idiopathic arthritis: a case report.
      J Med Case Rep. 2021 Nov 8;15(1):551. doi: 10.1186/s13256-021-03082-z.
      https://pubmed.ncbi.nlm.nih.gov/34749805/

    • Clarke SL, Mitchell RE, Sharp GC, Ramanan AV, Relton CL.
      Vitamin D levels and risk of juvenile idiopathic arthritis: A Mendelian randomization study.
      Arthritis Care Res (Hoboken). 2021 Nov 8. doi: 10.1002/acr.24815. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34748291/

 
OCTUBRE 2021

    • Wu J, Wang L, Xu Y, Zhang Z, Yan X, An Y, Zhang Y, Tang X.
      Multicentric Carpo-Tarsal Osteolysis Syndrome Mimicking Juvenile Idiopathic Arthritis: Two case reports and review of the literature.
      Front Pediatr. 2021 Oct 15;9:745812. doi: 10.3389/fped.2021.745812. eCollection 2021.
      https://pubmed.ncbi.nlm.nih.gov/34722426/

    • Horneff G, Klein A, Láday M, Lunt M, de Roock S, Ruperto N, Schoemaker C, Vijatov-Djuric G, Vojinovic J, Vougiouka O, Wulffraat NM; UK JIA Biologics Registers Investigators Group; Paediatric Rheumatology International Trials Organisation (PRINTO), Hyrich KL, Minden K, Swart JF.
      Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries.
      Rheumatology (Oxford). 2021 Oct 6:keab641. doi: 10.1093/rheumatology/keab641. Online ahead of print.PMID:34613385
      https://pubmed.ncbi.nlm.nih.gov/34613385/

    • García-Rodríguez F, Gamboa-Alonso A, Jiménez-Hernández S, Ochoa-Alderete L, Barrientos-Martínez VA, Alvarez-Villalobos NA, Luna-Ruíz GA, Peláez-Ballestas I, Villarreal-Treviño AV, de la O-Cavazos ME, Rubio-Pérez N.
      Economic impact of Juvenile Idiopathic Arthritis: a systematic review.
      Pediatr Rheumatol Online J. 2021 Oct 9;19(1):152. doi: 10.1186/s12969-021-00641-y.
      https://pubmed.ncbi.nlm.nih.gov/34627296/

    • Cavagnetto D, Abate A, Caprioglio A, Cressoni P, Maspero C.
      Three-dimensional volumetric evaluation of the different mandibular segments using CBCT in patients affected by juvenile idiopathic arthritis: a cross-sectional study.
      Prog Orthod. 2021 Oct 1;22(1):32. doi: 10.1186/s40510-021-00380-6.
      https://pubmed.ncbi.nlm.nih.gov/34595615/

SEPTIEMBRE 2021

    • Kearsley-Fleet L, Klotsche J, van Straalen JW, Costello W, D'Angelo G, Giancane G, Trincianti C, Van Dijkhuizen EHP, Alongi A, Mazzoni M, Swart JF, Nikishina I, Lahdenne P, Rutkowska-Sak L, Avcin T, Quartier P, Panaviene V, Uziel Y, Pruunsild C, Vargova V, Vilaiyuk S, Dolezalova P, Ringold S, Garrone M, Ruperto N, Ravelli A, Consolaro A; Paediatric Rheumatology International Trials Organisation.
      Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis.
      Arthritis Rheumatol. 2021 Sep 28. doi: 10.1002/art.41879. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34582120/

    • Costello R, McDonagh J, Hyrich K, Humphreys J.
      Incidence and prevalence of Juvenile Idiopathic Arthritis in the United Kingdom 2000-2018: results from the Clinical Practice Research Datalink.
      Rheumatology (Oxford). 2021 Sep 29:keab714. doi: 10.1093/rheumatology/keab714. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34586398/

    • van Straalen JW, Krol RM, Giancane G, Panaviene V, Ailioaie LM, Doležalová P, Cattalini M, Susic G, Sztajnbok F, Maritsi D, Constantin T, Sawhney S, Rygg M, Oliveira SK, Nordal EB, Saad-Magalhaes C, Rubio-Perez N, Jelusic M, de Roock S, Wulffraat NM, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO).
      Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use.
      Rheumatology (Oxford). 2021 Sep 11:keab678. doi: 10.1093/rheumatology/keab678. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34508559/

    • Filosco F, Giallongo A, Leonardi S, Tomaselli V, Barone P.
      Early intra-articular corticosteroid injection is predictor of remission of juvenile idiopathic arthritis.
      Minerva Pediatr (Torino). 2021 Sep 13. doi: 10.23736/S2724-5276.21.06343-6. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34515444/

    • Grazziotin LR, Currie G, Twilt M, Ijzerman MJ, Kip MMA, Koffijberg H, et al.; UCAN CAN-DU, UCAN CURE consortia.
      Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study.
      Rheumatol Ther. 2021 Sep;8(3):1303-1322. doi: 10.1007/s40744-021-00331-x. Epub 2021 Jul 18.
      https://pubmed.ncbi.nlm.nih.gov/34275124/

    • Kindgren E, Ludvigsson J.
      Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study.
      Pediatr Rheumatol Online J. 2021 Sep 16;19(1):145. doi: 10.1186/s12969-021-00611-4.
      https://pubmed.ncbi.nlm.nih.gov/34530851/

    • Lassoued Ferjani H, Maatallah K, Miri S, Triki W, Nessib DB, Kaffel D, Hamdi W.
      Enthesitis-related arthritis: monitoring and specific tools.
      J Pediatr (Rio J). 2021 Sep 28:S0021-7557(21)00121-2. doi: 10.1016/j.jped.2021.08.002. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34597529/

    • Saidi O, Rochette E, Bourdier P, Ratel S, Merlin E, Pereira B, Duché P. 
      Sleep in children and adolescents with juvenile idiopathic arthritis: a systematic review and meta-analysis of case-control studies.
      Sleep. 2021 Sep 15:zsab233. doi: 10.1093/sleep/zsab233. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34525202/

    • Arif CA, Randy C, Matthew S, Serhat S, Brian K, Peter W, Jue W, Viet V, Linh T, How KC.
      Comparison of the condyle-fossa relationship and resorption between patients with and without Juvenile Idiopathic Arthritis (JIA).
      J Oral Maxillofac Surg. 2021 Sep 12:S0278-2391(21)01114-9. doi: 10.1016/j.joms.2021.09.004. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34627744/

    • Rajendiran A, Klemm P, Schippers A, Scheufen A, Schwarz T, Peitz J, Brandenburg LO, Wagner N, Consolaro A, Raggi F, Bosco MC, Luedde T, Foell D, Denecke B, Horneff G, Ohl K, Tenbrock K.
      miR-23a contributes to T cellular redox metabolism in juvenile idiopathic oligoarthritis.
      Rheumatology (Oxford). 2021 Sep 24:keab709. doi: 10.1093/rheumatology/keab709. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34559194/ 

    • Yamazaki S, Shimizu M, Akutsu Y, Shimbo A, Mori M
      Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis.
      Mod Rheumatol. 2021 Sep 20:roab055. doi: 10.1093/mr/roab055. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34918100/

 
AGOSTO 2021

    • Thiele F, Klein A, Hospach A, Windschall D, Mrusek S, Ruehlmann JM, Horneff G.
      Efficacy and Safety of Etanercept Biosimilars Compared with the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study.
      ACR Open Rheumatol. 2021 Aug 27. doi: 10.1002/acr2.11325. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34449981/

    •  Beukelman T, Lougee A, Matsouaka RA, Collier D, Rumsey DG, Schenfeld J, Stryker S, Twilt M, Kimura Y; CARRA Registry Investigators.
      Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
      Pediatr Rheumatol Online J. 2021 Aug 21;19(1):131. doi: 10.1186/s12969-021-00625-y.
      https://pubmed.ncbi.nlm.nih.gov/34419107/

    • Upadhyay J, Lemme J, Cay M, Van Der Heijden H, Sibai D, Goodlett B, Lo J, Hoyt K, Taylor M, Hazen MM, Halyabar O, Meidan E, Schreiber R, Chang MH, Nigrovic PA, Jaimes C, Henderson LA, Ecklund K, Sundel RP.
      A multidisciplinary assessment of pain in juvenile idiopathic arthritis.
      Semin Arthritis Rheum. 2021 Aug;51(4):700-711. doi: 10.1016/j.semarthrit.2021.05.011. 
      https://pubmed.ncbi.nlm.nih.gov/34139523/

    • Cardoso I, Frederiksen P, Specht IO, Händel MN, Thorsteinsdottir F, Heitmann BL, Kristensen LE.
      Age and Sex Specific Trends in Incidence of Juvenile Idiopathic Arthritis in Danish Birth Cohorts from 1992 to 2002: A Nationwide Register Linkage Study
      Int J Environ Res Public Health. 2021 Aug 6;18(16):8331. doi: 10.3390/ijerph18168331.
      https://pubmed.ncbi.nlm.nih.gov/34444082/

    •  Sahin S, Acari C, Sonmez HE, Kilic FZ, Sag E, Dundar HA, Adrovic A, Demir S, Barut K, Bilginer Y, Sozeri B, Unsal E, Ozen S, Kasapcopur O
      Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER.
      Pediatr Rheumatol Online J. 2021 Aug 23;19(1):134. doi: 10.1186/s12969-021-00613-2.
      https://pubmed.ncbi.nlm.nih.gov/34425847/

    • Gil EG, Åstrøm AN, Lie SA, Rygg M, Fischer J, Rosén A, Bletsa A, Luukko K, Shi XQ, Halbig J, Frid P, Cetrelli L, Tylleskär K, Rosendahl K, Skeie MS.
      Dental caries in children and adolescents with juvenile idiopathic arthritis and controls: a multilevel analysis.
      BMC Oral Health. 2021 Aug 25;21(1):417. doi: 10.1186/s12903-021-01758-y.
      https://pubmed.ncbi.nlm.nih.gov/34433437/

    • Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA.
      Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
      Pediatr Rheumatol Online J. 2021 Aug 23;19(1):135. doi: 10.1186/s12969-021-00629-8.
      https://pubmed.ncbi.nlm.nih.gov/34425842/ 
JULIO 2021

    • Schiappapietra B, Bava C, Rosina S, Pistorio A, Mongelli F, Pederzoli S, Verazza S, Lanni S, Muratore V, Davì S, Dalprà S, Varnier GC, Bertamino M, Suffia C, Bracciolini G, Giancane G, Consolaro A, Ravelli A.
      A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis.
      Clin Exp Rheumatol. 2021 Jul-Aug;39(4):913-919. Epub 2021 May 5. PMID: 34001309.
      https://pubmed.ncbi.nlm.nih.gov/34001309/

    •  Rumsey DG, Lougee A, Matsouaka R, Collier DH, Schanberg LE, Schenfeld J, Shiff NJ, Stoll ML, Stryker S, Weiss PF, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators.
      Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis.
      Arthritis Care Res (Hoboken). 2021 Jul;73(7):940-946. doi: 10.1002/acr.24537. PMID: 33331139.
      https://pubmed.ncbi.nlm.nih.gov/33331139/

    • de Sonnaville WFC, Speksnijder CM, Zuithoff NPA, Verkouteren DRC, Wulffraat NW, Steenks MH, Rosenberg AJWP.
      Mandibular range of motion in children with juvenile idiopathic arthritis with and without clinically established temporomandibular joint involvement and in healthy children; a cross-sectional study.
      Pediatr Rheumatol Online J. 2021 Jul 3;19(1):106. doi: 10.1186/s12969-021-00583-5. PMID: 34217306; PMCID: PMC8254997.
      https://pubmed.ncbi.nlm.nih.gov/34217306/

    • Xu D, Zhang Y, Zhang ZY, Tang XM.
      Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study.
      Pediatr Rheumatol Online J. 2021 Jul 12;19(1):112. doi: 10.1186/s12969-021-00587-1. PMID: 34247641; PMCID: PMC8273958.
      https://pubmed.ncbi.nlm.nih.gov/34247641/

JUNIO 2021

    • Silvia Rosina, Valentina Natoli, Stefania Santaniello, Chiara Trincianti, Alessandro Consolaro, Angelo Ravelli.
      Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis.
      Expert Rev Clin Immunol. 2021 Jun 17. doi: 10.1080/1744666X.2021.1945441. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34139935/

    •  Yukiko Kimura, Laura E Schanberg, George A Tomlinson et al.
      The Childhood Arthritis & Rheumatology Research Alliance Start Time Optimization of Biologics in Polyarticular Juvenile Idiopathic Arthritis Study (STOP-JIA): A Comparative Effectiveness Study of CARRA Consensus Treatment Plans for Untreated Polyarticular JIA.
      Arthritis Rheumatol. 2021 Jun 8. doi: 10.1002/art.41888. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34105312/

    •  Mei Sing Ong, Sarah Ringold, Yukiko Kimura et al.
      Improved disease course associated with early initiation of biologics in untreated polyarticular Juvenile Idiopathic Arthritis: A trajectory analysis of the STOP-JIA study.
      Arthritis Rheumatol. 2021 Jun 8. doi: 10.1002/art.41892. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34105303/

    •  R Naveen, Namita Mohindra, Neeraj Jain, Sanjukta Majumder, Amita Aggarwal.
      Hip involvement in children with enthesitis related arthritis (ERA) is associated with poor outcomes in adulthood.
      Clin Rheumatol. 2021 Jun 25;1-9. doi: 10.1007/s10067-021-05807-3. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34169374/

    •  Liane D Heale, Kristin M Houghton, Elham Rezaei et al.
      Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2021 Jun 29;19(1):97. doi: 10.1186/s12969-021-00584-4.
      https://pubmed.ncbi.nlm.nih.gov/34187498/

    •  Sulaiman M Al-Mayouf, Abeer Alrasheedi, Iman Almsellati et al.
      Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage.
      Int J Rheum Dis. 2021 Jun 29.  doi: 10.1111/1756-185X.14167. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34184820/

    •   Lillemor Berntson.
      A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2021 Jun 10;19(1):88. doi: 10.1186/s12969-021-00577-3.
      https://pubmed.ncbi.nlm.nih.gov/34112181/

    •  Colleen Nesbitt, Gregor Kuntze, Clodagh Toomey et al.
      Secondary consequences of juvenile idiopathic arthritis in children and adolescents with knee involvement: physical activity, adiposity, fitness, and functional performance.
      Rheumatol Int. 2021 Jun 16. doi: 10.1007/s00296-021-04920-5. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34132889/

    • Micol Romano, Valeria Gerloni, Orazio De Lucia et al.
      Serum calprotectin (S100A8/9), clinical and ultrasound assessment in patients with juvenile idiopathic arthritis.
      Clin Exp Rheumatol. 2021 Jun 8. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/34128789/

    • La C, Lê PQ, Ferster A, et al.
      Serum calprotectin (S100A8/A9): a promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis.
      RMD Open 2021;7:e001646. doi:10.1136/ rmdopen-2021-001646
      https://pubmed.ncbi.nlm.nih.gov/34108235/

 
MAYO 2021

    • Pagnini I, Scavone M, Maccora I, Mastrolia MV, Marrani E, Bertini F, Lamot L, Simonini G.
      The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?
      Front Med (Lausanne). 2021 May 13;8:667305. doi: 10.3389/fmed.2021.667305
      https://pubmed.ncbi.nlm.nih.gov/34055840/

    •  Kip MMA, de Roock S, van den Berg I, Currie G, Marshall DA, Grazziotin LR, Twilt M, Yeung RSM, Benseler SM, Vastert SJ, Wulffraat N, Swart JF, IJzerman MJ.
      Costs of hospital-associated care for patients with juvenile idiopathic arthritis in the Dutch healthcare system.
      Arthritis Care Res (Hoboken). 2021 May 2. doi:10.1002/acr.24621
      https://pubmed.ncbi.nlm.nih.gov/33938161/

    •  Ganeva M, Fuehner S, Kessel C, Klotsche J, Niewerth M, Minden K, Foell D, Hinze CH, Wittkowski H.
      Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.
      Pediatr Rheumatol Online J. 2021 May 1;19(1):64. doi:10.1186/s12969-021-00553-x
      https://pubmed.ncbi.nlm.nih.gov/33933108/

ABRIL 2021

    • Öman A, Dicksved J, Engstrand L, Berntson L
      Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
      Pediatr Rheumatol Online J. 2021 Apr 26;19(1):55
      https://pubmed.ncbi.nlm.nih.gov/33902613/

 
MARZO 2021

    • Lovell DJ, Huang B, Chen C, Angeles-Han ST, Simon TA, Brunner HI.
      Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis.
      RMD Open. 2021 Mar;7(1):e001435. doi: 10.1136/rmdopen-2020-001435.
      https://pubmed.ncbi.nlm.nih.gov/33731444/

    •  Nigrovic PA, Colbert RA, Holers VM, Ozen S, Ruperto N, Thompson SD, Wedderburn LR, Yeung RSM, Martini A.
      Biological classification of childhood arthritis: roadmap to a molecular nomenclature.
      Nat Rev Rheumatol. 2021 Mar 17. doi: 10.1038/s41584-021-00590-6. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/33731872/

    • Harhay R, Jeelani W, Agbor BTA, Hennon T, Wrotniak BH, Abdul-Aziz R.
      Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2021 Mar 20;19(1):36. doi: 10.1186/s12969-021-00520-6.
      https://pubmed.ncbi.nlm.nih.gov/33743721/

    •  Raab A, Kallinich T, Huscher D, Foeldvari I, Weller-Heinemann F, Dressler F, Kuemmerle-Deschner JB, Klein A, Horneff G.
      Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate - data of the German BIKER registry.
      Pediatr Rheumatol Online J. 2021 Mar 22;19(1):41. doi: 10.1186/s12969-021-00522-4.
      https://pubmed.ncbi.nlm.nih.gov/33752685/

    • Yue X, Huang B, Hincapie AL, Wigle PR, Qiu T, Li Y, Morgan EM, Guo JJ.
      Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis.
      Paediatr Drugs. 2021 Mar;23(2):171-182. doi: 10.1007/s40272-021-00436-4.
      https://pubmed.ncbi.nlm.nih.gov/33651370/

    • Doeleman MJH, de Roock S, Buijsse N, Klein M, Bonsel GJ, Seyfert-Margolis V, Swart JF, Wulffraat NM.
      Monitoring patients with juvenile idiopathic arthritis using health-related quality of life.
      Pediatr Rheumatol Online J. 2021 Mar 22;19(1):40. doi: 10.1186/s12969-021-00527-z.
      https://pubmed.ncbi.nlm.nih.gov/33752695/

    •  Rapley T, May C, Smith N, Foster HE.
      'Snakes & Ladders': factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis- a qualitative study
      Pediatr Rheumatol Online J. 2021 Mar 23;19(1):43. doi: 10.1186/s12969-021-00531-3.
      https://pubmed.ncbi.nlm.nih.gov/33757545/

    •  Pearce C, Newman S, Mulligan K.
      Illness Uncertainty in Parents of Children with Juvenile Idiopathic Arthritis.
      ACR Open Rheumatol. 2021 Mar 12. doi: 10.1002/acr2.11238. Online ahead of print.
      https://pubmed.ncbi.nlm.nih.gov/33710801/

    • Arnstad ED, Glerup M, Rypdal V, Peltoniemi S, Fasth A, Nielsen S, et al; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
      Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort.
      Pediatr Rheumatol Online J. 2021 Mar 18;19(1):33. doi: 10.1186/s12969-021-00499-0.
      https://pubmed.ncbi.nlm.nih.gov/33736650/

    • d'Angelo DM, Di Donato G, Breda L, Chiarelli F.
      Growth and puberty in children with juvenile idiopathic arthritis.
      Pediatr Rheumatol Online J. 2021 Mar 12;19(1):28. doi: 10.1186/s12969-021-00521-5.
      https://pubmed.ncbi.nlm.nih.gov/33712046/

FEBRERO 2021
ENERO 2021

    • Alexeeva E, Horneff G, Dvoryakovskaya T, Denisova R, Nikishina I, Zholobova E, Malievskiy V, Santalova G, Stadler E, Balykova L, Spivakovskiy Y, Kriulin I, Alshevskaya A, Moskalev A.
      Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial.
      Pediatr Rheumatol Online J. 2021 Jan 6;19(1):5. doi: 10.1186/s12969-020-00488-9. PMID: 33407590; PMCID: PMC7788754.
      https://pubmed.ncbi.nlm.nih.gov/33407590/

    • Ghantous N, Heshin-Bekenstein M, Dequattro K, Lakovsky Y, Hendel AM, Rappoport N, Aviel YB, Tirosh I, Harel L, Weiss PF, Gensler L, Mackenzie J, Amarilyo G.
      Do geography and ethnicity play a role in juvenile Spondyloarthritis? A multi-center binational retrospective study.
      Pediatr Rheumatol Online J. 2021 Jan 6;19(1):4. doi: 10.1186/s12969-020-00489-8. PMID: 33407634; PMCID: PMC7788991.
      https://pubmed.ncbi.nlm.nih.gov/33407634/

    • Meng X, Hou X, Wang P, Glessner JT, Qu HQ, March ME, Zhang S, Qi X, Zhu C, Nguyen K, Gao X, Li X, Liu Y, Zhou W, Zhang S, Li J, Sun Y, Yang J, Sleiman PMA, Xia Q, Hakonarson H, Li J.
      Association of novel rare coding variants with juvenile idiopathic arthritis.
      Ann Rheum Dis. 2021 Jan 6:annrheumdis-2020-218359. doi: 10.1136/annrheumdis-2020-218359. Epub ahead of print. PMID: 33408077.
      https://pubmed.ncbi.nlm.nih.gov/33408077/

    • McDonald J, Cassedy A, Altaye M, Andringa J, Cooper AM, Drews-Botsch C, Engelhard G Jr, Hennard T, Holland GN, Jenkins K, Lambert SR, Lipscomb J, McCracken C, McCurdy DK, Mwase N, Prahalad S, Shantha J, Stahl E, Miraldi Utz V, Walker AA, Yeh S, Angeles-Han ST.
      Comprehensive assessment of quality of life, functioning and mental health in children with juvenile idiopathic arthritis and non-infectious uveitis.
      Arthritis Care Res (Hoboken). 2021 Jan 9. doi: 10.1002/acr.24551. Epub ahead of print. PMID: 33421338.
      https://pubmed.ncbi.nlm.nih.gov/33421338/

    • Ruperto N, Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Cimaz R, Dare J, Espada G, Faugier E, Ferrandiz M, Gerloni V, Quartier P, Silva CA, Wagner-Weiner L, Gandhi Y, Passarell J, Nys M, Wong R, Martini A, Lovell DJ; Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO).
      Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
      J Rheumatol. 2021 Jan 15:jrheum.200154. doi: 10.3899/jrheum.200154. Epub ahead of print. PMID: 33452173.
      https://pubmed.ncbi.nlm.nih.gov/33452173/

    • Lipinska J, Kaszkowiak M, Malachowska B, Swidrowska-Jaros J, Smolewska E.
      Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value-a single-center study.
      Arthritis Res Ther. 2021 Jan 26;23(1):40. doi: 10.1186/s13075-021-02424-y. PMID: 33494811; PMCID: PMC7836505.
      https://pubmed.ncbi.nlm.nih.gov/33494811/

DICIEMBRE 2020

    • Chhabra A, Robinson C, Houghton K, Cabral DA, Morishita K, Tucker LB, Petty RE, Larché M, Batthish M, Guzman J.
      Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
      Rheumatology (Oxford). 2020 Dec 1;59(12):3727-3730
      https://pubmed.ncbi.nlm.nih.gov/32402087/

    • Yue X, Huang B, Hincapie AL, Wigle PR, Li Y, Qiu T, Lovell DJ, Morgan EM, Guo JJ.
      Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large pediatric rheumatology center in US.
      Rheumatology (Oxford). 2020 Dec 28:keaa877
      https://pubmed.ncbi.nlm.nih.gov/33369673/

    • Rumsey DG, Lougee A, Matsouaka R, Collier DH, Schanberg LE, Schenfeld J, Shiff NJ, Stoll ML, Stryker S, Weiss PF, Beukelman T; CARRA Registry Investigators.
      Juvenile Spondyloarthritis in the CARRA Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis.
      Arthritis Care Res (Hoboken). 2020 Dec 16. doi: 10.1002/acr.24537
      https://pubmed.ncbi.nlm.nih.gov/33331139/

    • Weiss PF, Fuhlbrigge RC, von Scheven E, Lovell DJ, Colbert RA, Brunner HI; PRCSG Advisory Council, the CARRA Executive Committee.
      Children with enthesitis-related arthritis could benefit from treatments targeted for adults with spondyloarthritis.
      Arthritis Care Res (Hoboken). 2020 Dec 5. doi: 10.1002/acr.24529
      https://pubmed.ncbi.nlm.nih.gov/33278336/

    • Cánovas R, Cobb J, Brozynska M, Bowes J, Li YR, Smith SL, Hakonarson H, Thomson W, Ellis JA, Abraham G, Munro JE, Inouye M.
      Genomic risk scores for juvenile idiopathic arthritis and its subtypes.
      Ann Rheum Dis. 2020 Dec;79(12):1572-1579
      https://pubmed.ncbi.nlm.nih.gov/32887683/

    • Bridges JM, Stoll ML.
      Treatment of Juvenile Spondyloarthritis: Where We Stand.
      Paediatr Drugs. 2020 Dec;22(6):603-615
      https://pubmed.ncbi.nlm.nih.gov/32885389/

    • Marino A, De Souza M, Giani T, Cimaz R.
      Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
      Expert Opin Pharmacother. 2020 Dec;21(17):2161-2168
      https://pubmed.ncbi.nlm.nih.gov/32726179/

    • Viscuso D, Storari M, Aprile M, Denotti G.
      Temporomandibular Disorders and Juvenile Idiopathic Arthritis: Scoping review with a case report.
      Eur J Paediatr Dent. 2020 Dec;21(4):303-308
      https://pubmed.ncbi.nlm.nih.gov/33337907/

    • Öman A, Dicksved J, Engstrand L, Berntson L.
      Fecal microbiota in untreated children with Juvenile Idiopathic Arthritis - a comparison with healthy children and healthy siblings.
      J Rheumatol. 2020 Dec 1:jrheum.200551
      https://pubmed.ncbi.nlm.nih.gov/33262301/

    • Butler S, Sculley D, Santos DS, Fellas A, Gironès X, Singh-Grewal D, Coda A.
      Usability of eHealth and Mobile Health Interventions by Young People Living With Juvenile Idiopathic Arthritis: Systematic Review.
      JMIR Pediatr Parent. 2020 Dec 1;3(2):e15833
      https://pubmed.ncbi.nlm.nih.gov/33258786/

    • Toupin-April K, Huber AM, Duffy CM, Proulx L, Morgan EM, Cohen JS, Gaboury I, Li LC, Tugwell P, Stinson J; JIA Option Map Group.
      Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map.
      Patient. 2020 Dec;13(6):719-728
      https://pubmed.ncbi.nlm.nih.gov/33033937/

    • Nagy A, Mosdosi B, Simon D, Dergez T, Berki T.
      Peripheral Blood Lymphocyte Analysis in Oligo- and Polyarticular Juvenile Idiopathic Arthritis Patients Receiving Methotrexate or Adalimumab Therapy: A Cross-Sectional Study.
      Front Pediatr. 2020 Dec 10;8:614354
      https://pubmed.ncbi.nlm.nih.gov/33363071/

    • Yildiz M, Dedeoglu R, Akdeniz B, Adrovic A, Haslak F, Karagozlu F, Koker O, Ulug N, Sahin S, Barut K, Oztunc F, Kasapcopur O.
      Systolic and Diastolic Cardiac Functions in Juvenile Spondyloarthropathies.
      J Clin Rheumatol. 2020 Dec 15
      https://pubmed.ncbi.nlm.nih.gov/33337801/

    • Metzemaekers M, Malengier-Devlies B, Yu K, Vandendriessche S, Yserbyt J, Matthys P, De Somer L, Wouters C, Proost P.
      Synovial fluid neutrophils from patients with juvenile idiopathic arthritis display a hyperactivated phenotype.
      Arthritis Rheumatol. 2020 Dec 2. doi: 10.1002/art.41605
      https://pubmed.ncbi.nlm.nih.gov/33264510/

 
NOVIEMBRE 2020

  • Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier GC, Verazza S, Giancane G, Consolaro A, Ravelli A.
    Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis
    Clin Exp Rheumatol. 2020 Nov 12.
    https://pubmed.ncbi.nlm.nih.gov/33200734/

  • Chang JC, Xiao R, Burnham JM, Weiss PF.
    Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention.
    Pediatr Rheumatol Online J. 2020 Nov 13;18(1):88
    https://pubmed.ncbi.nlm.nih.gov/33187519/
  • Fazaa A, Sellami M, Ouenniche K, Miladi S, Kassab S, Chekili S, Ben Abdelghani K, Laatar A.
    Physical activity assessment in children and adolescents with juvenile idiopathic arthritis compared with controls.
    Arch Pediatr. 2020 Nov 26:S0929-693X(20)30245-1. doi: 10.1016/j.arcped.2020.10.008.
    https://pubmed.ncbi.nlm.nih.gov/33250332/
  • Simonds MM, Schlefman AR, McCahan SM, Sullivan KE, Rose CD, Brescia AC.
    Juvenile idiopathic arthritis fibroblast-like synoviocytes influence chondrocytes to alter BMP antagonist expression demonstrating an interaction between the two prominent cell types involved in endochondral bone formation.
    Pediatr Rheumatol Online J. 2020 Nov 16;18(1):89.
    https://pubmed.ncbi.nlm.nih.gov/33198759/
  • Lunt LE, Shoop-Worrall S, Smith N, Cleary G, McDonagh J, Smith AD, Thomson W, McErlane F.
    Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs).
    Pediatr Rheumatol Online J. 2020 Nov 19;18(1):91.
    https://pubmed.ncbi.nlm.nih.gov/33213474/
  • Yan, Y., Rychlik, K.L., Rosenman, M.B. et al.
    Use of PROMIS® to screen for depression in children with arthritis.
    Pediatr Rheumatol 18, 92 (2020).
    https://pubmed.ncbi.nlm.nih.gov/33228749/
  • Frid P, Baraniya D, Halbig J, Rypdal V, Songstad NT, Rosèn A, Berstad JR, Flatø B, Alakwaa F, Gil EG, Cetrelli L, Chen T, Al-Hebshi NN, Nordal E, Al-Haroni M.
    Salivary Oral Microbiome of Children With Juvenile Idiopathic Arthritis: A Norwegian Cross-Sectional Study.
    Front Cell Infect Microbiol. 2020 Nov 4;10:602239. doi: 10.3389/fcimb.2020.602239.
    https://pubmed.ncbi.nlm.nih.gov/33251163/
 
OCTUBRE 2020

  • Brunner HI, Wong R, Nys M, Kou TD, Dominique A, Martini A, Lovell DJ, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic
    Arthritis.Paediatr Drugs. 2020 Oct 8. doi: 10.1007/s40272-020-00422-2. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/33029724/

  • Armaroli G, Klein A, Ganser G, Ruehlmann MJ, Dressler F, Hospach A, Minden K, Trauzeddel R, Foeldvari I, Kuemmerle-Deschner J, Weller-Heinemann F, Urban A, Horneff G.
    Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry.
    Arthritis Res Ther. 2020 Oct 29;22(1):258. doi: 10.1186/s13075-020-02326-5.
    https://pubmed.ncbi.nlm.nih.gov/33121528/

  • Vernocchi P, Marini F, Capuani G, Tomassini A, Conta G, Del Chierico F, Malattia C, De Benedetti F, Martini A, Dallapiccola B, van Dijkhuizen EHP, Miccheli A, Putignani L.
    Fused Omics Data Models Reveal Gut Microbiome Signatures Specific of Inactive Stage of Juvenile Idiopathic Arthritis in Pediatric Patients.
    Microorganisms. 2020 Oct 6;8(10):E1540. doi: 10.3390/microorganisms8101540.
    https://pubmed.ncbi.nlm.nih.gov/33036309/

  • López-Isac E, Smith SL, Marion MC, Wood A, Sudman M, Yarwood A, Shi C, Gaddi VP, Martin P, Prahalad S, Eyre S, Orozco G, Morris A, Langefeld C, Thompson SD, Thomson W, Bowes J.
    Combined genetic analysis of juvenile idiopathic arthritis clinical subtypes identifies novel risk loci, target genes and key regulatory mechanisms.
    Ann Rheum Dis. 2020 Oct 26:annrheumdis-2020-218481. doi: 10.1136/annrheumdis-2020-218481. Online ahead of print
    https://pubmed.ncbi.nlm.nih.gov/33106285/

  • Fischer J, Skeie MS, Rosendahl K, Tylleskär K, Lie S, Shi XQ, Gil EG, Cetrelli L, Halbig J, von Wangenheim Marti L, Rygg M, Frid P, Stoustrup P, Rosèn A.
    Prevalence of temporomandibular disorder in children and adolescents with juvenile idiopathic arthritis - a Norwegian cross- sectional multicentre study.
    BMC Oral Health. 2020 Oct 13;20(1):282. doi: 10.1186/s12903-020-01234-z.PMID: 33050890
    https://pubmed.ncbi.nlm.nih.gov/33050890/

  • Frid P, Augdal TA, Larheim TA, Halbig J, Rypdal V, Songstad NT, Rosén A, Tylleskär KB, Berstad JR, Flatø B, Stoustrup P, Rosendahl K, Kirkhus E, Nordal E.
    Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study.
    Pediatr Rheumatol Online J. 2020 Oct 1;18(1):75. doi: 10.1186/s12969-020-00464-3
    https://pubmed.ncbi.nlm.nih.gov/32998740/

  • Weiss PF, Chauvin NA.
    Imaging in the diagnosis and management of axial spondyloarthritis in children
    Best Pract Res Clin Rheumatol. 2020 Oct 6:101596. doi: 10.1016/j.berh.2020.101596. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/33036917/

 
SEPTIEMBRE 2020

  • Cánovas R, Cobb J, Brozynska M, Bowes J, Li YR, Smith SL, Hakonarson H, Thomson W, Ellis JA, Abraham G, Munro JE, Inouye M.
    Genomic risk scores for juvenile idiopathic arthritis and its subtypes.
    Ann Rheum Dis. 2020 Sep 4:annrheumdis-2020-217421. doi: 10.1136/annrheumdis-2020-217421. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32887683/

  • Dedeoglu R, Yildiz M, Karagozlu F, Oztunc F, Ulug N, Akdeniz B, Adrovic A, Haslak F, Sahin S, Barut K, Kasapcopur O.
    Unexpected increase of aortic stiffness in juvenile Spondyloarthropathies.
    Cardiol Young. 2020 Sep 17:1-9. doi: 10.1017/S1047951120002796. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32938508/

  • Paç Kısaarslan A, Şahin N, Özdemir Çiçek S, Gündüz Z, Poyrazoğlu H, Düşünsel R.
    Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy.
    Mod Rheumatol. 2020 Sep 7:1-7. doi: 10.1080/14397595.2020.1812809. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32815445/

  • Boyko Y, Ivanova V, Vakaruk M, Kozina T, Shevchenko N, Vaizer N, Synoverska O, Chubata O, Marchuk O, Havrylyuk A.
    Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment.
    Reumatologia. 2020;58(4):202-207. doi: 10.5114/reum.2020.98431.
    https://pubmed.ncbi.nlm.nih.gov/32921826/

  • Mannion ML, Xie F, Horton DB, Ringold S, Correll CK, Dennos A, Beukelman T; CARRA Registry Investigators.
    Biologic Switching among Non-Systemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    J Rheumatol. 2020 Sep 15:jrheum.200437. doi: 10.3899/jrheum.200437. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32934124/

  • Malattia C, Ruperto N, Pederzoli S, Palmisani E, Pistorio A, Wouters C, Dolezalova P, Flato B, Garay S, Giancane G, Wells C, Douglass W, Brunner HI, De Benedetti F, Ravelli A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
    Arthritis Res Ther. 2020 Sep 10;22(1):211. doi: 10.1186/s13075-020-02303-y
    https://pubmed.ncbi.nlm.nih.gov/32912276/

  • Brunner HI, Ruperto N, Zuber Z, Cuttica R, Keltsev V, Xavier RM, Burgos-Vargas R, Calvo Penades I, Silverman ED, Espada G, Ferrandiz Zavaler M, Kimura Y, Duarte C, Job-Deslandre C, Joos R, Douglass W, Wimalasundera S, Bharucha KN, Wells C, Lovell DJ, Martini A, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO), the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label 2-Year Extension of a Phase 3 Trial.
    Arthritis Rheumatol. 2020 Sep 20. doi: 10.1002/art.41528. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32951358/

  • Ozdel S, Baglan E, Cakıcı EK, Yazılıtas F, Yücel H, Senel S, Bulbul M.
    Clinical Features in 305 Patients with Juvenile Idiopathic Arthritis: A Single Center Turkish Study
    Pediatr Int. 2020 Sep 24. doi: 10.1111/ped.14481. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32969552/

  • Roszkiewicz J, Michałek D, Ryk A, Swacha Z, Szmyd B, Smolewska E.
    The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study.
    Int J Rheum Dis. 2020 Sep 23. doi: 10.1111/1756-185X.13972. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32969158/

  • Pawlaczyk-Kamienska T, Pawlaczyk-Wróblewska E, Borysewicz-Lewicka M.
    Early diagnosis of temporomandibular joint arthritis in children with juvenile idiopathic arthritis. A systematic review.
    Eur J Paediatr Dent. 2020 Sep;21(3):219-226. doi: 10.23804/ejpd.2020.21.03.12.
    https://pubmed.ncbi.nlm.nih.gov/32893656/

  • Lypka M, Shah K, Jones J.
    Prosthetic temporomandibular joint reconstruction in a cohort of adolescent females with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2020 Sep 4;18(1):68. doi: 10.1186/s12969-020-00453-6.
    https://pubmed.ncbi.nlm.nih.gov/32887620/

  • Thakral A, Pinto D, Miller M, Curran ML, Klein-Gitelman M, French DD.
    Direct Healthcare Costs Associated with Oligoarticular Juvenile Idiopathic Arthritis at a Single Center.
    Int J Rheumatol. 2020 Sep 1;2020:5640425. doi: 10.1155/2020/5640425.
    https://pubmed.ncbi.nlm.nih.gov/32952562/

  • Al-Mayouf SM, Hashad S, Khawaja K, Alrasheedi A, Abdwani R, Abushhaiwia A, AlSuwaiti M, Alzyoud R, Al Abrawi S, Asiri A, Alshaikh M, Sharif E, Muzaffer M, Alsewairi W, Zlenti M, Kawaja E, Almutairi M, Majeed M, Lotfy H, AlMarri M, Almutairi N; Pediatric Arab Rheumatology Group (PRAG).
    Cumulative damage in juvenile idiopathic arthritis: A multi-center study from the Pediatric Rheumatology Arab Group (PRAG).
    Arthritis Care Res (Hoboken). 2020 Sep 4. doi: 10.1002/acr.24436. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32886859/

  • Fathalla BM, Elgabaly EA, Tayoun AA.
    Coexistence of a novel WISP3 pathogenic variant and an MEFV mutation in an Arabic family with progressive pseudorheumatoid dysplasia mimicking polyarticular juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2020 Sep 7;18(1):69. doi: 10.1186/s12969-020-00462-5.
    https://pubmed.ncbi.nlm.nih.gov/32894151/

 
AGOSTO 2020
  • Klein-Wieringa IR, Brinkman DMC, Ten Cate R, Hissink Muller PCE.
    Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?
    Curr Opin Rheumatol. 2020 Sep;32(5):403-413.doi: 10.1097/BOR.0000000000000727.
    https://pubmed.ncbi.nlm.nih.gov/32657803/
  • Roszkiewicz J, Swacha Z, Smolewska E.
    Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA
    Pediatr Rheumatol Online J. 2020 Aug 12;18(1):64. doi: 10.1186/s12969-020-00455-4.
    https://pubmed.ncbi.nlm.nih.gov/32787934/
  • Brix N, Rosthøj S, Glerup M, Hasle H, Herlin T.
    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children
    PLoS One. 2020 Aug 11;15(8):e0237530. doi: 10.1371/journal.pone.0237530. eCollection 2020.
    https://pubmed.ncbi.nlm.nih.gov/32780759/
  • Turmel-Roy J, Bédard MA, Millette M, Simonyan D, Proulx-Gauthier JP, Rousseau-Nepton I.
    Risk of adrenal insufficiency following intra-articular or periarticular corticosteroid injections among children with chronic arthritis.
    J Pediatr Endocrinol Metab. 2020 Aug 26:/j/jpem.ahead-of-print/jpem-2020-0219/jpem-2020-0219.xml. doi: 10.1515/jpem-2020-0219.
    https://pubmed.ncbi.nlm.nih.gov/32845867/
  • Antonarakis GS, Blanc A, Courvoisier DS, Scolozzi P.
    Effect of intra-articular corticosteroid injections on pain and mouth opening in juvenile idiopathic arthritis with temporomandibular involvement: A systematic review and meta-analysis
    J Craniomaxillofac Surg. 2020 Aug;48(8):772-778. doi: 10.1016/j.jcms.2020.06.010. Epub 2020 Jun 27.
    https://pubmed.ncbi.nlm.nih.gov/32680671/
  • Bridges JM, Stoll ML
    Treatment of Juvenile Spondyloarthritis: Where We Stand.
    Paediatr Drugs. 2020 Sep 3. doi: 10.1007/s40272-020-00416-0.
    https://pubmed.ncbi.nlm.nih.gov/32885389/
  • Al-Mayouf SM, Hashad S, Khawaja K, Alrasheedi A, Abdwani R, Abushhaiwia A, AlSuwaiti M, Alzyoud R, Al Abrawi S, Asiri A, Alshaikh M, Sharif E, Muzaffer M, Alsewairi W, Zlenti M, Kawaja E, Almutairi M, Majeed M, Lotfy H, AlMarri M, Almutairi N; Pediatric Arab Rheumatology Group (PRAG).
    Cumulative damage in juvenile idiopathic arthritis: A multi-center study from the Pediatric Rheumatology Arab Group (PRAG)
    Arthritis Care Res (Hoboken). 2020 Sep 4. doi: 10.1002/acr.24436.
    https://pubmed.ncbi.nlm.nih.gov/32886859/
  • Gicchino MF, Di Sessa A, Guarino S, Miraglia Del Giudice E, Olivieri AN, Marzuillo P.
    Prevalence of and factors associated to chronic kidney disease and hypertension in a cohort of children with juvenile idiopathic arthritis.
    Eur J Pediatr. 2020 Aug 29. doi: 10.1007/s00431-020-03792-4.
    https://pubmed.ncbi.nlm.nih.gov/32860100/
  • Hussain KS, Gulati R, Satheesh S, Negi VS.
    Early-onset subclinical cardiovascular damage assessed by non-invasive methods in children with Juvenile Idiopathic Arthritis: analytical cross-sectional study.
    Rheumatol Int. 2020 Aug 28. doi: 10.1007/s00296-020-04689-z.
    https://pubmed.ncbi.nlm.nih.gov/32857280/
  • Lundberg V, Sandlund M, Eriksson C, Janols R, Lind T, Fjellman-Wiklund A.
    How children and adolescents with juvenile idiopathic arthritis participate in their healthcare: health professionals' views.
    Disabil Rehabil. 2020 Sep 2:1-8. doi: 10.1080/09638288.2020.1811406.
    https://pubmed.ncbi.nlm.nih.gov/32875956/
  • Pinchi V, Bianchi I, Pradella F, Vitale G, Focardi M, Tonni I, Ferrante L, Bucci A.Int
    Dental age estimation in children affected by juvenile rheumatoid arthritis.
    J Legal Med. 2020 Aug 20. doi: 10.1007/s00414-020-02395-w.
    https://pubmed.ncbi.nlm.nih.gov/32820356/
  • Ht Kwok C, Learoyd AE, Canet-Pons J, Trang T, Fitzgerald M.
    Spinal interleukin-6 contributes to central sensitisation and persistent pain hypersensitivity in a model of juvenile idiopathic arthritis
    Brain Behav Immun. 2020 Aug 10;S0889-1591(20)31007-2. doi: 10.1016/j.bbi.2020.08.004. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32791212/
  • Fischer J, Dirks J, Haase G, Holl-Wieden A, Hofmann C, Girschick H, Morbach H.
    IL-21+CD4+ T helper cells co-expressing IFN-γ and TNF-α accumulate in the joints of antinuclear antibody positive patients with juvenile idiopathic arthritis
    Clin Immunol. 2020 Aug;217:108484. doi: 10.1016/j.clim.2020.108484.
    https://pubmed.ncbi.nlm.nih.gov/32485239/
  • Avar-Aydin PO, Nepesov S, Barut K, Sahin S, Adrovic A, Cokugras HC, Kasapcopur O.
    Decreased frequency of allergy in juvenile idiopathic arthritis: results of a case-control study.
    Mod Rheumatol. 2020 Aug 20:1-19. doi: 10.1080/14397595.2020.1812820.
    https://pubmed.ncbi.nlm.nih.gov/32815440/
  • Schmidt T, Berthold E, Arve-Butler S, Gullstrand B, Mossberg A, Kahn F, Bengtsson AA, Månsson B, Kahn R.
    Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment-a distinct inflammatory pattern for oligoarticular juvenile arthritis
    Arthritis Res Ther. 2020 Aug 12;22(1):186.doi: 10.1186/s13075-020-02279-9.
    https://pubmed.ncbi.nlm.nih.gov/32787920/
  • Pawlaczyk-Kamieńska T, Kulczyk T, Pawlaczyk-Wróblewska E, Borysewicz-Lewicka M, Niedziela M.
    Limited Mandibular Movements as a Consequence of Unilateral or Asymmetrical Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis Patients
    J Clin Med. 2020 Aug 8;9(8):E2576. doi: 10.3390/jcm9082576.
    https://pubmed.ncbi.nlm.nih.gov/32784489/
 
 
JULIO 2020
  • Brunner HI, Chen C, Bovis F, De Benedetti F, Espada G, Joos R, Akikusa J, Chaitow J, Boteanu AL, Kimura Y, Rietschel C, Siri D, Smolewska E, Schmeling H, Brown DE, Martini A, Lovell DJ, Huang B, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2020 Jul 23. doi: 10.1002/acr.24384. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32702212/
  • Lovell DJ, Brunner HI, Reiff AO, Jung L, Jarosova K, Němcová D, Mouy R, Sandborg C, Bohnsack JF, Elewaut D, Gabriel C, Higgins G, Kone-Paut I, Jones OY, Vargová V, Chalom E, Wouters C, Lagunes I, Song Y, Martini A, Ruperto N.
    Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate.
    RMD Open. 2020 Jul;6(2):e001208. doi: 10.1136/rmdopen-2020-001208.
    https://pubmed.ncbi.nlm.nih.gov/32665432/

  • Aranda-Valera IC, Arias de la Rosa I, Roldán-Molina R, Ábalos-Aguilera MDC, Torres-Granados C, Patiño-Trives A, Luque-Tevar M, Ibáñez-Costa A, Guzmán-Ruiz R, Malagón MDM, Escudero-Contreras A, López-Pedrera C, Collantes-Estévez E, Barbarroja N.
    Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission.
    Pediatr Rheumatol Online J. 2020 Jul 14;18(1):59. doi: 10.1186/s12969-020-00448-3.
    https://pubmed.ncbi.nlm.nih.gov/32665015/

  • Nicek A, Talib N, Lovell D, Smith C, Becker ML, Jones JT.
    Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists.
    Pediatr Rheumatol Online J. 2020 Jul 13;18(1):57. doi: 10.1186/s12969-020-00445-6.
    https://pubmed.ncbi.nlm.nih.gov/32660497/
  • Lalloo C, Harris LR, Hundert AS, Berard R, Cafazzo J, Connelly M, Feldman BM, Houghton K, Huber A, Laxer RM, Luca N, Schmeling H, Spiegel L, Tucker LB, Pham Q, Davies-Chalmers CC, Stinson JN.
    The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial.
    Rheumatology (Oxford). 2020 Jul 2:keaa178. doi: 10.1093/rheumatology/keaa178. Epub ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32613229/
  • Jiang K, Kessler H, Park Y, Sudman M, Thompson SD, Jarvis JN.
    Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis(JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.
    PLoS One. 2020 Jul 30;15(7):e0235857. doi: 10.1371/journal.pone.0235857. eCollection 2020.
    https://pubmed.ncbi.nlm.nih.gov/32730263/
  • Klein-Wieringa IR, Brinkman DMC, Ten Cate R, Hissink Muller PCE.
    Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?
    Curr Opin Rheumatol. 2020 Jul 9. doi: 10.1097/BOR.0000000000000727. Online ahead of print.
    https://pubmed.ncbi.nlm.nih.gov/32657803/
  • Chhabra A, Oen K, Huber AM, Shiff NJ, Boire G, Benseler SM, Berard RA, Scuccimarri R, Feldman BM, Lim LSH, Barsalou J, Bruns A, Cabral DA, Chédeville G, Ellsworth J, Houghton K, Lang B, Morishita K, Rumsey DG, Rosenberg AM, Tse SM, Watanabe Duffy K, Duffy CM, Guzman J; ReACCh-Out Investigators.
    Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian Cohort.
    Arthritis Care Res (Hoboken). 2020 Jul;72(7):897-906. doi: 10.1002/acr.23922. Epub 2020 Jun 5.
    https://pubmed.ncbi.nlm.nih.gov/31074591/
  • Klein A, Minden K, Hospach A, Foeldvari I, Weller-Heinemann F, Trauzeddel R, Huppertz HI, Horneff G.
    Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis.
    Ann Rheum Dis. 2020 Jul;79(7):969-974. doi: 10.1136/annrheumdis-2019-216843. Epub 2020 Apr 16.
    https://pubmed.ncbi.nlm.nih.gov/32299797/
 
JUNIO 2020

  • Rubinstein TB, Bullock DR, Ardalan K, Mowrey WB, Brown NM, Bauman LJ, Stein RE.
    Adverse Childhood Experiences are Associated with Childhood-Onset Arthritis in a National Sample of US Youth: An Analysis of the 2016 National Survey of Children's Health.
    J Pediatr. 2020 Jun 15:S0022-3476(20)30748-4. doi: 10.1016/j.jpeds.2020.06.046.
    https://pubmed.ncbi.nlm.nih.gov/32553837/

  • Chamlati R, Connolly B, Laxer R, Stimec J, Panwar J, Tse S, Muthusami P, Amaral J, Temple M, Parra DA.
    Image guided sacroiliac joint corticosteroid injections in children: an 18-year single-center retrospective study.
    Pediatr Rheumatol Online J. 2020 Jun 17;18(1):52. doi: 10.1186/s12969-020-00435-8.
    https://pubmed.ncbi.nlm.nih.gov/32552835/

  • Meneghetti TC, Padilha TMH, Azevedo VF, Cat MNL, Sarolli BMS, de Carvalho VO.
    The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis.
    Adv Rheumatol. 2020 Jun 17;60(1):33. doi: 10.1186/s42358-020-00136-6.
    https://pubmed.ncbi.nlm.nih.gov/32552795/

  • Shiari R, Salar N, Parvneh VJ, Rahmani K, Yeganeh MH, Shiari S.
    Midfoot Arthritis in Children: Is There Any Relation With Malignancy?
    Clin Med Insights Arthritis Musculoskelet Disord. 2020 Jun 8;13:1179544120924643.
    https://pubmed.ncbi.nlm.nih.gov/32550767/

  • Xin L, He F, Li S, Zhou ZX, Ma XL.
    Intestinal microbiota and juvenile idiopathic arthritis: current understanding and future prospective.
    World J Pediatr. 2020 Jun 12. doi: 10.1007/s12519-020-00371-3.
    https://pubmed.ncbi.nlm.nih.gov/32533534/

  • Ricciuto A, Sherman PM, Laxer RM.
    Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis.
    Clin Immunol. 2020 Jun;215:108415. doi: 10.1016/j.clim.2020.108415.
    https://pubmed.ncbi.nlm.nih.gov/32278875/

  • Dave M, Rankin J, Pearce M, Foster HE.
    Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
    Pediatr Rheumatol Online J. 2020 Jun 12;18(1):49. doi: 10.1186/s12969-020-00443-8.
    https://pubmed.ncbi.nlm.nih.gov/32532304/

  • Elnaggar RK, Mahmoud WS, Moawd SA, Azab AR.
    Impact of core stability exercises on bone mineralization and functional capacity in children with polyarticular juvenile idiopathic arthritis: a randomized clinical trial.
    Clin Rheumatol. 2020 Jun 8. doi: 10.1007/s10067-020-05219-9.
    https://pubmed.ncbi.nlm.nih.gov/32514677/

  • Simon TA, Harikrishnan GP, Kawabata H, Singhal S, Brunner HI, Lovell DJ.
    Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study.
    Pediatr Rheumatol Online J. 2020 Jun 5;18(1):43. doi: 10.1186/s12969-020-00426-9.
    https://pubmed.ncbi.nlm.nih.gov/32503658/

  • Stoustrup P, Twilt M, Herlin T.
    Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2020 Jun 1;47(6):793-795. doi: 10.3899/jrheum.191169.
    https://pubmed.ncbi.nlm.nih.gov/32482885/

  • Bagge-Petersen CM, Skovdal M, Langstrup H.
    The socio-material self-care practices of children living with hemophilia or juvenile idiopathic arthritis in Denmark.
    Soc Sci Med. 2020 Jun;255:113022. doi: 10.1016/j.socscimed.2020.113022.
    https://pubmed.ncbi.nlm.nih.gov/32422525/

  • Bollhalder A, Patcas R, Eichenberger M, Müller L, Schroeder-Kohler S, Saurenmann RK, Kellenberger CJ.
    Magnetic Resonance Imaging Followup of Temporomandibular Joint Inflammation, Deformation, and Mandibular Growth in Juvenile Idiopathic Arthritis Patients Receiving Systemic Treatment.
    J Rheumatol. 2020 Jun 1;47(6):909-916. doi: 10.3899/jrheum.190168.
    https://pubmed.ncbi.nlm.nih.gov/31523042/

 
MAYO 2020
  • Kattackal TR, Cavallo S, Brosseau L, Sivakumar A, Del Bel MJ, Dorion M, Ueffing E, Toupin-April K
    Assessing the reporting quality of physical activity programs in randomized controlled trials for the management of juvenile idiopathic arthritis using three standardized assessment tools.
    Pediatr Rheumatol Online J. 2020 May 24;18(1):41.
    https://doi.org/10.1186/s12969-020-00434-9
  • Kuntze G, Nettel-Aguirre A, Brooks J, Esau S, Nesbitt C, Mosher D, Twilt M, Benseler S, Ronsky JL, Emery CA
    Consequences of Juvenile Idiopathic Arthritis on Single Leg Squat Performance in Youth.
    Arthritis Care Res (Hoboken). 2020 May 14
    https://doi.org/10.1002/acr.24254
  • Ayaz NA, Karadağ ŞG, Koç R, Demirkan FG, Çakmak F, Sönmez HE.
    Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study.
    Rheumatol Int. 2020 May 16.
    https://doi.org/10.1007/s00296-020-04596-3
  • Chhabra A, Robinson C, Houghton K, Cabral DA, Morishita K, Tucker LB, Petty RE, Larché M, Batthish M, Guzman J.
    Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
    Rheumatology (Oxford). 2020 May 13:keaa118.
    https://doi.org/10.1093/rheumatology/keaa118
  • Tanya M, Teh KL, Das L, Hoh SF, Gao X, Arkachaisri T.
    Juvenile idiopathic arthritis in Southeast Asia: the Singapore experience over two decades.
    Clin Rheumatol. 2020 May 16.
    https://doi.org/10.1007/s10067-020-05081-9
 
ABRIL 2020
  • Weiss PF, Roth
    Juvenile-Versus Adult-Onset Spondyloarthritis: Similar, but Different.
    J.Rheum Dis Clin North Am. 2020 May;46(2):241-257. doi: 10.1016/j.rdc.2020.01.003.
    https://pubmed.ncbi.nlm.nih.gov/32340699
  • Schoemaker CG, Swart JF, Wulffraat NM
    Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?
    Pediatr Rheumatol Online J. 2020 Apr 16;18(1):34. doi: 10.1186/s12969-020-00428-7.
    https://pubmed.ncbi.nlm.nih.gov/32299430
 
MARZO 2020
  • Barber CEH, Barnabe C, Benseler S, Chin R, Johnson N, Luca N, Miettunen P, Twilt M, Veeramreddy D, Shiff NJ, Schmeling H.
    Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2020 Mar 6;18(1):22. doi: 10.1186/s12969-020-0413-7.
    https://www.ncbi.nlm.nih.gov/pubmed/32143720
  • Cimaz R, Maioli G, Calabrese G.
    Current and emerging biologics for the treatment of juvenile idiopathic arthritis.
    Expert Opin Biol Ther. 2020 Mar 2:1-16. doi: 10.1080/14712598.2020.1733524. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32116038
  • Barber CEH, Twilt M, Pham T, Currie GR, Benseler S, Yeung RSM, Batthish M, Blanchette N, Guzman J, Lang B, LeBlanc C, Levy DM, O'Brien C, Schmeling H, Soon G, Spiegel L, Whitney K, Marshall DA
    A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
    Arthritis Res Ther. 2020 Mar 19;22(1):53.
    https://www.ncbi.nlm.nih.gov/pubmed/32192528
  • Bridgewood C, Sharif K, Sherlock J, Watad A, McGonagle D.
    Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
    Immunol Rev. 2020 Mar;294(1):27-47. 
    https://www.ncbi.nlm.nih.gov/pubmed/31957051
  • Majumder S, Aggarwal A.
    Juvenile idiopathic arthritis and the gut microbiome: Where are we now?
    Best Pract Res Clin Rheumatol. 2020 Mar 11:101496. doi: 10.1016/j.berh.2020.101496. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32171669
  • Ali M, Kaddafy S, Abdelaziz A, Abonar A, Hanafy M, Hussein H, Shabana H, Abd El-Hmid R, Ali M.
    PADI4 (rs2240340), PDCD1 (rs10204525), and CTLA4 (231775) Gene Polymorphisms and Polyarticular Juvenile Idiopathic Arthritis.
    Br J Biomed Sci. 2020 Mar 12. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/32163016
  • Sperling LC, Lockshin B, Darling T.
    Eruptive collagenomas associated with adalimumab treatment of juvenile rheumatoid arthritis.
    J Cutan Pathol. 2020 Mar;47(3):197-201. doi: 10.1111/cup.13594. No abstract available.
    https://www.ncbi.nlm.nih.gov/pubmed/32037611
 
FEBRERO 2020
  • Batthish M, Berard R, Cabral D, Bolaria R, Chédeville G, Duffy C, Gerhold K, Gerschman T, Huber A, Proulx-Gauthier JP, Rosenberg A, Rumsey D, Schmeling H, Shiff N, Soon G, Bruns A, Tucker L, Guzman J; Canadian Alliance of Pediatric Rheumatology Investigators .
    A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
    Rheumatology (Oxford). 2020 Feb 11. pii: keaa006. doi: 10.1093/rheumatology/keaa006.
    https://www.ncbi.nlm.nih.gov/pubmed/32044978
  • Özdel S, Bağlan E, Çakıcı EK, Yazılıtas F, Gür G, Çelikkaya E, Güngör T, Bülbül M.
    Similarities between pediatric FMF patients with sacroiliitis and pediatric juvenile spondyloarthropathy patients with sacroiliitis: a preliminary study.
    Acta Clin Belg. 2020 Feb 3:1-6. doi: 10.1080/17843286.2020.1724450.
    https://www.ncbi.nlm.nih.gov/pubmed/32009575
  • Schoemaker CG, Wulffraat NM, Vastert SJ.
    The patient and parent perspective on methotrexate in recent Juvenile Idiopathic Arthritis guidelines.
    Arthritis Rheumatol. 2020 Feb 23. doi: 10.1002/art.41234.
    https://www.ncbi.nlm.nih.gov/pubmed/32090463
  • Lavilla P, Manzanares Á, Rabadán E, de Inocencio J.
    Juvenile idiopathic arthritis and Turner's syndrome.
    An Pediatr (Barc). 2020 Feb 11. pii: S1695-4033(20)30004-7. doi:10.1016/j.anpedi.2019.12.005.
    https://www.ncbi.nlm.nih.gov/pubmed/32057710
  • Cedströmer AL, Andlin-Sobocki A, Abbu N, Hedenberg-Magnusson B, Dahlström L, Berntson L.
    Condylar alterations and facial growth in children with juvenile idiopathic arthritis.
    J Orofac Orthop. 2020 Feb 20. doi: 10.1007/s00056-020-00216-8.
    https://www.ncbi.nlm.nih.gov/pubmed/32077980
  • Merle CL, Hoffmann R, Schmickler J, Rühlmann M, Challakh N, Haak R, Schmalz G, Ziebolz D.
    Comprehensive Assessment of Orofacial Health and Disease Related Parameters in Adolescents with Juvenile Idiopathic Arthritis-A Cross-Sectional Study.
    J Clin Med. 2020 Feb 13;9(2). pii: E513. doi: 10.3390/jcm9020513.
    https://www.ncbi.nlm.nih.gov/pubmed/32069957
  • Winsz-Szczotka K, Kuźnik-Trocha K, Gruenpeter A, Wojdas M, Dąbkowska K, Olczyk K.
    Association of Circulating COMP and YKL-40 as Markers of Metabolic Changes of Cartilage with Adipocytokines in Juvenile Idiopathic Arthritis.
    Metabolites. 2020 Feb 10;10(2). pii: E61. doi: 10.3390/metabo10020061.
    https://www.ncbi.nlm.nih.gov/pubmed/32050571
 
 
ENERO 2020
  • Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Watanabe Duffy K, Gordon J, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Morishita K, Oen KG, Petty RE, Ramsey SE, Scuccimarri R, Spiegel L, Stringer E, Taylor-Gjevre RM, Tse SML, Tucker LB, Turvey SE, Tupper S, Yeung RSM, Benseler S, Ellsworth J, Guillet C, Karananayake C, Muhajarine N, Roth J, Schneider R, Rosenberg AM.
    Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2020 Jan 9. pii: kez615. doi: 10.1093/rheumatology/kez615. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31919503
  • Barendregt AM, Veldkamp SR, Hissink Muller PCE, van de Geer A, Aarts C, van Gulik EC, Schilham MW, Kessel C, Keizer MP, Hemke R, Nassar-Sheikh Rashid A, Dolman KM, Schonenberg-Meinema D, Ten Cate R, van den Berg JM, Maas M, Kuijpers TW.
    MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2020 Jan 6. pii: kez590. doi: 10.1093/rheumatology/kez590. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31904851
  • Henrey A, Rypdal V, Rypdal M, Loughin T, Nordal E, Guzman J; ReACCh-Out and NoSPeR Investigators.
    Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort.
    Arthritis Res Ther. 2020 Jan 15;22(1):10. doi: 10.1186/s13075-019-2091-8.
    https://www.ncbi.nlm.nih.gov/pubmed/31941530
  • Klein A, Becker I, Minden K, Hospach A, Schwarz T, Foeldvari I, Huegle B, Borte M, Weller-Heinemann F, Dressler F, Kuemmerle-Deschner J, Oommen PT, Foell D, Trauzeddel R, Rietschel C, Horneff G.
    Biologic Therapies in Polyarticular Juvenile Idiopathic Arthritis. Comparison of Long-Term Safety Data from the German BIKER Registry.
    ACR Open Rheumatol. 2020 Jan;2(1):37-47. doi: 10.1002/acr2.11091. Epub 2019 Nov 24.
    https://www.ncbi.nlm.nih.gov/pubmed/31943968
  • McErlane F, Armitt G, Cobb J, Bailey K, Cleary G, Douglas S, Lunt L, Rashid A, Sampath S, Shoop-Worrall S, Smith N, Foster H, Thomson W.
    CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2020 Jan 1;59(1):137-145. doi: 10.1093/rheumatology/kez214.
    https://www.ncbi.nlm.nih.gov/pubmed/31243450
  • Kyvsgaard N, Thastum M, Mikkelsen TS, Christensen AE, Herlin T.
    Coping strategies and anxiety in association with methotrexate-induced nausea in juvenile idiopathic arthritis.
    Rheumatol Int. 2020 Jan 29. doi: 10.1007/s00296-020-04520-9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31996982
  • Bhattacharya S, Misra R, Aggarwal A.
    Patients with enthesitis related arthritis show similar monocyte function pattern as seen in adult axial spondyloarthropathy.
    Pediatr Rheumatol Online J. 2020 Jan 15;18(1):6. doi: 10.1186/s12969-020-0403-9.
    https://www.ncbi.nlm.nih.gov/pubmed/31941549
  • Spel L, Martinon F.
    Inflammasomes contributing to inflammation in arthritis.
    Immunol Rev. 2020 Jan 16. doi: 10.1111/imr.12839. [Epub ahead of print] Review.
    https://www.ncbi.nlm.nih.gov/pubmed/31944344
  • Solmaz D, Bakirci S, Kimyon G, Gunal EK, Dogru A, Bayindir O, Dalkilic E, Ozisler C, Can M, Akar S, Cetin GY, Yavuz S, Kilic L, Tarhan EF, Kucuksahin O, Omma A, Gonullu E, Yildiz F, Ersozlu ED, Cinar M, Al-Onazi A, Erden A, Tufan MA, Yilmaz S, Pehlevan S, Kalyoncu U, Aydin SZ.
    Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease.
    Arthritis Care Res (Hoboken). 2020 Jan;72(1):63-68. doi: 10.1002/acr.23836.
    https://www.ncbi.nlm.nih.gov/pubmed/30680951
 
 
DICIEMBRE 2019
  • Vieira MC, Tosta PG, Nicole FM, Roberto LEV, Vianna JGP, Castro PC, Lourenço RB, Serrano EV, Valim V, Luchi WM.
    Chronic Inflammatory Arthropathy Preceding Acute Systemic Manifestations of Sarcoidosis: A Possible Overlap of Idiopathic Juvenile Arthritis and Sarcoidosis.
    Case Rep Rheumatol. 2019 Dec 7;2019:6483245
    https://www.ncbi.nlm.nih.gov/pubmed/31886005
  • Horton DB, Salas J, Wec A, Kohlheim M, Kapadia P, Beukelman T, Boneparth A, Haverkamp K, Mannion ML, Moorthy LN, Ringold S, Rosenthal M.
    Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers.
    Arthritis Care Res (Hoboken). 2019 Dec 27. doi: 10.1002/acr.24129.
    https://www.ncbi.nlm.nih.gov/pubmed/31880862
  • Seaman SC, Hong S, Dlouhy BJ, Menezes AH.
    Current management of juvenile idiopathic arthritis affecting the craniovertebral junction.
    Childs Nerv Syst. 2019 Dec 16. doi: 10.1007/s00381-019-04469-6
    https://www.ncbi.nlm.nih.gov/pubmed/31845026
  • Tarkiainen M, Tynjälä P, Vähäsalo P, Kröger L, Aalto K, Lahdenne P.
    Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
    Pediatr Rheumatol Online J. 2019 Dec 16;17(1):80
    https://www.ncbi.nlm.nih.gov/pubmed/31842940
  • Grevich S, Lee P, Leroux B, Ringold S, Darveau R, Henstorf G, Berg J, Kim A, Velan E, Kelly J, Baltuck C, Reeves A, Leahey H, Hager K, Brittnacher M, Hayden H, Miller S, McLean J, Stevens A.
    Oral health and plaque microbial profile in juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2019 Dec 16;17(1):81.
    https://www.ncbi.nlm.nih.gov/pubmed/31842923
  • Giani T, Madera A, Cimaz R.
    Association of juvenile idiopathic arthritis and morphea: a case series.
    Clin Rheumatol. 2019 Dec 14. doi: 10.1007/s10067-019-04850-5
    https://www.ncbi.nlm.nih.gov/pubmed/31838640
  • Ortega-Avila AB, Cervera-Garvi P, Ramos-Petersen L, Gijon-Nogueron G.
    Systematic review of measurement instruments for patients with juvenile idiopathic arthritis in the foot and ankle.
    Eur J Phys Rehabil Med. 2019 Dec 13. doi: 10.23736/S1973-9087.19.05827-1
    https://www.ncbi.nlm.nih.gov/pubmed/31833737
  • Arvonen M, Vänni P, Sarangi AN, V Tejesvi M, Vähäsalo P, Aggarwal A, Stoll ML.
    Microbial orchestra in juvenile idiopathic arthritis: Sounds of disarray?
    Immunol Rev. 2019 Dec 13. doi: 10.1111/imr.12826.
    https://www.ncbi.nlm.nih.gov/pubmed/31833578
  • Rypdal V, Guzman J, Henrey A, Loughin T, Glerup M, Arnstad ED, Aalto K, Rygg M, Nielsen S, Herlin T, Fasth A, Berntson L, Rypdal M, Nordal E; ReACCh-Out and NoSPeR Investigators.
    Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort.
    Arthritis Res Ther. 2019 Dec 5;21(1):270.
    https://www.ncbi.nlm.nih.gov/pubmed/31806043
  • Stoustrup P, Herlin T, Spiegel L, Rahimi H, Koos B, Pedersen TK, Twilt M; Temporomandibular joint Juvenile Arthritis Work group (TMJaw).
    Standardizing the clinical orofacial examination in Juvenile idiopathic arthritis: An interdisciplinary, consensus-based, short screening protocol.
    J Rheumatol. 2019 Dec 1. pii: jrheum.190661. doi: 10.3899/jrheum.190661
    https://www.ncbi.nlm.nih.gov/pubmed/31787607
  • Martini A.
    Are there new targets for juvenile idiopathic arthritis?
    Semin Arthritis Rheum. 2019 Dec;49(3S):S11-S13
    https://www.ncbi.nlm.nih.gov/pubmed/31779842
 
OCTUBRE 2019
  • Lucafò M, Franzin M, Lagatolla C, Franca R, Bramuzzo M, Stocco G, Decorti G.
    Validation and adaptation of a German screening tool to identify patients at risk of juvenile idiopathic arthritis
    Clin Transl Sci. 2019 Nov 1. doi: 10.1111/cts.12722. [Epub ahead of print] Review.
    https://www.ncbi.nlm.nih.gov/pubmed/31667541
  • Berthold E, Månsson B, Kahn R.
    Outcome in juvenile idiopathic arthritis: a population-based study from Sweden.
    Arthritis Res Ther. 2019 Oct 28;21(1):218. doi: 10.1186/s13075-019-1994-8.
    https://www.ncbi.nlm.nih.gov/pubmed/31661011
  • Foley C, Floudas A, Canavan M, Biniecka M, MacDermott EJ, Veale DJ, Mullan RH, Killeen OG, Fearon U.
    Increased T cell plasticity with dysregulation of T follicular helper, T peripheral helper and T regulatory cell responses in children with JIA and Down syndrome-associated arthritis
    Arthritis Rheumatol. 2019 Oct 27. doi: 10.1002/art.41150. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/31657128
  • Luijten MAJ, Terwee CB, van Oers HA, Joosten MMH, van den Berg JM, Schonenberg-Meinema D, Dolman KM, Ten Cate R, Roorda LD, Grootenhuis MA, van Rossum MAJ, Haverman L.
    Psychometric properties of the pediatric Patient-Reported Outcomes Measurement Information System (PROMIS®) item banks in a Dutch clinical sample of children with Juvenile Idiopathic Arthritis
    Arthritis Care Res (Hoboken). 2019 Oct 18. doi: 10.1002/acr.24094. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31628731
  • Sule S, Fontaine K.
    Coronary Artery Disease in Adults with History of Juvenile Arthritis
    Arthritis Care Res (Hoboken). 2019 Oct 10. doi: 10.1002/acr.24087. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31600032
  • Stoustrup P, Twilt M.
    Improving treatment of the temporomandibular joint in juvenile idiopathic arthritis: let's face it
    Expert Rev Clin Immunol. 2019 Oct 16:1-3. doi: 10.1080/1744666X.2020.1676151. [Epub ahead of print].

    https://www.ncbi.nlm.nih.gov/pubmed/31575293
 
SEPTIEMBRE 2019
  • Leong JY, Chen P, Yeo JG, Ally F, Chua C, Nur Hazirah S, Poh SL, Pan L, Lai L, Lee ESC, Bathi LDT, Arkachaisri T, Lovell D, Albani S; Pediatric Rheumatology Collaborative Study Group.
    Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal.
    Ann Rheum Dis. 2019 Sep 20. pii: annrheumdis-2019-216059. doi: 10.1136/annrheumdis-2019-216059. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31540934
  • Glerup M, Stoustrup P, Hauge L, Rypdal V, Nordal E, Frid P, Arnstad ED, Rygg M, Thorarensen O, Ekelund M, Berntson L, Fasth A, Nilsson H, Peltoniemi S, Aalto K, Arte S, Toftedal P, Nielsen S, Kreiborg S, Herlin T, Pedersen TK.
    Long-term Outcomes of Temporomandibular Joints in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190231. doi: 10.3899/jrheum.190231. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31523047
  • Bollhalder A, Patcas R, Eichenberger M, Müller L, Schroeder-Kohler S, Saurenmann RK, Kellenberger CJ.
    Magnetic Resonance Imaging Follow-up of Temporomandibular Joint Inflammation, Deformation and Mandibular Growth in Juvenile Idiopathic Arthritis Patients on Systemic Treatment.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190168. doi: 10.3899/jrheum.190168. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31523042
  • Khraishi M, Millson B, Woolcott J, Jones H, Marshall L, Ruperto N.
    Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2019 Sep 10;17(1):64. doi: 10.1186/s12969-019-0358-x.
    https://www.ncbi.nlm.nih.gov/pubmed/31500631
  • Glerup M, Thiel S, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort.
    Pediatr Rheumatol Online J. 2019 Sep 9;17(1):63. doi: 10.1186/s12969-019-0367-9.
    https://www.ncbi.nlm.nih.gov/pubmed/31500626
  • Hissink Muller PCE, van Braak WG, Schreurs D, Nusman CM, Bergstra SA, Hmke R, Schonenberg-Meinema D, van den Berg JM, Kuijpers TW, Koopman-Keemink Y, van Rossum MAJ, van Suijlekom-Smit LWA, Brinkman DMC, Allaart CF, Ten Cate R, Maas M.
    No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2019 Sep 4;17(1):62. doi: 10.1186/s12969-019-0362-1.
    https://www.ncbi.nlm.nih.gov/pubmed/31484539
  • Elham Rezaei, Daniel Hogan, Brett Trost, Anthony J Kusalik, Gilles Boire, David A Cabral, Sarah Campillo, Gaëlle Chédeville, Anne-Laure Chetaille, Paul Dancey,
    Ciaran Duffy, Karen Watanabe Duffy, Simon W M Eng, John Gordon, Jaime Guzman, Kristin Houghton, Adam M Huber, Roman Jurencak, Bianca Lang, Ronald M Laxer, Kimberly Morishita, Kiem G Oen, Ross E Petty, Suzanne E Ramsey, Stephen W Scherer, Rosie Scuccimarri, Lynn Spiegel, Elizabeth Stringer, Regina M Taylor-Gjevre, Shirley M L Tse, Lori B Tucker, Stuart E Turvey, Susan Tupper, Richard F Wintle, Rae S M Yeung, Alan M Rosenberg, BBOP Study Group.
    Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories
    Rheumatology, kez382, https://doi.org/10.1093/rheumatology/kez382
    https://academic.oup.com/rheumatology/article-abstract/doi/10.1093/rheumatology/kez382/5570882/
  • Giancane G, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
    Treatment of juvenile idiopathic arthritis: what's new?
    Curr Opin Rheumatol. 2019 Sep;31(5):428-435. doi:10.1097/BOR.0000000000000632.
    https://www.ncbi.nlm.nih.gov/pubmed/31169547
 
AGOSTO 2019
  • Brunner HI, Nanda K, Toth M, Foeldvari I, Bohnsack J, Milojevic D, Rabinovich CE, Kingsbury DJ, Marzan K, Chalom E, Horneff G, Kuester RM, Dare JA, Trachana M, Jung LK, Olson J, Minden K, Quartier P, Bereswill M, Kalabic J, Kupper H, Lovell DJ, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry 7-Year Interim Results.
    Arthritis Care Res (Hoboken). 2019 Aug 17. doi: 10.1002/acr.24044.
    https://www.ncbi.nlm.nih.gov/pubmed/31421019
  • Barber CEH, Lix LM, Lacaille D, Marshall DA, Kroeker K, Benseler S, Twilt M, Schmeling H, Barnabe C, Hazlewood GS, Bykerk V, Homik J, Thorne JC, Burt J, Mosher D, Katz S, Shiff NJ.
    Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis(JIA) care.
    BMC Health Serv Res. 2019 Aug 14;19(1):572.
    https://www.ncbi.nlm.nih.gov/pubmed/31412858
  • Drechsel P, Stüdemann K, Niewerth M, Horneff G, Fischer-Betz R, Seipelt E, Spähtling-Mestekemper S, Aries P, Zink A, Klotsche J, Minden K.
    Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry.
    Rheumatology (Oxford). 2019 Aug 14. pii: kez309. doi: 10.1093/rheumatology/kez309.
    https://www.ncbi.nlm.nih.gov/pubmed/31412128
  • Lunt LE, Bosworth A, Bezzant M, Walker-Bone K, Hyrich KL, Thomson W, McDonagh JE, Verstappen SMM.
    A UK study: vocational experiences of young adults with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2019 Aug 6;17(1):54.
    https://www.ncbi.nlm.nih.gov/pubmed/31387599
  • Shih YJ, Yang YH, Lin CY, Chang CL, Chiang BL.
    Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
    Pediatr Rheumatol Online J. 2019 Aug 23;17(1):58. https://www.ncbi.nlm.nih.gov/pubmed/31443722
 
JULIO 2019
  • Flanagan ER, Benham H, Figueroa J, Diaz J, Tress J, Sherry DD.
    Retrospective review of immobilization vs. immediate resumption of activity in patients with Oligoarticular juvenile idiopathic arthritis following knee injections.
    Pediatr Rheumatol Online J. 2019 Jul 12;17(1):42.
    https://www.ncbi.nlm.nih.gov/pubmed/31299977
  • Verstegen RHJ, McMillan R, Feldman BM, Ito S, Laxer RM
    Towards therapeutic drug monitoring of TNF inhibitors for children with juvenile idiopathic arthritis: a scoping review.
    Rheumatology (Oxford). 2019 Jul 23. pii: kez285. doi: 10.1093/rheumatology/kez285. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31335941
  • Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F, Alongi A, Civino A, Quartulli L, Consolaro A, Ravelli A.
    Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.
    Arthritis Res Ther. 2019 Jul 8;21(1):168.
    https://www.ncbi.nlm.nih.gov/pubmed/31287015
  • Shoop-Worrall SJW, Wu Q, Davies R, Hyrich KL, Wedderburn LR.
    Predicting disease outcomes in juvenile idiopathic arthritis: challenges, evidence, and new directions.
    Lancet Child Adolesc Health. 2019 Jul 19. pii: S2352-4642(19)30188-9. doi: 10.1016/S2352-4642(19)30188-9. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31331873
  • Buckley L, Ware E, Kreher G, Wiater L, Mehta J, Burnham JM.
    Outcome Monitoring and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis.
    J Rheumatol. 2019 Jul 15. pii: jrheum.190268. doi: 10.3899/jrheum.190268. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31308202
  • Nordal E, Rypdal V, Arnstad ED, Aalto K, Berntson L, Ekelund M, F et al.
    Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study.
    Pediatr Rheumatol Online J. 2019 Jul 15;17(1):44.
    https://www.ncbi.nlm.nih.gov/pubmed/31307487
  • El Miedany Y, El Gaafary M, Lotfy H, El Aroussy N, Mekkawy D, Nasef SI, Farag Y, Almedany S, Wassif G; PRINTO Egypt.
    Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking.
     Clin Rheumatol. 2019 Jul 20. doi: 10.1007/s10067-019-04687-y. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31327085
  • Ayaz NA, Karadağ ŞG, Çakmak F, Çakan M, Tanatar A, Sönmez HE.
    Leflunomide treatment in juvenile idiopathic arthritis.
     Rheumatol Int. 2019 Jul 20. doi: 10.1007/s00296-019-04385-7. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31327053
  • Kyvsgaard N, Mikkelsen TS, Thastum M, Christensen AE, Wehner PS, Nysom K, Herlin T.
    Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
     PLoS One. 2019 Jul 11;14(7):e0219539.
    https://www.ncbi.nlm.nih.gov/pubmed/31295288
  • Lee RR, Rashid A, Ghio D, Thomson W, Cordingley L.
    "Seeing Pain Differently": A Qualitative Investigation Into the Differences and Similarities of Pain and Rheumatology Specialists' Interpretation of Multidimensional Mobile Health Pain Data From Children and Young People With Juvenile Idiopathic Arthritis.
    JMIR Mhealth Uhealth. 2019 Jul 2;7(7):e12952.
    https://www.ncbi.nlm.nih.gov/pubmed/31267979
  • Kindgren E, Guerrero-Bosagna C, Ludvigsson J.
    Heavy metals in fish and its association with autoimmunity in the development of juvenile idiopathic arthritis: a prospective birth cohort study.
    Pediatr Rheumatol Online J. 2019 Jul 2;17(1):33
    https://www.ncbi.nlm.nih.gov/pubmed/31266504
  • Xiao Y, Liu H, Chen L, Wang Y, Yao X, Jiang X.
    Association of microRNAs genes polymorphisms with arthritis: a systematic review and meta-analysis.
    Biosci Rep. 2019 Jul 18;39(7). pii: BSR20190298. doi: 10.1042/BSR20190298.
    https://www.ncbi.nlm.nih.gov/pubmed/31235484
  • Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, Kricorian G, Chung JB.
    Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial.
    Arthritis Rheumatol 2019 Jul; 71(7):1112-1124.
    https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40851
 
JUNIO 2019
  • Murias Loza S, Graña Gil G
    Response to: Current Status of Treatment With Intra-Articular Infiltrations in Juvenile Idiopathic Arthritis.
    Reumatol Clin. 2019 Jun 26. pii: S1699-258X(19)30106-8. doi: 10.1016/j.reuma.2019.05.006.
    https://www.ncbi.nlm.nih.gov/pubmed/31255549
  • Khan S, Mancini J, Hopper C, Rennick JE.
    Perceptions of methotrexate intolerance and its impact on daily life in school-age children with juvenile idiopathic arthritis.
    J Pediatr Nurs. 2019 Jun 26;48:49-54. doi: 10.1016/j.pedn.2019.06.004. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31254860
  • Giani T, De Masi S, Maccora I, Tirelli F, Simonini G, Falconi M, Cimaz R
    The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis.
    Front Pharmacol. 2019 Jun 12;10:637. doi: 10.3389/fphar.2019.00637.
    https://www.ncbi.nlm.nih.gov/pubmed/31249526
  • Hanns L, Radziszewska A, Suffield L, Josephs F, Chaplin H, Peckham H, Sen D, Christie D, Carvalho LA, Ioannou Y.
    Anxiety associates with pain and disability but not increased measures of inflammation for adolescent patients with juvenile idiopathic arthritis.
    Arthritis Care Res (Hoboken). 2019 Jun 14. doi: 10.1002/acr.24006. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31199593
  • Nigrovic PA, Martínez-Bonet M, Thompson SD.
    Implications of juvenile idiopathic arthritis genetic risk variants for disease pathogenesis and classification.
    Curr Opin Rheumatol. 2019 Jun 4. doi: 10.1097/BOR.0000000000000637. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31169548
  • Giancane G, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
    Treatment of juvenile idiopathic arthritis: what's new?
    Curr Opin Rheumatol. 2019 Jun 4. doi: 10.1097/BOR.0000000000000632. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31169547
  • Busch R, Kollnberger S, Mellins ED.
    HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.
    Nat Rev Rheumatol. 2019 Jun;15(6):364-381. doi: 10.1038/s41584-019-0219-5.
    https://www.ncbi.nlm.nih.gov/pubmed/31092910
 
ABRIL 2019
  • Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo M, Stoll ML, Rabinovich E, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.
    2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
    Arthritis Care Res (Hoboken). 2019 Apr 25. doi: 10.1002/acr.23870. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/31021516
  • Stoustrup P, Glerup M, Bilgrau AE, Küseler A, Verna C, Christensen AE, Kristensen KD, Nørholt SE, Twilt M, Herlin T, Pedersen TK.
    Cumulative Incidence of Orofacial Manifestations in Early Juvenile Idiopathic Arthritis: A Regional, Three Year Cohort Study
    Arthritis Care Res (Hoboken). 2019 Apr 11. doi: 10.1002/acr.23899. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30973675
  • Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N, Yamasaki Y, Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S.
    Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.
    Pediatr Rheumatol Online J. 2019 Apr 30;17(1):17. doi: 10.1186/s12969-019-0319-4.
    https://www.ncbi.nlm.nih.gov/pubmed/31039807
 
MARZO 2019
  • Kearsley-Fleet L, Vicente González L, Steinke D, Davies R, De Cock D, Baildam E, Beresford MW, Foster HE, Southwood TR, Thomson W, Hyrich KL; Biologics for Children with Rheumatic Diseases (BCRD) Study and the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN).
    Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis.
    Rheumatology (Oxford). 2019 Mar 8. pii: kez048. doi: 10.1093/rheumatology/kez048. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30851113
  • Pardeo M, Wang J, Ruperto N, Alexeeva E, Chasnyk V, Schneider R, Horneff G, Huppertz HI, Minden K, Onel K, Zemel L, Martin A, Koné-Paut I, Siamopoulou-Mavridou A, Silva CA, Porter-Brown B, Bharucha KN, Brunner HI, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) .
    Neutropenia During Tocilizumab Treatment Is Not Associated With Infection Risk in Systemic or Polyarticular-Course Juvenile Idiopathic Arthritis.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180795. doi: 10.3899/jrheum.180795. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30824645
  • Doeleman MJH, van Maarseveen EM, Swart JF.
    Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis.
    Rheumatology (Oxford). 2019 Feb 26. pii: kez030. doi: 10.1093/rheumatology/kez030. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30809664
  • Shiff NJ, Oen K, Kroeker K, Lix LM.
    Trends in Population-Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada.
    Arthritis Care Res (Hoboken). 2019 Mar;71(3):413-418.
    https://www.ncbi.nlm.nih.gov/pubmed/29799673  
  • Rabionet R, Remesal A, Mensa-Vilaró A, Murías S, Alcobendas R, González-Roca E, Ruiz-Ortiz E, Antón J, Iglesias E, Modesto C, Comas D, Puig A, Drechsel O, Ossowski S, Yagüe J, Merino R, Estivill X, Arostegui JI.
    Biallelic loss-of-function LACC1/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis.
    Sci Rep. 2019 Mar 14;9(1):4579.
    https://www.ncbi.nlm.nih.gov/pubmed/30872671
  • Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.
    Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
    Arthritis Rheumatol. 2019 Mar;71(3):451-459.
    https://www.ncbi.nlm.nih.gov/pubmed/30225949
  • Rosser EC, Lom H, Bending D, Duurland CL, Bajaj-Elliott M, Wedderburn LR.
    Innate Lymphoid Cells and T Cells Contribute to the Interleukin-17A Signature Detected in the Synovial Fluid of Patients With Juvenile Idiopathic Arthritis.
    Arthritis Rheumatol. 2019 Mar;71(3):460-467.
    https://www.ncbi.nlm.nih.gov/pubmed/30350355
  • Sperling CD, Kjaer SK, Hargreave M, Jensen A.
    Risk of juvenile idiopathic arthritis among children conceived after fertility treatment: a nationwide registry-based cohort study.
    Hum Reprod. 2019 Mar 30. pii: dez035. doi: 10.1093/humrep/dez035. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30927428
  • Lourenço DMR, Kozu K, Aikawa NE, Sallum AME, Campos LMA, Abdo CHN, Pereira RMR, Baracat EC, Bonfá E, Silva CA.
    Sexual function in female juvenile idiopathic arthritis patients.
    Adv Rheumatol. 2019 Mar 22;59(1):13. doi: 10.1186/s42358-019-0058-8.
    https://www.ncbi.nlm.nih.gov/pubmed/30902114
  • Pitta AC, Ferreira GRV, Tomioka RB,Elitsur R, Hollenbeck A, Tasan L, Torok KS, Cassidy E, Blasiole B, Parsons E, Acock C, Angelelli J, Angelelli IC.
    Efficacy and cost savings with the use of a minimal sedation / anxiolysis protocol for intra-articular corticosteroid injections in children with juvenile idiopathic arthritis: a retrospective review of prospectively collected data.
    Pediatr Rheumatol Online J. 2019 Mar 20;17(1):11.
    https://www.ncbi.nlm.nih.gov/pubmed/30894194
  • Tollisen A, Selvaag AM, Aasland A, Lerdal A, Flatø B.
    Longitudinal health status from early disease to adulthood and associated prognostic factors in juvenile idiopathic arthritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180948. doi: 10.3899/jrheum.180948. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30877211
  • Kavadichanda CG, Seth G, Kumar G, Gulati R, Negi VS.
    Clinical correlates of HLA-B*27 and its subtypes in enthesitis-related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients.
    Int J Rheum Dis. 2019 Mar 18. doi: 10.1111/1756-185X.13551. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30884197
FEBRERO 2019
  • Yong SB, Huang JY, Chiou JY, Wei JC.
    Adult outcome of juvenile idiopathic arthritis: A nationwide population-based retrospective cohort study in Taiwan.
    Int J Rheum Dis. 2019 Feb 27. doi: 10.1111/1756-185X.13527. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30816022
  • Eng SWM, Aeschlimann FA, van Veenendaal M, Berard RA, Rosenberg AM, Morris Q, Yeung RSM; ReACCh-Out Research Consortium.
    Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization.
    PLoS Med. 2019 Feb 26;16(2):e1002750. doi: 10.1371/journal.pmed.1002750.
    https://www.ncbi.nlm.nih.gov/pubmed/30807586
  • Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Toftedal P, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T; Nordic Study Group of Pediatric Rheumatology (NoSPeR)
    Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort.
    Arthritis Care Res (Hoboken). 2019 Feb 14. doi: 10.1002/acr.23853.
    https://www.ncbi.nlm.nih.gov/pubmed/30762291
  • Kyllönen MS, Kautiainen H, Puolakka K, Vähäsalo P.
    The mortality rate and causes of death among juvenile idiopathic arthritis patients in Finland.
    Clin Exp Rheumatol. 2019 Feb 11. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30767877
  • Grande SW, Longacre MR, Palmblad K, Montan MV, Berquist RP, Hager A, Kotzbauer G.
    Empowering Young People Living With Juvenile Idiopathic Arthritis to Better Communicate With Families and Care Teams: Content Analysis of Semistructured Interviews.
    JMIR Mhealth Uhealth. 2019 Feb 22;7(2):e10401. doi: 10.2196/10401.
    https://www.ncbi.nlm.nih.gov/pubmed/30794202
  • Martínez Del Val E, Rodríguez Martínez A, Sánchez Becerra V, Cruz Rojo J, Enríquez Merayo E, Barral Mena E, de Inocencio Arocena J.
    Characteristics of synovial fluid in patients with juvenile idiopathic arthritis
    An Pediatr (Barc). 2019 Feb 16. pii: S1695-4033(19)30019-0. doi: 10.1016/j.anpedi.2019.01.004.
    https://www.ncbi.nlm.nih.gov/pubmed/30782446
  • Panwar J, Tse SML, Lim L, Tolend MA, Radhakrishnan S, Salman M, Moineddin R, Doria AS, Stimec J.
    Spondyloarthritis Research Consortium of Canada Scoring System for Sacroiliitis in JuvenileSpondyloarthritis/Enthesitis-related Arthritis: A Reliability, Validity, and Responsiveness Study.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180222. doi: 10.3899/jrheum.180222.
    https://www.ncbi.nlm.nih.gov/pubmed/30709956
  • Beukelman T, Nigrovic PA.
    Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone?
    J Rheumatol. 2019 Feb;46(2):124-126. doi: 10.3899/jrheum.180922.
    https://www.ncbi.nlm.nih.gov/pubmed/30710000
  • Uziel Y.
    Juvenile Idiopathic Arthritis-Education, Knowledge, and Patient Outcomes.
    J Pediatr. 2019 Feb 5. pii: S0022-3476(19)30113-1.
    https://www.ncbi.nlm.nih.gov/pubmed/30737036
  • Rumsey DG, Guzman J, Rosenberg AM, Huber AM, Scuccimarri R, Shiff NJ, Bruns A, Feldman BM, Eurich DT; Research in Arthritis in Canadian Children Emphasizing Outcomes Investigators.
    Children with Enthesitis Have Worse Quality of Life, Function, and Pain, Irrespective of their Juvenile Arthritis Category.
    Arthritis Care Res (Hoboken). 2019 Feb 11. doi: 10.1002/acr.23844.
    https://www.ncbi.nlm.nih.gov/pubmed/30740939
  • Milatz F, Klotsche J, Niewerth M, Geisemeyer N, Trauzeddel R, Weißbarth-Riedel E, Kallinich T, Peitz J, Hartmann M, Minden K.
    Participation in school sports among children and adolescents with juvenile idiopathic arthritis in the German National Paediatric Rheumatologic Database, 2000-2015: results from a prospective observational cohort study.
    Pediatr Rheumatol Online J. 2019 Feb 11;17(1):6. doi: 10.1186/s12969-019-0306-9.
    https://www.ncbi.nlm.nih.gov/pubmed/30744659
  • Tarakçı E, Arman N, Barut K, Adroviç A, Kasapçopur Ö.
    Fatigue and sleep in children and adolescents with juvenile idiopathic arthritis:a cross-sectional study
    Turk J Med Sci. 2019 Feb 11;49(1):58-65. doi: 10.3906/sag-1711-167.
    https://www.ncbi.nlm.nih.gov/pubmed/30761857
 
ENERO 2019
  • Pavo MR, de Inocencio J.
    Pediatrician Beliefs about Juvenile Idiopathic Arthritis May Result in Referral Delays: A Spanish National Survey.
    J Pediatr. 2019 Jan 21. pii: S0022-3476(18)31812-2. doi: 10.1016/j.jpeds.2018.12.038. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30679051
  • Stoustrup P, Resnick CM, Pedersen TK, Abramowicz S, Michelotti A, Küseler A, Verna C, Kellenberger CJ, Berit Nordal E, Caserta G, Jankovska I, Halbig JM, Kristensen KD, Arvidsson LZ, Spiegel L, Stoll ML, Lerman M, Glerup M, Defabianis P, Frid P, Alstergren P, Cron RQ, Ringold S, Nørholt SE, Peltomäki T, Herlin T, Peacock ZS, Twilt M; TMJ Juvenile Arthritis Working Group.
    Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based Recommendations.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180785. doi: 10.3899/jrheum.180785. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30647179
  • Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Huber AM, Oen K, Gerhold K, Feldman BM, Scuccimarri R, Houghton K, Chédeville G, Morishita K, Lang B, Dancey P, Rosenberg AM, Barsalou J, Bruns A, Watanabe Duffy K, Benseler S, Duffy CM, Tucker LB; ReACCh-Out Investigators.
    Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180456. doi: 10.3899/jrheum.180456. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30647178
  • De Filippo C, Di Paola M, Giani T, Tirelli F, Cimaz R.
    Gut microbiota in children and altered profiles in juvenile idiopathic arthritis.
    J Autoimmun. 2019 Jan 9. pii: S0896-8411(18)30650-4. doi: 10.1016/j.jaut.2019.01.001. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30638708
 
DICIEMBRE 2018
  • van Dijkhuizen EHP, Del Chierico F, Malattia C, Russo A, Pires Marafon D, Ter Haar NM, Magni-Manzoni S, Vastert SJ, Dallapiccola B, Prakken B, Martini A, De Benedetti F, Putignani L.
    Microbiome analytics of the gut microbiota in juvenile idiopathic arthritis patients: an observational, longitudinal cohort study.
    Arthritis Rheumatol. 2018 Dec 28. doi: 10.1002/art.40827. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30592383
  • Sengler C, Zink J, Klotsche J, Niewerth M, Liedmann I, Horneff G, Kessel C, Ganser G, Thon A, Haas JP, Hospach A, Weller-Heinemann F, Heiligenhaus A, Foell D, Zink A, Minden K
    Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort.
    Arthritis Res Ther. 2018 Dec 13;20(1):276. doi: 10.1186/s13075-018-1765-y.
    https://www.ncbi.nlm.nih.gov/pubmed/30545399
  • Więch P, Sałacińska I, Bazaliński D, Dąbrowski M
    Body composition and phase angle as an indicator of nutritional status in children with juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2018 Dec 27;16(1):82. doi: 10.1186/s12969-018-0297-y.
    https://www.ncbi.nlm.nih.gov/pubmed/30587206
 
NOVIEMBRE 2018
  • Jeamsripong S, Charuvanij S
    Features distinguishing juvenile idiopathic arthritis among children with musculoskeletal complaints.
    World J Pediatr. 2018 Nov 29. doi: 10.1007/s12519-018-0212-0. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30498888
  • Leong JY, Guan YJ, Albani S, Arkachaisri T
    Recent advances in our understanding of the pathogenesis of juvenile idiopathic arthritis and their potential clinical implications.
    Expert Rev Clin Immunol. 2018 Nov;14(11):933-944. doi: 10.1080/1744666X.2018.1529757.
    https://www.ncbi.nlm.nih.gov/pubmed/30269617
 
OCTUBRE 2018
  • Marino A, Stagi S, Simonini G, Carli N, Caparello MC, Giani T, Pagnini I, De Masi S, Cimaz R.
    Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.
    Clin Exp Rheumatol. 2018 Sep-Oct;36(5):929-933. Epub 2018 Jul 19.
    https://www.ncbi.nlm.nih.gov/pubmed/30148444
  • Leschied JR, Smith EA, Baker S, Khalatbari S, Aronovich S.
    Contrast-enhanced MRI compared to direct joint visualization at arthroscopy in pediatric patients with suspected temporomandibular joint synovitis
    Pediatr Radiol. 2018 Oct 31. doi: 10.1007/s00247-018-4291-9. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30382321
  • Kearsley-Fleet L, Sampath S, McCann LJ, Baildam E, Beresford MW, Davies R, De Cock D, Foster HE, Southwood TR, Thomson W, Hyrich KL.
    Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritisin a cohort study in the United Kingdom
    Rheumatology (Oxford). 2018 Oct 24. doi: 10.1093/rheumatology/key306. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30358861
  • Oude Voshaar MAH, Das Gupta Z, Bijlsma JWJ, Boonen A, Chau J, Courvoisier DS, Curtis JR, Ellis B, Ernestam S, Gossec L, Hale C, Hornjeff J, Leung KYY, Lidar M, Mease P, Michaud K, Mody GM, Ndosi M, Opava CH, Pinheiro GRC, Salt M, Soriano ER, Taylor WJ, Voshaar MJH, Weel AEAM, de Wit M, Wulffraat N, van de Laar MAFJ, Vonkeman HE.
    The International Consortium for Health Outcome Measurement (ICHOM)Set of Outcomes that Matter to People Living with Inflammatory Arthritis Consensus from an international Working Group
    Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23799. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30358135
  • Nørgaard M, Herlin T.
    Specific Sport Habits, Leisure-Time and School-Educational Physical Activity in Children with Juvenile Idiopathic Arthritis - Patterns and Barriers
    Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23795. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30354015
  • Rosser EC, Lom H, Bending D, Duurland CL, Bajaj-Elliott M, Wedderburn LR.
    Brief Report: Innate lymphoid cells and T-cells contribute to the IL-17A signature detected in the synovial fluid of patients with Juvenile Idiopathic Arthritis
    Arthritis Rheumatol. 2018 Oct 22. doi: 10.1002/art.40731. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30350355
 
SEPTIEMBRE 2018
  • Cabrera N, Lega JC, Kassai B, Wouters C, Kondi A, Cannizzaro E, Woerner A, Chausset A, Roethlisberger S, Jeanneret C, Aeschlimann F, Malik S, Duquesne A, Kaiser D, Higel L, Maes A, Berthet G, Hentgen V, Kone-Paut I, Belot A, Hofer M.
    Safety of biological agents in paediatric rheumatic diseases: a real-life multicenter retrospective study using the JIRcohorte database.
    Joint Bone Spine. 2018 Sep 7. pii: S1297-319X(18)30283-5. doi: 10.1016/j.jbspin.2018.08.003. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30201476
  • Scott C, Chan M, Slamang W, Okong'o L, Petty R, Laxer RM, Katsicas MM, Fredrick F, Chipeta J, Faller G, Pileggi G, Saad-Magalhaes C, Wouters C, Foster HE, Kubchandani R, Ruperto N, Russo R.
    Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.
    Clin Rheumatol. 2018 Sep 28. doi: 10.1007/s10067-018-4304-y. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30267356
  • Öman A, Hansson T, Carlsson M, Berntson L.
    Evaluation of screening for celiac disease in children with juvenile idiopathic arthritis.
    Acta Paediatr. 2018 Sep 28. doi: 10.1111/apa.14598. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30265401
  • Hunter H.
    Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?
    Arch Dis Child. 2018 Sep 27. pii: archdischild-2018-315528. doi: 10.1136/archdischild-2018-315528. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30262509
  • Nieto-González JC, Monteagudo I
    Estado actual del tratamiento con infiltraciones intraarticulares en la artritis idiopática juvenil
    Reumatol Clin. 2018 Sep 19. pii: S1699-258X(18)30174-8. doi: 10.1016/j.reuma.2018.07.015. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30243614
  • Ventura-Ríos L, Faugier E, Barzola L, De la Cruz-Becerra LB, Sánchez-Bringas G, García AR, Maldonado R, Roth J, Hernández-Díaz C.
    Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2018 Sep 17;16(1):58
    https://www.ncbi.nlm.nih.gov/pubmed/30223838
  • Chi H, Teng J, Yang C, Su Y.
    Bone tumors developed in patients with juvenile inflammatory arthritis after anti-TNFα therapy.
    Immunotherapy. 2018 Sep;10(12):1033-1039.
    https://www.ncbi.nlm.nih.gov/pubmed/30185135
  • Powell AP, English J.
    Exercise for Athletes with Inflammatory Arthritis.
    Curr Sports Med Rep. 2018 Sep;17(9):302-307
    https://www.ncbi.nlm.nih.gov/pubmed/30204634
 
AGOSTO 2018
  • Demir F, Çebi AH, Kalyoncu M.
    Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis.
    Clin Rheumatol. 2018 Aug 31. doi: 10.1007/s10067-018-4277-x. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30171379
  • Alexeeva E, Dvoryakovskaya T, Denisova R, Sleptsova T, Isaeva K, Chomahidze A, Fetisova A, Mamutova A, Alshevskaya A, Gladkikh V, Moskalev A.
    Comparative Analysis of the Etanercept Efficacy in Children with Juvenile Idiopathic Arthritis Under the Age of 4 Years and Children of Older Age Groups Using the Propensity Score Matching Method.
    Mod Rheumatol. 2018 Aug 28:1-20. doi: 10.1080/14397595.2018.1516329. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30149747
  • Smith CJF, Förger F, Bandoli G, Chambers CD.
    Factors associated with preterm delivery among women with rheumatoid arthritis and juvenile idiopathic arthritis.
    Arthritis Care Res (Hoboken). 2018 Aug 21. doi: 10.1002/acr.23730. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30133181
  • Bašić J, Vojinović J, Jevtović-Stoimenov T, Despotović M, Sušić G,Lazarević D, Milošević V, Cvetković M, Pavlović D.
    Vitamin D receptor gene polymorphism influences lipid profile in patients with juvenile idiopathic arthritis.
    Clin Rheumatol. 2018 Aug 20. doi: 10.1007/s10067-018-4264-2. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30128913
  • Ferguson ID, Griffin P, Michel JJ, Yano H, Gaffen SL, Mueller RG, Dvergsten JA, Piganelli JD, Rosenkranz ME, Kietz DA, Vallejo AN.
    T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis.
    Front Immunol. 2018 Aug 6;9:1802. doi: 10.3389/fimmu.2018.01802.
    https://www.ncbi.nlm.nih.gov/pubmed/30127787
  • Okamoto N, Yokota S, Takei S, Okura Y, Kubota T, Shimizu M, Nozawa T, Iwata N, Umebayashi H, Kinjo N, Kunishima T, Yasumura J, Mori M.
    Clinical Practice Guidance for Juvenile Idiopathic Arthritis (JIA) 2018.
    Mod Rheumatol. 2018 Aug 21:1-53. doi: 10.1080/14397595.2018.1514724. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30126298
  • Rochette E, Merlin E, Hourdé C, Evrard B, Peraira B, Echaubard S, Duché P.
    Inflammatory Response 24 h Post-Exercise in Youth with Juvenile Idiopathic Arthritis.
    Int J Sports Med. 2018 Aug 17. doi: 10.1055/a-0640-9063. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30119133
  • Zanwar A, Phatak S, Aggarwal A.
    Prospective validation of the Juvenile Spondyloarthritis Disease Activity Index in children with enthesitis-related arthritis.
    Rheumatology (Oxford). 2018 Aug 9. doi: 10.1093/rheumatology/key246. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30107576
  • Rocha FAC, Landim JIVD, Aguiar MG, Accioly JPE, Lechiu CN, Costa LHA, Júnior CNR, da Rocha LN, Rocha HAL.
    Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
    Rheumatol Int. 2018 Aug 13. doi: 10.1007/s00296-018-4128-8. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30101369
  • Throm AA, Moncrieffe H, Orandi AB, Pingel JT, Geurs TL, Miller HL, Daugherty AL, Malkova ON, Lovell DJ, Thompson SD, Grom AA, Cooper MA, Oh ST, French AR.
    Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry.
    JCI Insight. 2018 Aug 9;3(15). pii: 121544. doi: 10.1172/jci.insight.121544. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30089725
  • Waite-Jones JM, Swallow V.
    Peer-based social support for young-people with Juvenile Arthritis: views of young people, parents/carers and healthcare professionals within the UK.
    J Pediatr Nurs. 2018 Aug 2. pii: S0882-5963(18)30205-7. doi: 10.1016/j.pedn.2018.07.012. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30078727
  • Mars NJ, Kerola AM, Kauppi MJ, Pirinen M, Elonheimo O, Sokka-Isler T.
    Healthcare costs and outcomes in adult patients with juvenile idiopathic arthritis: a population-based study.
    Scand J Rheumatol. 2018 Aug 2:1-7. doi: 10.1080/03009742.2018.1475580. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30070935
  • Mars NJ, Kerola AM, Kauppi MJ, Pirinen M, Elonheimo O, Sokka-Isler T.
    Healthcare costs and outcomes in adult patients with juvenile idiopathic arthritis: a population-based study.
    Scand J Rheumatol. 2018 Aug 2:1-7. doi: 10.1080/03009742.2018.1475580. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30070935
  • Weiss PF, Colbert RA.
    Juvenile Spondyloarthritis: A Distinct Form of Juvenile Arthritis.
    Pediatr Clin North Am. 2018 Aug;65(4):675-690. doi: 10.1016/j.pcl.2018.03.006.
    https://www.ncbi.nlm.nih.gov/pubmed/30031493
  • Bharucha KN, Brunner HI, Calvo Penadés I, Nikishina I, Rubio-Pérez N, Oliveira S, Kobusinska K, Schmeling H, Sztajnbok F, Weller-Heinemann F, Zholobova E, Zulian F, Allen R, Chaitow J, Frane J, Wells C, Ruperto N, De Benedetti F; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group.
    Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.
    J Rheumatol. 2018 Aug;45(8):1173-1179. doi: 10.3899/jrheum.170326. Epub 2018 Jul 1.
    https://www.ncbi.nlm.nih.gov/pubmed/29961686
 
JULIO 2018
  • Minden K, Horneff G, Niewerth M, Seipelt E, Aringer M, Aries P, Foeldvari I, Haas JP, Klein A, Tatsis S, Tenbrock K, Zink A, Klotsche J.
    The time of DMARD start in Juvenile Idiopathic Arthritis determines the likelihood of a drug-free remission in young adulthood.
    Arthritis Care Res (Hoboken). 2018 Jul 25. doi: 10.1002/acr.23709. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/30044538
  • Arnstad ED, Rypdal V, Peltoniemi S, Herlin T, Berntson L, Fasth A, Nielsen S, Glerup M, Ekelund M, Zak M, Aalto K, Nordal E, Romundstad PR, Rygg M; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    Early self-reported pain in juvenile idiopathic arthritis (JIA) is related to long-term outcomes. Results from the Nordic JIA cohort study.
    Arthritis Care Res (Hoboken). 2018 Jul 28. doi: 10.1002/acr.23715. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30055093
  • Rahimi H, Twilt M, Herlin T, Spiegel L, Pedersen TK, Küseler A, Stoustrup P.
    Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study.
    Pediatr Rheumatol Online J. 2018 Jul 13;16(1):47. doi: 10.1186/s12969-018-0259-4.
    https://www.ncbi.nlm.nih.gov/pubmed/30005677
  • Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.
    Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.
    Arthritis Care Res (Hoboken). 2018 Jul;70(7):1046-1051. doi: 10.1002/acr.23435. Epub 2018 Apr 24.
    https://www.ncbi.nlm.nih.gov/pubmed/28973842
  • Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Berman A, Calvo Penadés I, Antón J, Ávila-Zapata F, Cuttica R, Horneff G, Foeldvari I, Keltsev V, Kingsbury DJ, Viola DO, Joos R, Lauwerys B, Paz Gastañaga ME, Rama ME, Wouters C, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Miraval T, Ally MMTM, Rubio-Pérez N, Solau Gervais E, van Zyl R, Li X, Nys M, Wong R, Banerjee S, Lovell DJ, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
    Arthritis Rheumatol. 2018 Jul;70(7):1144-1154. doi: 10.1002/art.40466. Epub 2018 May 20.
    https://www.ncbi.nlm.nih.gov/pubmed/29481737
  • Klotsche J, Minden K, Niewerth M, Horneff G.
    Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA.
    Ann Rheum Dis.2018 Jul;77(7):996-1002. doi: 10.1136/annrheumdis-2017-211968. Epub 2018 Feb 16.
    https://www.ncbi.nlm.nih.gov/pubmed/29453217
 
JUNIO 2018
  •  Piancino MG, Cannavale R, Dalmasso P, Tonni I, Garagiola U, Perillo L, Olivieri AN.
    Cranial structure and condylar asymmetry of patients with juvenile idiopathic arthritis: a risky growth pattern.
    Clin Rheumatol. 2018 Jun 21. doi: 10.1007/s10067-018-4180-5
    https://www.ncbi.nlm.nih.gov/pubmed/29931517
  • van Dijkhuizen EHP, Aidonopoulos O, Ter Haar NM, Pires Marafon D, Magni-Manzoni S, Ioannidis YE, Putignani L, Vastert SJ, Malattia C, De Benedetti F, Martini A; MD-Paedigree Consortium.
    Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort study.
    Rheumatology (Oxford). 2018 Jun 20. doi: 10.1093/rheumatology/key148
    https://www.ncbi.nlm.nih.gov/pubmed/29931340
  • Ohl K, Nickel H, Moncrieffe H, Klemm P, Scheufen A, Föll D, Wixler V, Schippers A, Wagner N, Wedderburn LR, Tenbrock K.
    The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2018 Jun 20;16(1):39. doi: 10.1186/s12969-018-0253-x
    https://www.ncbi.nlm.nih.gov/pubmed/29925386
  • Ferrara G, Pastore S, Sancin L, Torelli L, Radillo O, Bramuzzo M, Bibalo C, Tommasini A, Ventura A, Taddio A.
    Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171200. doi: 10.3899/jrheum.171200
    https://www.ncbi.nlm.nih.gov/pubmed/29907671
  • Isola G, Perillo L, Migliorati M, Matarese M, Dalessandri D, Grassia V, Alibrandi A, Matarese G.
    The impact of temporomandibular joint arthritis on functional disability and global health in patients with juvenile idiopathic arthritis.
    Eur J Orthod. 2018 Jun 6. doi: 10.1093/ejo/cjy034
    https://www.ncbi.nlm.nih.gov/pubmed/29878100
  • Unal E, Batu ED, Sonmez HE, Arici ZS, Arin G, Karaca NB, Sag E, Demir S, Hakli DA, Ozcadirci A, Oflaz FB, Alpar R, Bilginer Y, Ozen S.
    A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q.
    Rheumatol Int. 2018 Jun 5. doi: 10.1007/s00296-018-4075-4
    https://www.ncbi.nlm.nih.gov/pubmed/29869009
  • Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED.
    Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.
    J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131
    https://www.ncbi.nlm.nih.gov/pubmed/29858347
  • Naz S, Asif M, Naz F, Farooq H, Hamid MH.
    Spectrum of Joint Deformities in Children with Juvenile Idiopathic Arthritis.
    J Coll Physicians Surg Pak. 2018 Jun;28(6):470-473. doi: 10.29271/jcpsp.2018.06.470
    https://www.ncbi.nlm.nih.gov/pubmed/29848426
  • Bishop JC, Britton JF, Murphy AM, Sule S, Mitchell S, Takemoto C, Collaco JM, Karnsakul W, Cuffari C, Dietz E, Bodurtha J.
    Juvenile Idiopathic Arthritis Associated with Combined JP-HHT Syndrome: A Novel Phenotype Associated with a Novel Variant in SMAD4.
    J Pediatr Genet. 2018 Jun;7(2):78-82. doi: 10.1055/s-0037-1609060
    https://www.ncbi.nlm.nih.gov/pubmed/29707409
  • Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
    Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
    Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030
    https://www.ncbi.nlm.nih.gov/pubmed/29643108
  • Heath-Watson S, Sule S.
    Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives.
    Rheumatol Ther. 2018 Jun;5(1):1-4. doi: 10.1007/s40744-018-0098-2
    https://www.ncbi.nlm.nih.gov/pubmed/29480358
  • Hinks A, Marion MC, Cobb J, Comeau ME, Sudman M, Ainsworth HC, Bowes J; Juvenile Idiopathic Arthritis Consortium for Immunochip, Becker ML, Bohnsack JF, Haas JP, Lovell DJ, Mellins ED, Nelson JL, Nordal E, Punaro M, Reed AM, Rose CD, Rosenberg AM, Rygg M, Smith SL, Stevens AM, Videm V, Wallace CA, Wedderburn LR, Yarwood A, Yeung RSM, Langefeld CD, Thompson SD, Thomson W, Prahalad S.
    Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis.
    Arthritis Rheumatol. 2018 Jun;70(6):957-962. doi: 10.1002/art.40443
    https://www.ncbi.nlm.nih.gov/pubmed/29426059
  • Bridgewood C, Watad A, Cuthbert RJ, McGonagle D.
    Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics.
    Curr Opin Rheumatol. 2018 Jun 9. doi: 10.1097/BOR.0000000000000529
    https://www.ncbi.nlm.nih.gov/pubmed/29889692
  • Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
    Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
    Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030.
    https://www.ncbi.nlm.nih.gov/pubmed/29643108
  • Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED.
    Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.
    J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131.
    https://www.ncbi.nlm.nih.gov/pubmed/29858347
  • Helliwell PS, Gladman DD, Gottlieb AB.
    Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    J Rheumatol Suppl. 2018 Jun;94:1-3. doi: 10.3899/jrheum.180129.
    https://www.ncbi.nlm.nih.gov/pubmed/29858345
  • Naz S, Asif M, Naz F, Farooq H, Hamid MH.
    Spectrum of Joint Deformities in Children with Juvenile Idiopathic Arthritis.
    J Coll Physicians Surg Pak. 2018 Jun;28(6):470-473. doi: 10.29271/jcpsp.2018.06.470.
    https://www.ncbi.nlm.nih.gov/pubmed/29848426
 
MAYO 2018
  • Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
    Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
    Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030.
    https://www.ncbi.nlm.nih.gov/pubmed/29643108
  • Ringold S, Nigrovic PA, Feldman BM, Tomlinson GA, von Scheven E, Wallace CA, Huber AM, Schanberg LE, Li SC, Weiss PF, Fuhlbrigge RC, Morgan EM, Kimura Y.
    The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases.
    Arthritis Rheumatol. 2018 May;70(5):669-678. doi: 10.1002/art.40395. Epub 2018 Mar 31.
    https://www.ncbi.nlm.nih.gov/pubmed/29333701
  • Rypdal V, Arnstad ED, Aalto K, Berntson L, Ekelund M, Fasth A, Glerup M, Herlin T, Nielsen S, Peltoniemi S, Zak M, Rygg M, Rypdal M, Nordal E; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
    Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.
    Arthritis Res Ther. 2018 May 3;20(1):91. doi: 10.1186/s13075-018-1571-6.
    https://www.ncbi.nlm.nih.gov/pubmed/29724248
  • Karacan I, Uğurlu S, Şahin S, Everest E, Kasapçopur Ö, Tolun A, Özdoğan H, Turanli ET.
    LACC1 Gene Defects in Familial Form of Juvenile Arthritis.
    J Rheumatol. 2018 May;45(5):726-728. doi: 10.3899/jrheum.170834. No abstract available.
    https://www.ncbi.nlm.nih.gov/pubmed/29717096
  • Listing M, Mönkemöller K, Liedmann I, Niewerth M, Sengler C, Listing J, Foell D, Heiligenhaus A, Klein A, Horneff G, Ganser G, Haas JP, Klotsche J, Minden K.
    The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON).
    Arthritis Res Ther. 2018 May 30;20(1):106. doi: 10.1186/s13075-018-1588-x.
    https://www.ncbi.nlm.nih.gov/pubmed/29848349
  • Aquilani A, Pires Marafon D, Marasco E, Nicolai R, Messia V, Perfetti F, Magni-Manzoni S, De Benedetti F.
    Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor-negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication.
    J Rheumatol. 2018 May 1. pii: jrheum.170794. doi: 10.3899/jrheum.170794. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29717035
  • Finch SL, Rosenberg AM, Vatanparast H.
    Vitamin D and juvenile idiopathic arthritis.
    Pediatr Rheumatol Online J. 2018 May 16;16(1):34. doi: 10.1186/s12969-018-0250-0. Review.
    https://www.ncbi.nlm.nih.gov/pubmed/29769136
  • Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A, Flatø B.
    Physical Functioning, Pain, and Health-Related Quality of Life in Adults With Juvenile Idiopathic Arthritis: A Longitudinal 30-Year Followup Study.
    Arthritis Care Res (Hoboken). 2018 May;70(5):741-749. doi: 10.1002/acr.23327. Epub 2018 Mar 7.
    https://www.ncbi.nlm.nih.gov/pubmed/28732134
  • Nalbanti P, Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Farmaki E, Bamidis P, Papachristou F.
    Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.
    Rheumatol Int. 2018 May 29. doi: 10.1007/s00296-018-4062-9. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29845429
  • Salonen PH, Säilä H, Salonen JH, Linna M, Helminen M, Kauppi MJ.
    Pneumonia in children with juvenile idiopathic arthritis in Finland 1999-2014: a nationwide retrospective register linkage study.
    Clin Exp Rheumatol. 2018 May-Jun;36(3):502-507. Epub 2017 Dec 27.
    https://www.ncbi.nlm.nih.gov/pubmed/29303705
  • Rapoff MA.
    Assessing Barriers to Therapeutic Regimens for Young People with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 May;45(5):588-589. doi: 10.3899/jrheum.171399. No abstract available.
    https://www.ncbi.nlm.nih.gov/pubmed/29717093
  • Favier LA, Taylor J, Loiselle Rich K, Jones KB, Vora SS, Harris JG, Gottlieb BS, Robbins L, Lai JT, Lee T, Kohlheim M, Gill J, Bouslaugh L, Young A, Griffin N, Morgan EM, Modi AC.
    Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results.
    J Rheumatol. 2018 May;45(5):690-696. doi: 10.3899/jrheum.171087. Epub 2018 Feb 1.
    https://www.ncbi.nlm.nih.gov/pubmed/29419467
  • Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED.
    Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.
    J Rheumatol Suppl. 2018 Jun;94:11-16. doi: 10.3899/jrheum.180131.
    https://www.ncbi.nlm.nih.gov/pubmed/29858347
  • Stoll ML, Amin D, Powell KK, Poholek CH, Strait RH, Aban I, Beukelman T, Young DW, Cron RQ, Waite PD.
    Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 May 15. pii: jrheum.171306. doi: 10.3899/jrheum.171306. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29764966
  • Samad A, Stoll ML, Lavi I, Hsu JJ, Strand V, Robinson TN, Mellins ED, Zisman D; CARRA Legacy Registry Investigators.
    Adiposity in Juvenile Psoriatic Arthritis.
    J Rheumatol. 2018 Mar;45(3):411-418. doi: 10.3899/jrheum.170598. Epub 2017 Dec 15.
    https://www.ncbi.nlm.nih.gov/pubmed/29247150
  • Fellas A, Singh-Grewal D, Santos D, Coda A.
    Physical Examination Tools Used to Identify Swollen and Tender Lower Limb Joints in Juvenile Idiopathic Arthritis: A Scoping Review.
    Arthritis. 2018 May 15;2018:3408162. doi: 10.1155/2018/3408162. eCollection 2018. Review.
    https://www.ncbi.nlm.nih.gov/pubmed/29862076
  • Helliwell PS, Gladman DD, Gottlieb AB.
    Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    J Rheumatol Suppl. 2018 Jun;94:1-3. doi: 10.3899/jrheum.180129.
    https://www.ncbi.nlm.nih.gov/pubmed/29858345
  • Janicka-Szczepaniak M, Orczyk K, Szymbor K, Chlebna-Sokół D, Smolewska E.
    Is it possible to predict a risk of osteoporosis in patients with juvenile idiopathic arthritis? A study of serum levels of bone turnover markers.
    Acta Biochim Pol. 2018 May 30. doi: 10.18388/abp.2017_2561. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29850656
  • Naz S, Asif M, Naz F, Farooq H, Hamid MH.
    Spectrum of Joint Deformities in Children with Juvenile Idiopathic Arthritis.
    J Coll Physicians Surg Pak. 2018 Jun;28(6):470-473. doi: 10.29271/jcpsp.2018.06.470.
    https://www.ncbi.nlm.nih.gov/pubmed/29848426
  • Feger DM, Longson N, Dodanwala H, Ostrov BE, Olsen NJ, June RR.
    Comparison of Adults With Polyarticular Juvenile Idiopathic Arthritis to Adults With Rheumatoid Arthritis: A Cross-sectional Analysis of Clinical Features and Medication Use.
    J Clin Rheumatol. 2018 May 17. doi: 10.1097/RHU.0000000000000819. [Epub ahead of print
    https://www.ncbi.nlm.nih.gov/pubmed/29781829
 
ABRIL 2018
  • Shoop-Worrall SJ, Verstappen SM, McDonagh JE, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.
    Long term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition.
    Arthritis Rheumatol. 2018 Apr 12. doi: 10.1002/art.40519. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29648683
  • Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
    Treating juvenile idiopathic arthritis to target: recommendations of an international task force.
    Ann Rheum Dis. 2018 Apr 11. pii: annrheumdis-2018-213030. doi: 10.1136/annrheumdis-2018-213030. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29643108
  • Bielak M, Husmann E, Weyandt N, Haas JP, Hügle B, Horneff G, Neudorf U, Lutz T, Lilienthal E, Kallinich T, Tenbrock K, Berendes R, Niehues T, Wittkowski H, Weißbarth-Riedel E, Heubner G, Oommen P, Klotsche J, Foell D, Lainka E.
    IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).
    Pediatr Rheumatol Online J. 2018 Apr 5;16(1):22. doi: 10.1186/s12969-018-0236-y.
    https://www.ncbi.nlm.nih.gov/pubmed/29622022
  • El-Barbary AM, Hussein MS, Almedany SH, Rageh EM, Alsalawy AM, Aboelhawa MA, Elkholy RM, Shafik NM, Elharoun AS.
    Role of Interleukin 37 as a Novel Proangiogenic Factor in Juvenile Idiopathic Arthritis.
    J Clin Rheumatol. 2018 Apr 16. doi: 10.1097/RHU.0000000000000779. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29683837
  • de Inocencio J, Anton J, Calvo Penades I, Mesa Del Castillo Bermejo P, Alcobendas R, Boteanu AL, Bou R, Iglesias E, González Fernandez MI, López Montesinos B, Santin P, Alcañiz Rodriguez P, Lorente Sanchez MJ, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
    The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
    Rheumatol Int. 2018 Apr;38(Suppl 1):91-98. doi: 10.1007/s00296-018-3976-6. Epub 2018 Apr 7.
    https://www.ncbi.nlm.nih.gov/pubmed/29637328
  • Lovell DJ, Brunner HI, Ringold S, Weiss PF, Martin N, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
    The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
    Rheumatol Int. 2018 Apr;38(Suppl 1):35-42. doi: 10.1007/s00296-018-3984-6. Epub 2018 Apr 7.
    https://www.ncbi.nlm.nih.gov/pubmed/29637338
  • Martin N, Davidson J, Anderson C, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
    The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
    Rheumatol Int. 2018 Apr;38(Suppl 1):67-73. doi: 10.1007/s00296-018-3985-5. Epub 2018 Apr 7.
    https://www.ncbi.nlm.nih.gov/pubmed/29637357
  • Quartier P, Hofer M, Wouters C, Truong TTT, Duong NP, Agbo-Kpati KP, Uettwiller F, Melki I, Mouy R, Bader-Meunier B, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
    The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
    Rheumatol Int. 2018 Apr;38(Suppl 1):195-201. doi: 10.1007/s00296-018-3951-2. Epub 2018 Apr 7.
    https://www.ncbi.nlm.nih.gov/pubmed/29637356
  • Weitzman ER, Wisk LE, Salimian PK, Magane KM, Dedeoglu F, Hersh AO, Kimura Y, Mandl KD, Ringold S, Natter M.
    Adding patient-reported outcomes to a multisite registry to quantify quality of life and experiences of disease and treatment for youth with juvenile idiopathic arthritis.
    J Patient Rep Outcomes. 2018;2. pii: 16. doi: 10.1186/s41687-017-0025-2. Epub 2018 Jan 4.
    https://www.ncbi.nlm.nih.gov/pubmed/29645010
  • Stoll ML, Kau CH, Waite PD, Cron RQ.
    Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?
    Pediatr Rheumatol Online J. 2018 Apr 25;16(1):32. doi: 10.1186/s12969-018-0244-y.
    https://www.ncbi.nlm.nih.gov/pubmed/29695255
  • Hanns L, Cordingley L, Galloway J, Norton S, Carvalho LA, Christie D, Sen D, Carrasco R, Rashid A, Foster H, Baildam E, Chieng A, Davidson J, Wedderburn LR, Hyrich K, Thomson W, Ioannou Y.
    Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study.
    Rheumatology (Oxford). 2018 Apr 25. doi: 10.1093/rheumatology/key088. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29697850
 
MARZO 2018
      • Sherman G, Nemet D, Moshe V, Consolaro A, Ravelli A, Ruperto N, Uziel Y; Paediatric Rheumatology International Trials Organisation (PRINTO).
        Disease activity, overweight, physical activity and screen time in a cohort of patients with juvenileidiopathic arthritis.
        Clin Exp Rheumatol. 2018 Mar 21. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29600947
      • Sontichai W, Vilaiyuk S.
        The correlation between the Childhood Health Assessment Questionnaire and disease activity in juvenile idiopathic arthritis.
        Musculoskeletal Care. 2018 Mar 24. doi: 10.1002/msc.1239. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29573557
      • Jeyaratnam J, Ter Haar NM, Lachmann HJ, Kasapcopur O, Ombrello AK, Rigante D, Dedeoglu F, Baris EH, Vastert SJ, Wulffraat NM, Frenkel J.
        The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.
        Pediatr Rheumatol Online J. 2018 Mar 21;16(1):19. doi: 10.1186/s12969-018-0235-z.
        https://www.ncbi.nlm.nih.gov/pubmed/29562920https://www.ncbi.nlm.nih.gov/pubmed/29562920
      • Marino A, Real-Fernández F, Rovero P, Giani T, Pagnini I, Cimaz R, Simonini G.
        Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations.
        Clin Rheumatol. 2018 Mar 5. doi: 10.1007/s10067-018-4057-7. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29508177
      • Chen Y, Zou K, Sun J, Yang Y, Liu G.
        Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
        Pharmacogenomics. 2018 Mar 28. doi: 10.2217/pgs-2017-0208. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29589488
      • Vidovic M, Lamot L, Lamot M, Harjacek M.
        Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response.
        Clin Exp Rheumatol. 2018 Mar 21. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29600948
 
FEBRERO 2018
      • Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Berman A, Penadés IC, Antón J, Ávila-Zapata F, Cuttica R, Horneff G, Foeldvari I, Keltsev V, Kingsbury DJ, Viola DO, Joos R, Lauwerys B, Paz Gastañaga ME, Rama ME, Wouters C, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Miraval T, Ally MM, Rubio-Pérez N, Solau Gervais E, van Zyl R, Li X, Nys M, Wong R, Banerjee S, Lovell DJ, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO)the Pediatric Rheumatology Collaborative Study Group (PRCSG).
        Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study
        Arthritis Rheumatol. 2018 Feb 26. doi: 10.1002/art.40466. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29481737
      • Heath-Watson S, Sule S.
        Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives
        Rheumatol Ther. 2018 Feb 26. doi: 10.1007/s40744-018-0098-2. [Epub ahead of print]
        https://www-ncbi-nlm-nih-gov/pubmed/29480358
      • Hinks A, Marion MC, Cobb J, Comeau ME, Sudman M, Ainsworth HC, Bowes J; Juvenile ArthritisConsortium for Immunochip, Becker ML, Bohnsack JF, Haas JP, Lovell DJ, Mellins ED, Nelson JL, Nordal E, Punaro M, Reed AM, Rose CD, Rosenberg AM, Rygg M, Smith SL, Stevens AM, Videm V, Wallace CA, Wedderburn LR, Yarwood A, Yeung RS, Langefeld CD, Thompson SD, Thomson W, Prahalad S.
        The genetic profile of RF-positive polyarticular juvenile idiopathic arthritis (JIA) resembles adult rheumatoid arthritis (RA)
        Arthritis Rheumatol. 2018 Feb 9. doi: 10.1002/art.40443.
        https://www.ncbi.nlm.nih.gov/pubmed/29426059
      • van Dijkhuizen EHP, Egert T, Egert Y, Costello W, Schoemaker C, Fernhout M, Kepic M, Martini A, Scala S, Rotstein-Grein I, Vastert SJ, Wulffraat NM.
        Patient's experiences with the care for juvenile idiopathic arthritis across Europe
        Pediatr Rheumatol Online J. 2018 Feb 8;16(1):10. doi: 10.1186/s12969-018-0226-0.
        https://www.ncbi.nlm.nih.gov/pubmed/29422094
      • Klotsche J, Minden K, Niewerth M, Horneff G.
        Ann Rheum Dis. 2018 Feb 16. pii: annrheumdis-2017-211968. doi: 10.1136/annrheumdis-2017-211968
        Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA
        https://www.ncbi.nlm.nih.gov/pubmed/29453217
 
ENERO 2018

      • Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, Rieber N, Hufnagel M, Jansson AF, Hedrich C, Winowski H, Berger T, Foeldvari I, Ganser G, Hospach A, Huppertz HI, Mönkemöller K, Neudorf U, Weißbarth-Riedel E, Wittkowski H, Horneff G, Foell D; PRO-KIND SJIA project collaborators.
        Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
        Pediatr Rheumatol Online J. 2018 Jan 22;16(1):7. doi: 10.1186/s12969-018-0224-2.
        https://www.ncbi.nlm.nih.gov/pubmed/29357887

      • Gohar F, Anink J, Moncrieffe H, Van Suijlekom-Smit LWA, Prince FHM, van Rossum MAJ, Dolman KM, Hoppenreijs EPAH, Ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Foell D, Holzinger D.
        S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.
        J Rheumatol. 2018 Jan 15. pii: jrheum.170438. doi: 10.3899/jrheum.170438. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29335345

      • Antonarakis GS, Courvoisier DS, Hanquinet S, Dhouib A, Carlomagno R, Hofer M, Scolozzi P.
        Benefit of Temporomandibular Joint Lavage With Intra-Articular Steroids Versus Lavage Alone in the Management of Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis.
        J Oral Maxillofac Surg. 2018 Jan 8. pii: S0278-2391(18)30007-7. doi: 10.1016/j.joms.2017.12.030. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29391161

      • Marasco E, Aquilani A, Cascioli S, Moneta GM, Caiello I, Farroni C, Giorda E, D'Oria V, Pires Marafon D, Magni-Manzoni S, Carsetti R, De Benedetti F.
        Switched Memory B Cells Are Increased In Oligoarticular And Polyarticular Juvenile Idiopathic Arthritis And Their Change Over Time Is Related To Response To TNF Inhibitors.
        Arthritis Rheumatol. 2018 Jan 5. doi: 10.1002/art.40410. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29316374

      • Schenck S, Rosenbauer J, Niewerth M, Klotsche J, Minden K, Schwarz T, Foeldvari I, Horneff G, Weller-Heinemann F, Holl RW, Thon A.
        Comorbidity of Type 1 Diabetes Mellitus in Patients with Juvenile Idiopathic Arthritis.
        J Pediatr. 2018 Jan;192:196-203. doi: 10.1016/j.jpeds.2017.07.050.
        https://www.ncbi.nlm.nih.gov/pubmed/29246341

 
DICIEMBRE 2017
        • Ruperto N, Brunner HI, Zuber Z, Tzaribachev N, Kingsbury DJ, Foeldvari I, et al for the Pediatric Rheumatology International Trials Organization (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG).
          Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
          Pediatr Rheumatol Online J. 2017 Dec 28;15(1):86.
          https://www.ncbi.nlm.nih.gov/pubmed/29282090
        • Pastore S, Naviglio S, Canuto A, Lepore L, Martelossi S, Ventura A, Taddio A.
          Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.
          Paediatr Drugs. 2017 Dec 6. doi: 10.1007/s40272-017-0267-8. [Epub ahead of print]
          https://www.ncbi.nlm.nih.gov/pubmed/29214394
        • Samad A, Stoll ML, Lavi I, Hsu JJ, Strand V, Robinson TN, Mellins ED, Zisman D; for the CARRA Legacy Registry Investigators.
          Adiposity in Juvenile Psoriatic Arthritis.
          J Rheumatol. 2017 Dec 15. pii: jrheum.170598. doi: 10.3899/jrheum.170598. [Epub ahead of print]
          https://www.ncbi.nlm.nih.gov/pubmed/29247150
        • Ursin K, Lydersen S, Skomsvoll JF, Wallenius M.
          Disease Activity of Juvenile Idiopathic Arthritis during and after Pregnancy: A Prospective Multicenter Study.
          J Rheumatol. 2017 Dec 1. pii: jrheum.161410. doi: 10.3899/jrheum.161410. [Epub ahead of print]
          https://www.ncbi.nlm.nih.gov/pubmed/29196380
        • Ramanathan K, Glaser A, Lythgoe H, Ong J, Beresford MW, Midgley A, Wright HL.
          Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes.
          Rheumatology (Oxford). 2017 Dec 12. doi: 10.1093/rheumatology/kex441. [Epub ahead of print]
          https://www.ncbi.nlm.nih.gov/pubmed/29240923
        • Sura A, Failing C, Sturza J, Stannard J, Riebschleger M.
          Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis.
          Pediatr Rheumatol Online J. 2018 Jan 5;16(1):2.
          https://www.ncbi.nlm.nih.gov/pubmed/29304824
        • Kostik MM, Isupova EA, Chikova IA, Dubko MF, Masalova VV, Snegireva LS, Kalashnikova OV, Chasnyk VG.
          Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.
          Clin Exp Rheumatol. 2017 Dec 15. [Epub ahead of print]
          https://www.ncbi.nlm.nih.gov/pubmed/29303703
 
NOVIEMBRE 2017
          • Shoop-Worrall SJW, Kearsley-Fleet L, Thomson W, Verstappen SMM, Hyrich KL.
            How common is remission in juvenile idiopathic arthritis: A systematic review.
            Semin Arthritis Rheum. 2017 Dec;47(3):331-337
            https://www.ncbi.nlm.nih.gov/pubmed/28625712
          • Kinard BE, Abramowicz S.
            Juvenile Idiopathic Arthritis Practice Patterns Among Oral and Maxillofacial Surgeons.
            J Oral Maxillofac Surg. 2017 Nov;75(11):2333.e1-2333.e8
            https://www.ncbi.nlm.nih.gov/pubmed/28822720
          • Hügle B, Spiegel L, Hotte J, Wiens S, Herlin T, Cron RQ, Stoll ML, Vinod S, Stoustrup P, Pedersen TK, Twilt M.
            Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.
            J Rheumatol. 2017 Nov;44(11):1632-1635
            https://www.ncbi.nlm.nih.gov/pubmed/28864647
          • Fotis L, Shaikh N, Baszis KW, Samson CM, Lev-Tzion R, French AR, Tarr PI.
            Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.
            J Rheumatol. 2017 Nov;44(11):1624-1631
            https://www.ncbi.nlm.nih.gov/pubmed/28916545
          • Cepika AM, Banchereau R, Segura E, Ohouo M, Cantarel B, Goller K, Cantrell V, Ruchaud E, Gatewood E, Nguyen P, Gu J, Anguiano E, Zurawski S, Baisch JM, Punaro M, Baldwin N, Obermoser G, Palucka K, Banchereau J, Amigorena S, Pascual V.
            A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis.
            J Exp Med. 2017 Nov 6;214(11):3449-3466
            https://www.ncbi.nlm.nih.gov/pubmed/28935693
          • Azzouz DF, Silverman GJ.
            Is Gut Microbial LPS a Potential Trigger of Juvenile Idiopathic Arthritis?
            J Rheumatol. 2017 Nov;44(11):1569-1571
            https://www.ncbi.nlm.nih.gov/pubmed/29093074
          • Glerup M, Herlin T, Twilt M.
            Clinical Outcome and Long-term Remission in JIA.
            Curr Rheumatol Rep. 2017 Nov 4;19(12):75
            https://www.ncbi.nlm.nih.gov/pubmed/29101579
          • Horneff G, Klein A, Ganser G, Sailer-Höck M, Günther A, Foeldvari I, Weller-Heinemann F.
            Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2017 Nov 7;15(1):78
            https://www.ncbi.nlm.nih.gov/pubmed/29116003
          • Swart JF, van Dijkhuizen EHP, Wulffraat NM, de Roock S.
            Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
            Ann Rheum Dis. 2017 Nov 14
            https://www.ncbi.nlm.nih.gov/pubmed/29138257
          • França CMP, Sallum AME, Braga ALF, Strufaldi FL, Silva CAA, Farhat SCL.
            Risk Factors Associated with Juvenile Idiopathic Arthritis: Exposure to Cigarette Smoke and Air Pollution from Pregnancy to Disease Diagnosis.
            J Rheumatol. 2017 Nov 15
            https://www.ncbi.nlm.nih.gov/pubmed/29142039
          • Cooper M, Rouhi A, Barber CEH.
            A Systematic Review of Quality Measures for Inflammatory Arthritis.
            J Rheumatol. 2017 Nov 15Horneff G, Schulz AC, Klotsche J, Hospach A, Minden K, Foeldvari I, Trauzeddel R,
            https://www.ncbi.nlm.nih.gov/pubmed/29142026
          • Ganser G, Weller-Heinemann F, Haas JP.
            Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
            Arthritis Res Ther. 2017 Nov 22;19(1):256
            https://www.ncbi.nlm.nih.gov/pubmed/29166924
          • Rashid A, Cordingley L, Carrasco R, Foster HE, Baildam EM, Chieng A, Davidson JE, Wedderburn LR, Ioannou Y, McErlane F, Verstappen SMM, Hyrich KL, Thomson W.
            Patterns of pain over time among children with juvenile idiopathic arthritis.
            Arch Dis Child. 2017 Nov 25
            https://www.ncbi.nlm.nih.gov/pubmed/29175824
          • Grevich S, Shenoi S.
            Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.
            Adolesc Health Med Ther. 2017 Nov 9;8:125-135
            https://www.ncbi.nlm.nih.gov/pubmed/29184458
          • Hammaker D, Firestein GS.
            Epigenetics of inflammatory arthritis.
            Curr Opin Rheumatol. 2017 Nov 30
            https://www.ncbi.nlm.nih.gov/pubmed/29194108
          • McErlane F, Carrasco R, Kearsley-Fleet L, Baildam EM, Wedderburn LR, Foster HE, Ioannou Y, Chieng SEA, Davidson JE, Thomson W, Hyrich KL.
            Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).
            Semin Arthritis Rheum. 2017 Nov 7
            https://www.ncbi.nlm.nih.gov/pubmed/29217290
 
OCTUBRE 2017
          • Onuora S.
            Juvenile idiopathic arthritis: Evidence of gut-driven inflammation in new JIA.
            Nat Rev Rheumatol. 2017 Oct 5. doi: 10.1038/nrrheum.2017.168. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28978993
          • Cimaz R, Marino A, Martini A.
            How I treat juvenile idiopathic arthritis: A state of the art review.
            Autoimmun Rev. 2017 Oct;16(10):1008-1015. doi: 10.1016/j.autrev.2017.07.014.
            https://www.ncbi.nlm.nih.gov/pubmed/28778702
          • Nigrovic PA, Raychaudhuri S, Thompson SD.
            Genetics and the classification of arthritis in adults and children.
            Arthritis Rheumatol. 2017 Oct 12. doi: 10.1002/art.40350. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29024575
          • Zervou MI, Dimopoulou DG, Eliopoulos E, Trachana M, Pratsidou-Gkertsi P, Andreou A, Sidiropoulos P, Spandidos DA, Garyfallos A, Goulielmos GN.
            Τhe genetics of juvenile idiopathic arthritis: Searching for new susceptibility loci.
            Mol Med Rep. 2017 Oct 5. doi: 10.3892/mmr.2017.7733. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28990043
          • Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.
            Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration.
            Arthritis Care Res (Hoboken). 2017 Oct 3. doi: 10.1002/acr.23435. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28973842
          • Adrovic A, Sezen M, Barut K, Sahin S, Acikel C, Demirkaya E, Kasapcopur O.
            The performance of classification criteria for juvenile spondyloarthropathies.
            Rheumatol Int. 2017 Oct 10. doi: 10.1007/s00296-017-3837-8. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/29018906
          • Stoor P, Hodzic Z, Arte S.
            Surgical Treatment of Dentofacial Deformities Caused by Juvenile Idiopathic Arthritis
            J Craniofac Surg. 2017 Oct 16. doi: 10.1097/SCS.0000000000004029. [Epub ahead of print]
            https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29040144
          • De Silvestri A, Capittini C, Poddighe D, Marseglia GL, Mascaretti L, Bevilacqua E, Pasi A, Martinetti M, Tinelli C.
            HLA-DRB1 alleles and juvenile idiopathic arthritis: Diagnostic clues emerging from a meta-analysis
            Autoimmun Rev. 2017 Oct 13. pii: S1568-9972(17)30257-4. doi: 10.1016/j.autrev.2017.10.007. [Epub ahead of print] Review.
            https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29037901
          • Ammerlaan J, van Os-Medendorp H, de Boer-Nijhof N, Scholtus L, Kruize AA, van Pelt P, Prakken B, Bijlsma H.
            Short term effectiveness and experiences of a peer guided web-based self-management intervention for young adults with juvenile idiopathic arthritis
            Pediatr Rheumatol Online J. 2017 Oct 13;15(1):75. doi: 10.1186/s12969-017-0201-1.
            https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29029616
 
SEPTIEMBRE 2017
          • Cepika AM, Banchereau R, Segura E, Ohouo M, Cantarel B, Goller K, Cantrell V, Ruchaud E, Gatewood E, Nguyen P, Gu J, Anguiano E, Zurawski S, Baisch JM, Punaro M, Baldwin N, Obermoser G, Palucka K, Banchereau J, Amigorena, Pascual V.
            A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis.
            J Exp Med. 2017 Sep 21. pii: jem.20170412. doi: 10.1084/jem.20170412. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28935693
          • Brunelli JB, Schmidt AR, Sallum AME, Goldenstein-Schainberg C, Bonfá E, Silva CA, Aikawa NE.
            High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.
            Mod Rheumatol. 2017 Sep 26:1-7. doi: 10.1080/14397595.2017.1349059.
            https://www.ncbi.nlm.nih.gov/pubmed/28949278
          • Weiss PF, Xiao R, Brandon TG, Pagnini I, Wright TB, Beukelman T, Morgan-DeWitt E, Feudtner C.
            Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.
            J Rheumatol. 2017 Sep 15. pii: jrheum.170251. doi: 10.3899/jrheum.170251. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28916542
          • Hügle B, Spiegel L, Hotte J, Wiens S, Herlin T, Cron RQ, Stoll ML, Vinod S, Stoustrup P, Pedersen TK, Twilt M.
            Isolated Arthritis of the Temporomandibular Joint as the Initial Manifestation of Juvenile Idiopathic Arthritis.
            J Rheumatol. 2017 Sep 1. pii: jrheum.170263. doi: 10.3899/jrheum.170263. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28864647
          • Fotis L, Shaikh N, Baszis KW, Samson CM, Lev-Tzion R, French AR, Tarr PI.
            Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis.
            J Rheumatol. 2017 Sep 15. pii: jrheum.161589. doi: 10.3899/jrheum.161589. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28916545
          • Giancane G, Alongi A, Rosina S, Calandra S, Consolaro A, Ravelli A.
            Open issues in the assessment and management of pain in juvenile idiopathic arthritis.
            Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 107(5):123-126.
            https://www.ncbi.nlm.nih.gov/pubmed/28967364
          • Shiff NJ, Tupper S, Oen K, Guzman J, Lim H, Lee CH, et al.
            Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort.
            Pain. 2017 Sep 18. doi: 10.1097/j.pain.0000000000001064. [Epub ahead of print].
            https://www.ncbi.nlm.nih.gov/pubmed/28937578
          • Céspedes Cruz AI, Méndez Núñez M, Solís Vallejo E, Zeferino Cruz M, Torres Jiménez AR, Ocampo Sánchez V, Flores Meza B, Quintana Ruiz N.
            Frequency of auditory involvement and of associated factors in patients with juvenile idiopathic arthritis.
            Reumatol Clin. 2017 Sep 8. pii: S1699-258X(17)30179-1. doi: 10.1016/j.reuma.2017.07.003. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28923429
          • Mendelson A, Rabinowicz N, Reis Y, Amarilyo G, Harel L, Hashkes PJ, Uziel Y.
            Comics as an educational tool for children with juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2017 Sep 2;15(1):69. doi: 10.1186/s12969-017-0198-5.
            https://www.ncbi.nlm.nih.gov/pubmed/28865469
 
AGOSTO 2017
          • Murdaca G, Negrini S, Magnani O, Penza E, Pellecchio M, Gulli R, Mandich P, Puppo F.
            Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis.
            Mod Rheumatol. 2017 Aug 24:1-15. doi: 10.1080/14397595.2017.1366006. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28837372
          • Guzman J, Kerr T, Ward LM, Ma J, Oen K, Rosenberg AM, Feldman BM, Boire G, Houghton K, Dancey P, Scuccimarri R, Bruns A, Huber AM, Watanabe Duffy K, Shiff NJ, Berard RA, Levy DM, Stringer E, Morishita K, Johnson N, Cabral DA, Larché M, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey SE, Roth J, Campillo S, Benseler S, Chédeville G, Schneider R, Tse SML, Bolaria R, Gross K, Feldman D, Cameron B, Jurencak R, Dorval J, LeBlanc C, St Cyr C, Gibbon M, Yeung RSM, Duffy CM, Tucker LB.
            Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
            Pediatr Rheumatol Online J. 2017 Aug 22;15(1):68. doi: 10.1186/s12969-017-0196-7.
            https://www.ncbi.nlm.nih.gov/pubmed/28830457
          • Belot A.
            New Classification for Juvenile Idiopathic Arthritis: Is the Tower of Babel Falling?
            Joint Bone Spine. 2017 Aug 4. pii: S1297-319X(17)30143-4. doi: 10.1016/j.jbspin.2017.08.001. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28826661
          • Rodríguez C, Castillo DM, De Avila J, Mosquera ÁC, Lafaurie GI. Romero-Sánchez C, Malagón C, Vargas C, Fernanda Torres M, Moreno LC.
            Porphyromonas Gingivalis and IgG1 and IgG2 Subclass Antibodies in Patients with Juvenile Idiopathic Arthritis.
            J Dent Child (Chic). 2017 May 15;84(2):72-79.
            https://www.ncbi.nlm.nih.gov/pubmed/28814366
          • Morgan EM, Riebschleger MP, Horonjeff J, Consolaro A, Munro JE, Thornhill S, Beukelman T, Brunner HI, Creek EL, Harris JG, Horton DB, Lovell DJ, Mannion ML, Olson JC, Rahimi H, Gallo MC, Calandra S, Ravelli A, Ringold S, Shenoi S, Stinson J, Toupin-April K, Strand V, Bingham CO 3rd.
            Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
            J Rheumatol. 2017 Aug 15. pii: jrheum.161389. doi: 10.3899/jrheum.161389. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28811355
          • Cai RA, Beste D, Chaplin H, Varakliotis S, Suffield L, Josephs F, Sen D, Wedderburn LR, Ioannou Y, Hailes S, Eleftheriou D.
            Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis.
            JMIR Mhealth Uhealth. 2017 Aug 15;5(8):e121. doi: 10.2196/mhealth.7229.
            https://www.ncbi.nlm.nih.gov/pubmed/28811270
          • Camacho-Lovillo MS, Bulnes-Ramos A, Goycochea-Valdivia W, Fernández-Silveira L1, Núñez-Cuadros E, Neth O, Pérez-Romero P.
            Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay.
            Pediatr Rheumatol Online J. 2017 Aug 7;15(1):62. doi: 10.1186/s12969-017-0190-0.
            https://www.ncbi.nlm.nih.gov/pubmed/28784185
          • Cimaz R, Marino A, Martini A.
            How I treat juvenile idiopathic arthritis: A state of the art review.
            Autoimmun Rev. 2017 Aug 1. pii: S1568-9972(17)30197-0. doi: 10.1016/j.autrev.2017.07.014. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28778702
          • Yuwen W, Lewis FM, Walker AJ, Ward TM.
            Struggling in the Dark to Help My Child: Parents' Experience in Caring for a Young Child with Juvenile Idiopathic Arthritis.
            J Pediatr Nurs. 2017 Aug 1. pii: S0882-5963(17)30016-7. doi: 10.1016/j.pedn.2017.07.007. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28778610
          • Limenis E, Feldman BM, Achonu C, Batthish M, Lang B, Mclimont M, Ota S, Ramanan A, Scuccimarri R, Young NL, Schneider R.
            Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis.
            J Rheumatol. 2017 Aug 1. pii: jrheum.161534. doi: 10.3899/jrheum.161534. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28765240
 
JULIO 2017
          • Armbrust W, Bos GJFJ, Wulffraat NM, van Brussel M, Cappon J, Dijkstra PU, Geertzen JHB, Legger GE, van Rossum MAJ, Sauer PJJ, Lelieveld OTHM.
            Internet Program for Physical Activity and Exercise Capacity in Children With Juvenile Idiopathic Arthritis: A Multicenter Randomized Controlled Trial.
            Arthritis Care Res (Hoboken). 2017 Jul 21. doi: 10.1002/acr.23327. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/27696793
          • Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A, Flatø B.
            Physical Functioning, Pain and Health-Related Quality of Life in Adults with Juvenile Idiopathic Arthritis: A Longitudinal 30-Year Follow-Up Study.
            Arthritis Care Res (Hoboken). 2017 Jul 21. doi: 10.1002/acr.23327. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28732134
          • Shoop-Worrall SJW, Verstappen SMM, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.
            How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.
            Ann Rheum Dis. 2017 Aug;76(8):1381-1388. doi: 10.1136/annrheumdis-2016-210511. Epub 2017 Apr 7.
            https://www.ncbi.nlm.nih.gov/pubmed/28389553
          • Zajc Avramovič M, Dolžan V , Toplak N, Accetto M, Lusa L, Avčin T.
            Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of MethotrexateTreatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis
            J Rheumatol. 2017 Aug;44(8):1216-1223. doi: 10.3899/jrheum.160950. Epub 2017 Jun 1.
            https://www.ncbi.nlm.nih.gov/pubmed/28572465
          • Antoun MB, Adamsbaum C, Semerano L, Paut IK, Rossi-Semerano L.
            Clinical predictors of magnetic resonance imaging-detected sacroiliitis in children with enthesitis related arthritis.
            Joint Bone Spine. 2017 Jul 27. pii: S1297-319X(17)30136-7. doi: 10.1016/j.jbspin.2017.07.003. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28757344
          • Maritsi DN, Coffin SE, Argyri I, Vartzelis G, Spyridis N, Tsolia MN.
            Immunogenicity and safety of the inactivated hepatitis A vaccine in children with juvenile idiopathic arthritis on methotrexate treatment: a matched case-control study.
            Clin Exp Rheumatol. 2017 Jul-Aug;35(4):711-715. Epub 2017 Jul 13.
            https://www.ncbi.nlm.nih.gov/pubmed/28721859
          • McIntosh LA, Marion MC, Sudman M, Comeau ME, Becker ML, Bohnsack JF, Fingerlin TE, Griffin TA, Haas JP, Lovell DJ, Maier LA, Nigrovic PA, Prahalad S, Punaro M, Rosé CD, Wallace CA, Wise CA; Boston Children's JIA Registry; German Society for Pediatric Rheumatology (GKJR); JIA Gene Expression Studies; NIAMS JIA Genetic Registry; TREAT Study; Understanding TNF Therapy in JIA Project, Moncrieffe H, Howard TD, Langefeld CD, Thompson SD.
            Genome-wide association meta-analysis reveals novel juvenile idiopathic arthritis susceptibility loci.
            Arthritis Rheumatol. 2017 Jul 18. doi: 10.1002/art.40216. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28719732
 
JUNIO 2017
          • Alexeeva EI, Namazova-Baranova LS, Bzarova TM, Valieva SI, Denisova RV, Sleptsova TV, Isaeva KB, Chomahidze AM, Taibulatov NI, Fetisova AN, Karaseva AV, Baranov AA.
            Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
            Pediatr Rheumatol Online J. 2017 Jun 14;15(1):51.
            https://www.ncbi.nlm.nih.gov/pubmed/28615036
          • Brinkman WB, Lipstein EA, Taylor J, Schoettker PJ, Naylor K, Jones K, Vora SS, Mims CC, Roth-Wojcicki E, Gottlieb B, Griffin N, Lannon C, Morgan E.
            Design and implementation of a decision aid for juvenile idiopathic arthritis medication choices.
            Pediatr Rheumatol Online J. 2017 Jun 5;15(1):48
            https://www.ncbi.nlm.nih.gov/pubmed/28583183
          • Moncrieffe H, Bennett MF, Tsoras M, Luyrink LK, Johnson AL, Xu H, Dare J, Becker ML, Prahalad S, Rosenkranz M, O'Neil KM, Nigrovic PA, Griffin TA, Lovell DJ, Grom AA, Medvedovic M, Thompson SD.
            Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
            Rheumatology (Oxford). 2017 Jun 3. doi: 10.1093/rheumatology/kex206. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/?term=28582527
          • Gorczyca D, Postępski J, Czajkowska A, Paściak M, Prescha A, Olesińska E, Gruenpeter A, Lachór-Motyka I, Szponar B.
            The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity.
            Clin Rheumatol. 2017 Jun;36(6):1269-1279
            https://www.ncbi.nlm.nih.gov/pubmed/28247163
          • Halonen S, Kankaanpää E, Kari J, Parmanne P, Relas H, Kronström K, Luosujärvi R, Peltomaa R.
            Synovial fluid detection in intra-articular injections using a bioimpedance probe (BIP) needle-a clinical study.
            Clin Rheumatol. 2017 Jun;36(6):1349-1355.
            https://www.ncbi.nlm.nih.gov/pubmed/26873101
          • Scheuern A, Tyrrell PN, Haas JP, Hügle B.
            Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect.
            Rheumatology (Oxford). 2017 Jun 1;56(6):901-906.
            https://www.ncbi.nlm.nih.gov/pubmed/28122960
 
MAYO 2017
          • Imane Elbinoune; Bouchra Amine; Samira Rostom; Siham Shyen; Dalal Elbadri; Majda Ezzahri; Nada Mawani; Fanata Moussa; Sanae Gueddari; Wabi Moudjibou; Mariam Erraoui; Jihane Bahha; Redouane Abouqal; Bouchra Chkirate; Najia Hajjaj-Hassouni
            Discordance between physician’s and parent’s global assessments in juvenile idiopathic arthritis.
            Ann Paediatr Rheum. 2017; 5(3): 71-78
            https://www.ncbi.nlm.nih.gov/pubmed/?term=16782733
          • Berard RA, Laxer RM.
            Learning the hard way: clinical trials in juvenile idiopathic arthritis.
            Ann Rheum Dis. 2017 May 25. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28546255
          • Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK, Lahdenne P, Ravelli A, Martini A, Pistorio A, Ruperto N; Paediatric Rheumatology International Trials Organisation.
            Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis.
            Arthritis Care Res (Hoboken). 2017 May;69(5):677-686. doi: 10.1002/acr.23003.
            https://www.ncbi.nlm.nih.gov/pubmed/27564918
          • Gmuca S, Xiao R, Brandon TG, Pagnini I, Wright TB, Beukelman T, Morgan EM, Weiss PF.
            Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches.
            Arthritis Res Ther. 2017 May 2;19(1):84. doi: 10.1186/s13075-017-1297-x.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=PMC5414167
          • Giancane G, Alongi A, Ravelli A.
            Update on the pathogenesis and treatment of juvenile idiopathic arthritis.
            Curr Opin Rheumatol. 2017 May 22. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28538013
          • Kindgren E, Fredrikson M, Ludvigsson J.
            Early feeding and risk of Juvenile idiopathic arthritis: a case control study in a prospective birth cohort.
            Pediatr Rheumatol Online J. 2017 May 26;15(1):46. doi: 10.1186/s12969-017-0175-z.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28549465
          • Schlichtiger J, Haas JP, Barth S, Bisdorff B, Hager L, Michels H, Hügle B, Radon K.
            Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general population.
            Pediatr Rheumatol Online J. 2017 May 22;15(1):45. doi: 10.1186/s12969-017-0172-2.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28532479
          • Coda A, Sculley D, Santos D, Girones X, Brosseau L, Smith DR, Burns J, Rome K, Munro J, Singh-Grewal D.
            Harnessing interactive technologies to improve health outcomes in juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2017 May 16;15(1):40. doi: 10.1186/s12969-017-0168-y.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28511689
          • Ključevšek D, Emeršič N, Toplak N, Avčin T.
            Clinical and MRI outcome of cervical spine lesions in children with juvenile idiopathic arthritis treated with anti-TNFα drugs early in disease course.
            Pediatr Rheumatol Online J. 2017 May 15;15(1):38. doi: 10.1186/s12969-017-0173-1.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28506237
          • Bell SW, Shenoi S, Nelson JL, Bhatti P, Mueller BA.
            Juvenile idiopathic arthritis in relation to perinatal and maternal characteristics: a case control study.
            Pediatr Rheumatol Online J. 2017 May 11;15(1):36. doi: 10.1186/s12969-017-0167-z.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28494794
          • Moncrieffe H, Bennett MF, Tsoras M, Luyrink LK, Johnson AL, Xu H, Dare J, Becker ML, Prahalad S, Rosenkranz M, O'Neil KM, Nigrovic PA, Griffin TA, Lovell DJ, Grom AA, Medvedovic M, Thompson SD.
            Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
            Rheumatology (Oxford). 2017 Jun 3. doi: 10.1093/rheumatology/kex206. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28582527
          • Alberdi-Saugstrup M1,2,3, Zak M4, Nielsen S4, Herlin T5, Nordal E6, Berntson L7, Fasth A8, Rygg M9,10, Klaus Müller4,11; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
            High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
            Rheumatol Int. 2017 May;37(5):695-703. doi: 10.1007/s00296-017-3657-x. Epub 2017 Mar 10.
            https://www.ncbi.nlm.nih.gov/pubmed/?term=28283733
          • Luque Ramos A, Hoffmann F, Albrecht K, Klotsche J, Zink A, Minden K.
            Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
            Semin Arthritis Rheum. 2017 May 12
            https://www.ncbi.nlm.nih.gov/pubmed/28583690
 
ABRIL 2017
          • Lee WJ, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT.
            Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
            Rheumatology (Oxford). 2017 Apr 18. doi: 10.1093/rheumatology/kex049. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28431162
          • Rumsey DG, Guzman J, Rosenberg AM, Huber AM, Scuccimarri R, Shiff NJ, Bruns A, Feldman BM, Eurich DT; ReACCh-Out Investigators
            Characteristics and Course of Enthesitis in a Juvenile Idiopathic Arthritis Inception Cohort.
            Arthritis Care Res (Hoboken). 2017 Apr 20. doi: 10.1002/acr.23256. [Epub ahead of print]
            https://www.ncbi.nlm.nih.gov/pubmed/28426894
          • Beukelman T, Kimura Y, Ilowite NT, Mieszkalski K, Natter MD, Burrell G, Best B, Jones J, Schanberg LE; CARRA Registry Investigators
            The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
            Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30. doi: 10.1186/s12969-017-0160-6.
            https://www.ncbi.nlm.nih.gov/pubmed/28416023
          • Weiß A, Minden K, Listing J, Foeldvari I, Sieper J, Rudwaleit M.
            Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC
            RMD Open. 2017 Mar 21;3(1):e000366. doi: 10.1136/rmdopen-2016-000366. eCollection 2017.
            https://www.ncbi.nlm.nih.gov/pubmed/28405472
          • Selvaag AM, Kirkhus E, Törnqvist L, Lilleby V, Aulie HA, Flatø B.
            Radiographic damage in hands and wrists of patients with juvenile idiopathic arthritis after 29 years of disease duration.
            Pediatr Rheumatol Online J. 2017 Apr 11;15(1):20. doi: 10.1186/s12969-017-0151-7.
            https://www.ncbi.nlm.nih.gov/pubmed/28399930
          • Navallas M, Inarejos EJ, Iglesias E, Cho Lee GY, Rodríguez N, Antón J.
            MR Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: Technique and Findings
            Radiographics. 2017 Mar-Apr;37(2):595-612. doi: 10.1148/rg.2017160078.
            https://www.ncbi.nlm.nih.gov/pubmed/28287946
 
MARZO 2017
          • Shoop-Worrall SJ, Verstappen SM, Baildam E, Chieng A, Davidson J, Foster H, Ioannou Y, McErlane F, Wedderburn LR, Thomson W, Hyrich KL.
            How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.
            Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210511. doi: 10.1136/annrheumdis-2016-210511. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28389553
          • Roszkiewicz J, Smolewska E.
            In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
            Curr Rheumatol Rep. 2017 Apr;19(4):19. doi: 10.1007/s11926-017-0646-8
            https://www.ncbi.nlm.nih.gov/pubmed/28361333
          • Armbrust W, Bos GJ, Geertzen JH, Sauer PJ, Dijkstra PU, Lelieveld OT.
            Measuring Physical Activity in Juvenile Idiopathic Arthritis: Activity Diary Versus Accelerometer.
            J Rheumatol. 2017 Apr 1. pii: jrheum.160671. doi: 10.3899/jrheum.160671. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28365580
          • Oen K, Guzman J, Dufault B, Tucker LB, Shiff NJ, Watanabe Duffy K, Lee JJ, Feldman BM, Berard RA, Dancey P, Huber AM, Scuccimarri R, Cabral DA, Morishita KA, Ramsey SE, Rosenberg AM, Boire G, Benseler SM, Lang B, Houghton K, Miettunen PM, Chédeville G, Levy DM, Bruns A, Schmeling H, Haddad E, Yeung RS, Duffy CM; Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) investigators.
            Health-related quality of life in an inception cohort of children with Juvenile Idiopathic Arthritis: A longitudinal analysis.
            Arthritis Care Res (Hoboken). 2017 Mar 20. doi: 10.1002/acr.23236. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28320056
          • Alberdi-Saugstrup M, Zak M, Nielsen S, Herlin T, Nordal E, Berntson L, Fasth A, Rygg M, Klaus Müller; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
            High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
            Rheumatol Int. 2017 Mar 10. doi: 10.1007/s00296-017-3657-x.
            https://www.ncbi.nlm.nih.gov/pubmed/28283733
          • Hashaad NI, Fawzy RM, Elazem AA, Youssef MI.
            Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity.
            Eur J Rheumatol. 2017 Mar;4(1):19-23. doi: 10.5152/eurjrheum.2017.160071.
            https://www.ncbi.nlm.nih.gov/pubmed/28293448
          • Kwon HJ, Kim YL, Lee HS, Lee SM.
            A study on the physical fitness of children with juvenile rheumatoid arthritis.
            J Phys Ther Sci. 2017 Mar;29(3):378-383. doi: 10.1589/jpts.29.378.
            https://www.ncbi.nlm.nih.gov/pubmed/28356614
          • Frittoli RB, Longui BS, Silva AM, Filho AA, Monteiro MÂ, Appenzeller S.
            Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review.
            Rev Bras Reumatol Engl Ed. 2017 Mar - Apr;57(2):100-106. doi: 10.1016/j.rbre.2016.07.009.
            https://www.ncbi.nlm.nih.gov/pubmed/28343613
          • Kessel C, Lippitz K, Weinhage T, Hinze C, Wittkowski H, Holzinger D, Fall N, Grom AA, Gruen N, Foell D.
            Pro-inflammatory cytokine environments can drive IL-17 over-expression by γδT cells in systemicjuvenile idiopathic arthritis.
            Arthritis Rheumatol. 2017 Mar 15. doi: 10.1002/art.40099. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28296284
          • Lee M, Isaacs J.
            The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis.
            Eur J Rheumatol. 2017 Mar;4(1):68-69. doi: 10.5152/eurjrheum.2016.055.
            https://www.ncbi.nlm.nih.gov/pubmed/28293458
FEBRERO 2017
          • Zisman D, Gladman DD, Stoll ML, Strand V, Lavi I, Hsu JJ, Mellins ED; and the CARRA Legacy Registry Investigators.
            The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
            J Rheumatol. 2017 Feb 1. pii: jrheum.160717. doi: 10.3899/jrheum.160717. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28148698
          • Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.
            A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
            Pediatr Rheumatol Online J. 2017 Feb 6;15(1):11. doi: 10.1186/s12969-017-0138-4.
            https://www.ncbi.nlm.nih.gov/pubmed/28166785
          • Ekelund M, Aalto K, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
            Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study.
            Pediatr Rheumatol Online J. 2017 Feb 22;15(1):13. doi: 10.1186/s12969-017-0145-5.
            https://www.ncbi.nlm.nih.gov/pubmed/28222745
          • Alberdi-Saugstrup M, Enevold C, Zak M, Nielsen S, Nordal E, Berntson L, Fasth A, Rygg M, Müller K; Nordic Study Group of Pediatric Rheumatology (NoSPeR).
            Non-HLA gene polymorphisms in juvenile idiopathic arthritis: associations with disease outcome.
            Scand J Rheumatol. 2017 Feb 1:1-8. doi: 10.1080/03009742.2016.1238959. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28145159
          • Adriano LS, de França Fonteles MM, de Fátima Menezes Azevedo M, Beserra MP, Romero NR.
            Medication adherence in patients with juvenile idiopathic arthritis.
            Rev Bras Reumatol Engl Ed. 2017 Jan - Feb;57(1):23-29. doi: 10.1016/j.rbre.2016.05.004. Epub 2016 May 30.
            https://www.ncbi.nlm.nih.gov/pubmed/28137399
          • Wulffraat N.
            The value of old drugs for juvenile idiopathic arthritis.
            Lancet. 2017 Feb 2. pii: S0140-6736(17)30180-0. doi: 10.1016/S0140-6736(17)30180-0. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28162780
          • Nusman CM, Hemke R, Lavini C, Schonenberg-Meinema D, van Rossum MA, Dolman KM, van den Berg JM, Maas M, Kuijpers TW.
            Dynamic contrast-enhanced magnetic resonance imaging can play a role in predicting flare in juvenile idiopathic arthritis.
            Eur J Radiol. 2017 Mar;88:77-81. doi: 10.1016/j.ejrad.2017.01.003. Epub 2017 Jan 4.
            https://www.ncbi.nlm.nih.gov/pubmed/28189212
          • Xia Y, Cui P, Li Q, Liang F, Li C, Yang J.
            Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases.
            Braz J Med Biol Res. 2017 Feb 16;50(2):e5958. doi: 10.1590/1414-431X20165958.
            https://www.ncbi.nlm.nih.gov/pubmed/28225869
          • Skrabl-Baumgartner A, Christine Hauer A, Erwa W, Jahnel J.
            HLA genotyping as first-line screening tool for coeliac disease in children with juvenile idiopathic arthritis.
            Arch Dis Child. 2017 Feb 23. pii: archdischild-2016-311544. doi: 10.1136/archdischild-2016-311544. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28232458
          • Dewoolkar M, Cimaz R, Chickermane PR, Khubchandani RP.
            Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis.
            Indian J Pediatr. 2017 Feb 23. doi: 10.1007/s12098-017-2293-5. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28229369
          • Wiens AD, Prahalad S, Inan OT, Wiens AD, Prahalad S, Inan OT, Wiens AD, Inan OT, Prahalad S.
            VibroCV: a computer vision-based vibroarthrography platform with possible application to Juvenile Idiopathic Arthritis.
            Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4431-4434. doi:10.1109/EMBC.2016.7591710.
            https://www.ncbi.nlm.nih.gov/pubmed/28227495
          • Park SK, Hwang PH, Yun SK, Kim HU, Park J.
            Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature.
            Ann Dermatol. 2017 Feb;29(1):74-78. doi: 10.5021/ad.2017.29.1.74. Epub 2017 Feb 3.
            https://www.ncbi.nlm.nih.gov/pubmed/28223750
          • Wang Y, Chen L, Li F, Bao M, Zeng J, Xiang J, Luo H, Li J, Tang L.
            TLR4 rs41426344 increases susceptibility of rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in a central south Chinese Han population.
            Pediatr Rheumatol Online J. 2017 Feb 21;15(1):12. doi: 10.1186/s12969-017-0137-5.
            https://www.ncbi.nlm.nih.gov/pubmed/28222760
          • Adriano LS1, de França Fonteles MM2, de Fátima Menezes Azevedo M3, Beserra MP2, Romero NR2.
            Medication adherence in patients with juvenile idiopathic arthritis.
            Rev Bras Reumatol Engl Ed. 2017 Jan - Feb;57(1):23-29. doi: 10.1016/j.rbre.2016.05.004. Epub 2016 May 30.
            https://www.ncbi.nlm.nih.gov/pubmed/28137399
          • Mizuta M, Shimizu M, Nakagishi Y, Kasai K, Yachie A.
            Bicipital synovial cyst associated with systemic juvenile idiopathic arthritis: new insights obtained from unique pathological findings.
            Int J Rheum Dis. 2017 Feb 10. doi: 10.1111/1756-185X.12994. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28185428
          • Hisa K, Yanagimachi MD, Naruto T, Miyamae T, Kikuchi M, Hara R, Imagawa T, Yokota S, Mori M.
            PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
            PLoS One. 2017 Feb 9;12(2):e0171961. doi: 10.1371/journal.pone.0171961. eCollection 2017.
            https://www.ncbi.nlm.nih.gov/pubmed/28182665
          • Uziel Y.
            Juvenile Idiopathic Arthritis in the Era of International Cooperation.
            Rambam Maimonides Med J. 2017 Jan 30;8(1). doi: 10.5041/RMMJ.10278.
            https://www.ncbi.nlm.nih.gov/pubmed/28178439
          • Sarkar S, Alam MM, Das G, Datta S.
            Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.
            Indian J Pediatr. 2017 Feb 8. doi: 10.1007/s12098-017-2292-6. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28176230
          • Stinson J, Connelly M, Huber A, Luca N, Spiegel L, Tsimicalis A, Luca S, Tajuddin N, Berard R, Barsalou J, Campillo S, Dancey P, Duffy C, Feldman B, Johnson N, McGrath P, Shiff N, Tse S, Tucker L, Victor J.
            Development and usability testing of an iPad and desktop psycho-educational game for children with Juvenile Idiopathic Arthritis and their parents.
            J Pain. 2016 Apr;17(4S):S106. doi: 10.1016/j.jpain.2016.01.335. Epub 2016 Mar 24.
            https://www.ncbi.nlm.nih.gov/pubmed/28162331
          • Srivastava R, Phatak S, Aggarwal A.
            ERAP1 rs30187 single nucleotide polymorphism does not confer disease susceptibility in North Indian children with enthesitis-related arthritis.
            Clin Rheumatol. 2017 Feb 4. doi: 10.1007/s10067-017-3560-6. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28161768
          • Macedo de Menezes L, Deon Rizzatto SM, Martinelli Santayana de Lima E, Baccarin Matje PR, Picarelli MM.
            Juvenile idiopatic arthritis in orthodontics: Case report with a 6-year follow-up.
            Am J Orthod Dentofacial Orthop. 2017 Feb;151(2):384-396. doi: 10.1016/j.ajodo.2015.12.032.
            https://www.ncbi.nlm.nih.gov/pubmed/28153169
          • Horton DB, Onel KB, Beukelman T, Ringold S.
            Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
            J Rheumatol. 2017 Feb 1. pii: jrheum.161078. doi: 10.3899/jrheum.161078. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28148696
          • Al-Mayouf SM, Naji H, Alismail K, Alazami AM, Sheikh F, Conca W, Al-Mousa H.
            Evolving spectrum of LRBA deficiency-associated chronic arthritis: is there a causative role in juvenile idiopathic arthritis?
            Clin Exp Rheumatol. 2017 Jan 27. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28134088
          • Glerup M, Herlin T, Twilt M.
            Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
            Clin Rheumatol. 2017 Mar;36(3):671-676. doi: 10.1007/s10067-017-3540-x. Epub 2017 Jan 17.
            https://www.ncbi.nlm.nih.gov/pubmed/28097448
          • Pasini AM, Gagro A, Roić G, Vrdoljak O, Lujić L, Žutelija-Fattorini M.
            Ataxia Telangiectasia and Juvenile Idiopathic Arthritis.
            Pediatrics. 2017 Feb;139(2). pii: e20161279. doi: 10.1542/peds.2016-1279. Epub 2017 Jan 12.
            https://www.ncbi.nlm.nih.gov/pubmed/28082406
          • Merker J, Hartmann M, Kreuzpointner F, Schwirtz A, Haas JP.
            Excellent balance skills despite active and inactive juvenile idiopathic arthritis - unexpected results of a cross-sectional study.
            Clin Exp Rheumatol. 2017 Jan-Feb;35(1):161-168. Epub 2017 Jan 5.
            https://www.ncbi.nlm.nih.gov/pubmed/28079509
          • Nakamura H, Sugai T, Kato M, Hatanaka KC, Atsumi T
            Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis.
            Clin Exp Rheumatol. 2017 Jan-Feb;35(1):174. Epub 2017 Jan 5.
            https://www.ncbi.nlm.nih.gov/pubmed/28079502
          • Burden-Teh E, Thomas KS, Rangaraj S, Cranwell J, Murphy R.
            Early recognition and detection of juvenile psoriatic arthritis: a call for a standardized approach to screening.
            Clin Exp Dermatol. 2017 Mar;42(2):153-160. doi: 10.1111/ced.13010. Epub 2017 Jan 2.
            https://www.ncbi.nlm.nih.gov/pubmed/28044348
ENERO 2017
          • Ravelli A, Davì S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EH, Lattanzi B, Filocamo G, Verazza S, Gerloni V, Gattinara M, Pontikaki I, Insalaco A, De Benedetti F, Civino A, Presta G, Breda L, Marzetti V, Pastore S, Magni-Manzoni S, Maggio MC, Garofalo F, Rigante D, Gattorno M, Malattia C, Picco P, Viola S, Lanni S, Ruperto N, Martini A; Italian Pediatric Rheumatology Study Group.
            Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. 
            Lancet. 2017 Feb 2. pii: S0140-6736(17)30065-X. doi: 10.1016/S0140-6736(17)30065-X. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28162781       
          • Taylor J, Giannini EH, Lovell DJ, Huang B, Morgan E.
             Lack of Concordance in Inter-Rater Scoring of the Provider's Global Assessment of Children with Juvenile Idiopathic Arthritis with Low Disease Activity.
            Arthritis Care Res (Hoboken). 2017 Jan 24. doi: 10.1002/acr.23203. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28118522
          • Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.
            A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
            Pediatr Rheumatol Online J. 2017 Feb 6;15(1):11. doi: 10.1186/s12969-017-0138-4.
            https://www.ncbi.nlm.nih.gov/pubmed/28166785
          • Aalto K, Lahdenne P, Kolho KL
            Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.
            Pediatr Rheumatol Online J. 2017 Jan 31;15(1):9. doi: 10.1186/s12969-016-0132-2.
            https://www.ncbi.nlm.nih.gov/pubmed/28143478
          • Glerup M, Herlin T, Twilt M.
            Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
            Clin Rheumatol. 2017 Jan 17. doi: 10.1007/s10067-017-3540-x. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28097448
DICIEMBRE 2016
          • Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A; Italian Pediatric Rheumatology Study Group.
            Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
            Pediatr Rheumatol Online J. 2016 Dec 20;14(1):68.
            https://www.ncbi.nlm.nih.gov/pubmed/27993144
          • Armbrust W, Lelieveld OH, Tuinstra J, Wulffraat NM, Bos GJ, Cappon J, van Rossum MA, Sauer PJ, Hagedoorn M.
            Fatigue in patients with Juvenile Idiopathic Arthritis: relationship to perceived health, physical health, self-efficacy, and participation.
            Pediatr Rheumatol Online J. 2016 Dec 6;14(1):65.
            https://www.ncbi.nlm.nih.gov/pubmed/27919265
          • Hinks A, Bowes J, Cobb J, Ainsworth HC, Marion MC, Comeau ME, Sudman M, Han B; Juvenile Arthritis Consortium for Immunochip., Becker ML, Bohnsack JF, de Bakker PI, Haas JP, Hazen M, Lovell DJ, Nigrovic PA, Nordal E, Punnaro M, Rosenberg AM, Rygg M, Smith SL, Wise CA, Videm V, Wedderburn LR, Yarwood A, Yeung RS, Prahalad S, Langefeld CD, Raychaudhuri S, Thompson SD, Thomson W.
            Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases.
            Ann Rheum Dis. 2016 Dec 20.
            https://www.ncbi.nlm.nih.gov/pubmed/27998952
          • Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group., Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W.
            Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
            Ann Rheum Dis. 2016 Dec 7
            https://www.ncbi.nlm.nih.gov/pubmed/27927641
          • Klotsche J, Raab A, Niewerth M, Sengler C, Ganser G, Kallinich T, Niehues T, Hufnagel M, Thon A, Hospach T, Horneff G, Minden K.
            Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.
            Arthritis Rheumatol. 2016 Dec;68(12):3023-3034.
            https://www.ncbi.nlm.nih.gov/pubmed/27332999
          • Resnick CM, Vakilian PM, Breen M, Zurakowski D, Caruso P, Henderson L, Nigrovic PA, Kaban LB, Peacock ZS.
            Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis.
            Arthritis Care Res (Hoboken). 2016 Dec;68(12):1795-1802.
            https://www.ncbi.nlm.nih.gov/pubmed/27110936
          • Luca NJ, Burnett HF, Ungar WJ, Moretti ME, Beukelman T, Feldman BM, Schwartz G, Bayoumi AM.
            Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Plyarticular Juvenile Idiopathic Arthritis
            Arthritis Care Res (Hoboken). 2016 Dec;68(12):1803-1811.
            https://www.ncbi.nlm.nih.gov/pubmed/27059807
          • Horneff G, Klein A, Oommen PT, Hospach A, Foeldvari I, Feddersen I, Minden K.
            Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry.
            Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1113-1120.
            https://www.ncbi.nlm.nih.gov/pubmed/27749226
          • Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, Benseler SM, Tucker LB; on behalf of the ReACCh-Out Investigators.
            Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
            J Rheumatol. 2016 Dec 15.
            https://www.ncbi.nlm.nih.gov/pubmed/27980015
 
NOVIEMBRE 2016
          • Kallinich T, Thorwarth A, von Stuckrad SL, Rösen-Wolff A, Luksch H, Hundsdoerfer P, Minden K, Krawitz P.
            Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course.
            Pediatr Rheumatol Online J. 2016 Nov 24;14(1):63.
            https://www.ncbi.nlm.nih.gov/pubmed/27881174
          • Lipinska J, Lipinska S, Kasielski M, Smolewska E.
            Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
            Clin Rheumatol. 2016 Nov;35(11):2699-2706.
            https://www.ncbi.nlm.nih.gov/pubmed/27457366
          • Horneff G, Klein A, Klotsche J, Minden K, Huppertz HI, Weller-Heinemann F, Kuemmerle-Deschner J, Haas JP, Hospach A.
            Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab.
            Arthritis Res Ther. 2016 Nov 24;18(1):272.
            https://www.ncbi.nlm.nih.gov/pubmed/27881144
          • Nozawa T, Nishimura K, Ohara A, Hara R, Ito S.
            Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
            Mod Rheumatol. 2016 Nov 16:1-19.
            https://www.ncbi.nlm.nih.gov/pubmed/27846755
          • Bohr AH, Pedersen FK, Nielsen CH, Müller KG.
            Lipoprotein cholesterol fractions are related to markers of inflammation in children and adolescents with juvenile idiopathic arthritis: a cross sectional study.
            Pediatr Rheumatol Online J. 2016 Nov 11;14(1):61.
            https://www.ncbi.nlm.nih.gov/pubmed/27835952
          • Capone M, Maggi L, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Cimaz R, Ramazzotti M, Piccinni MP, Barra G, De Palma R, Liotta F, Maggi E, Romagnani S, Annunziato F, Cosmi L.
            Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients.
            Clin Mol Allergy. 2016 Nov 8;14:16.
            https://www.ncbi.nlm.nih.gov/pubmed/27826220
          • Maggi L, Cimaz R, Capone M, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Pagnini I, Giani T, Simonini G, Scaletti C, Liotta F, Maggi E, Annunziato F, Cosmi L.
            Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients.
            Int Arch Allergy Immunol. 2016;171(1):45-53.
            https://www.ncbi.nlm.nih.gov/pubmed/27820937
          • Nisihara R, Skare T, Jardim AC, Utiyama SR.
            Celiac disease autoantibodies in juvenile idiopathic arthritis.
            Rheumatol Int. 2016 Nov 2.
            https://www.ncbi.nlm.nih.gov/pubmed/27807636
          • Tu ZQ, Xue HY, Chen W, Cao LF, Zhang WQ.
            Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.
            Rheumatol Int. 2016 Nov 19.
            https://www.ncbi.nlm.nih.gov/pubmed/27866247
 
OCTUBRE 2016
          • Davies R, Southwood T, Kearsley-Fleet L, Lunt M, Baildam E, Beresford MW, Foster HE, Douglas S, Thomson W, De Cock D; BCRD Study Group.; BSPAR-ETN Study Group., Hyrich KL.
            Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.
            Arch Dis Child. 2016 Oct 31
            https://www.ncbi.nlm.nih.gov/pubmed/27799155
          • Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.
            Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS)
            Semin Arthritis Rheum. 2016 Oct;46(2):190-5
            https://www.ncbi.nlm.nih.gov/pubmed/27422803
          • Geven EJ, van den Bosch MH, Di Ceglie I, Ascone G, Abdollahi-Roodsaz S, Sloetjes AW, Hermann S, Schäfers M, van de Loo FA, van der Kraan PM, Koenders MI, Foell D, Roth J, Vogl T, van Lent PL.
            S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis
            Arthritis Res Ther. 2016 Oct 24;18(1):247
            https://www.ncbi.nlm.nih.gov/pubmed/27776554
 
SEPTIEMBRE 2016
          • Cellucci T, Guzman J, Petty RE, Batthish M, Benseler SM, Ellsworth JE, Houghton KM, LeBLANC CM, Huber AM, Luca N, Schmeling H, Shiff NJ, Soon GS, Tse SM. Pediatric Committee of the Canadian Rheumatology Association.
            Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
            J Rheumatol. 2016 Oct;43(10):1773-1776.
            https://www.ncbi.nlm.nih.gov/pubmed/27698103
          • Windschall D, Horneff G.
            Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis.
            Clin Rheumatol. 2016 Oct 5.
            https://www.ncbi.nlm.nih.gov/pubmed/27709443
          • Verwoerd A, Ter Haar NM, de Roock S, Vastert SJ, Bogaert D.
            The human microbiome and juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2016 Sep 20;14(1):55.
            https://www.ncbi.nlm.nih.gov/pubmed/27650128
          • Beukelman T, Xie F, Baddley JW, Chen L, Mannion ML, Saag KG, Zhang J, Curtis JR.
            The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.
            Arthritis Res Ther. 2016 Sep 22;18(1):210.
            https://www.ncbi.nlm.nih.gov/pubmed/27655411
          • Aupiais C, Basmaci R, Ilharreborde B, Blachier A, Desmarest M, Job-Deslandre C, Faye A, Bonacorsi S, Alberti C, Lorrot M.
            Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis.
            Arch Dis Child. 2016 Sep 21.
            https://www.ncbi.nlm.nih.gov/pubmed/27655660
          • Bahrami T, Soltani S, Moazzami K, Yekaninejad MS, Salmaninejad A, Soltaninejad E, Ziaee V, Rezaei N.
            Association of PTPN22 Gene Polymorphisms with Susceptibility to Juvenile Idiopathic Arthritis in Iranian Population.
            Fetal Pediatr Pathol. 2016 Oct 12:1-7
            https://www.ncbi.nlm.nih.gov/pubmed/27732119
          • Ziaee V, Maddah M, Harsini S, Rezaei A, Sadr M, Zoghi S, Moradinejad MH, Rezaei N.
            Association of interleukin-1 family gene polymorphisms with juvenile idiopathic arthritis in Iranian population.
            Allergol Immunopathol (Madr). 2016 Oct 4.
            https://www.ncbi.nlm.nih.gov/pubmed/27717726
          • Isola G1, Ramaglia L, Cordasco G, Lucchese A, Fiorillo L, Matarese G.
            The effect of a functional appliance in the management of temporomandibular
            joint disorders in patients with juvenile idiopathic arthritis.
            Minerva Stomatol. 2016 Sep 13.
            https://www.ncbi.nlm.nih.gov/pubmed/27716739
          • Gaur P, Myles A, Misra R, Aggarwal A.
            Intermediate monocytes are increased in Enthesitis Related Arthritis a category of Juvenile idiopathic arthritis.
            Clin Exp Immunol. 2016 Oct 5.
            https://www.ncbi.nlm.nih.gov/pubmed/27706807
          • Armbrust W, Joyce Bos GJ, Wulffraat NM, van Brussel M, Cappon J, Dijkstra PU, Geertzen JH, Legger GE, van Rossum MA, Sauer PJ, Lelieveld OT.
            Internet program for physical activity and exercise capacity in children with juvenile idiopathic arthritis: a multicenter randomized controlled trial.
            Arthritis Care Res (Hoboken). 2016 Oct 1.
            https://www.ncbi.nlm.nih.gov/pubmed/27696793
          • Put K, Vandenhaute J, Avau A, Van Nieuwenhuijze A, Brisse E, Dierckx T, Rutgeerts O, Garcia-Perez J, Toelen J, Waer M, Leclercq G, Goris A, Van Weyenbergh J, Liston A, de Somer L, Wouters C, Matthys P11.
            Inflammatory gene expression profile and defective IFN-γ and granzyme K in natural killer cells of systemic juvenile idiopathic arthritis patients.
            Arthritis Rheumatol. 2016 Oct 1.
            https://www.ncbi.nlm.nih.gov/pubmed/27696741
          • Memari AH, Chamanara E, Ziaee V, Kordi R, Raeeskarami SR.
            Behavioral Problems in Juvenile Idiopathic Arthritis: A Controlled Study to Examine the Risk of Psychopathology in a Chronic Pediatric Disorder.
            Int J Chronic Dis. 2016;2016:5726236.
            https://www.ncbi.nlm.nih.gov/pubmed/27656678
          • Lantz JM, Joshi S, OʼHearn M.
            The Effects of Orthopedic Manual Physical Therapy in the Management of Juvenile Idiopathic Arthritis: A Case Report.
            Pediatr Phys Ther. 2016 Winter;28(4):490-7.
            https://www.ncbi.nlm.nih.gov/pubmed/27661250
          • Maggi L, Cosmi L, Simonini G, Annunziato F, Cimaz R.
            T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies.
            Autoimmun Rev. 2016 Sep 15.
            https://www.ncbi.nlm.nih.gov/pubmed/27640318
          • Lipstein EA, Lovell DJ, Denson LA, Kim SC, Spencer C, Britto MT.
            Parents' information needs and influential factors when making decisions about TNF-α inhibitors.
            Pediatr Rheumatol Online J. 2016 Sep 15;14(1):53.
            https://www.ncbi.nlm.nih.gov/pubmed/27641835
          • Ziaee V, Maddah M, Moradinejad MH, Rezaei A, Zoghi S, Sadr M, Harsini S, Rezaei N.
            Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis.
            Clin Rheumatol. 2016 Sep 20.
            https://www.ncbi.nlm.nih.gov/pubmed/27646136
          • Abinun M, Lane JP, Wood M, Friswell M, Flood TJ, Foster HE.
            Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.
            Emerg Infect Dis. 2016 Oct;22(10):1720-7.
            https://www.ncbi.nlm.nih.gov/pubmed/27648582
          • De Rosa G, De Nisco A, Piastra M, Valentini P, Rigante D.
            Efficacy of high-dose methylprednisolone pulses in a child with noninfectious persistent pleuropericarditis revealing systemic juvenile idiopathic arthritis.
            Reumatismo. 2016 Sep 9;68(2):114-5.
            https://www.ncbi.nlm.nih.gov/pubmed/27608803
          • Zeft AS, Prahalad S, Schneider R, Dedeoglu F, Weiss PF, Grom AA, Mix C, Pope Rd CA.
            Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.
            Clin Exp Rheumatol. 2016 Sep-Oct;34(5):946-952.
            https://www.ncbi.nlm.nih.gov/pubmed/27607024
          • Mannion ML, Xie F, Baddley J, Chen L, Curtis JR, Saag K, Zhang J, Beukelman T.
            Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients.
            Pediatr Rheumatol Online J. 2016 Sep 5;14(1):49.
            https://www.ncbi.nlm.nih.gov/pubmed/27596158
          • Ibrahim EF, Rashid A, Thomas M.
            Linked semiconstrained and unlinked total elbow replacement in juvenile idiopathic arthritis: a case comparison series with mean 11.7-year follow-up.
            J Shoulder Elbow Surg. 2016 Aug 31.
            https://www.ncbi.nlm.nih.gov/pubmed/27592371
 
AGOSTO 2016
          • Weiss PF.
            Update on enthesitis-related arthritis.
            Curr Opin Rheumatol. 2016 Sep;28(5):530-6. 
            http://www.ncbi.nlm.nih.gov/pubmed/27466726
          • Zeft AS, Prahalad S, Schneider R, Dedeoglu F, Weiss PF, Grom AA, Mix C, Pope CA.
            Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.
            Clin Exp Rheumatol. 2016 Sep 1. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27607024  
          • Yokota S, Itoh Y, Morio T, et al
            Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
            Ann Rheum Dis 2016;75:1654-1660
            http://ard.bmj.com/content/75/9/1654.abstract
          • Kearsley-Fleet L, Davies R, Baildam E et al
            Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers
            Rheumatology (Oxford) 2016; 55(9):1556-65.
            http://rheumatology.oxfordjournals.org/content/55/9/1556.abstract
          • Stinson J, Ahola Kohut S, Forgeron P, Amaria K, Bell M, Kaufman M, Luca N, Luca S, Harris L, Victor C, Spiegel L.
            The iPeer2Peer Program: a pilot randomized controlled trial in adolescents with Juvenile Idiopathic Arthritis.
            Pediatr Rheumatol Online J. 2016 Sep 2;14(1):48.
            http://www.ncbi.nlm.nih.gov/pubmed/27590668
          • Kavanaugh A, McInnes IB, Mease PJ, Hall S, Chinoy H, Kivitz AJ, Wang Z, Mpofu S.
            Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
            J Rheumatol. 2016 Sep;43(9):1713-7.
            http://www.ncbi.nlm.nih.gov/pubmed/27307536
          • Van der Heijde D, Landewé RB, Mease PJ, et al.
            Secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active Psoriatic Arthritis
            Arthritis Rheumatol 2016; 68 (8):1914-21.
            http://onlinelibrary.wiley.com/doi/10.1002/art.39685/pdf 
          • Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group.
            Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
            Ann Rheum Dis. 2016 Aug 23. pii: annrheumdis-2016-209709. doi: 10.1136/annrheumdis-2016-209709. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27553214
          • Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK,
            Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis.
            Arthritis Care Res (Hoboken). 2016 Aug 26. doi: 10.1002/acr.23003. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27564918
          • Doğruel D, Yılmaz M, Bingöl G, Altıntaş DU, Güneşer Kendirli S.
            Fraction of exhaled nitric oxide as a predictor in juvenile idiopathic arthritis progression.
            Clin Rheumatol. 2016 Aug 10. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27511473
          • Peters S, Ota S, Bolous E, Reich E, Chait S, Feldman BM.
            The Responsiveness of the Modified Childhood Health Assessment Questionnaire.
            J Rheumatol. 2016 Aug 1. pii: jrheum.151139. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27481906
          • Thorsen SU, Pipper CB, Alberdi-Saugstrup M, Nielsen S, Cohen A, Lundqvist M, Thygesen LC, Ascherio A, Svensson J.
            No association between vitamin D levels around time of birth and later risk of developing oligo- and polyarticular juvenile idiopathic arthritis: a Danish case-cohort study.
            Scand J Rheumatol. 2016 Jul 27:1-8. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27460412
 
JULIO 2016
          • Becker I, Horneff G.
            Risk of serious infection in juvenile idiopathic arthritis patients associated with TNF-inhibitors and disease activity in the German BIKER registry.
            Arthritis Care Res (Hoboken). 2016 Jul 7. doi: 10.1002/acr.22961. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27390133 
          • Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML.
            Gut microbiota-host interactions and juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2016 Jul 22;14(1):44. doi: 10.1186/s12969-016-0104-6.
            http://www.ncbi.nlm.nih.gov/pubmed/27448997
          • Bos GJ, Lelieveld OT, Armbrust W, Sauer PJ, Geertzen JH, Dijkstra PU.
            Physical activity in children with Juvenile Idiopathic Arthritis compared to controls.
            Pediatr Rheumatol Online J. 2016 Jul 7;14(1):42. doi: 10.1186/s12969-016-0102-8.
            http://www.ncbi.nlm.nih.gov/pubmed/27387754
          • Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T2, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD.
            Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis.
            Arthritis Rheumatol. 2016 Jul;68(7):1758-68. doi: 10.1002/art.39606.
            http://www.ncbi.nlm.nih.gov/pubmed/26815131
          • Gohar F, Kessel C, Lavric M, Holzinger D, Foell D.
            Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?
            Arthritis Res Ther. 2016 Jul 13;18:163. doi: 10.1186/s13075-016-1069-z.
            http://www.ncbi.nlm.nih.gov/pubmed/27411444
 
JUNIO 2016
          • Díaz-Peña R, Vidal-Castiñeira JR, López-Vázquez A, López-Larrea C.
            HLA-B*40:01 Is Associated with Ankylosing Spondylitis in HLA-B27-positive Populations.
            J Rheumatol. 2016 Jun;43(6):1255-6. doi: 10.3899/jrheum.151096.
            http://www.ncbi.nlm.nih.gov/pubmed/27252503
          • Kristensen KD, Stoustrup P, Küseler A, Pedersen TK, Twilt M, Herlin T
            Clinical predictors of temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic literature review.
            Semin Arthritis Rheum. 2016 Jun;45(6):717-32. doi: 10.1016/j.semarthrit.2015.11.006
            http://www.ncbi.nlm.nih.gov/pubmed/26708936
          • Janow G, Schanberg LE, Setoguchi S, Hasselblad V, Mellins ED, Schneider R, Kimura Y; CARRA Legacy Registry Investigators.
            The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
            J Rheumatol. 2016 Jun 15. pii: jrheum.150997
            http://www.ncbi.nlm.nih.gov/pubmed/27307527
          • Walters HM, Pan N, Lehman TJ, Adams A, Kalliolias GD, Zhu YS, Santiago F, Nguyen J, Sitaras L, Cunningham-Rundles S, Walsh TJ, Toussi SS.
            The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.
            Clin Exp Immunol. 2016 Jun;184(3):308-17. doi: 10.1111/cei.12782
            http://www.ncbi.nlm.nih.gov/pubmed/26934060
          • Zamora-Legoff JA, Krause ML, Crowson CS, Muskardin TW, Mason T, Matteson EL.
            Treatment of patients with juvenile idiopathic arthritis (JIA) in a population-based cohort.
            Clin Rheumatol. 2016 Jun;35(6):1493-9. doi: 10.1007/s10067-016-3190-4
            http://www.ncbi.nlm.nih.gov/pubmed/26825065
          • Taddio A, Cattalini M, Simonini G, Cimaz R.
            Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.
            Expert Rev Clin Immunol. 2016 Jun;12(6):641-9. doi:10.1586/1744666X.2016.1146132
            http://www.ncbi.nlm.nih.gov/pubmed/26809126
          • Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M
            Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.
            Pediatr Res. 2016 Jun;79(6):895-901. doi: 10.1038/pr.2016.27.
            http://www.ncbi.nlm.nih.gov/pubmed/26882369
 
MAYO 2016
          • Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G et al.
            Extended report: Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
            Ann Rheum Dis 2016;75:855-861. doi:10.1136/annrheumdis-annrheumdis-2014-206747.
            http://ard.bmj.com/content/75/5/855.abstract 
          • Demirkaya E, Lanni S, Bovis F, Galasso R, Ravelli A, Palmisani E, et al.
            A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis.
            Arthritis Rheumatol 68:1540–1550. doi:10.1002/art.39583
            http://onlinelibrary.wiley.com/doi/10.1002/art.39583/abstract 
          • Alcobendas R, Rodríguez-Vidal A, Pascual-Salcedo D, Murias S, Remesal A, Diego C, et al.
            Monitoring serum etanercept levels in juvenile idiopathic arthritis: a pilot study.
            Clin Exp Rheumatol 2016 Apr 28. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/27156742 
          • Akmatov M, Stumme M, Pessler F.
            Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012.
            Clin Exp Rheumatol. 2016 Apr 28. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27156925
          • Quartier P.
            Choice of biologic drug among children with juvenile idiopathic arthritis.
            Rheumatology first published online May 11, 2016. doi: 10.1093/rheumatology/kew209
            http://rheumatology.oxfordjournals.org/content/early/2016/05/11/rheumatology.kew209.extract 
          • Kearsley-Fleet L, Davies R, Lunt M, Southwood TR, Hyrich KL.
            Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
            Rheumatology (2016) 55 (5): 840-847. doi: 10.1093/rheumatology/kev434
            http://rheumatology.oxfordjournals.org/content/55/5/840.abstract
 
ABRIL 2016
          • Kinard BE, Bouloux GF, Prahalad S, Vogler L, Abramowicz S
            Arthroscopy of the Temporomandibular Joint in Patients With Juvenile Idiopathic Arthritis
            J Oral Maxillofac Surg. 2016 Jan 22. pii: S0278-2391(16)00120-8. doi: 10.1016/j.joms.2016.01.028. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/26896757
          • Barth S, Haas JP, Schlichtiger J, Molz J, Bisdorff B, Michels H, Hügle B, Radon K.
            Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
            PLoS One. 2016 Apr 26;11(4):e0153267. doi: 10.1371/journal.pone.0153267. eCollection 2016.
            http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27115139
          • Consolaro A, Giancane G, Schiappapietra B, Davì S, Calandra S, Lanni S, Ravelli A.
            Clinical outcome measures in juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2016 Apr 18;14(1):23. doi: 10.1186/s12969-016-0085-5. Review.
            http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27089922
          • Kuhlmann A, Schmidt T, Treskova M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G; BURQOL-RD Research Network.
            Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
            Eur J Health Econ. 2016 Apr 16. [Epub ahead of print] http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27086322
          • Livermore P, Eleftheriou D, Wedderburn LR.
            The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
            Pediatr Rheumatol Online J. 2016 Apr 12;14(1):21. doi: 10.1186/s12969-016-0083-7.
            http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27068023
          • Consolaro A, Ravelli A.
            Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas - Key to Understanding Etiology and Genetic Factors?
            J Rheumatol. 2016 Apr;43(4):683-5. doi: 10.3899/jrheum.160173.
            http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27037240
          • El Assar de la Fuente S, Angenete O, Jellestad S, Tzaribachev N, Koos B, Rosendahl K.
            Juvenile idiopathic arthritis and the temporomandibular joint: A comprehensive review.
            J Craniomaxillofac Surg. 2016 May;44(5):597-607. doi: 10.1016/j.jcms.2016.01.014. Epub 2016 Feb 3.
            http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/26924432
 
MARZO 2016
          • Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Raad JJ, Jarosova K, Anton J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
            Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
            J Rheumatol. 2016 Mar 1. pii: jrheum.150430. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26932344
          • McErlane F, Foster HE, Carrasco R, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.
            Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.
            Rheumatology (Oxford). 2016 Mar 25. pii: kew021. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/27016664
          • Chan MO, Petty RE, Guzman J; ReACCh-Out Investigators.
            A Family history of Psoriasis in a first-degree relative in children with JIA: to include or exclude?
            J Rheumatol. 2016 Mar 15. pii: jrheum.150555. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26980584
          • Turnier JL, Brunner HI.
            Tocilizumab for treating juvenile idiopathic arthritis.
            Expert Opin Biol Ther. 2016 Apr;16(4):559-66. doi: 10.1517/14712598.2016.1150997
            http://www.ncbi.nlm.nih.gov/pubmed/26848760
          • Makay B, Gücenmez ÖA, Ünsal E.
            Inactive disease in Enthesitis-related Arthritis: Association of increased body mass index.
            J Rheumatol. 2016 Mar 15. pii: jrheum.151208. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26980582
          • Katsicas MM, Russo R.
            Biologic agents in juvenile spondyloarthropathies.
            Pediatr Rheumatol Online J. 2016 Mar 12;14(1):17. doi: 10.1186/s12969-016-0076-6
            http://www.ncbi.nlm.nih.gov/pubmed/26968522
          • Gómez-Ramírez O, Gibbon M, Berard R, Jurencak R, Green J, Tucker L, Shiff N, Guzman J
            A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2016 Mar 9;14(1):13. doi: 10.1186/s12969-016-0073-9.
            http://www.ncbi.nlm.nih.gov/pubmed/26961237
          • Lin CH, Lin CL, Shen TC, Wei CC.
            Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study.
            Pediatr Rheumatol Online J. 2016 Mar 10;14(1):15. doi: 10.1186/s12969-016-0074-8.
            http://www.ncbi.nlm.nih.gov/pubmed/26965056
          • Schulert GS, Fall N, Harley JB, Shen N, Lovell DJ, Thornton S, Grom AA.
            Monocyte microRNA expression in active systemic juvenile idiopathic arthritis implicates miR-125a-5p in polarized monocyte phenotypes.
            Arthritis Rheumatol. 2016 Mar 25. doi: 10.1002/art.39694. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27014994
          • Finkel TH, Li J, Wei Z, Wang W, Zhang H, Behrens EM, et al.
            Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility.
            BMC Med Genet. 2016 Mar 22;17(1):24. doi: 10.1186/s12881-016-0285-3.
            http://www.ncbi.nlm.nih.gov/pubmed/27005825
 
FEBRERO 2016
          • Clement CC, Moncriefe H, Lele A, Janow G, Becerra A, Bauli F, Saad FA, Perino G, Montagna C, Cobelli N, Hardin J, Stern LJ, Ilowite N, Porcelli SA, Santambrogio L.
            Autoimmune response to transthyretin in juvenile idiopathic arthritis.
            JCI Insight. 2016 Feb;1(2). pii: e85633. Epub 2016 Feb 25.
            http://www.ncbi.nlm.nih.gov/pubmed/26973882
          • Scheuern A, Fischer N, McDonald J, Brunner HI, Haas JP, Hügle B.
            Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2016 Feb 29;14(1):11. doi: 10.1186/s12969-016-0071-y.
            http://www.ncbi.nlm.nih.gov/pubmed/26928923
          • El Assar de la Fuente S, Angenete O, Jellestad S, Tzaribachev N, Koos B, Rosendahl K.
            Juvenile idiopathic arthritis and the temporomandibular joint: A comprehensive review.
            J Craniomaxillofac Surg. 2016 Feb 3. pii: S1010-5182(16)00028-7. doi: 10.1016/j.jcms.2016.01.014. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26924432
          • Nicolai R, Cortis E, Ravà L, Bracaglia C, Pardeo M, Insalaco A, Buonuomo PS, Tozzi AE, De Benedetti F.
            Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis.
            J Pediatric Infect Dis Soc. 2016 Mar;5(1):76-9. doi: 10.1093/jpids/piu078. Epub 2014 Jul 31.
            http://www.ncbi.nlm.nih.gov/pubmed/26908493
          • Race DL, Sims-Gould J, Tucker LB, Duffy CM, Feldman DE, Gibbon M, Houghton KM, Stinson JN, Stringer E, Tse SM, McKay HA.
            'It might hurt, but you have to push through the pain': Perspectives on physical activity from children with juvenile idiopathic arthritis and their parents.
            J Child Health Care. 2016 Feb 23. pii: 1367493516632616. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26907570
          • Fay M1, Rapley T, Foster H, Pain C, Gerrand C.
            Can Seeding in the Clinic Reach a Wide Audience? A Proof of Concept Study on Spreading a Health Message About Juvenile Idiopathic Arthritis Using a Shareable Online Video.
            Interact J Med Res. 2016 Feb 22;5(1):e6. doi: 10.2196/ijmr.4608.
            http://www.ncbi.nlm.nih.gov/pubmed/26903485
          • Mani P, Uno K, Duong M, Wolski K, Spalding S, Husni ME, Nicholls SJ.
            HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.
            Cardiovasc Diagn Ther. 2016 Feb;6(1):34-43. doi: 10.3978/j.issn.2223-3652.2015.12.14.
            http://www.ncbi.nlm.nih.gov/pubmed/26885490
          • Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M.
            Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.
            Pediatr Res. 2016 Feb 16. doi: 10.1038/pr.2016.27. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26882369
          • Evensen K, Aulie HA, Rønning OM, Flatø B, Russell D.
            Carotid Atherosclerosis in Adult Patients with Persistently Active Juvenile Idiopathic Arthritis Compared with Healthy Controls.
            J Rheumatol. 2016 Feb 15. pii: jrheum.150499. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26879363
          • Fitzpatrick L, Broadaway KA, Ponder L, Angeles-Han ST, Jenkins K, Rouster-Stevens K, Pelajo CF, Conneely K, Epstein MP, Lopez-Benitez J,Vogler LB, Prahalad S; CARRA Registry Investigators.
            Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
            J Rheumatol. 2016 Feb 15. pii: jrheum.150891. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26879356
          • Aguiar F, Brito I.
            Structural damage to the hip in systemic juvenile idiopathic arthritis: A case of regression with Anakinra.
            Reumatol Clin. 2016 Feb 9. pii: S1699-258X(16)00004-8. doi: 10.1016/j.reuma.2015.12.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26872537
          • Lange L, Thiele GM, McCracken C, Wang G, Ponder LA, Angeles-Han ST, Rouster-Stevens KA, Hersh AO, Vogler LB, Bohnsack JF, Abramowicz S, Mikuls TR, Prahalad S.
            Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2016 Feb 9;14(1):8. doi: 10.1186/s12969-016-0068-6.
            http://www.ncbi.nlm.nih.gov/pubmed/26861944
          • Anderson JH, Anderson KR, Aulie HA, Crowson CS, Mason TG, Ardoin SP, Reed AM, Flatø B.
            Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.
            Scand J Rheumatol. 2016 Feb 8:1-5. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26854592
          • van Dijkhuizen EH, Pouw JN, Scheuern A, Hügle B, Hardt S, Ganser G, Kümmerle-Deschner JB, Horneff G, Holzinger D, Bulatović Ćalasan M,Wulffraat NM.
            Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
            Clin Exp Rheumatol. 2016 Jan-Feb;34(1):148-54. Epub 2016 Feb 2.
            http://www.ncbi.nlm.nih.gov/pubmed/26843067
          • Barth S, Schlichtiger J, Bisdorff B, Hügle B, Michels H, Radon K, Haas JP.
            Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study.
            Pediatr Rheumatol Online J. 2016 Feb 3;14(1):6. doi: 10.1186/s12969-016-0066-8.
            http://www.ncbi.nlm.nih.gov/pubmed/26842529
          • Kapusta MA.
            A Portrait of Juvenile Arthritis with Multiple Joint Abnormalities.
            J Rheumatol. 2016 Feb;43(2):450-1. doi: 10.3899/jrheum.150356.
            http://www.ncbi.nlm.nih.gov/pubmed/26834249
          • Ehrmann Feldman D, Vinet É, Bernatsky S, Duffy C, Hazel B, Meshefedjian G, Sylvestre MP, Bérard A.
            Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis.
            J Rheumatol. 2016 Feb 1. pii: jrheum.150592. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26834215
          • Hsieh YJ, Darvann TA, Hermann NV, Larsen P, Liao YF, Bjoern-Joergensen J, Kreiborg S.
            Facial morphology in children and adolescents with juvenile idiopathic arthritis and moderate to severe temporomandibular joint involvement.
            Am J Orthod Dentofacial Orthop. 2016 Feb;149(2):182-91. doi: 10.1016/j.ajodo.2015.07.033.
            http://www.ncbi.nlm.nih.gov/pubmed/26827974
          • Macaubas C, Wong E, Zhang Y, Nguyen KD, Lee J, Milojevic D, Shenoi S, Stevens AM, Ilowite N, Saper V, Lee T, Mellins ED.
            Altered signaling in systemic juvenile idiopathic arthritis monocytes.
            Clin Immunol. 2016 Feb;163:66-74. doi: 10.1016/j.clim.2015.12.011. Epub 2015 Dec 31.
            http://www.ncbi.nlm.nih.gov/pubmed/26747737
 
ENERO 2016
          • Kearsley-Fleet L, Davies R, Baildam E, Beresford MW, Foster HE, Southwood TR, Thomson W, Hyrich KL.
            Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.
            Rheumatology (Oxford). 2016 Jan 4. pii: kev429. [Epub ahead of print] http://rheumatology.oxfordjournals.org/content/early/2016/01/03/rheumatology.kev429.full.pdf+html
          • Hilderson D, Moons P, Van der Elst K, Luyckx K, Wouters C, Westhovens R.
            The clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: results of the DON'T RETARD project.
            Rheumatology (Oxford). 2016 Jan;55(1):133-42. doi: 10.1093/rheumatology/kev284. Epub 2015 Aug 28.
            http://www.ncbi.nlm.nih.gov/pubmed/26320142
 
DICIEMBRE 2015
 
            • Esbjörnsson, A.-C., Iversen, M. D., André, M., Hagelberg, S., Schwartz, M. H. and Broström, E. W
              Effect of Intraarticular Corticosteroid Foot Injections on Walking Function in Children With Juvenile Idiopathic Arthritis
              Arthritis Care Res, 67: 1693–1701. doi: 10.1002/acr.22624
              http://www.ncbi.nlm.nih.gov/pubmed/26017638
            • Markula-Patjas K, Valta H, Pekkinen M, Andersson S, Aalto K, Lahdenne P, Viljakainen H, Mäkitie O.
              Body composition and adipokines in patients with juvenile idiopathic arthritis and systemic glucocorticoids
              Clin Exp Rheumatol. 2015 Nov-Dec;33(6):924-30
              http://www.ncbi.nlm.nih.gov/pubmed/26315132
            • Srivastava R, Agnihotry S, Aggarwal R, Bajpai P, Aggarwal A.
              HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India.
              Clin Exp Rheumatol. 2015 Nov-Dec;33(6):931-5.
              http://www.ncbi.nlm.nih.gov/pubmed/26314893
 
          • Nigrovic PA.
            Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.
            Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15785-6. doi: 10.1073/pnas.1521837113.
            http://www.ncbi.nlm.nih.gov/pubmed/26677874
          • Stoustrup P, Kristensen KD, Küseler A, Pedersen TK, Herlin T
            Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms.
            Pediatr Rheumatol Online J. 2015 Dec 21;13(1):62. doi: 10.1186/s12969-015-0060-6.
            http://www.ncbi.nlm.nih.gov/pubmed/26689191  
          • Mulligan K, Wedderburn LR, Newman S
            The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people.
            Pediatr Rheumatol Online J. 2015 Dec 12;13(1):58. doi: 10.1186/s12969-015-0052-6.
            http://www.ncbi.nlm.nih.gov/pubmed/26653415
          • Bohr AH, Nielsen S, Müller K, Karup Pedersen F, Andersen LB
            Reduced physical activity in children and adolescents with Juvenile Idiopathic Arthritis despite satisfactory control of inflammation.
             Pediatr Rheumatol Online J. 2015 Dec 10;13(1):57. doi: 10.1186/s12969-015-0053-5.
            http://www.ncbi.nlm.nih.gov/pubmed/26653716  
          • Keller H, Müller LM, Markic G, Schraner T, Kellenberger CJ, Saurenmann RK.
            Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2015 Dec 9;13(1):56. doi: 10.1186/s12969-015-0056-2.
            http://www.ncbi.nlm.nih.gov/pubmed/26646650
          • Brosseau L, Toupin-April K, Wells GA, Smith CA, Pugh AG, Stinson JN, Duffy CM, Gifford W, Moher D, Sherrington C, Cavallo S, De Angelis G, Loew L, Rahman P, Marcotte R, Taki J, Bisaillon J, King J, Coda A, Hendry GJ, Gauvreau J, Hayles M, Hayles K, Feldman B, Kenny GP, Li JX, Briggs AM, Martini R, Feldman DE, Maltais DB, Tupper S, Bigford S, Bisch M
            Ottawa Panel Evidence-Based Clinical Practice Guidelines for Foot Care in the Management of Juvenile Idiopathic Arthritis.
            Arch Phys Med Rehabil. 2015 Dec 17. pii: S0003-9993(15)01480-X. doi: 10.1016/j.apmr.2015.11.011.
            http://www.ncbi.nlm.nih.gov/pubmed/26707409
NOVIEMBRE 2015
 
          • Patompong Ungprasert, Narat Srivali, Charat Thongprayoon
            Risk of Cardiovascular Disease in Patients with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-analysis
            Ann Paediatr Rheum. 2015; 4(3): 48-52
            doi: 10.5455/apr.073020151756   
          • E H Pieter van Dijkhuizen, Nico M Wulffraat
            Extended report:Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review
            Ann Rheum Dis 2015;74:1996-2005 Published Online First: 24 June 2014 doi:10.1136/annrheumdis-2014-205265
            [Abstract]
          • S. Shenoi, M.L. Shaffer and C.A. Wallace
            Environmental risk factors and early life exposures for Juvenile Idiopathic Arthritis; a case: Control study
            Arthritis Care & Research
            DOI: 10.1002/acr.22806
            Abstract
          • Rubén Burgos-Vargas, Shirley M. L. Tse, Gerd Horneff, Aileen L. Pangan, Jasmina Kalabic, Sandra Goss, Kristina Unnebrink and Jaclyn K. Anderson
            A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis (pages 1503–1512)
            Arthritis Care & Research
            DOI: 10.1002/acr.22657
            Abstract
          • Aimee O. Hersh, Sampath Prahalad
            Immunogenetics of juvenile idiopathic arthritis: A comprehensive review
            Journal of Autoimmunity
            Volume 64, November 2015, Pages 113–124
          • Deborah Barthel, Gerd Ganser, Rolf-Michael Kuester, Nils Onken, Kirsten Minden, Hermann Josef Girschick, Anton Hospach, and Gerd Horneff
            Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics
            J Rheumatol November doi:10.3899/jrheum.140472
            Abstract
          • Janneke Anink, Femke H. M. Prince, Maryanne Dijkstra, Marieke H. Otten, Marinka Twilt, Rebecca ten Cate, Simone L. Gorter, Yvonne Koopman-Keemink, Marion A. J. van Rossum, Esther P. A. Hoppenreijs, and Lisette W. A. van Suijlekom-Smit
            Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register
            Rheumatology (2015) 54 (11): 1964-1969 doi:10.1093/rheumatology/kev195
            Abstract
          • Simon Tarp, Gil Amarilyo, Ivan Foeldvari, Robin Christensen, Jennifer M. P. Woo, Neta Cohen, Tracy D. Pope, and Daniel E. Furst
            Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials
            Rheumatology
            doi:10.1093/rheumatology/kev382
            Abstract               
          • Lucie Brosseau, Désirée B. Maltais, Glen P. Kenny, Ciarán M. Duffy, Jennifer Stinson, Sabrina Cavallo, Karine Toupin-April, Debbie Ehrmann Feldman, Annette Majnemer, Isabelle J. Gagnon, and Marie-Ève Mathieu
            What we can learn from existing evidence about physical activity for juvenile idiopathic arthritis?
            Rheumatology
            doi:10.1093/rheumatology/kev389
            Extract
OCTUBRE 2015
          • Anink J, Prince FH, Dijkstra M, Otten MH, Twilt M, Ten Cate R, Gorter SL, Koopman-Keemink Y, van Rossum MA, Hoppenreijs EP, van Suijlekom-Smit LW.
            Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.
            Rheumatology (Oxford). 2015 Nov;54(11):1964-9. doi: 10.1093/rheumatology/kev195
            http://www.ncbi.nlm.nih.gov/pubmed/26078219
          • van Dijkhuizen EHP, Wulffraat NM.
            Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.
            Ann Rheum Dis 2015;74:1996-2005
            http://ard.bmj.com/content/74/11/1996.abstract
          • Ravelli A, Consolaro A, Schiappapietra B, Martini A
            The conundrum of juvenile psoriatic arthritis
            Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):40-3. Epub 2015 Oct 15. Review
            http://www.ncbi.nlm.nih.gov/pubmed/26470604
          • Obeid J, Nguyen T, Cellucci T, Larché MJ, Timmons BW.
            Effects of acute exercise on circulating endothelial and progenitor cells in children and adolescents with juvenile idiopathic arthritis and healthy controls: a pilot study
            Pediatr Rheumatol Online J. 2015 Oct 12;13(1):41. doi: 10.1186/s12969-015-0038-4.
            http://www.ncbi.nlm.nih.gov/pubmed/26458943
          • Backström M, Tynjälä P, Ylijoki H, Aalto K, Kärki J, Pohjankoski H, Keskitalo P, Sard S, Hietanen M, Lehto H, Kauko T, Vähäsalo P.
            Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.
            Rheumatology (Oxford). 2015 Oct 7. pii: kev353. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26447164
          • Du N, Jiang K, Sawle AD, Frank MB, Wallace CA, Zhang A, Jarvis JN.
            Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis
            Genome Med. 2015 Oct 24;7(1):109.
            http://www.ncbi.nlm.nih.gov/pubmed/26497493
          • Barthel D, Ganser G, Kuester RM, Onken N, Minden K, Girschick HJ, Hospach A, Horneff G.
            Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics
            J Rheumatol. 2015 Sep 15. pii: jrheum.140472.
            http://www.ncbi.nlm.nih.gov/pubmed/26373564
 
SEPTIEMBRE 2015
          • Ogdie A, Weiss P.
            The Epidemiology of Psoriatic Arthritis.
            Rheum Dis Clin North Am. 2015 Nov;41(4):545-68. doi: 10.1016/j.rdc.2015.07.001
            http://www.ncbi.nlm.nih.gov/pubmed/26476218
          • Taxter AJ, Wileyto EP, Behrens EM, Weiss PF.
            Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis
            J Rheumatol October 2015 42(10):1914-21;doi:10.3899/jrheum.150092
            http://www.jrheum.org/content/42/10/1914.abstract
          • Sieper J. van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA, Berd Y, Bergman G, Curtis S, Tzontcheva A, Huyck S and Weng HH.
            A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis.
            Arthritis Rheumatol 2015;67(10):2702–12
            http://onlinelibrary.wiley.com/doi/10.1002/art.39257/epdf
          • Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, et al for the Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation
            Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years
            Arthritis Rheumatol 2015;67(10):2759-70
            http://onlinelibrary.wiley.com/doi/10.1002/art.39234/epdf
          • Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Gilles Boire G, et al.
            The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
            Ann Rheum Dis 2015;74:1861-7 Published Online First: 13 June 2014
            http://ard.bmj.com/content/74/10/1854.abstract
          • Ogata A, Atsum Ti, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N et al.
            Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
            Arthritis Care Res (Hoboken). 2015 Oct;67(10):1354-62. doi: 10.1002/acr.22598.
            http://onlinelibrary.wiley.com/doi/10.1002/acr.22598/epdf
          • Yamasaki Y, Takei S, Imanaka H, Nerome Y, Kubota T, Nonaka Y, Akaike H, Takezaki T, Kawano Y.
            Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and Vascular Endothelial Growth Factor.
            Mod Rheumatol. 2015 Oct 16:1-23. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26474088
          • Mourão AF, Santos MJ, Mendonça S, Oliveira-Ramos F, Salgado M, Estanqueiro P, Melo-Gomes J, Martins F, Lopes A, Bettencourt BF, Bruges-Armas J, Costa J, Furtado C, Figueira R, Brito I, Branco J, Fonseca JE, Canhão H
            Genetic Predictors of Poor Prognosis in Portuguese Patients with Juvenile Idiopathic Arthritis: Data from Reuma.pt.
            J Immunol Res. 2015;2015:706515. doi: 10.1155/2015/706515. Epub 2015 Oct 4
            http://www.ncbi.nlm.nih.gov/pubmed/26504858
          • Kanetaka T, Mori M, Nishimura KI, Nozawa T, Kikuchi M, Sakurai N, Hara R, Yamazaki K, Yokota S.
            Characteristics of FDG-PET findings in the diagnosis of systemic juvenile idiopathic arthritis.
            Mod Rheumatol. 2015 Sep 29:1-6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26417716
          • Hyrich KL, Baildam E, Pickford H, Chieng A, Davidson JE, Foster H, Gardner-Medwin J, Wedderburn LR, Thomson W.
            Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis.
            Arch Dis Child. 2015 Sep 14. pii: archdischild-2014-308117. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26369575
 
AGOSTO 2015
          • Dilandro G, De Cosmi V, Corona F, Torcoletti M, Petaccia A, Filocamo G, Budelli A, Agostoni C.
            May biscuits contribute to iron balance? An observation in children with juvenile idiopatic arthritis.
            Int J Food Sci Nutr. 2015 Aug 27:1-4. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26313813
          • Hersh AO, Prahalad S.
            Immunogenetics of juvenile idiopathic arthritis: A comprehensive review.
            J Autoimmun. 2015 Aug 21. pii: S0896-8411(15)30020-2. doi: 10.1016/j.jaut.2015.08.002. EPUB ahead of print
            http://www.ncbi.nlm.nih.gov/pubmed/26305060
          • Steigerwald KA, Ilowite NT.
            Novel treatment options for juvenile idiopathic arthritis.
            Expert Rev Clin Pharmacol. 2015 Sep;8(5):559-73. doi: 10.1586/17512433.2015.1061428
            http://www.ncbi.nlm.nih.gov/pubmed/26294075
          • Lomholt JJ, Thastum M, Christensen AE, Leegaard A, Herlin T.
            Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: A study of feasibility and preliminary efficacy.
            Pediatr Rheumatol Online J. 2015 Aug 21;13:35. doi: 10.1186/s12969-015-0032-x.
            http://www.ncbi.nlm.nih.gov/pubmed/26293657
          • Chiaroni-Clarke RC, Li YR, Munro JE, Chavez RA, Scurrah KJ, Pezic A, Akikusa JD, Allen RC, Piper SE, Becker ML, Thompson SD, Lie BA, Flato B, Forre O, Punaro M, Wise C, Saffery R, Finkel TH, Hakonarson H, Ponsonby AL, Ellis JA.
            The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females.
            Genes Immun. 2015 Aug 20. doi:10.1038/gene.2015.32. EPUB ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26291515
          • Ammerlaan JJ, Scholtus LW, Drossaert CH, van Os-Medendorp H, Prakken B, Kruize AA, Bijlsma JJ.
            Feasibility of a Website and a Hospital-Based Online Portal for Young Adults With Juvenile Idiopathic Arthritis: Views and Experiences of Patients.
            JMIR Res Protoc. 2015 Aug 14;4(3) doi:10.2196/resprot.3952.
            http://www.ncbi.nlm.nih.gov/pubmed/26276373
          • Mou Y, Zhang P, Li Q, Lin Z, Liao Z, Wei Q, Gu J.
            Clinical Features in Juvenile-Onset Ankylosing Spondylitis Patients Carrying Different B27 Subtypes.
            Biomed Res Int. 2015;2015:594878. doi:10.1155/2015/594878.EPUB 2015 Jul 26.
            http://www.ncbi.nlm.nih.gov/pubmed/26273634
          • Farr S, Girsch W.
            The Hand and Wrist in Juvenile Rheumatoid Arthritis.
            J Hand Surg Am. 2015 Aug 10. pii:S0363-5023(15)00826-6. doi: 10.1016/j.jhsa.2015.06.111. EPUB ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26272796
          • Shenoi S, Ou JN, Ni C, Macaubas C, Gersuk VH, Wallace CA, Mellins ED, Stevens AM.
            Comparison of Biomarkers for Systemic Juvenile Idiopathic Arthritis.
            Pediatr Res. 2015 Aug 12. doi:10.1038/pr.2015.144. EPUB ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26267155
          • Santos D, Silva C, Silva M.
            Oral health and quality of life of children and adolescents with juvenile idiopathic arthritis according to their caregivers' perceptions.
            Spec Care Dentist. 2015 Aug 8. doi:10.1111/scd.12129. EPUB ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26255878
          • Devauchelle-Pensec V, Thepaut M, Pecquery R, Houx L.
            Managing monoarthritis in children.
            Joint Bone Spine. 2015 Aug 4. pii:S1297-319X(15)00110-4. doi: 10.1016/j.jbspin.2015.06.004. EPUB ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/26253943
          • Anink J, Van Suijlekom-Smit LW, Otten MH, Prince FH4, van Rossum MA5, Dolman KM, Hoppenreijs EP, Ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Vogl T, Gohar F, Foell D, Roth J, Holzinger D.
            MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis.
            Arthritis Res Ther. 2015 Aug 7;17:200. doi:10.1186/s13075-015-0723-1.
            http://www.ncbi.nlm.nih.gov/pubmed/26249667  
          • Gaur P, Misra R, Aggarwal A.
            Natural Killer cells and gamma-delta T cells alterations in Enthesitis Related Arthritis category of Juvenile idiopathic arthritis.
            Clin Immunol. 2015 Aug 2. pii:S1521-6616(15)30015-2. doi: 10.1016/j.clim.2015.07.012. EPUB ahead of print
            http://www.ncbi.nlm.nih.gov/pubmed/26244610  
          • Leksell E, Hallberg U, Magnusson B, Ernberg M, Hedenberg-Magnusson B.
            Perceived Oral Health and Care of Children with Juvenile Idiopathic Arthritis: A Qualitative Study.
            J Oral Facial Pain Headache. 2015 Summer;29(3):223-30.doi: 10.11607/ofph.1293.
            http://www.ncbi.nlm.nih.gov/pubmed/26244430  
          • Aggarwal A, Misra DP.
            Enthesitis-related arthritis.
            Clin Rheumatol. 2015 Aug 2. EPUB ahead of print
            http://www.ncbi.nlm.nih.gov/pubmed/26233720  
          • Abdwani R, Abdalla E, Al Abrawi S, Al-Zakwani I
            Epidemiology of juvenile idiopathic arthritis in Oman.
            Pediatr Rheumatol Online J. 2015 Aug 1;13(1):33. doi:10.1186/s12969-015-0030-z.
            http://www.ncbi.nlm.nih.gov/pubmed/26232056
 
JULIO 2015
          • Weiss PF, Xiao R, Biko DM, Chauvin NA
            Sacroiliitis at diagnosis of juvenile spondyloarthritis assessed by radiography, magnetic resonance imaging, and clinical examination.
            Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22665. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26212574
          • Burgos-Vargas R, Tse SM, Horneff G, Pangan AL, Kalabic J, Goss S, Unnebrink K, Anderson JK
            A randomized, double-blind, placebo-controlled, multicenter study of adalimumab in pediatric patients with enthesitis-related arthritis.
            Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22657. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26223543
          • Esbjörnsson AC, Aalto K, Broström EW, Fasth A, Herlin T, Nielsen S, Nordal E, Peltoniemi S, Rygg M, Zak M, Berntson L
            Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.
            Clin Exp Rheumatol. 2015 Jul 23. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26213158
          • Pardeo M, Pires Marafon D, Insalaco A, Bracaglia C, Nicolai R, Messia V, De Benedetti F.
            Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience.
            J Rheumatol. 2015 Aug;42(8):1523-7. doi: 10.3899/jrheum.141567. Epub 2015 Jun 1.
            http://www.ncbi.nlm.nih.gov/pubmed/26034148
          • Ilisson J, Zagura M, Zilmer K, Salum E, Heilman K, Piir A, Tillmann V, Kals J, Zilmer M, Pruunsild C
            Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
            Arthritis Res Ther. 2015 Jul 16;17:180. doi: 10.1186/s13075-015-0699-x.
            http://www.ncbi.nlm.nih.gov/pubmed/26179062
          • Armbrust W, Bos JJ, Cappon J, van Rossum MA, Sauer PJ, Wulffraat N, van Wijnen VK, Lelieveld OT.
            Design and acceptance of Rheumates@Work, a combined internet-based and in person instruction model, an interactive, educational, and cognitive behavioral program for children with juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2015 Jul 23;13(1):31. doi: 10.1186/s12969-015-0029-5.
            http://www.ncbi.nlm.nih.gov/pubmed/26202161
          • Oren-Ziv A, Hoppenstein D, Shles A, Uziel Y.
            Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review.
            Pediatr Rheumatol Online J. 2015 Jul 4;13(1):28. doi: 10.1186/s12969-015-0021-0.
            http://www.ncbi.nlm.nih.gov/pubmed/26141717
          • Lochbühler N, Saurenmann RK, Müller L, Kellenberger CJ
            Magnetic Resonance Imaging Assessment of Temporomandibular Joint Involvement and Mandibular Growth Following Corticosteroid Injection in Juvenile Idiopathic Arthritis.
            J Rheumatol. 2015 Aug;42(8):1514-22. doi: 10.3899/jrheum.141502. Epub 2015 Jun 1.
            http://www.ncbi.nlm.nih.gov/pubmed/26034145
 
JUNIO 2015
          • Calvo I, Antón J, López Robledillo JC, de Inocencio J, Gamir ML, Merino R, Lacruz L, Camacho M, Rua MJ, Bustabad S, Díaz Cordovés-Rego G.
            Recomendaciones para el uso de metotrexato en pacientes con artritis idiopática juvenil.
            An Pediatr (Barc). 2015 Jun 12. pii: S1695-4033(15)00223-4. doi: 10.1016/j.anpedi.2015.05.005.
            http://www.ncbi.nlm.nih.gov/pubmed/26077957 
          • Mandl P, Navarro-Compán V, Terslev L, Aegerter P, van der Heijde D, D'Agostino MA, Baraliakos X, Pedersen SJ, Jurik AG, Naredo E, Schueller-Weidekamm C, Weber U, Wick MC, Bakker PA, Filippucci E, Conaghan PG, Rudwaleit M, Schett G, Sieper J, Tarp S, Marzo-Ortega H, Østergaard M.
            EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.
            Ann Rheum Dis. 2015 Jul;74(7):1327-1339. doi: 10.1136/annrheumdis-2014-206971.
            http://www.ncbi.nlm.nih.gov/pubmed/25837448
          • Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Boström C, van Eijk-Hustings Y, Gossec L, Korandová J, Mendes G, Niedermann K, Primdahl J, Stoffer M, Voshaar M, van Tubergen A.
            EULAR recommendations for patient education for people with inflammatory arthritis.
            Ann Rheum Dis. 2015 Jun;74(6):954-62. doi: 10.1136/annrheumdis-2014-206807.
            http://www.ncbi.nlm.nih.gov/pubmed/25735643
          • Otten MH, Anink J, Prince FH, Twilt M, Vastert SJ, Ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.
            Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
            Ann Rheum Dis. 2015 Jul;74(7):1379-86. doi: 10.1136/annrheumdis-2013-204641.
            http://www.ncbi.nlm.nih.gov/pubmed/24641940
          • Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D,Martini A, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG); Paediatric Rheumatology International Trials Organisation PRINTO and the Pediatric Rheumatology Collaborative Study Group PRCSG.
            Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
            Ann Rheum Dis. 2015 Jun;74(6):1110-7. doi: 10.1136/annrheumdis-2014-205351.
            http://www.ncbi.nlm.nih.gov/pubmed/24834925
          • Miller J, Ponsonby AL, Pezic A, Kemp A, Piper SE, Akikusa JD, Allen RC, Munro JE, Ellis JA
            Sibling Exposure and Risk of Juvenile Idiopathic Arthritis
            Arthritis Rheumatol. 2015 Jul;67(7):1951-8
            http://www.ncbi.nlm.nih.gov/pubmed/25809130
          • Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.
            Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
            Rheumatology (Oxford). 2015 Jul;54(7):1170-6. doi: 10.1093/rheumatology/keu457.
            http://www.ncbi.nlm.nih.gov/pubmed/25504896
          • Rasu RS, Cline SK, Shaw JW, Hayes O, Agbor Bawa W, Cifaldi MA.
            Impact of JIA on parents' work absences.
            Rheumatology (Oxford). 2015 Jul;54(7):1177-85. doi: 10.1093/rheumatology/keu414.
            http://www.ncbi.nlm.nih.gov/pubmed/25504895
          • Gmuca S, Weiss PF.
            Juvenile spondyloarthritis.
            Curr Opin Rheumatol. 2015 Jul;27(4):364-72. doi: 10.1097/BOR.0000000000000185.
            http://www.ncbi.nlm.nih.gov/pubmed/26002028
 
MAYO 2015
 
ABRIL 2015
          • Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
            Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
            Ann Rheum Dis. 2015 Apr 29. doi: 10.1136/annrheumdis-annrheumdis-2014-206747. 
            http://www.ncbi.nlm.nih.gov/pubmed/25926155
          • Martini G, Biscaro F, Boscaro E, Calabrese F, Lunardi F, Facco M, Agostini C, Zulian F, Fadini GP.
            Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
            BMC Musculoskelet Disord. 2015 Apr 30;16(1):103. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25925313
          •  Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.
            Efficacy and safety of etanercept in enthesitis-related arthritis juvenile idiopathic arthritis: Results from a phase 3 randomized double-blind study.
            Arthritis Rheumatol. 2015 Apr 17. doi: 10.1002/art.39145. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25891010
          •  Scardapane A, Ferrante R, Nozzi M, Savino A, Antonucci I, Dadorante V, Balsamo M, Stuppia L, Chiarelli F, Breda L.
            TNF-α gene polymorphisms and juvenile idiopathic arthritis: Influence on disease outcome and therapeutic response.
            Semin Arthritis Rheum. 2015 Feb 19. pii: S0049-0172(15)00013-X. doi: 10.1016/j.semarthrit.2015.02.003. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25837015
 
MARZO 2015
            • Miller J, Ponsonby AL, Pezic A, Kemp A, Piper SE, Akikusa JD, Allen RC, Munro JE, Ellis JA.
              Sibling exposure and risk of juvenile idiopathic arthritis in the ChiLdhood Arthritis Risk factor Identification sTudY (CLARITY).
              Arthritis Rheumatol. 2015 Mar 25. doi: 10.1002/art.39129. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25809130
            • Arvonen M, Virta LJ, Pokka T, Kröger L, Vähäsalo P.
              Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group's Greater Susceptibility to Infections?
              J Rheumatol. 2015 Mar;42(3):521-6. doi: 10.3899/jrheum.14034
              http://www.ncbi.nlm.nih.gov/pubmed/25320218
            • Chickermane PR, Khubchandani RP.
              Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
              Clin Exp Rheumatol. 2015 Feb 18. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25738527
            • Dijkstra ME, Anink J, van Pelt PA, Hazes JM, van Suijlekom-Smit LW.
              Patient-reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Manikin Format.
              J Rheumatol. 2015 Mar;42(3):527-33. doi: 10.3899/jrheum.140073.
              http://www.ncbi.nlm.nih.gov/pubmed/25433530
            • Mease P, Sieper J, Van den Bosch F, Rahman P, Karunaratne PM, Pangan AL.
              Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
              Arthritis Rheum 2015 Apr; 67(4):914-923. DOI: 10.1002/art.39008
              http://onlinelibrary.wiley.com/doi/10.1002/art.39008/epdf
            • Deodhar A, Braun J, Inman RD, van der Heijde D, Zhou Y, Xu S, Han C, Hsu B
              Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
              Ann Rheum Dis 2015;74:757-761. doi:10.1136/annrheumdis-2014-205862
              http://ard.bmj.com/content/74/4/757.full.pdf+html
            • Hermann G, Thon A, Mönkemöller K, Lilienthal E, Klinkert C, Holder M et al
              Comorbidity of Type 1 Diabetes and Juvenile Idiopathic Arthritis
              J Pediatr. 2015 Apr;166(4):930-935.e3. doi: 10.1016/j.jpeds.2014.12.026 
              http://www.ncbi.nlm.nih.gov/pubmed/25641245
            • Félicie Costantino F, Talpin A, Said-Naha R, Goldberg M, Henny J, Chiocchia G, Garchon HJ, Zins M, Breban M
              Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort
              Ann Rheum Dis 2015;74:689-693. doi:10.1136/annrheumdis-2013-204436
              http://ard.bmj.com/content/74/4/689.abstract
            • Howland S, Fisher K
              Looking through the patient lens - Improving best practice for young people with juvenile idiopathic arthritis transitioning into adult care.
              Springerplus. 2015 Mar 5;4:111
              http://www.ncbi.nlm.nih.gov/pubmed/25774337
            • Araujo GR, Fonseca JE, Fujimura PT, Cunha-Junior JP, Silva CH, Mourão AF, Canhão H, Goulart LR, Gonçalves J, Ueira-Vieira C.
              Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis.
              Immunol Lett. 2015 Mar 20. pii: S0165-2478(15)00041-3. doi: 10.1016/j.imlet.2015.03.006. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25800643
 
FEBRERO 2015
          • van Dijkhuizen EH, Bulatović Ćalasan M, Pluijm SM, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
            Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study.
            Pediatr Rheumatol Online J. 2015 Feb 18;13:5.
            http://www.ncbi.nlm.nih.gov/pubmed/25745368
          • Schenck S, Niewerth M, Sengler C, Trauzeddel R, Thon A, Minden K, Klotsche J.
            Prevalence of overweight in children and adolescents with juvenile idiopathic arthritis.
            Scand J Rheumatol. 2015 Mar 6:1-8.
            http://www.ncbi.nlm.nih.gov/pubmed/25742802
          • Chickermane PR, Khubchandani RP.
            Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
            Clin Exp Rheumatol. 2015 Feb 18.
            http://www.ncbi.nlm.nih.gov/pubmed/25738527
          • Aupiais C, Ilharreborde B, Doit C, Blachier A, Desmarest M, Job-Deslandre C, Mazda K, Faye A, Bonacorsi S, Alberti C, Lorrot M.
            Aetiology of arthritis in hospitalised children: an observational study.
            Arch Dis Child. 2015 Mar 2.
            http://www.ncbi.nlm.nih.gov/pubmed/25732253
          • Shady MM, Fathy HA, Ali A, Youness ER, Fathy GA.
            Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
            J Pediatr (Rio J). 2015 Feb 26.
            http://www.ncbi.nlm.nih.gov/pubmed/25727025
          • Rusak M, Radzikowska U, Glowinska-Olszewska B, Dobrenko E, Piotrowska-Jastrzebska J, Dabrowska M, Bodzenta-Lukaszyk A, Bossowski A, Moniuszko M.
            Endothelial progenitor cell levels in juvenile idiopathic arthritis patients; effects of anti-inflammatory therapies.
            Pediatr Rheumatol Online J. 2015 Feb 19;13:6.
            http://www.ncbi.nlm.nih.gov/pubmed/25705139 
          • Aguiar CL, Pan N, Adams A, Barinstein L, Lehman TJ.
            Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review.
            Clin Rheumatol. 2015 Feb 20.
            http://www.ncbi.nlm.nih.gov/pubmed/25697878 
          • Winsz-Szczotka K, Kuźnik-Trocha K, Komosińska-Vassev K, Wisowski G, Gruenpeter A, Lachór-Motyka I, Żegleń B, Lemski W, Olczyk K.
            Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis.
            Biochem Biophys Res Commun. 2015 Feb 13.
            http://www.ncbi.nlm.nih.gov/pubmed/25684189
          • Renton W1, Whitehead B.
            Myositis as a presenting feature of systemic onset juvenile idiopathic arthritis.
            J Paediatr Child Health. 2015 Feb;51(2):233.
            http://www.ncbi.nlm.nih.gov/pubmed/25677488
          • Young CM, Horst DM, Murakami JW, Shiels WE 2nd.
            Ultrasound-guided corticosteroid injection of the subtalar joint for treatment of juvenile idiopathic arthritis.
            Pediatr Radiol. 2015 Feb 12.
            http://www.ncbi.nlm.nih.gov/pubmed/25672519
          • Nimmrich S, Horneff G.
            Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
            Rheumatol Int. 2015 Mar;35(3):465-70.
            http://www.ncbi.nlm.nih.gov/pubmed/25583050
ENERO 2015
          • Wakil SM, Monies DM, Abouelhoda M, Al-Tassan N, Al-Dusery H, Naim EA, Al-Younes B, Shinwari J, Al-Mohanna FA, Meyer BF, Al-Mayouf S.
            Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis.
            Arthritis Rheumatol. 2015 Jan;67(1):288-95. doi: 10.1002/art.38877.
            http://www.ncbi.nlm.nih.gov/pubmed/25220867
          • Lianne Kearsley-Fleet, Kimme L Hyrich, Rebecca Davies, Mark Lunt, and  Taunton R Southwood on behalf of the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
            Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
            Rheumatology first published online January 30, 2015.
            doi:10.1093/rheumatology/keu489
            http://rheumatology.oxfordjournals.org/content/early/2015/01/29/rheumatology.keu489.abstract
          •  Ćalasan MB, den Boer E, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
            Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients.
            Ann Rheum Dis. 2015 Feb;74(2):402-7. doi: 10.1136/annrheumdis-2013-203723. Epub 2013 Nov 28.
            http://www.ncbi.nlm.nih.gov/pubmed/24288013
          •  Nimmrich S, Horneff G.
            Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
            Rheumatol Int. 2015 Jan 13. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25583050
 
DICIEMBRE 2014
          • Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C.
            Description of active joint count trajectories in juvenile idiopathic arthritis.
            J Rheumatol. 2014 Dec;41(12):2466-73. doi: 10.3899/jrheum.130835
            http://www.ncbi.nlm.nih.gov/pubmed/25274882
          • Aikawa NE, França IL, Ribeiro AC, Sallum AM, Bonfa E, Silva CA.
            Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
            Vaccine. 2014 Dec 29. pii: S0264-410X(14)01683-1. doi: 10.1016/j.vaccine.2014.12.030. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25554240 
          • Chiaroni-Clarke RC, Munro JE, Chavez RA, Pezic A, Allen RC, Akikusa JD, Piper SE, Saffery R, Ponsonby AL, Ellis JA.
            Independent confirmation of juvenile idiopathic arthritis genetic risk loci previously identified by immunochip array analysis.
            Pediatr Rheumatol Online J. 2014 Dec 16;12:53. doi: 10.1186/1546-0096-12-53
            http://www.ncbi.nlm.nih.gov/pubmed/25540605 
          • Lundbäck P, Stridh P, Klevenvall L, Jenkins R, Fischer M, Sundberg E, Andersson U, Antoine D, Harris HE.
            Characterization of the inflammatory properties of actively released HMGB1 in juvenile idiopathic arthritis.
            Antioxid Redox Signal. 2014 Dec 22 [Epub ahead of print].
            http://www.ncbi.nlm.nih.gov/pubmed/25532033
          • van Dijkhuizen EP, Wulffraat NM.
            Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
            Pediatr Rheumatol Online J. 2014 Dec 11;12:51. doi: 10.1186/1546-0096-12-51
            http://www.ncbi.nlm.nih.gov/pubmed/25525416
          • Brunner H, Lomax KG, Levy S.
            Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis: Comment on the article by Ilowite et al.
            Arthritis Rheumatol. 2014 Dec 15. doi: 10.1002/art.38992.
            http://www.ncbi.nlm.nih.gov/pubmed/25512026
          • Ilowite NT for the RAPPORT Investigators.
            Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis.
            Arthritis Rheumatol. 2014 Dec 15. doi: 10.1002/art.38991. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25511916
          • Lamot L, Borovecki F, Tambic Bukovac L, Vidovic M, Perica M, Gotovac K, Harjacek M.
            Aberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis.
            PLoS One. 2014 Dec 15;9(12):e115416.
            http://www.ncbi.nlm.nih.gov/pubmed/25506924
          • Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.
            Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
            Rheumatology (Oxford). 2014 Dec 10. pii: keu457. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25504896 
          • Rasu RS, Cline SK, Shaw JW, Hayes O, Agbor Bawa W, Cifaldi MA.
            Impact of JIA on parents' work absences.
            Rheumatology (Oxford). 2014 Dec 10. pii: keu414. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25504895
          • De Benedetti F1, Brunner H, Ruperto N, Schneider R, Xavier R, Allen R, Brown D, Chaitow J, Pardeo M, Espada G, Gerloni V, Myones B, Frane J, Wang J, Lipman TH, Bharucha KN, Martini A, Lovell D; the Paediatric Rheumatology International Trials Organisation (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG)
            Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: Results from the TENDER trial.
            Arthritis Rheumatol. 2014 Dec 10. doi: 10.1002/art.38984. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25504861
          • Salonen PH, Säilä H, Salonen JH, Vuorela M, Kautiainen H, Lyytikäinen O, Kauppi MJ, Leirisalo-Repo M, Repo H.
            Bloodstream infections among children with juvenile idiopathic arthritis: a prospective study from the onset of disease.
            Clin Exp Rheumatol. 2014 Nov-Dec;32(6):979-83.
            http://www.ncbi.nlm.nih.gov/pubmed/25436839
          • Bryan AR, Rabinovich CE.
            Enthesitis-related arthritis: time to re-define?
            Curr Rheumatol Rep. 2014 Dec;16(12):466.
            http://www.ncbi.nlm.nih.gov/pubmed/25366933 
          • Weiss JE, Luca NJ, Boneparth A, Stinson
            Assessment and management of pain in juvenile idiopathic arthritis.
            Paediatr Drugs. 2014 Dec;16(6):473-81.
            http://www.ncbi.nlm.nih.gov/pubmed/25331986
 
NOVIEMBRE 2014
          • Dijkstra ME, Anink J, van Pelt PA, Hazes JM, van Suijlekom-Smit LW.
            Patient-reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Manikin Format.
            J Rheumatol. 2014 Nov 29. pii: jrheum.140073. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25433530
          • Salem KM, Radhakrishnan A, Behrbalk E, Boszczyk BM.
            The surgical management of atlanto-axial subluxation in juvenile rheumatoid arthritis.
            Eur Spine J. 2014 Nov 27. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25427669
          • Schulert GS, Grom AA.
            Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies.
            Annu Rev Med. 2014 Nov 5. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25386930
          • van den Broek T, Hoppenreijs E, Meerding J, Scholman R, Otten HG, Swart JF, Martini A, Prakken B, de Jager W.
            Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis.
            Ann Rheum Dis. 2014 Nov 10. pii: annrheumdis-2014-206424. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25384964
          • Adunuri NR, Feldman BM.
            A critical appraisal of studies measuring Quality of Life in Juvenile Idiopathic Arthritis.
            Arthritis Care Res (Hoboken). 2014 Nov 10. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25384887
          • Rigante D, Bosco A, Esposito S.
            The Etiology of Juvenile Idiopathic Arthritis.
            Clin Rev Allergy Immunol. 2014 Nov 12. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25384710
          • Bryan AR, Rabinovich CE.
            Enthesitis-Related Arthritis: Time to Re-define?
            Curr Rheumatol Rep. 2014 Dec;16(12):466.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25366933
          • Consolaro A, Schiappapietra B, Dalprà S, Calandra S, Martini A, Ravelli A.
            Optimisation of disease assessments in juvenile idiopathic arthritis.
            Clin Exp Rheumatol. 2014 Nov-Dec;32 Suppl 85(5):126-130.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25365101
          • Shimizu M, Nakagishi Y, Yoshida A, Yachie A.
            Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis.
            J Rheumatol. 2014 Nov;41(11):2328-30.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25362722
          • Guzman J, Gómez-Ramírez O, Jurencak R, Shiff NJ, Berard RA, Duffy CM, Oen K, Petty RE, Benseler SM, Brant R, Tucker LB.
            What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
            J Rheumatol. 2014 Nov;41(11):2260-9.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25225279
          • Zhao Y, Wallace C.
            Judicious use of biologicals in juvenile idiopathic arthritis.
            Curr Rheumatol Rep. 2014 Nov;16(11):454.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25218736
          • Eng SW, Duong TT, Rosenberg AM, Morris Q, Yeung RS; REACCH OUT and BBOP Research Consortia.
            The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis.
            Arthritis Rheumatol. 2014 Dec;66(12):3463-75
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25200124
          • Funk RS, van Haandel L, Leeder JS, Becker ML.
            Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.
            Arthritis Rheumatol. 2014 Dec;66(12):3476-85.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25186097
          • Akioka S.
            Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis.
            Ann Rheum Dis. 2014 Dec;73(12):e75.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25165031
          • Schmeling H, Horneff G, Benseler SM, Fritzler MJ.
            Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
            Nat Rev Rheumatol. 2014 Nov;10(11):682-690.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25112604
          • Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.
            Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
            Arthritis Rheumatol. 2014 Nov;66(11):3160-9.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25077692
          • Esposito S, Corona F, Barzon L, Cuoco F, Squarzon L, Marcati G, Torcoletti M, Gambino M, Palù G, Principi N.
            Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis.
            Expert Rev Vaccines. 2014 Nov;13(11):1387-93.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25066387
          • Shimizu M, Ueno K, Ishikawa S, Tokuhisa Y, Inoue N, Yachie A.
            Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus.
            Rheumatology (Oxford). 2014 Nov;53(11):2120-2.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25065006
          • Weiss PF, Colbert RA, Xiao R, Feudtner C, Beukelman T, DeWitt EM, Pagnini I, Wright TB, Wallace CA.
            Development and retrospective validation of the juvenile spondyloarthritis disease activity index.
            Arthritis Care Res (Hoboken). 2014 Dec;66(12):1775-82.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=PMC4245319
          • Kaufman KM, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich  AH, Fall N, Harley JB, Nirmala NR, Grom AA.
            Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
            Arthritis Rheumatol. 2014 Dec;66(12):3486-95.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=25047945
          • Coulson EJ, Hanson HJ, Foster HE.
            What does an adult rheumatologist need to know about juvenile idiopathic arthritis?
            Rheumatology (Oxford). 2014 Dec;53(12):2155-2166.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=24987157
          • Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A.
            Defining criteria for disease activity States in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score.
            Arthritis Care Res (Hoboken). 2014 Nov;66(11):1703-9.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=24980508
          • Bechtold S, Simon D.
            Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.
            Rheumatol Int. 2014 Nov;34(11):1483-8.
            http://www.ncbi.nlm.nih.gov/pubmed/?term=24760485
OCTUBRE 2014
          • Grom AA.
            Canakinumab for the treatment of systemic juvenile idiopathic arthritis.
            Expert Rev Clin Immunol. 2014 Nov;10(11):1427-35. Epub 2014 Oct 1.
            http://www.ncbi.nlm.nih.gov/pubmed/25269376
          • Berard RA, Tomlinson G, Li X, Oen K, Rosenberg AM, Feldman BM, Yeung RS, Bombardier C.
            Description of Active Joint Count Trajectories in Juvenile Idiopathic Arthritis.
            J Rheumatol. 2014 Oct 1. pii: jrheum.130835. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25274882
          • Levy D.
            Trends in medication usage in juvenile idiopathic arthritis: prescribing trends or trends in prescribers?
            J Rheumatol. 2014 Oct;41(10):1903-5. doi: 10.3899/jrheum.140946. No abstract available.
            http://www.ncbi.nlm.nih.gov/pubmed/25275091
          • Brabnikova-Maresova K, Jarosova K, Pavelka K, Stepan JJ.
            Serum sclerostin in adult high-activity patients with juvenile idiopathic arthritis.
            Arthritis Res Ther. 2014 Oct 4;16(5):460. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25280749
          • Jadon D, Shaddick G, Jobling A, Ramanan AV, Sengupta R.
            Clinical outcomes and progression to orthopedic surgery in juvenile versus adult-onset ankylosing spondylitis.
            Arthritis Care Res (Hoboken). 2014 Oct 20. doi: 10.1002/acr.22500. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25331747
          • Selvaag AM, Aulie HA, Lilleby V, Flatø B.
            Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis.
            Ann Rheum Dis. 2014 Oct 31. pii: annrheumdis-2014-206034. doi: 10.1136/annrheumdis-2014-206034. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25362042
          • Weiss JE, Luca NJ, Boneparth A, Stinson J.
            Assessment and Management of Pain in Juvenile Idiopathic Arthritis.
            Paediatr Drugs. 2014 Oct 21. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25331986
          • Anjali Patwardhan, Michael Gardner , Bert Bachrach, Prasad Bichu, Timothy Joseph Hayes
            The Juvenile Idiopathic Arthritis Patients Run a Higher Risk for Dyslipidemia as Compared to Adults with Arthritis
            Ann Paediatr Rheum. 2014; 3(3): 116-125
            http://www.scopemed.org/?mno=160450
          • Anne M Selvaag1, Hanne A Aulie1, Vibke Lilleby1, Berit Flatø.
            Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis
            Ann Rheum Dis doi:10.1136/annrheumdis-2014-206034
            http://ard.bmj.com/content/early/2014/10/31/annrheumdis-2014-206034.abstract
          • Suzanne M.M. Verstappen, Joanna Cobb, Helen E Foster, Bo Fu, Eileen Baildam, Lucy R Wedderburn, Joyce E Davidson, John Ioannou, Alice Chieng, Kimme L Hyrich and Wendy Thomson
            Low socio-economic status is associated with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS)
            Accepted manuscript online: 3 SEP 2014 01:20PM EST | DOI: 10.1002/acr.22466
            http://onlinelibrary.wiley.com/doi/10.1002/acr.22466/abstract
          • Kati P. Markula-Patjas, Kaisa K. Ivaska, Minna Pekkinen, Sture Andersson, Eeva Moilanen, Heli T. Viljakainen, and Outi Mäkitie
            High Adiposity and Serum Leptin Accompanied by Altered Bone Turnover Markers in Severe Juvenile Idiopathic Arthritis
            J Rheumatol published online before print October 15, 2014, doi:10.3899/jrheum.131107
            http://jrheum.org/content/early/2014/10/08/jrheum.131107.abstract
          • Miika Arvonen, Lauri J. Virta, Tytti Pokka, Liisa Kröger, and Paula Vähäsalo
            Repeated Exposure to Antibiotics in Infancy: A Predisposing Factor for Juvenile Idiopathic Arthritis or a Sign of This Group’s Greater Susceptibility to Infections?
            J Rheumatol published online before print October 15, 2014, doi:10.3899/jrheum.140348
            http://jrheum.org/content/early/2014/10/08/jrheum.140348.abstract
          • Jaime Guzman, Oralia Gómez-Ramírez, Roman Jurencak, Natalie J. Shiff, Roberta A. Berard, Ciaran M. Duffy, Kiem Oen, Ross E. Petty, Susanne M. Benseler, Rollin Brant, and Lori B. Tucker
            What Matters Most for Patients, Parents, and Clinicians in the Course of Juvenile Idiopathic Arthritis? A Qualitative Study
            J Rheumatol November 2014 41(11):2260-2269; published online before print September 15, 2014, doi:10.3899/jrheum.131536
            http://jrheum.org/content/41/11/2260.abstract
          • Cartwright T, Fraser E, Edmunds S, Wilkinson N, Jacobs K.
            Journeys of adjustment: the experiences of adolescents living with juvenile idiopathic arthritis.
            Child Care Health Dev. 2014 Oct 6. doi: 10.1111/cch.12206. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25287720
SEPTIEMBRE 2014
          • Wallace CA, Ringold S, Bohnsack J, Spalding SJ, Brunner HI, Milojevic D, Schanberg LE, Higgins GC, O'Neil KM, Gottlieb BS, Hsu J, Punaro MG, Kimura Y, Hendrickson A.
            Extension Study of Participants from the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis.
            J Rheumatol. 2014 Sep 1. pii: jrheum.140347. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25179849
          • Chang CY, Meyer RM, Reiff AO.
            Impact of Medication Withdrawal Method on Flare-free Survival in Patients withJuvenile Idiopathic Arthritis on Combination Therapy.
            ArthritisCare Res(Hoboken).2014 Sep 12. doi:10.1002/acr.22477.[Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25220674
          • Cedströmer AL, Ahlqwist M, Andlin-Sobocki A, Berntson L, Hedenberg-Magnusson B, Dahlström L.
            Temporomandibular condylar alterations in juvenile idiopathic arthritis most common in longitudinally severe disease despite medical treatment.
            Pediatr Rheumatol Online J.2014 Sep 14;12(1):43.
            http://www.ncbi.nlm.nih.gov/pubmed/25249821
 
          • Kavanaugh A, McInnes IB, Mease P, Krueger GG, Gladman D, van der Heijde D, Zhou Y, Lu J, Leu JH, Goldstein N, Beutler A.
            Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).
            Ann Rheum Dis. 2014 Sep;73(9):1689-94. doi: 10.1136/annrheumdis-2013-204902.
            http://www.ncbi.nlm.nih.gov/pubmed/24748630
          • Munro J, Murray K, Boros C, Chaitow J, Allen RC, Akikusa J, Adib N, Piper SE, Singh-Grewal D; Australian Paediatric Rheumatology Group.
            Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis.
            J Paediatr Child Health. 2014 Sep;50(9):663-6. doi: 10.1111/jpc.12462
            http://www.ncbi.nlm.nih.gov/pubmed/25156704
          • Schmeling H1, Minden K, Foeldvari I, Ganser G, Hospach T, Horneff G.
            Efficacy and safety of Adalimumab as first and second used biologic agent in juvenile idiopathic arthritis - the German Biologics JIA Registry (BiKeR).
            Arthritis Rheumatol. 2014 Sep; 66(9):2580-2589.
            http://www.ncbi.nlm.nih.gov/pubmed/24942886
          • Ilowite NT, Prather K, Lokhnygina Y, Schanberg LE, Elder M, Milojevic D, Verbsky JW, Spalding SJ, Kimura Y, Imundo LF, Punaro MG, Sherry DD, Tarvin SE,Zemel LS, Birmingham JD, Gottlieb BS, Miller ML, O'Neil K, Ruth NM, Wallace CA, Singer NG, Sandborg CI.
            The randomized placebo phase study of rilonacept in the treatment of systemic juvenile idiopathic arthritis(RAPPORT).
            Arthritis Rheumatol. 2014 Sep; 66(9):2570-2579.
            http://www.ncbi.nlm.nih.gov/pubmed/24839206
          • Moncrieffe H1, Prahalad S, Thompson SD.
            Genetics of juvenile idiopathic arthritis: new tools bring new approaches.
            Curr Opin Rheumatol. 2014 Sep;26(5):579-84. 
            http://www.ncbi.nlm.nih.gov/pubmed/25010442
          • Nirmala N1, Grom A, Gram H.
            Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes.
            Curr Opin Rheumatol. 2014 Sep;26(5):543-52. 
            http://www.ncbi.nlm.nih.gov/pubmed/25050926
AGOSTO 2014
          • Murias S, Alcobendas R, Pascual-Salcedo D, Remesal A, Peralta J, Merino R.
            Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experience.
            Rheumatology (Oxford). 2014 Aug 7. pii: keu305. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25102859
          • Haverman L, van Oers HA, Maurice-Stam H, Kuijpers TW, Grootenhuis MA, van Rossum MA.
            Health related quality of life and parental perceptions of child vulnerability among parents of a child with juvenile idiopathic arthritis: results from a web-based survey.
            Pediatr Rheumatol Online J. 2014 Aug 7;12:34.
            http://www.ncbi.nlm.nih.gov/pubmed/25120411
          • Huynh D, Kavanaugh A
            Psoriatic arthritis: current therapy and future approaches.
            Rheumatology (Oxford). 2014 Aug 14. pii: keu237. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/25125588
          • Schmeling H, Horneff G, Benseler SM, Fritzler MJ.
            Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?
            Nat Rev Rheumatol. 2014 Aug 12. doi: 10.1038/nrrheum.2014.140.
            http://www.ncbi.nlm.nih.gov/pubmed/25112604
          • Albarouni M, Becker I, Horneff G.
            Predictors of response to methotrexate in juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2014 Aug 13;12:35. doi: 10.1186/1546-0096-12-35.
            http://www.ncbi.nlm.nih.gov/pubmed/25143761
          • Clin Rev Allergy Immunol. 2014 Aug 1. [Epub ahead of print]Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment.
            Foeldvari I.
            http://www.ncbi.nlm.nih.gov/pubmed/25081063
          • Rheumatol Int. 2014 Aug 3.
            Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age.
            Giménez-Roca C1, Iglesias E, Torrente-Segarra V, Bou R, Sánchez-Manubens J, Calzada-Hernández J, Hernández S, Ricart S, Antón J.
            http://www.ncbi.nlm.nih.gov/pubmed/25086629
          • J Rheumatol. 2014 Aug 1.
            Determinants of Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Idiopathic Arthritis.
            Stagi S, Bertini F, Cavalli L, Matucci-Cerinic M, Brandi ML, Falcini F.
            http://www.ncbi.nlm.nih.gov/pubmed/25086083
 
JULIO 2014
          • Koos B, Twilt M, Kyank U, Fischer-Brandies H, Gassling V, Tzaribachev N.
            Reliability of Clinical Symptoms in Diagnosing Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
            J Rheumatol. 2014 Jul 1. pii: jrheum.131337. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24986847
          • J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
            Female sex and oligoarthritis category are not risk factors for uveitis in italian children with juvenile idiopathic arthritis.
            Calandra S1, Gallo MC1, Consolaro A1, Pistorio A1, Lattanzi B1, Bovis F1, Muratore V1, De Marco R1, Martini A1, Ravelli A2.
            http://www.ncbi.nlm.nih.gov/pubmed/24931957
          • Coulson EJ1, Hanson HJ1, Foster HE2.
            What does an adult rheumatologist need to know about juvenile idiopathic arthritis?
            Rheumatology (Oxford). 2014 Jul 1. 
            http://www.ncbi.nlm.nih.gov/pubmed/24987157
          • Miyamae T1, Tanaka E, Kishi T, Matsuyama T, Igarashi T, Fujikawa S, Taniguchi A, Momohara S, Yamanaka H.
            Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
            Mod Rheumatol. 2014 Jul 14:1-5. 
            http://www.ncbi.nlm.nih.gov/pubmed/25019624
          • Davì S1, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite N, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA,Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM,Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology Collaborative Study Group; the Histiocyte Society.
            Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
            Arthritis Rheumatol. 2014 Jul 7. doi: 10.1002/art.38769. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25041889
          • Arthritis Rheumatol. 2014 Jul 21.
            Whole exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
            Kaufman KM1, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich A, Fall N, Harley JB, Nirmala NR, Grom AA.
            http://www.ncbi.nlm.nih.gov/pubmed/25047945
          • Weiss PF1, Colbert RA, Xiao R, Feudtner C, Beukelman T, Morgan DeWitt E, Pagnini I, Wright TB, Wallace CA.
            Development and retrospective validation of the juvenile spondyloarthritis disease activity (JSpADA) index.
            Arthritis Care Res (Hoboken). 2014 Jul 21. 
            http://www.ncbi.nlm.nih.gov/pubmed/25047959
          • Ahmed S1, Ali SR1, Ishaque S1, Sami N2
            Clinical and biochemical characteristics of children with juvenile idiopathic arthritis.
            J Coll Physicians Surg Pak. 2014 Jul;24(7):498-502. 
            http://www.ncbi.nlm.nih.gov/pubmed/25052974
          • Reinards TH1, Albers HM1, Brinkman DM2, Kamphuis SS3, van Rossum MA4, Girschick HJ5, Wouters C6, Hoppenreijs EP7, Saurenmann RK8, Hinks A9, Ellis JA10, Bakker E11, Verduijn W12, Slagboom P13, Huizinga TW14, Toes RE14, Houwing-Duistermaat JJ15, Ten Cate R1, Schilham MW16.
            CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis.
            Ann Rheum Dis. 2014 Jul 23. 
            http://www.ncbi.nlm.nih.gov/pubmed/25057181
          • Esposito S1, Corona F, Barzon L, Cuoco F, Squarzon L, Marcati G, Torcoletti M, Gambino M, Palù G, Principi N.
            Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis.
            Expert Rev Vaccines. 2014 Jul 28:1-7. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25066387
          • Lin C1, MacKenzie JD2, Courtier JL2, Gu JT2, Milojevic D3.
            Magnetic resonance imaging findings in juvenile spondyloarthropathy and effects of treatment observed on subsequent imaging.
            Pediatr Rheumatol Online J. 2014 Jul 11;12:25. doi: 10.1186/1546-0096-12-25. eCollection 2014.
            http://www.ncbi.nlm.nih.gov/pubmed/25067925
          • Moore TL1, Gillian BE, Crespo-Pagnussat S, Feller L, Chauhan AK.
            Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
            Clin Exp Rheumatol. 2014 Jul 17. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25068682
          • Minoia F1, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao Y, Huasong Z, Kitoh T, Avcin T,Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology 
            Collaborative Study Group, and the Histiocyte Society. 
            Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis A multinational, multicenter study of 362 patients.
            Arthritis Rheumatol. 2014 Jul 30. doi: 10.1002/art.38802. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/25077692
 
JUNIO 2014
          • Nigrovic PA.
            Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?
            Arthritis Rheumatol. 2014 Jun;66(6):1405-13
            http://www.ncbi.nlm.nih.gov/pubmed/24623686
          • Autmizguine J, Cohen-Wolkowiez M, Ilowite N, For The Rapport Investigators.
            Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.
            J Clin Pharmacol. 2014 Jul 30. doi: 10.1002/jcph.372. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/25079592
          • Consolaro A1, Negro G, Gallo MC, Bracciolini G, Ferrari C, Schiappapietra B, Pistorio A, Bovis F, Ruperto N, Martini A, Ravelli A.
            Defining criteria for disease activity states in non-systemic juvenile idiopathic arthritis based on a three-variable Juvenile Arthritis Disease Activity Score.
            Arthritis Care Res (Hoboken). 2014 Jun 30. doi: 10.1002/acr.22393. [Epub ahead of print]
          • Van Dijkhuizen EH1, Wulffraat NM2.
            Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.
            Ann Rheum Dis. 2014 Jun 24. pii: annrheumdis-2014-205265. doi: 10.1136/annrheumdis-2014-205265. [Epub ahead of print]
          • Liu YC, Tu YL, Wu RC, Huang JL, Yao TC
            Life-threatening pneumonitis complicating low-dose methotrexate treatment for juvenile idiopathic arthritis in a child
            Pediatr Emerg Care. 2014 Jun;30(6):415-7
            http://www.ncbi.nlm.nih.gov/pubmed/24892681
          • Lipstein EA, Dodds CM, Lovell DJ, Denson LA, Britto MT.
            Making decisions about chronic disease treatment: a comparison of parents and their adolescent children.
            Health Expect. 2014 Jun 3. doi: 10.1111/hex.12210. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24889468
          • Ritchlin CT.
            Psoriatic Enthesitis: An Update from the GRAPPA 2013 Annual Meeting.
            J Rheumatol. 2014 Jun;41(6):1220-3. doi: 10.3899/jrheum.140174.
            http://www.ncbi.nlm.nih.gov/pubmed/24882856
 
MAYO 2014
          • Ortop Traumatol Rehabil. 2014 May 7;16(2):185-95. doi: 10.5604/15093492.1105236.
            Physiotherapy in pauciarticular juvenile idiopathic arthritis. Case study.
            Zuk B1, Kaczor Z2, Zuk-Drążyk B3, Księżopolska-Orłowska K1.
            http://www.ncbi.nlm.nih.gov/pubmed/25041889
          • Sztajnbok F, Boechat NL, Ribeiro SB, Oliveira SK, Sztajnbok DC, Sant'Anna CC.
            Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis
            Pediatr Rheumatol Online J. 2014 May 22;12:17. doi: 10.1186/1546-0096-12-17
             
          • Stevens A, Meyer S, Hanson D, Clayton P, Donn RP.
            Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis
            Arthritis Res Ther. 2014 May 8;16(3):R109. doi: 10.1186/ar4559.
             
          • Sjakste T, Paramonova N, Rumba-Rozenfelde I, Trapina I, Sugoka O, Sjakste N.
            Juvenile Idiopathic Arthritis Subtype- and Sex-specific Associations with Genetic Variants in the PSMA6/PSMC6/PSMA3 Gene Cluster.
            Pediatr Neonatol. 2014 May 26. pii: S1875-9572(14)00063-1. doi: 10.1016/j.pedneo.2014.01.007. [Epub ahead of print]
             
          • Lotfy HM, Kandil ME, Issac MS, Salah S, Ismail NA, Abdel Mawla MA
            MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis.
            Mol Diagn Ther. 2014 May 27. [Epub ahead of print]
          • Bulatović Ćalasan M1, Wulffraat NM.
            Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.
            Expert Rev Clin Immunol. 2014 May 26:1-12. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/24857620
          • Berntson L.
            Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report.
            Clin Rheumatol. 2014 May 23. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/24852669
          • Guzman J1, Oen K2, Tucker LB1, Huber AM3, Shiff N4, Boire G5, Scuccimarri R6, Berard R7, Tse SM8, Morishita K1, Stringer E3, Johnson N9, Levy DM8, Duffy KW10, Cabral DA1, Rosenberg AM4, Larché M11, Dancey P12, Petty RE1, Laxer RM8, Silverman E8, Miettunen P9, Chetaille AL13, Haddad E14, Houghton K1,Spiegel L8, Turvey SE1, Schmeling H9, Lang B3, Ellsworth J15, Ramsey S3, Bruns A5, Campillo S6, Benseler S9, Chédeville G6, Schneider R8, Yeung R8, Duffy CM10; for the ReACCh-Out investigators.
            The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
            Ann Rheum Dis. 2014 May 19. pii: annrheumdis-2014-205372. doi: 10.1136/annrheumdis-2014-205372. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/24842571
          • Kaminiarczyk-Pyzalka D, Adamczak K, Mikos H, Klimecka I, Moczko J, Niedziela M.
            Serum TNF-alpha levels and indicators of disease activity in children with oligoarticular juvenile idiopathic arthritis(oJIA) in the first year of the disease.
            Clin Lab. 2014;60(5):799-807.
            http://www.ncbi.nlm.nih.gov/pubmed/24839823
          • Brunner HI1, Ruperto N2, Zuber Z3, Keane C4, Harari O4, Kenwright A4, Lu P5, Cuttica R6, Keltsev V7, Xavier RM8, Calvo I9, Nikishina I10, Rubio-Pérez N11,Alexeeva E12, Chasnyk V13, Horneff G14, Opoka-Winiarska V15, Quartier P16, Silva CA17, Silverman E18, Spindler A19, Baildam E20, Gámir ML21, Martin A22,Rietschel C23, Siri D24, Smolewska E25, Lovell D1, Martini A26, De Benedetti F27; for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).
            Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
            Ann Rheum Dis. 2014 May 16. pii: annrheumdis-2014-205351. doi: 10.1136/annrheumdis-2014-205351. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/24834925
          • Aoki C1, Inaba Y, Choe H, Kaneko U, Hara R, Miyamae T, Imagawa T, Mori M, Oba MS, Yokota S, Saito T.
            Discrepancy Between Clinical and Radiological Responses to Tocilizumab Treatment in Patients with Systemic-onset Juvenile Idiopathic Arthritis.
            J Rheumatol. 2014 May 1. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/24786929
          • Wallace CA1, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG,Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ.
            Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic ArthritisTreated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors.
            J Rheumatol. 2014 May 1. [Epub ahead of print]
            http://www.ncbi.nlm.nih.gov/pubmed/24786928
          • Jiang K1, Sawle AD, Frank MB, Chen Y, Wallace CA, Jarvis JN.
            Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis.
            Arthritis Rheumatol. 2014 May;66(5):1363-71. doi: 10.1002/art.38341.
            http://www.ncbi.nlm.nih.gov/pubmed/24782192
          • Brescia AC1, Simonds MM, McCahan SM, Fawcett PT, Rose CD.
            The Role of Transforming Growth Factor β Signaling in Fibroblast-like Synoviocytes From Patients With Oligoarticular Juvenile Idiopathic Arthritis: Dysregulation of Transforming Growth Factor β Signaling, Including Overexpression of Bone Morphogenetic Protein 4, May Lead to a Chondrocyte Phenotype and May Contribute to Bony Hypertrophy.
            Arthritis Rheumatol. 2014 May;66(5):1352-62. doi: 10.1002/art.38336.
            http://www.ncbi.nlm.nih.gov/pubmed/24782191
          • Leow OM, Lim LK, Ooi PL, Shek LP, Ang EY, Son MB1.
            Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital.
            Singapore Med J. 2014 May;55(5):248-52.
             
          • Lotfy HM1, Kandil ME, Issac MS, Salah S, Ismail NA, Abdel Mawla MA.
            MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis.
            Mol Diagn Ther. 2014 May 27. [Epub ahead of print]
 
ABRIL 2014
          • Fanaras N1, Parry NS2, Matthews NS3.
            Multidisciplinary Approach in the Management of Absolute Trismus With Bilateral Temporomandibular Joint Replacements for a Patient With Juvenile Idiopathic Arthritis.
            J Oral Maxillofac Surg. 2014 Apr 30. 
            http://www.ncbi.nlm.nih.gov/pubmed/25085804
          • Aulie HA1, Selvaag AM, Günther A, Lilleby V, Molberg O, Hartmann A, Holdaas H, Flatø B.
            Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis.
            Ann Rheum Dis. 2014 Apr 2. doi: 10.1136/annrheumdis-2013-204804. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24695010
          • Ana F. Mourão, Maria J. Santos, José Melo-Gomes, Fernando M. Martins, José A. Costa, Filipa Ramos, Iva Brito, Cátia Duarte, Ricardo Figueira, GuilhermeFigueiredo, Carolina Furtado, Ana Lopes, Margarida Oliveira, Ana Rodrigues, Manuel Salgado, Miguel Sousa, Jamie C. Branco, João E. Fonseca and Helena Canhão
            Using the Juvenile Arthritis Disease Activity Score Based on Erythrocyte Sedimentation Rate or C-Reactive Protein Level: Results From the Portuguese Register
            Arthritis Care Res.2014 Apr 66(4):585–591. doi: 10.1002/acr.22215
            http://onlinelibrary.wiley.com/doi/10.1002/acr.22215/abstract
          • Curr Rheumatol Rep. 2014 Apr;16(4):410. doi: 10.1007/s11926-014-0410-2.
            Importance of adherence in the outcome of juvenile idiopathic arthritis.
            Len CA, Miotto E Silva VB, Terreri MT.
            http://www.ncbi.nlm.nih.gov/pubmed/24504596
 
MARZO 2014
          • de Oliveira Sato J, Albuquerque Pedrosa Fernandes T, Bicalho do Nascimento C, Corrente JE, Saad-Magalhaes C.
            Probability of remission of juvenile idiopathic arthritis following treatment with steroid joint injection
            Clin Exp Rheumatol. 2014 Mar-Apr;32(2):291-6.
          • Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Perez N, Silva CA et al.
            A169: cumulative long-term safety, efficacy and patient-reported outcomes in children with juvenile idiopathic arthritis treated with intravenous abatacept: up to 7 years of treatment.
            Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S218-9. doi: 10.1002/art.38595.
          • Otten MH1, Anink J, Prince FH, Twilt M, Vastert SJ, Ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.
            Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
            Ann Rheum Dis. 2014 Mar 18.doi: 10.1136/annrheumdis-2013-204641. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24641940
          • Stagi S, Cavalli L, Signorini C, Bertini F, Cerinic MM, Brandi ML, Falcini F.
            Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone massdeterminants using dual energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography.
            Arthritis Res Ther. 2014 Mar 31;16(2):R83. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24684763
          • Ann Rheum Dis. 2014 Mar 1;73 Suppl 1:A95. doi: 10.1136/annrheumdis-2013-205124.220.
            Children with juvenile idiopathic arthritis (JIA): findings in videocapillaroscopy.
            Uceda J, Velloso ML, Martínez R, Marenco JL.
            http://www.ncbi.nlm.nih.gov/pubmed/24489354
          • J Rheumatol. 2014 Mar;41(3):547-53. doi: 10.3899/jrheum.130563. Epub 2014 Feb 1.
            Limitations in the Classification of Childhood-onset Rheumatoid Arthritis.
            Ferrell EG1, Ponder LA, Minor LS, Angeles-Han ST, Kennedy CW, Rouster-Stevens KA, Rohani-Pichavant M, Vogler LB, Prahalad S.
            http://www.ncbi.nlm.nih.gov/pubmed/24488421
          • Curr Rheumatol Rep. 2014 Mar;16(3):406. doi: 10.1007/s11926-013-0406-3.
            Current developments in the use of biomarkers for juvenile idiopathic arthritis.
            Duurland CL, Wedderburn LR.
            http://www.ncbi.nlm.nih.gov/pubmed/24445961
          • Duurland CL, Wedderburn LR.
            Current developments in the use of biomarkers for juvenile idiopathic arthritis.
            Curr Rheumatol Rep. 2014 Mar;16(3):406. doi: 10.1007/s11926-013-0406-3.
            http://www.ncbi.nlm.nih.gov/pubmed/24445961
          • Rheumatology (Oxford). 2014 Mar 4. [Epub ahead of print]Definition of improvement in juvenile idiopathic arthritis using the Juvenile Arthritis Disease Activity Score.
            Horneff G, Becker I.
            http://www.ncbi.nlm.nih.gov/pubmed/24599918
          • Rheumatology (Oxford). 2014 Mar 4. [Epub ahead of print]Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis.
            Geikowski T1, Becker I, Horneff G; on behalf of the German BIKER Registry Collaborative Study Group.
            http://www.ncbi.nlm.nih.gov/pubmed/24599916
FEBRERO 2014
          • J Foot Ankle Res. 2014 Feb 6;7(1):10. doi: 10.1186/1757-1146-7-10.
            An exploration of parents' preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment.
            Hendry GJ, Turner DE, Gardner-Medwin J, Lorgelly PK, Woodburn J.
            http://www.ncbi.nlm.nih.gov/pubmed/24502508
          • Clin Biochem. 2014 Feb 1. pii: S0009-9120(14)00055-1 [Epub ahead of print]Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis.
            Winsz-Szczotka K, Komosińska-Vassev K, Kuźnik-Trocha K, Gruenpeter A, Lachór-Motyka I, Olczyk K.
            http://www.ncbi.nlm.nih.gov/pubmed/24495859
          • Indian J Pediatr. 2014 Feb 5. [Epub ahead of print]Spirometric Evaluation in Juvenile Idiopathic Arthritis: Data from Eastern India.
            Alam MM1, Ray B, Sarkar S, Mandal O, Mondal R, Hazra A, Das NK.
            http://www.ncbi.nlm.nih.gov/pubmed/24493318
          • Nat Rev Rheumatol. 2014 Feb 4. doi: 10.1038/nrrheum.2014.4. [Epub ahead of print]Neural mechanisms underlying the pain of juvenile idiopathic arthritis.
            de Lalouvière LL, Ioannou Y, Fitzgerald M.
            http://www.ncbi.nlm.nih.gov/pubmed/24492386
          • Clin Exp Rheumatol. 2014 Feb 24. [Epub ahead of print]Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis.
            Satija M, Yadav TP, Sachdev N, Chhabra A, Jahan A, Dewan V.
            http://www.ncbi.nlm.nih.gov/pubmed/24564946
          • BMC Musculoskelet Disord. 2014 Feb 21;15(1):51. [Epub ahead of print]The association between lean mass and bone mineral content in the high disease activity group of adult patients with juvenile idiopathic arthritis.
            Brabnikova Maresova K, Jarosova K, Pavelka K, Stepan JJ.
            http://www.ncbi.nlm.nih.gov/pubmed/24558956
          • Autoimmunity. 2014 Feb 20. [Epub ahead of print]Genetic background of juvenile idiopathic arthritis.
            Chistiakov DA1, Savost'anov KV, Baranov AA.
            http://www.ncbi.nlm.nih.gov/pubmed/24555814
          • Clin J Pain. 2014 Feb 14. [Epub ahead of print]Comparison of Average Weekly Pain Using Recalled Paper and Momentary Assessment Electronic Diary Reports in Children with Arthritis.
            Stinson JN, Jibb LA, Lalloo C, Feldman BM, McGrath PJ, Petroz GC, Streiner D, Dupuis A, Gill N, Stevens BJ.
            http://www.ncbi.nlm.nih.gov/pubmed/24535055
          • Nurs Child Young People. 2014 Feb 11;26(1):26-9. doi: 10.7748/ncyp2014.02.26.1.26.e393.
            Juvenile idiopathic arthritis: updated guide to administering methotrexate
            Livermore P.
            http://www.ncbi.nlm.nih.gov/pubmed/24517621
          • Arthritis Rheumatol. 2014 Feb;66(2):470-8. doi: 10.1002/art.38245.
            The p38-Mediated Rapid Down-Regulation of Cell Surface gp130 Expression Impairs Interleukin-6 Signaling in the Synovial Fluid of Juvenile Idiopathic Arthritis Patients.
            Honke N, Ohl K, Wiener A, Bierwagen J, Peitz J, Di Fiore S, Fischer R, Wagner N, Wüller S, Tenbrock K.
            http://www.ncbi.nlm.nih.gov/pubmed/24504821
          • Arthritis Rheumatol. 2014 Feb;66(2):462-9. doi: 10.1002/art.38223.
            Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
            Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE.
            http://www.ncbi.nlm.nih.gov/pubmed/24504820
          • Klotsche J, Minden K, Thon A, Ganser G, Urban A, Horneff G.
            Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
            Arthritis Care Res (Hoboken). 2014 Feb;66(2):253-62. doi: 10.1002/acr.22112.
            http://www.ncbi.nlm.nih.gov/pubmed/23983081
          • Seid M, Huang B, Niehaus S, Brunner HI, Lovell DJ.
            Determinants of health-related quality of life in children newly diagnosed with juvenile idiopathic arthritis.
            Arthritis Care Res (Hoboken). 2014 Feb;66(2):263-9. doi: 10.1002/acr.22117.
            http://www.ncbi.nlm.nih.gov/pubmed/23983144
          • Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE.
            Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.
            Arthritis Rheumatol. 2014 Feb;66(2):462-9. doi: 10.1002/art.38223.
            http://www.ncbi.nlm.nih.gov/pubmed/24504820
          • Goulabchand R, Mouterde G, Barnetche T, Lukas C, Morel J, Combe B.
            Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.
            Ann Rheum Dis. 2014 Feb 1;73(2):414-9. doi: 10.1136/annrheumdis-2012-202641. Epub 2013 Jan 25.
            http://www.ncbi.nlm.nih.gov/pubmed/23355079
          • Bulatovic Calasan M, de Vries LD, Vastert SJ, Heijstek MW, Wulffraat NM.
            Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis.
            Rheumatology (Oxford). 2014 Feb;53(2):307-12. doi: 10.1093/rheumatology/ket310. Epub 2013 Oct 24.
            http://www.ncbi.nlm.nih.gov/pubmed/24162034
          • Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, Lindqvist URC.
            Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)
            Ann Rheum Dis 2014;73:407-413 doi:10.1136/annrheumdis-2012-201972
            http://ard.bmj.com/content/73/2/407.abstract
          • McInnes IB, Sieper J, Braun J, Emery P, van der Heijde D, Isaacs JD et al.
            Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
            Ann Rheum Dis 2014;73:349-356 Published Online First: 29 January 2013
            http://ard.bmj.com/content/73/2/349.abstract
          • Alcântara AC, Leite CA, Leite AC, Sidrim JJ, Silva FS Jr, Rocha FA.
            A Longterm Prospective Real-life Experience with Leflunomide in Juvenile Idiopathic Arthritis.
            J Rheumatol. 2014 Feb;41(2):338-44. doi: 10.3899/jrheum.130294. Epub 2013 Dec 15.
            http://www.ncbi.nlm.nih.gov/pubmed/24334641
          • Limenis E, Grosbein HA, Feldman BM.
            The relationship between physical activity levels and pain in children with juvenile idiopathic arthritis.
            J Rheumatol. 2014 Feb;41(2):345-51. doi: 10.3899/jrheum.130734. Epub 2013 Dec 15.
            http://www.ncbi.nlm.nih.gov/pubmed/24334648
ENERO 2014
          • Foeldvari I, Tzaribachev N, Cron RQ.
            Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2014 Jan 25;12(1):6. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24461073
          • Weiss PF, Chauvin NA, Klink AJ, Localio R, Feudtner C, Jaramillo D, Colbert RA, Sherry DD, Keren R.
            Detection of enthesitis in children with enthesitis-related arthritis: dolorimetry compared to ultrasonography.
            Arthritis Rheumatol. 2014 Jan; 66(1):218-27. doi: 10.1002/art.38197.
            http://www.ncbi.nlm.nih.gov/pubmed/24449586
          • Kostik MM, Smirnov AM, Demin GS, Scheplyagina LA, Larionova VI.
            Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism.
            Mol Biol Rep. 2014 Jan 12. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24415299
          • Finnegan S, Robson J, Scaife C, McAllister C, Pennington SR, Gibson DS, Rooney ME.
            Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease.
            Arthritis Res Ther. 2014 Jan 13;16(1):R8. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24410838
          • Poddubnyy D, Hermann KG, Callhoff J, Listing J, Sieper J.
            Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).
            Ann Rheum Dis. 2014 Jan 3. doi: 10.1136/annrheumdis-2013-204248. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24389297
          • Jiang K, Sawle AD, Frank MB, Chen Y, Wallace CA, Jarvis JN.
            Whole blood gene expression profiling predicts therapeutic response in polyarticular juvenile idiopathic arthritis at 6 months.
            Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38341. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24402890
          • Hugle B, Burgos-Vargas R, Inman RD, O'Shea F, Laxer RM, Stimec J, Whitney-Mahoney K, Duvnjak M, Anderson M, Tse SM.
            Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.
            Clin Exp Rheumatol. 2014 Jan 3. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24387974
          • Pastore S, Gortani G, Taddio A, Barbi E.
            Procedural sedation for intra-articular corticosteroid injections in juvenile idiopathic arthritis (JIA) should be a standard of care.
            Eur J Pediatr. 2014 Jan 3. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24384792
          • Armbrust W, Kaak JG, Bouma J, Lelieveld OT, Wulffraat NM, Sauer PJ, van Sonderen E.
            Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.
            Pediatr Rheumatol Online J. 2013 Dec 24;11(1):48. doi: 10.1186/1546-0096-11-48.
            http://www.ncbi.nlm.nih.gov/pubmed/24368009
          • Albers HM, Reinards TH, Brinkman DM, Kamphuis SS, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Bakker E, Verduijn W, Slagboom P, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ten Cate R, Schilham MW.
            Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.
            Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204466. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24347572
 
DICIEMBRE 2013
          • Armbrust W, Kaak JG, Bouma J, Lelieveld OT, Wulffraat NM, Sauer PJ, van Sonderen E.
            Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.
            Pediatr Rheumatol Online J. 2013 Dec 24;11(1):48. doi: 10.1186/1546-0096-11-48.
            http://www.ncbi.nlm.nih.gov/pubmed/24368009
          • Albers HM, Reinards TH, Brinkman DM, Kamphuis SS, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Bakker E, Verduijn W, Slagboom P, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ten Cate R, Schilham MW.
            Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.
            Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204466. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24347572
          • Vastert SJ, de Jager W, Noordman BJ, Holzinger D, Kuis W, Prakken BJ, Wulffraat NM.
            Effectiveness of first line use of recombinant IL-1RA treatment in steroid naïve systemic juvenile idiopathic arthritis: Results of a prospective cohort study.
            Arthritis Rheum. 2013 Dec 18. doi: 10.1002/art.38296. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24352936
          • Consolaro A, Ruperto N, Bracciolini G, Frisina A, Gallo MC, Pistorio A, Verazza S, Negro G, Gerloni V, Goldenstein-Schainberg C, Sztajnbok F, Wulffraat NM,Martini A, Ravelli A; for the Paediatric Rheumatology International Trials Organization (PRINTO).
            Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score.
            Ann Rheum Dis. 2013 Dec 17. doi: 10.1136/annrheumdis-2013-204186. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24347571
          • Rothmund F, Gerss J, Ruperto N, Däbritz J, Wittkowski H, Frosch M, Wulffraat NM, Wedderburn LR, Holzinger D, Gohar F, Vastert SJ, Brik R, Deslandre CJ,Melo-Gomes JA, Magalhães CS, Barcellona R, Russo R, Gattorno M, Martini A, Roth J, Foell D; for the Paediatric Rheumatology International Trials Organization (PRINTO).
            Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis.
            Arthritis Care Res (Hoboken). 2013 Dec 10. doi: 10.1002/acr.22248. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24339418
          • Ringold S, Weiss PF, Colbert RA, Dewitt EM, Lee T, Onel K, Prahalad S, Schneider R, Shenoi S, Vehe RK, Kimura Y; for the Juvenile Idiopathic Arthritis Research Committee of the Children's Arthritis and Rheumatology Research Alliance (CARRA).
            Childhood arthritis and rheumatology research alliance consensus treatment plans for new onset polyarticular juvenile idiopathic arthritis.
            Arthritis Care Res (Hoboken). 2013 Dec 10. doi: 10.1002/acr.22259. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24339215
          • Uettwiller F, Perlbarg J, Pinto G, Bader-Meunier B, Mouy R, Compeyrot-Lacassagne S, Melki I, Wouters C, Prieur AM, Landais P, Polak M, Quartier P.
            Effect of Biologic Treatments on Growth in Children with Juvenile Idiopathic Arthritis.
            J Rheumatol. 2013 Dec 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24293576
          • Shafferman A, Fontaine KR, Cron RQ, Beukelman T.
            Changes in Body Mass Index in Children with Juvenile Idiopathic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
            J Rheumatol. 2013 Dec 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24293573
 
NOVIEMBRE 2013
          • McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich KL.
            Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis.
            Rheumatology (Oxford). 2013 Nov;52(11):1941-51. doi: 10.1093/rheumatology/ket150
            http://www.ncbi.nlm.nih.gov/pubmed/23630368
          • Zhou J, Tang X, Ding Y, An Y, Zhao X.
            Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.
            Pediatr Allergy Immunol. 2013 Nov;24(7):691-6.
            http://www.ncbi.nlm.nih.gov/pubmed/24112428
 
OCTUBRE 2013
          • Mawani N, Amine B, Rostom S, El Badri D, Ezzahri M, Moussa F, Shyen S, Gueddari S, Wabi M, Shkirat B, Hassouni NH.
            Moroccan parents caring for children with juvenile idiopathic arthritis: positive and negative aspects of their experiences.
            Pediatr Rheumatol Online J. 2013 Oct 20;11(1):39. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24138932
          • Goodman SB, Hwang K, Imrie S.
            High Complication Rate in Revision Total Hip Arthroplasty in Juvenile Idiopathic Arthritis.
            Clin Orthop Relat Res. 2013 Oct 18. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24136805
          • Shyen S, Amine B, Rostom S, El Badri D, Ezzahri M, Mawani N, Moussa F, Gueddari S, Wabi M, Abouqal R, Chkirate B, Hajjaj-Hassouni N.
            Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis.
            Clin Rheumatol. 2013 Oct 19. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24135889
          • Cedströmer AL, Andlin-Sobocki A, Berntson L, Hedenberg-Magnusson B, Dahlström L.
            Temporomandibular signs, symptoms, joint alterations and disease activity in juvenile idiopathic arthritis -- an observational study.
            Pediatr Rheumatol Online J. 2013 Oct 17;11(1):37. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24134193
          • Pelegrín L, Casaroli-Marano R, Antón J, Carmen García de Vicuña M, Molina-Prat N, Ignacio Aróstegui J, Yagüe J, Ríos J, Adán A.
            Predictive Value of Selected Biomarkers, Polymorphisms, and Clinical Features for Oligoarticular Juvenile Idiopathic Arthritis-associated Uveitis.
            Ocul Immunol Inflamm. 2013 Oct 16. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24131380
 
SEPTIEMBRE 2013
          • Castillo-Gallego C, Aydin SZ, Emery P, McGonagle DG, Marzo-Ortega H.
            Magnetic Resonance Imaging Assessment of Axial Psoriatic Arthritis: Extent of Disease Relates to HLA–B27.
            Arthritis Rheum 2013 Sep;65(9):2274-8.
            http://onlinelibrary.wiley.com/doi/10.1002/art.38050/abstract
          • Ringold S, Weiss PF, Beukelman T, Dewitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK.
            2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications.
            Arthritis Rheum. 2013 Oct;65(10):2499-2512  doi: 10.1002/art.38092.
            http://www.ncbi.nlm.nih.gov/pubmed/24092554
 
AGOSTO 2013
          • Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML.
            High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis
            J Rheumatol. 2013 Aug 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23950184
 
JULIO 2013
          • Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius A, Sundberg E, Erlandsson Harris H.
            HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration.
            J Rheumatol. 2013 Jul 15. [Epub ahead of print]
          • Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, Hirsch R.
            Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.
            J Rheumatol. 2013 Jul;40(7):1191-9. doi: 10.3899/jrheum.121131. Epub 2013 May 15.
          • Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, Bohm M, Nieto-Gonzalez JC, Pistorio A, Lanni S, Consolaro A, Martini A, Ravelli A.
            Delineating the role of multiple intra-articular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era.
            Arthritis Care Res (Hoboken). 2013 Jul;65 (7):1112-20. doi: 10.1002/acr.21947.
 
JUNIO 2013
          • Anink J, Otten MH, Gorter SL, Prince FH, van Rossum MA, van den Berg JM, van Pelt PA, Kamphuis S, Brinkman DM, Swen WA, Swart JF, Wulffraat NM, Dolman KM, Koopman-Keemink Y, Hoppenreijs EP, Armbrust W, Ten Cate R, van Suijlekom-Smit LW.
            Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?
            Rheumatology (Oxford). 2013 Jun 4. [Epub ahead of print]
          • Hinks A, Cobb J, Marion MC, et al.
            Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.
            Nat Genet. 2013 Jun;45(6):664-9. doi: 10.1038/ng.2614.
 
MAYO 2013
          • Otten MH, Prince FH, Anink J, Ten Cate R, Hoppenreijs EP, Armbrust W, Koopman-Keemink Y, van Pelt PA, Kamphuis S, Gorter SL,Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.
            Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.
            Ann Rheum Dis. 2013 May;72(5):721-7. doi: 10.1136/annrheumdis-2011-201060. Epub 2012 Jun 23.
            http://www.ncbi.nlm.nih.gov/pubmed/22730374
          • Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, Dolezalova P, Job-Deslandre C, Wulffraat N, Alvarez D, Zang C, Wajdula J, Woodworth D, Vlahos B, Martini A, Ruperto N; for the Paediatric Rheumatology International Trials Organisation (PRINTO).
            Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: Part 1 (week 12) of the CLIPPER study.
            Ann Rheum Dis. 2013 May 21. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/ 23696632
          • Pelajo CF, Angeles-Han ST, Prahalad S, Sgarlat CM, Davis TE, Miller LC, Lopez-Benitez JM.
            Evaluation of the association between Hispanic ethnicity and disease activity and severity in a large cohort of patients with juvenile idiopathic arthritis.
            Rheumatol Int. 2013 May 10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/23660749
          • Saha A, Chopra Y, Theis JD, Vrana JA, Sethi S.
            AA Amyloidosis Associated With Systemic-Onset Juvenile Idiopathic Arthritis.
            Am J Kidney Dis. 2013 May 9. pii: S0272-6386 (13) 00675-6.
            doi: 10.1053/j.ajkd.2013.02.377. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23664546
          • Dey S, Jahan A, Yadav TP, Bhagwani DK, Sachdev N.
            Measurement of Bone Mineral Density by Dual Energy X-ray Absorptiometry in Juvenile Idiopathic Arthritis.
            Indian J Pediatr. 2013 May 4. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/23645223
          • Leegaard A, Lomholt JJ, Thastum M, Herlin T.
            Decreased Pain Threshold in Juvenile Idiopathic Arthritis: A Cross-sectional Study.
            J Rheumatol. 2013 May 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23637324
          • Berntson L, Nordal E, Aalto K, Peltoniemi S, Herlin T, Zak M, Nielsen S, Rygg M; for the Nordic Study Group of Paediatric Rheumatology.
            HLA-B27 Predicts a More Chronic Disease Course in an 8-year Followup Cohort of Patients with Juvenile Idiopathic Arthritis.
            J Rheumatol 2013 May;40(5):725-731.
            http://www.ncbi.nlm.nih.gov/pubmed/23547219
          • Lomholt JJ, Thastum M, Herlin T.
            Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment.
            Pediatr Rheumatol Online J. 2013 May 6;11(1):21. doi: 10.1186/1546-0096-11-21.
            http://www.ncbi.nlm.nih.gov/pubmed/23641813
          • Kröger L, Piippo-Savolainen E, Tyrväinen E, Penttilä P, Kröger H.
            Osteochondral lesions in children with juvenile idiopathic arthritis.
            Pediatr Rheumatol Online J. 2013 May 1;11(1):18. doi: 10.1186/1546-0096-11-18.
            http://www.ncbi.nlm.nih.gov/pubmed/23634779
          • Kimura Y, Weiss JE, Haroldson KL et al.
            Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis†
            Arthritis Care Res (Hoboken). 2013 May; 65:745-52.
            http://onlinelibrary.wiley.com/doi/10.1002/acr.21889/abstract
          • Hurd A, Beukelman T.
            Infectious complications in juvenile idiopathic arthritis.
            Curr Rheumatol Rep. 2013 May;15:327. doi: 10.1007/s11926-013-0327-1.
            http://www.ncbi.nlm.nih.gov/pubmed/23529583
          • Tuompo R, Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M.
            Reactive arthritis following Salmonella infection: a population-based study.
            Scand J Rheumatol. 2013 May;42(3):196-202. doi: 10.3109/03009742.2012.739201.
          • Bertilsson L, Andersson-Gäre B, Fasth A, Petersson IF, Forsblad-d'Elia H.
            Disease Course, Outcome, and Predictors of Outcome in a Population-based Juvenile Chronic Arthritis Cohort Followed for 17 Years.
            J Rheumatol. 2013 May;40(5):715-24. doi: 10.3899/jrheum.120602.
ABRIL 2013
          • Moncrieffe H, Ursu S, Holzinger D, Patrick F, Kassoumeri L, Wade A, Roth J, Wedderburn LR.
            A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein
            Rheumatology (Oxford). 2013 Apr 25. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23620557
          • Collado P, Naredo E, Calvo C, Gamir ML, Calvo I, García ML, Merino R, Graña J, Bustabab S, Garrido J; on behalf of the ECO-JIA Study Group.
            Reduced joint assessment vs comprehensive assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis.
            Rheumatology (Oxford). 2013 Apr 25. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23620551
          • Prince FH, van Suijlekom-Smit LW.
            Cost of Biologics in the Treatment of Juvenile Idiopathic Arthritis: A Factor not to be Overlooked.
            Paediatr Drugs. 2013 Apr 21. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23606042
          • Hinks A, Cobb J, Marion MC et al.
            Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.
            Nat Genet. 2013 Apr 21. doi: 10.1038/ng.2614. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23603761
          • Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ.
            Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009.
            J Rheumatol. 2013 Apr 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23588938
          • Ishikawa S, Shimizu M, Ueno K, Sugimoto N, Yachie A.
            Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
            Cytokine. 2013 Apr 3. pii: S1043-4666(13)00109-9. doi: 10.1016/j.cyto.2013.03.007. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23561929
          • Anink J, Otten MH, Prince FH, Hoppenreijs EP, Wulffraat NM, Swart JF, Ten Cate R, van Rossum MA, van den Berg JM, Dolman KM, Koopman-Keemink Y, Armbrust W, Kamphuis S, van Pelt PA, Gorter SL, van Suijlekom-Smit LW.
            Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
            Rheumatology (Oxford). 2013 Apr;52(4):712-7. doi: 10.1093/rheumatology/kes373. Epub 2012 Dec 24.
            http://www.ncbi.nlm.nih.gov/pubmed/23267169
          • De Sanctis S, Marcovecchio ML, Gaspari S, Del Torto M, Mohn A, Chiarelli F, Breda L.
            Etanercept Improves Lipid Profile and Oxidative Stress Measures in Patients with Juvenile Idiopathic Arthritis.
            J Rheumatol. 2013 Apr 1. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23547210
          • Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP.
            Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
            Ann Rheum Dis. 2013 Apr;72(4):517-24. doi: 10.1136/annrheumdis-2011-201244. Epub 2012 May 5.
            http://www.ncbi.nlm.nih.gov/pubmed/22562972
 
MARZO 2013
          • Głowińska-Olszewska B, Bossowski A, Dobreńko E, Hryniewicz A, Konstantynowicz J, Milewski R, Luczyński W, Piotrowska-Jastrzębska J, Kowal-Bielecka O.
            Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis.
            Mediators Inflamm. 2013;2013:436702. doi: 10.1155/2013/436702. Epub 2013 Mar 11.
            http://www.ncbi.nlm.nih.gov/pubmed/23554546
          • Butbul Aviel Y, Tyrrell P, Schneider R, Dhillon S, Feldman BM, Laxer R, Saurenmann RK, Spiegel L, Cameron B, Tse SM, Silverman E.
            Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?
            Pediatr Rheumatol Online J. 2013 Mar 15;11:11. doi: 10.1186/1546-0096-11-11.
            http://www.ncbi.nlm.nih.gov/pubmed/23497068
          • Coulson EJ, Ng WF, Goff I, Foster HE.
            Cardiovascular risk in juvenile idiopathic arthritis.
            Rheumatology (Oxford). 2013 Mar 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23502074
          • Stoll ML, Morlandt AB, Teerawattanapong S, Young D, Waite PD, Cron RQ.
            Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: a retrospective study.
            Rheumatology (Oxford). 2013 Mar;52(3):554-9. doi: 10.1093/rheumatology/kes318. Epub 2012 Dec 5.
            http://rheumatology.oxfordjournals.org/content/52/3/554.full.pdf+html
 
FEBRERO 2013
          • Solari N, Palmisani E, Consolaro A, Pistorio A, Viola S, Buoncompagni A, Gattorno M, Picco P, Ruperto N, Malattia C, Martini A, Ravelli A.
            Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept.
            J Rheumatol. 2013 Feb;40(2):192-200. doi: 10.3899/jrheum.120842. Epub 2012 Dec 1.
            http://www.ncbi.nlm.nih.gov/pubmed/23204218
 
ENERO 2013
          • Ungar WJ, Costa V, Burnett HF, Feldman BM, Laxer RM.
            The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: A systematic review.Semin Arthritis Rheum. 2013 Jan 18. pii: S0049-0172(12)00263-6. doi: 10.1016/j.semarthrit. 2012.10.006. [Epub ahead of print]
          • Russo RA, Katsicas MM.
            Patients with Very Early-onset Systemic Juvenile Idiopathic Arthritis Exhibit More Inflammatory Features and a Worse Outcome.
            J Rheumatol 2013 Jan 15. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23322471
 
DICIEMBRE 2012
          • De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell DJ, and Martini A, for the PRINTO and PRCSG.
            Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis.
            N Engl J Med 2012; 367:2385-2395. December 20, 2012 DOI: 10.1056/NEJMoa1112802
          • Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A and Lovell DJ, M.D., M.P.H. fo rthe PRINTO and PRCSG.
            Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
            N Engl J Med 2012; 367:2396-2406. December 20, 2012 DOI: 10.1056/NEJMoa1205099
NOVIEMBRE 2012
          • Otten MH, Anink J,Spronk S,van Suijlekom-Smit LW.
            Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
            Ann Rheum Dis 2012 Nov 21. [Epub ahead of print]
SEPTIEMBRE 2012
          • Stoll ML, Sharpe T, Beukelman T, Good J, Young D, Cron RQ.
            Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
            J Rheumatol 2012 Sep;39(9):1880-7. doi: 10.3899/jrheum.111441. Epub 2012 May 15.
            http://www.ncbi.nlm.nih.gov/pubmed/22589268
          • Burnett HF, Regier DA, Feldman BM, Miller FA, Ungar WJ.
            Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.
            Arthritis Care Res (Hoboken). 2012 Sep;64(9):1382-91. doi: 10.1002/acr.21698.
            http://www.ncbi.nlm.nih.gov/pubmed/22504893
          • Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ.
            Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.
            Arthritis Care Res (Hoboken). 2012 Sep;64(9):1357-64. doi: 10.1002/acr.21709.
            http://www.ncbi.nlm.nih.gov/pubmed/22511558
          • Klein A, Kaul I, Foeldvari I, Ganser G, Urban A, Horneff G.
            Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry.
            Arthritis Care Res (Hoboken). 2012 Sep;64(9):1349-56. doi: 10.1002/acr.21697
            http://www.ncbi.nlm.nih.gov/pubmed/22649024
 
JULIO 2012
          • DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, Schneider R, Stoll ML, Angeles-Han S, Milojevic D, Schikler KN, Vehe RK, Weiss JE, Weiss P, Ilowite NT, Wallace CA; Juvenile Idiopathic Arthritis Disease-specific Research Committee of Childhood Arthritis Rheumatology and Research Alliance.
            Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.
            Arthritis Care Res (Hoboken). 2012 Jul;64(7):1001-10. doi: 10.1002/acr.21625.
            http://www.ncbi.nlm.nih.gov/pubmed/22290637
 
JUNIO 2012
          • Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic D, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Hamilton S, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance.
            Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
            Arthritis Rheum. 2012 Jun;64(6):2012-21. doi: 10.1002/art.34343. Epub 2011 Dec 19.
            http://www.ncbi.nlm.nih.gov/pubmed/22183975
 
ABRIL 2012
          • Furst DE, Keystone EC, Braun J, Breedveld FC, Burmester GR, De Benedetti F, Dörner T, Emery P, Fleischmann R, Gibofsky A, Kalden JR, Kavanaugh A, Kirkham B, Mease P, Sieper J, Singer NG, Smolen JS, Van Riel PL, Weisman MH, Winthrop K.
            Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
            Ann Rheum Dis. 2012 Apr;71 Suppl 2:i2-45.
            http://www.ncbi.nlm.nih.gov/pubmed/22460137
FEBRERO 2012
          • Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M, Ganser G, Heiligenhaus A, Horneff G, Illhardt A, Kopp I, Krauspe R, Markus B, Michels H, Schneider M, Singendonk W, Sitter H, Spamer M, Wagner N, Niehues T.
            Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis.
            Clin Immunol. 2012 Feb;142(2):176-93. Epub 2011 Oct 26.
            http://www.ncbi.nlm.nih.gov/pubmed/22154868
 
 
 
 

Autmizguine J, Cohen-Wolkowiez M, Ilowite N, For The Rapport Investigators.

Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.

J Clin Pharmacol. 2014 Jul 30. doi: 10.1002/jcph.372. [Epub ahead of print]

http://www.ncbi.nlm.nih.gov/pubmed/25079592

 
 
 
PATROCINADORES
abbvie kisspng-logo-novartis-healthcare-private-limited-brand-nov-zpsob-platby-ix-bilaterln-esko-slovensk-5b68603aa47fe12537627915335670346738 sobi